data_2oqs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2oqs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 306' ' ' VAL . 5.6 mp . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 110.392 -0.225 . . . . 6.06 110.392 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.81 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 2.33 110.733 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 1.1 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.418 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.45 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.726 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.33 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.724 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.37 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 2.32 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 3.33 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.9 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 2.15 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.92 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.726 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.1 t60 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.98 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.96 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 1.27 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.54 111.849 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.77 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.724 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 1.46 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 2.17 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.401 HG22 HD23 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 1.26 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.513 HG22 ' HG2' ' B' ' 303' ' ' GLU . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.98 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 3.18 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.87 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 2.18 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 3.27 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.45 111.694 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 2.06 111.051 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.74 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 3.21 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 3.17 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 6.21 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 2.04 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.62 110.098 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 3.13 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.22 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.81 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 2.31 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 2.39 109.532 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 1.25 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 2.12 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 2.05 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.84 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 1.23 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 1.12 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.582 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 2.37 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 1.37 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.88 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 20.2 t60 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.61 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 1.28 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 1.21 111.371 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 1.27 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 1.15 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 2.34 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.94 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.95 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 3.13 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.89 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 2.61 110.452 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 2.07 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 2.47 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 2.0 111.784 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 2.19 109.536 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.838 0.351 . . . . 4.18 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.513 ' HG2' HG22 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.401 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 1.23 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.97 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 12' ' ' LEU . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 81.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 6.06 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.81 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 2.33 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 1.1 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 HG11 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 1.45 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.675 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.33 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.66 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.37 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 2.32 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 3.33 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.9 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 2.15 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.92 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.98 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.96 111.296 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 1.27 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.54 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.77 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.66 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 1.46 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 2.17 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 1.26 110.205 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.495 HG21 ' CG ' ' B' ' 303' ' ' GLU . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.98 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 3.18 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.87 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 2.18 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.45 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 2.06 111.053 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.74 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 3.21 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 3.17 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 6.21 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 2.04 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.62 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 3.13 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.22 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.665 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.81 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 2.31 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 2.39 109.924 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 1.25 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' HD22 ' A' ' 62' ' ' LEU . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 2.12 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 53.1 m-80 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 2.05 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.84 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 60' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 1.23 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 1.12 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 2.37 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 1.37 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.88 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.61 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 1.28 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.545 HG13 HG13 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 1.21 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 1.27 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 1.15 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 2.34 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.94 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.95 112.269 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 3.13 110.678 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.89 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 2.61 110.13 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 2.07 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 2.47 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 2.0 110.795 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.9 mmmt . . . . . 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 2.19 110.55 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.464 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 32.2 ttm180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.776 0.322 . . . . 4.18 110.816 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.495 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.441 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 1.23 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.97 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.545 HG13 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.589 0.233 . . . . 6.06 111.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.81 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 2.33 110.249 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 1.1 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.587 HD13 ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 1.45 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.707 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.33 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.622 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.37 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 2.32 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 3.33 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.9 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.5 p-10 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 2.15 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.92 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.707 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 61.8 t60 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.98 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.474 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 1.27 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.54 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.77 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 1.46 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 2.17 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 1.26 109.708 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.479 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.98 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 3.18 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.87 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 2.18 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 3.27 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.45 111.966 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 2.06 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.74 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 3.21 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 3.17 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 6.21 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 2.04 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.62 110.127 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 3.13 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.22 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.81 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 2.31 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 2.39 110.254 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 1.25 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 62' ' ' LEU . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 2.12 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 2.05 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.84 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 60' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 1.23 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 1.12 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 2.37 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.624 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 1.37 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.88 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.651 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.61 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 1.28 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 1.21 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 1.27 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 1.15 112.049 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.73 ' CD1' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 2.34 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.94 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.95 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 3.13 111.473 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.89 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 2.61 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 2.07 109.972 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 2.47 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 2.0 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 2.19 109.773 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.854 0.359 . . . . 4.18 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.534 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 1.23 111.502 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.97 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.5 mp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.652 0.263 . . . . 6.06 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.81 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 2.33 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 1.1 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 1.45 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.726 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.33 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.503 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.37 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 2.32 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 3.33 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.9 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 2.15 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.92 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.726 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 53.5 t60 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.98 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.96 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 1.27 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.54 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.77 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.581 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 1.46 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 2.17 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 1.26 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.556 HG21 ' HG2' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.98 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 3.18 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.87 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 2.18 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 3.27 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.45 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 2.06 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.74 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 3.21 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 3.17 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 6.21 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 2.04 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.62 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 3.13 111.381 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.22 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.81 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 62' ' ' LEU . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 2.31 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 2.39 110.218 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 1.25 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.462 ' CG2' HD22 ' A' ' 62' ' ' LEU . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 2.12 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 2.05 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.84 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 1.23 110.56 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 1.12 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD2' HD11 ' A' ' 54' ' ' LEU . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 2.37 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 1.37 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.88 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.7 t60 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.61 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 1.28 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 1.21 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 1.27 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 1.15 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 2.34 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.94 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.95 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 3.13 110.827 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.89 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 2.61 110.75 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 2.07 110.051 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 2.47 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 2.0 112.556 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 2.19 109.358 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.875 0.369 . . . . 4.18 111.142 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.556 ' HG2' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 1.23 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 38.5 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.97 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 62.9 mt . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 6.06 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.81 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 2.33 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 1.1 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.428 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 1.45 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.33 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.37 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 2.32 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 3.33 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.9 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 2.15 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.92 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.98 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' A' ' 26' ' ' PRO . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.96 111.274 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 25' ' ' ILE . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 1.27 111.82 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.54 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.77 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.648 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 1.46 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 2.17 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.26 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.548 HG21 ' HG2' ' B' ' 303' ' ' GLU . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.98 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 3.18 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.87 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 2.18 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 3.27 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.45 111.975 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 2.06 111.24 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.472 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.74 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 3.21 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 3.17 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 6.21 111.029 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 2.04 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.62 110.225 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 3.13 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.22 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.81 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 2.31 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 2.39 109.863 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 1.25 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 2.12 111.47 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.5 m-80 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 2.05 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.84 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 1.23 110.72 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 1.12 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.648 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 2.37 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 1.37 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.88 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.61 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 1.28 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 1.21 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 1.27 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 62' ' ' LEU . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 1.15 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 2.34 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.94 111.877 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.95 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.41 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 3.13 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.89 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 2.61 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.41 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 2.07 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 2.47 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 2.0 111.62 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 2.19 110.015 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.595 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.846 0.355 . . . . 4.18 110.741 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.548 ' HG2' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.42 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 1.23 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.97 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 74' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 110.153 -0.314 . . . . 6.06 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.81 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 2.33 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 1.1 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.414 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 1.45 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.33 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.651 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.37 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 2.32 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 3.33 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.9 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.547 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 2.15 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.92 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.98 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.96 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 1.27 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.54 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.77 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.651 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 1.46 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 2.17 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 1.26 109.878 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.462 HG21 ' CG ' ' B' ' 303' ' ' GLU . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.98 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 3.18 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.87 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 2.18 110.873 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 3.27 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.45 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 2.06 110.909 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.424 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.74 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 3.21 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 3.17 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 6.21 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 2.04 111.496 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.62 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 3.13 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.22 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.81 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.441 HD12 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 2.31 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 2.39 110.297 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 1.25 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.556 ' CG2' HD21 ' A' ' 62' ' ' LEU . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 2.12 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 2.05 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.84 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 1.23 110.551 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 1.12 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 2.37 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.675 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 1.37 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.88 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 14.1 t60 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.61 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 31' ' ' ILE . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 1.28 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 1.21 111.205 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 1.27 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 1.15 110.976 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' HD12 ' A' ' 12' ' ' LEU . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 2.34 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.94 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.95 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 3.13 111.304 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.89 111.619 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 2.61 111.009 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 2.07 109.616 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 2.47 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 2.0 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 2.19 109.328 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.547 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.798 0.332 . . . . 4.18 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.462 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.97 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.3 mp . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 111.812 0.301 . . . . 6.06 111.812 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.81 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 2.33 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 1.1 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.471 HG21 ' HA ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 1.45 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.33 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.37 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 2.32 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 3.33 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.9 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.451 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 2.15 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.92 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.687 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 65.8 t60 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.98 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.96 110.684 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 1.27 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.54 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.77 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.571 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 1.46 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 2.17 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 16' ' ' ILE . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.534 HG21 ' CG ' ' B' ' 303' ' ' GLU . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.98 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 3.18 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.87 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 2.18 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 3.27 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.45 111.973 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 2.06 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.493 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 3.21 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 3.17 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 6.21 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 2.04 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.62 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 3.13 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.22 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.81 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 2.31 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 2.39 110.073 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 1.25 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.613 HG23 HD23 ' A' ' 62' ' ' LEU . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 2.12 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 2.05 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.84 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 1.23 110.575 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 1.12 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.613 HD23 HG23 ' A' ' 57' ' ' VAL . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 2.37 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 1.37 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.88 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.538 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.61 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 1.28 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 1.21 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 1.27 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 1.15 111.158 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 2.34 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.94 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.95 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 3.13 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.89 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 2.61 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 2.07 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 2.47 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.434 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 2.0 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 2.19 109.585 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.813 0.339 . . . . 4.18 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.534 ' CG ' HG21 ' A' ' 34' ' ' THR . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.538 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 1.23 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.97 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 6.06 110.976 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.81 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 2.33 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 1.1 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.427 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 1.45 111.659 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.718 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.33 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.37 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 2.32 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 3.33 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.9 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.443 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 2.15 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.92 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 65.2 t60 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.98 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.96 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 1.27 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.54 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.77 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 1.46 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 2.17 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 1.26 109.205 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' CG ' ' B' ' 303' ' ' GLU . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.98 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 3.18 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.87 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 2.18 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 3.27 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.45 112.008 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 2.06 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.74 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 3.21 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 3.17 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 6.21 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 2.04 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.62 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 3.13 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.22 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.81 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 2.31 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 2.39 109.607 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 1.25 111.743 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' CG2' HD23 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 2.12 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 2.05 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.84 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 1.23 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 1.12 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 2.37 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 1.37 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.88 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.515 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.2 t60 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.61 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 1.28 110.484 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 1.21 110.712 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.621 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 1.27 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 1.15 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 2.34 109.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.94 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.95 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' HG21 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 3.13 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.89 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 2.61 112.549 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 2.07 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 2.47 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 2.0 111.948 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 2.19 109.343 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.889 0.376 . . . . 4.18 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.54 ' CG ' HG22 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 1.23 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.476 ' CG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.97 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 74' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 109.893 -0.41 . . . . 6.06 109.893 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.434 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.81 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 2.33 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 1.1 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 1.45 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.71 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.33 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.37 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 2.32 114.402 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 3.33 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.9 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.661 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.2 p-10 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 2.15 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.92 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.71 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.98 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.96 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 1.27 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.54 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.77 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.642 HG21 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 1.46 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 2.17 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 1.26 109.857 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.531 HG21 ' HG2' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.98 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 3.18 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.87 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 2.18 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 3.27 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.45 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 2.06 110.879 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.74 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 3.21 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 3.17 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 6.21 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 2.04 111.652 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.62 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 3.13 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.22 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.81 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 2.31 112.004 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 2.39 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 1.25 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 2.12 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 2.05 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.84 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 1.23 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 1.12 109.57 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.444 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 2.37 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 1.37 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.88 110.072 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.661 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.61 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 1.28 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 1.21 111.834 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 1.27 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 1.15 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 2.34 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.94 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.95 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 3.13 111.441 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.89 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 2.61 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 2.07 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 2.47 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 2.0 111.946 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 2.19 110.265 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.824 0.345 . . . . 4.18 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.531 ' HG2' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 1.23 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.97 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 70.8 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 6.06 111.172 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.81 113.544 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 2.33 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 1.1 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 1.45 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.33 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.639 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.37 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 2.32 113.681 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 3.33 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.9 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 2.15 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.92 113.125 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.677 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 72.0 t60 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.98 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.96 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 1.27 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.54 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.77 109.657 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.639 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 1.46 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 2.17 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 1.26 109.943 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.98 113.052 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 3.18 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.87 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 2.18 110.838 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.45 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 2.06 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 3.21 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 3.17 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 6.21 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 2.04 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.62 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 3.13 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.22 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.81 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.584 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 63' ' ' GLU . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 2.39 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 1.25 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 2.12 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 2.05 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.84 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 1.23 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 1.12 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 2.37 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 1.37 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.88 110.224 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.3 t60 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.61 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 1.28 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.21 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 1.27 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 1.15 111.045 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 2.34 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.94 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.95 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 3.13 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.89 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 2.61 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 2.07 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 2.47 110.698 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 2.0 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 2.19 109.869 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.499 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.703 0.287 . . . . 4.18 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 1.23 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.97 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 111.466 0.173 . . . . 6.06 111.466 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.81 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 2.33 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 1.1 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 1.45 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.708 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.33 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.37 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 2.32 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 3.33 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.9 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 2.15 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.92 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.708 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.98 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.96 110.995 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 1.27 113.059 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.54 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.77 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.675 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 1.46 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 2.17 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 1.26 109.806 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.405 HG22 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.98 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 3.18 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.87 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 2.18 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 3.27 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.45 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 2.06 111.142 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.74 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 3.21 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 3.17 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 6.21 111.66 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 2.04 111.296 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.62 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 3.13 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.22 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.81 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 2.31 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 2.39 109.694 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 1.25 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 62' ' ' LEU . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 2.12 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 2.05 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.84 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 1.23 110.862 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 1.12 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 2.37 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 1.37 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.88 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 19.1 t60 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.61 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 1.28 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG21 HG22 ' B' ' 304' ' ' THR . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 1.21 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 1.27 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 1.15 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 2.34 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.94 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.95 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 3.13 110.845 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.89 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 2.61 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 2.07 110.73 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 2.47 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 2.0 111.848 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 2.19 110.007 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.789 0.328 . . . . 4.18 110.825 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.405 ' CG ' HG22 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 1.23 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 18.0 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 6.06 110.686 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.81 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 2.33 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 1.1 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 1.45 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.33 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.37 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 2.32 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 3.33 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.9 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.7 p-10 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 2.15 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.92 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.7 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 70.0 t60 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.98 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.96 110.883 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 1.27 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.54 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.77 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 1.46 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 2.17 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 1.26 109.756 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 ' HB3' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.98 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 3.18 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.87 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 2.18 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 3.27 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.45 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 2.06 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HB2' HG23 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.74 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 3.21 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 3.17 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 6.21 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 2.04 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.62 110.413 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 3.13 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.22 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.81 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 2.31 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 2.39 109.616 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 1.25 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 62' ' ' LEU . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 2.12 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 2.05 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.84 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 1.23 110.888 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 1.12 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 2.37 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 1.37 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.88 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.594 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.61 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 1.28 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 1.21 111.128 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 1.27 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 1.15 111.001 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 2.34 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.94 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.95 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 3.13 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.89 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 2.61 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 2.07 109.796 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 2.47 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 2.0 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 2.19 109.914 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.828 0.347 . . . . 4.18 111.034 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.461 ' HB3' HG23 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 1.23 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.97 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.572 0.212 . . . . 6.06 111.572 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.81 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 2.33 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 1.1 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 1.45 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.739 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.33 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.723 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.37 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 2.32 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 3.33 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.9 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 2.15 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.92 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.739 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 75.0 t60 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.98 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.96 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 1.27 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.54 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.42 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.77 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.723 HD11 ' HA3' ' A' ' 18' ' ' GLY . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 1.46 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.98 113.447 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 3.18 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.87 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 2.18 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 3.27 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.45 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 2.06 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.405 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.74 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 3.21 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 3.17 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 6.21 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 2.04 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.62 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 3.13 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.22 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.81 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 2.31 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 2.39 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 1.25 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 62' ' ' LEU . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 2.12 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 2.05 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.84 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 1.23 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 1.12 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.634 ' CD1' ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 2.37 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 1.37 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.88 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.569 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.61 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB1' ' CG2' ' A' ' 31' ' ' ILE . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 1.28 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.494 HG21 HG22 ' B' ' 304' ' ' THR . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 1.21 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 1.27 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 1.15 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 2.34 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.94 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.95 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 3.13 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.89 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 2.61 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 2.07 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 2.47 108.829 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.453 HD12 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 2.0 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 2.19 109.937 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 4.18 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.494 HG22 HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 1.23 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.97 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 6.06 110.471 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.81 113.412 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 2.33 110.708 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 1.1 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.494 ' HB ' HG21 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 1.45 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.33 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.37 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 2.32 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 3.33 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.9 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 2.15 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.92 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.64 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.98 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.96 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 1.27 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.54 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.77 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 1.46 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 2.17 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 50' ' ' ILE . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 1.26 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.414 HG23 ' HG2' ' B' ' 303' ' ' GLU . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.98 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 3.18 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.87 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 2.18 110.913 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 3.27 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.45 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 2.06 110.779 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.45 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.74 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 3.21 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 3.17 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 6.21 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 2.04 111.454 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.62 110.016 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 HG23 HG11 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 3.13 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.22 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.81 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 2.31 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 2.39 110.317 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 1.25 112.086 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 2.12 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 2.05 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.84 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 1.23 110.762 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 1.12 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD11 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 2.37 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 1.37 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.88 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.3 t60 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.61 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 1.28 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG22 ' CG2' ' B' ' 304' ' ' THR . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 1.21 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 1.27 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 1.15 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.482 HD21 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 2.34 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.94 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.95 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 3.13 112.55 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.89 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 2.61 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 2.07 110.441 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 2.47 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 2.0 112.034 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 2.19 109.582 178.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.903 0.382 . . . . 4.18 111.137 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.516 ' CG2' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 1.23 111.336 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.97 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 6.06 110.794 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.81 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 2.33 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 1.1 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 1.45 110.8 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.752 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.33 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.651 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.37 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 2.32 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 3.33 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.9 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 2.15 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.92 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.752 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 78.2 t60 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.98 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.96 110.85 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 1.27 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.54 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 53' ' ' LYS . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.77 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.651 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 1.46 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 2.17 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 1.26 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.456 ' CB ' ' HG2' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.98 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 3.18 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.87 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 2.18 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 3.27 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.45 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HD13 ' A' ' 36' ' ' ILE . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 2.06 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.435 ' HB2' HG21 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.74 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 3.21 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 3.17 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 6.21 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 2.04 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.62 110.4 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 3.13 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.22 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.81 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 2.31 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 2.39 110.46 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 1.25 112.117 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 54' ' ' LEU . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 2.12 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 72.2 m-80 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 2.05 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.84 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 1.23 110.527 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 1.12 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 2.37 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 1.37 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.575 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.5 t60 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.61 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 1.28 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG22 HG23 ' B' ' 304' ' ' THR . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 1.21 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.442 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 1.27 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 1.15 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 74' ' ' LEU . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 2.34 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.442 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.94 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.95 111.312 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 3.13 111.225 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.89 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 2.61 110.178 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 2.07 111.81 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 2.47 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 2.0 111.316 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 2.19 109.804 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.765 0.317 . . . . 4.18 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.548 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 1.23 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 28.2 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 111.884 0.327 . . . . 6.06 111.884 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.81 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 2.33 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 1.1 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG12 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 1.45 110.864 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.698 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.33 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.37 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 2.32 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 3.33 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.9 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 2.15 109.548 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.92 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.98 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.96 110.993 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 1.27 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.54 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.77 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 1.46 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 2.17 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 1.26 110.685 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.524 HG23 ' HG2' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.98 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 3.18 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.87 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 2.18 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 3.27 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.45 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 2.06 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.74 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 3.21 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 3.17 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 6.21 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 2.04 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.62 110.258 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 3.13 111.191 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.22 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.81 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HB3' HD23 ' A' ' 62' ' ' LEU . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 2.31 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 2.39 110.088 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 1.25 111.969 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' A' ' 62' ' ' LEU . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 2.12 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 2.05 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.84 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 1.23 110.519 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 1.12 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 2.37 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 1.37 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.88 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.9 t60 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.61 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 1.28 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 1.21 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.517 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 1.27 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 1.15 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 2.34 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.94 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.95 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 3.13 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.89 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 2.61 110.678 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 2.07 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 2.47 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 2.0 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 2.19 110.467 179.365 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.76 0.314 . . . . 4.18 110.844 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.446 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 1.23 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 20.0 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.97 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 6.06 111.118 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.81 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 2.33 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 1.1 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 1.45 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.691 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.33 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.37 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 2.32 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 3.33 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.9 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 2.15 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 5.3 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.92 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.691 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 70.4 t60 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.98 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.96 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 1.27 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.54 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.77 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.623 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 1.46 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 2.17 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 50' ' ' ILE . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.98 113.014 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 3.18 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.87 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 2.18 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 3.27 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.45 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 2.06 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.463 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.74 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 3.21 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 3.17 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 6.21 111.047 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 2.04 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.62 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.401 HG22 HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 3.13 111.181 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.22 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.81 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 2.31 111.989 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 2.39 109.811 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 1.25 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 62' ' ' LEU . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 2.12 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 2.05 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.84 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 1.23 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 1.12 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 57' ' ' VAL . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 2.37 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 1.37 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.88 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.563 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.5 t60 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.61 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 31' ' ' ILE . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 1.28 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 ' HA ' HG11 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 1.21 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 1.27 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 1.15 111.166 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 2.34 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.94 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.95 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 3.13 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.89 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 2.61 111.251 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 2.07 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 2.47 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 2.0 112.014 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 2.19 109.705 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.776 0.322 . . . . 4.18 111.136 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.97 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 6.06 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.81 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 2.33 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 1.1 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 1.45 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.695 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.33 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.712 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.37 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 2.32 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 3.33 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.9 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 2.15 110.426 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.92 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 64.6 t60 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.98 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.96 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.427 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 1.27 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.54 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.77 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.712 HD11 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 1.46 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.427 HG21 HD23 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 1.26 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.46 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.98 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 3.18 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.87 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 2.18 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 3.27 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.45 111.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 2.06 111.279 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.44 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.74 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 3.21 111.522 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 3.17 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 6.21 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD23 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 2.04 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.62 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 3.13 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.22 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.81 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.457 HD23 HG21 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 2.31 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 2.39 110.134 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 1.25 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.474 ' CG2' HD23 ' A' ' 62' ' ' LEU . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 2.12 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 2.05 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.84 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 1.23 110.645 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 1.12 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 2.37 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 1.37 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.88 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.61 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 1.28 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG22 HG22 ' B' ' 304' ' ' THR . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 1.21 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 1.27 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 1.15 110.996 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 2.34 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.94 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.95 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 3.13 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.89 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 2.61 110.563 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 2.07 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 2.47 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 2.0 112.094 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 2.7 mmpt? . . . . . 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 2.19 109.582 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.781 0.324 . . . . 4.18 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.47 HG22 HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 1.23 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.534 HG22 HD11 ' A' ' 12' ' ' LEU . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.4 mp . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 111.81 0.3 . . . . 6.06 111.81 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.81 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 2.33 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 1.1 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 1.45 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.33 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.37 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 2.32 113.06 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 3.33 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.9 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 2.15 109.926 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.92 112.86 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.682 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 76.4 t60 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.98 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.96 110.66 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 1.27 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.54 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.77 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.619 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 1.46 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 2.17 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.98 113.252 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 3.18 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.87 110.817 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 2.18 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 3.27 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 12' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.45 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 2.06 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.74 111.773 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 3.21 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 3.17 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 6.21 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 2.04 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.62 110.197 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 3.13 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.22 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.705 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.81 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 2.31 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 2.39 109.882 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 1.25 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 2.12 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 2.05 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.84 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 1.23 110.503 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 1.12 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 HD13 ' HB1' ' A' ' 73' ' ' ALA . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 2.37 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 1.37 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.88 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 11.9 t60 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.61 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 1.28 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.487 HG22 HG21 ' B' ' 304' ' ' THR . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 1.21 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 1.27 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' A' ' 62' ' ' LEU . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 1.15 111.53 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 54' ' ' LEU . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 2.34 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.94 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.95 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 3.13 111.122 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.89 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 2.61 110.685 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 2.07 109.934 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 2.47 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 2.0 111.829 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.6 mmmt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 2.19 110.0 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.795 0.331 . . . . 4.18 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.487 HG21 HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 1.23 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.97 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 6.06 111.343 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.81 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 2.33 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 1.1 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG22 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 1.45 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.33 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.37 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 2.32 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 3.33 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.9 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.0 p-10 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 2.15 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.92 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.705 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 55.3 t60 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.98 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.415 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 1.27 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.54 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.77 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 1.46 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 2.17 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 1.26 109.761 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.461 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.98 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 3.18 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.87 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 2.18 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 3.27 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.45 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 2.06 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.459 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.74 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 3.21 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 3.17 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 6.21 111.33 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 2.04 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.62 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.404 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 3.13 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.22 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.665 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.81 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 2.31 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 2.39 110.013 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 1.25 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 62' ' ' LEU . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 2.12 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 2.05 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.84 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 1.23 110.403 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 1.12 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CG ' HG12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 2.37 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 1.37 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.88 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.667 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 24.6 t60 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.61 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 31' ' ' ILE . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 1.28 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 1.21 111.973 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 1.27 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 1.15 110.493 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 16' ' ' ILE . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 2.34 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.94 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.95 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 3.13 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.89 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 2.61 110.509 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 2.07 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 2.47 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 2.0 112.24 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 2.19 109.442 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.778 0.323 . . . . 4.18 110.734 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.537 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.476 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.23 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.97 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 12' ' ' LEU . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.432 HD22 HG23 ' B' ' 306' ' ' VAL . 10.0 mp . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 111.742 0.275 . . . . 6.06 111.742 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.81 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 2.33 110.356 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 1.1 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 1.45 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.699 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.33 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.37 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 2.32 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 3.33 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.9 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 2.15 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.92 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 58.1 t60 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.98 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.96 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 1.27 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.54 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.77 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 1.46 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 2.17 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 1.26 110.348 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.98 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 3.18 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.87 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 2.18 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 3.27 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.45 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 2.06 110.941 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.74 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 3.21 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 3.17 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 6.21 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 2.04 111.236 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.62 110.479 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 3.13 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.22 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.81 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 2.31 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 2.39 110.158 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 1.25 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 54' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 2.12 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 2.05 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.84 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 1.23 110.758 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 1.12 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 54' ' ' LEU . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 2.37 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 1.37 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.88 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.61 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 1.21 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 1.27 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 1.15 111.39 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 2.34 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.94 111.839 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.95 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 3.13 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.89 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 2.61 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 2.07 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 2.47 110.142 179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 2.0 111.879 -178.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 1.9 mtpt . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 2.19 109.957 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.35 . . . . 4.18 110.968 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.644 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 1.23 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.97 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.432 HG23 HD22 ' A' ' 12' ' ' LEU . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 6.06 111.604 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.81 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 2.33 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 1.1 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 1.45 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.67 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.33 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.37 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 2.32 112.998 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 3.33 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.9 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 2.15 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.92 113.027 -178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.67 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 75.7 t60 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.98 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.96 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 1.27 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.54 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.77 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 1.46 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 2.17 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' CG2' HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 1.26 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.98 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 3.18 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.87 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 2.18 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 3.27 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.45 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 2.06 111.121 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.74 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 3.21 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 3.17 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 6.21 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 2.04 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 1.6 pm0 -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.62 110.279 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 3.13 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.22 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.81 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 2.31 111.95 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 2.39 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 1.25 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 2.12 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 2.05 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.84 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 1.23 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 1.12 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 2.37 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 1.37 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.88 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.1 t60 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.61 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 1.28 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG21 HG21 ' B' ' 304' ' ' THR . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 1.21 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 1.15 110.945 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.494 ' HB3' HD12 ' A' ' 12' ' ' LEU . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 2.34 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.94 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.95 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 3.13 111.476 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.89 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 2.61 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 2.07 110.993 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 2.47 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 2.0 112.007 -178.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 2.19 110.563 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.85 0.357 . . . . 4.18 110.908 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 1.23 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.97 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.431 HD23 HD13 ' A' ' 74' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.116 -0.327 . . . . 6.06 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.81 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 2.33 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 1.1 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 1.45 111.778 -178.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.719 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.33 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.658 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.37 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 2.32 113.948 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 3.33 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.9 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 2.15 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.92 113.012 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.9 t60 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.98 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.96 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 1.27 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.77 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.658 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 1.46 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 2.17 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 1.26 109.881 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.549 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.98 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 3.18 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.87 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 2.18 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 3.27 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.45 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 2.06 110.828 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.479 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.74 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 3.21 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 3.17 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 6.21 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 2.04 111.278 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.62 110.312 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 3.13 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.22 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.81 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 2.31 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 2.39 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 1.25 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 54' ' ' LEU . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 2.12 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 2.05 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.84 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 1.23 110.697 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 1.12 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 2.37 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 1.37 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.88 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.3 t60 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.61 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 1.28 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 1.21 111.246 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 1.27 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 1.15 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 2.34 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.94 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.95 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 3.13 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.89 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 2.61 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 2.07 110.624 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 2.47 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.466 ' HG ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 2.0 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 2.19 110.274 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.68 0.276 . . . . 4.18 111.037 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.549 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.454 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 1.23 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.97 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 8.4 mp . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.591 0.234 . . . . 6.06 110.869 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.81 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 2.33 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 1.1 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 1.45 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.33 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.37 115.318 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 2.32 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 3.33 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.9 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 2.15 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.92 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.676 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.98 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.96 111.368 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 1.27 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.54 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.77 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 1.46 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 2.17 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 HD22 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 1.26 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.98 113.139 -178.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 3.18 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.87 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 2.18 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 3.27 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.45 111.91 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 2.06 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.74 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 3.21 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 3.17 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 6.21 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 2.04 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.62 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 3.13 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.22 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.81 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 2.31 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 2.39 109.781 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 1.25 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 54' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 2.12 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 2.05 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.84 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 1.23 110.761 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 1.12 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 31' ' ' ILE . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 2.37 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 1.37 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.88 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.61 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 67' ' ' HIS . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 1.28 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' B' ' 304' ' ' THR . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 1.21 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 1.27 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 1.15 111.144 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD2' HD23 ' A' ' 62' ' ' LEU . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 2.34 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.94 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.95 111.262 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 3.13 111.446 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.89 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 2.61 110.981 179.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 2.07 110.072 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 2.47 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 54' ' ' LEU . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 2.0 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 2.19 110.222 179.044 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.805 0.336 . . . . 4.18 110.916 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 1.23 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.97 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.495 0.188 . . . . 6.06 111.181 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.81 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 2.33 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.643 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 1.1 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 1.45 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.37 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 2.32 112.957 178.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 3.33 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.9 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 2.15 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.92 112.756 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.687 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 66.3 t60 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.98 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.96 110.563 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 1.27 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.54 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.687 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.77 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.623 HD12 ' HG ' ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 1.46 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 2.17 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 1.26 110.039 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.447 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.98 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 3.18 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.87 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 2.18 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 3.27 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.45 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 2.06 111.339 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.74 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 3.21 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 3.17 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 6.21 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 2.04 111.226 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.62 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 3.13 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.22 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.81 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.474 ' HB3' HD22 ' A' ' 62' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 2.31 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 2.39 109.652 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 1.25 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 62' ' ' LEU . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 2.12 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 2.05 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.84 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 1.23 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 1.12 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HG ' HD12 ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 2.37 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 1.37 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.88 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.61 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 67' ' ' HIS . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 1.28 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 1.21 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 1.27 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 1.15 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 2.34 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.94 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.95 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 3.13 111.469 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.89 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 2.61 110.072 178.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 2.07 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 2.47 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 2.0 111.78 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 2.19 109.955 178.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.852 0.358 . . . . 4.18 111.018 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.437 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 1.23 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.643 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.97 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 16.2 mt . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 6.06 111.512 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.81 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 2.33 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 1.1 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 1.45 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.709 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.33 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.707 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.37 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 2.32 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 3.33 110.47 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.9 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 2.15 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.92 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 68.1 t60 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.98 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.96 110.851 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 1.27 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.54 111.749 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.77 110.841 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.707 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 1.46 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 2.17 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 50' ' ' ILE . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 1.26 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.558 HG22 ' HG2' ' B' ' 303' ' ' GLU . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.98 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 3.18 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 42' ' ' ALA . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.87 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 2.18 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 3.27 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.45 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 2.06 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.74 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 3.21 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 3.17 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 6.21 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 2.04 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.62 110.403 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG11 ' A' ' 33' ' ' VAL . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 3.13 111.198 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.22 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.81 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 2.31 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 2.39 109.6 178.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 1.25 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 2.12 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 2.05 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.84 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 1.23 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 1.12 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 2.37 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 1.37 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.474 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.88 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.61 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG23 ' A' ' 31' ' ' ILE . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 1.28 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 304' ' ' THR . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 1.21 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 1.27 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 1.15 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 2.34 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.94 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.95 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 3.13 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.89 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 2.61 111.065 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 2.07 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 2.47 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 2.0 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 2.19 109.73 178.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.769 0.319 . . . . 4.18 111.062 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.558 ' HG2' HG22 ' A' ' 34' ' ' THR . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 1.23 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.97 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.2 mp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 111.838 0.31 . . . . 6.06 111.838 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.81 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 2.33 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 1.1 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.541 HG23 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 1.45 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.706 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.33 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.37 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 2.32 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 3.33 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.9 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 2.15 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.92 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.706 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.98 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.96 111.381 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 1.27 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.54 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.77 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.625 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 1.46 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 2.17 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 1.26 110.04 178.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 -178.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 3.18 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.87 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 3.27 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.45 111.949 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 2.06 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.74 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 3.21 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 3.17 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 6.21 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 2.04 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.62 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 3.13 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.22 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.81 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 2.31 111.778 -178.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 2.39 110.184 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 1.25 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 2.12 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 2.05 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.84 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 1.23 110.722 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 1.12 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 73' ' ' ALA . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 2.37 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 1.37 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.88 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.9 t60 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.61 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 1.28 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG21 HG22 ' B' ' 304' ' ' THR . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 1.21 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 1.27 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' A' ' 62' ' ' LEU . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 1.15 111.177 -179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 2.34 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.94 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.95 111.334 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.502 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 3.13 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.89 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 2.61 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.502 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 2.07 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 2.47 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 2.0 111.941 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 2.19 110.215 179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.84 0.352 . . . . 4.18 110.959 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.495 HG22 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 1.23 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.97 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 7.0 mp . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 6.06 111.195 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.81 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 2.33 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 1.1 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 1.45 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.69 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.33 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.37 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 2.32 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 3.33 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.9 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 2.15 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.92 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.69 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 66.5 t60 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.98 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.527 HG22 ' HD2' ' A' ' 26' ' ' PRO . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.96 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 25' ' ' ILE . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 1.27 112.165 -179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.54 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.77 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 1.46 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 2.17 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 50' ' ' ILE . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 1.26 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 303' ' ' GLU . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.98 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 3.18 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.87 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 2.18 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 3.27 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.45 111.975 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 2.06 111.015 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.453 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.74 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 3.21 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 3.17 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 6.21 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 2.04 111.006 179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.62 110.281 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.417 HG21 HG13 ' A' ' 33' ' ' VAL . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 3.13 111.327 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.22 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.81 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.489 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 2.31 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 2.39 109.701 178.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 1.25 110.98 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 2.12 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 2.05 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.84 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 1.23 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 1.12 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 2.37 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 1.37 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.88 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.61 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' HIS . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 1.28 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG12 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 1.21 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.594 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 1.27 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 1.15 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 2.34 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.94 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.95 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 3.13 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.89 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 2.61 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 2.07 110.317 178.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 2.47 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 2.0 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 2.19 109.734 178.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.46 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.893 0.378 . . . . 4.18 110.953 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.479 HG21 HG23 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.97 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.5 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 6.06 110.444 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.81 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 2.33 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 1.1 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 1.45 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.33 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.37 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 2.32 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 3.33 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.9 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 2.15 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.92 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.699 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 57.1 t60 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.98 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.96 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 1.27 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.54 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.77 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 1.46 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 2.17 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 1.26 109.733 178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.98 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 3.18 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.404 HD12 ' HB1' ' A' ' 42' ' ' ALA . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.87 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 2.18 111.439 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 3.27 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.45 112.144 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 2.06 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.74 111.201 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 3.21 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 3.17 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 6.21 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 2.04 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.62 110.206 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 3.13 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.22 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.81 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.487 HD11 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 2.31 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 2.39 110.122 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 1.25 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.527 ' CG2' HD23 ' A' ' 62' ' ' LEU . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 2.12 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 2.05 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.84 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 1.23 110.393 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 1.12 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' A' ' 57' ' ' VAL . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 2.37 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.676 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 1.37 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.88 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.61 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 1.28 110.852 178.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 1.21 110.94 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.63 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 1.27 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 1.15 111.148 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.426 ' N ' HD21 ' A' ' 74' ' ' LEU . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 2.34 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.94 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.95 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 3.13 111.074 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.89 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 2.61 110.735 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 2.07 109.98 178.585 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 2.47 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 2.0 112.204 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 2.19 109.778 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.811 0.339 . . . . 4.18 110.547 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 1.23 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.97 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 12' ' ' LEU . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.9 mp . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 6.06 112.074 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.81 113.012 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 2.33 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 1.1 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.41 HD11 HG12 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 1.45 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.725 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.33 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.37 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 2.32 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 3.33 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.9 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 2.15 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.92 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.725 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.98 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.96 111.362 -179.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 1.27 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.54 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.77 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 1.46 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.704 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 2.17 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 1.26 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.614 HG22 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.98 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 3.18 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.87 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 2.18 111.046 -179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 3.27 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.45 111.751 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 2.06 111.19 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.488 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.74 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 3.21 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 3.17 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 6.21 111.262 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 HG22 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 2.04 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.62 110.239 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.431 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 3.13 111.398 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.22 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.704 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.81 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 2.31 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.39 109.95 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 1.25 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 54' ' ' LEU . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 2.12 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 2.05 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.84 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 1.23 110.262 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 1.12 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 31' ' ' ILE . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 2.37 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 1.37 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.88 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.545 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.1 t60 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.61 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.468 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 1.28 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG23 HG22 ' B' ' 304' ' ' THR . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 1.21 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 1.27 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 1.15 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 2.34 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.94 111.97 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.95 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 3.13 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.89 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 2.61 109.852 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 2.07 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 2.47 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 2.0 111.761 -178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? . . . . . 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 2.19 109.338 178.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 302' ' ' ARG . . . . . 0.438 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 4.18 111.243 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 303' ' ' GLU . . . . . 0.614 ' HB3' HG22 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 304' ' ' THR . . . . . 0.458 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 1.23 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 305' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.97 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 16' ' ' ILE . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.753 0.311 . . . . 3.67 111.287 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -100.4 154.22 18.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 2.47 110.965 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -145.28 127.06 8.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.247 -0.649 . . . . 1.86 109.247 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 9.4 mtmt -94.33 91.32 6.65 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.261 0.553 . . . . 3.54 111.321 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.9 mt -89.86 130.91 36.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.211 -0.904 . . . . 2.63 111.271 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.41 125.89 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.007 -0.542 . . . . 2.44 111.047 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.2 118.91 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 3.61 111.619 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.3 164.06 13.13 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.909 -0.587 . . . . 1.79 112.434 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.82 -42.38 66.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.86 2.374 . . . . 2.89 112.449 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -68.12 0.32 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.228 -0.442 . . . . 5.28 110.483 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.22 -140.91 8.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.943 -0.646 . . . . 2.53 112.685 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 306' ' ' VAL . 5.6 mp -83.44 -52.2 6.72 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.392 -0.225 . . . . 6.06 110.392 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.81 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 2.33 110.733 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 1.1 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 1.45 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.726 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.33 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.724 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.37 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 2.32 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 3.33 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.9 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.45 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 2.15 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.92 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.726 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.1 t60 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.98 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.96 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 1.27 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.54 111.849 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.77 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.724 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 1.46 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 2.17 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.401 HG22 HD23 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 1.26 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.513 HG22 ' HG2' ' B' ' 303' ' ' GLU . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.98 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 3.18 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HG23 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.87 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 2.18 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 3.27 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.45 111.694 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 2.06 111.051 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.412 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.74 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 3.21 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 3.17 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 6.21 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 2.04 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.62 110.098 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 3.13 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.22 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.81 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 2.31 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 2.39 109.532 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 1.25 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 2.12 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 2.05 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.84 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 1.23 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 1.12 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.582 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 2.37 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 1.37 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.88 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 20.2 t60 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.61 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 1.28 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 1.21 111.371 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 1.27 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 62' ' ' LEU . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 1.15 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 2.34 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.94 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.95 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 3.13 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.89 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.41 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 2.61 110.452 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 2.07 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 2.47 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 2.0 111.784 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -112.77 113.76 26.0 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 2.19 109.536 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 39.6 t -108.51 133.57 53.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 2.51 111.188 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.78 147.57 23.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.277 -0.42 . . . . 2.07 111.141 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 115.58 65.33 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.351 -0.386 . . . . 4.7 110.597 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.439 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 53.6 Cg_endo -70.12 117.68 5.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.499 2.133 . . . . 2.28 112.54 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -132.42 -64.0 0.78 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.495 -0.32 . . . . 4.36 110.467 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.64 162.31 7.67 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.229 -0.51 . . . . 4.69 113.145 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.76 -45.36 5.77 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.608 0.242 . . . . 7.36 110.846 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.978 0.418 . . . . 8.46 110.97 179.826 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.594 0.235 . . . . 4.83 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.484 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 -142.13 129.17 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 4.18 111.016 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.513 ' HG2' HG22 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.401 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 1.23 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.97 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.405 HG21 HD21 ' A' ' 12' ' ' LEU . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.762 0.315 . . . . 3.67 111.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.55 158.55 34.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.188 -0.46 . . . . 2.47 110.857 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -145.99 118.35 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.436 -0.347 . . . . 1.86 110.845 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HG2' ' HD2' ' A' ' 80' ' ' PHE . 8.8 ttpt -117.16 147.6 42.32 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.804 -0.443 . . . . 3.54 109.804 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.23 170.45 18.93 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.27 -0.269 . . . . 2.63 110.658 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.87 139.2 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.582 -0.281 . . . . 2.44 110.459 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 77' ' ' THR . 9.1 tptm -56.88 133.01 54.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.81 0.338 . . . . 3.61 111.672 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.46 -150.75 27.31 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.928 -0.578 . . . . 1.79 112.064 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.65 -83.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.78 2.32 . . . . 2.89 111.681 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -61.96 -68.09 0.35 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.431 0.158 . . . . 5.28 111.287 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.53 -110.5 0.28 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.742 -0.742 . . . . 2.53 113.078 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 81.3 mt -86.62 -51.8 5.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 6.06 111.29 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.417 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.81 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 2.33 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 1.1 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 HG11 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 1.45 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.675 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.33 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.66 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.37 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 2.32 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 3.33 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.9 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.464 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 2.15 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.92 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.675 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.98 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.96 111.296 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 1.27 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.54 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.77 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.66 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 1.46 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 2.17 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 1.26 110.205 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.495 HG21 ' CG ' ' B' ' 303' ' ' GLU . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.98 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 3.18 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.47 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.87 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 2.18 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.45 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 2.06 111.053 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.47 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.74 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 3.21 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 3.17 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 6.21 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 2.04 111.207 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.62 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 3.13 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.22 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.665 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.81 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 2.31 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 2.39 109.924 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 1.25 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' HD22 ' A' ' 62' ' ' LEU . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 2.12 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 53.1 m-80 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 2.05 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.84 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' HG21 ' A' ' 60' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 1.23 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 1.12 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 2.37 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 1.37 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.88 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.61 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 1.28 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.545 HG13 HG13 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 1.21 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 1.27 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 1.15 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 2.34 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.94 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.95 112.269 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 7' ' ' LYS . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 3.13 110.678 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.89 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.402 ' HD2' ' HG2' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 2.61 110.13 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 2.07 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 2.47 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 2.0 110.795 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.9 mmmt -108.22 110.98 22.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 2.19 110.55 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 72.6 t -112.89 122.99 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.284 -0.416 . . . . 2.51 111.141 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.93 121.99 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.324 -0.398 . . . . 2.07 111.225 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -69.97 116.93 49.03 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.112 -0.495 . . . . 4.7 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.576 ' HD3' ' HG3' ' A' ' 53' ' ' LYS . 32.8 Cg_exo -59.96 135.35 62.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.993 2.462 . . . . 2.28 112.134 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 p -146.01 131.39 18.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.532 -0.304 . . . . 4.36 111.167 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.79 8.45 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.078 -0.582 . . . . 4.69 113.369 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 p -70.48 -36.77 74.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.184 0.492 . . . . 7.36 111.272 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.87 0.367 . . . . 8.46 110.96 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.922 0.391 . . . . 4.83 111.523 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.464 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 32.2 ttm180 -147.42 136.31 22.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 4.18 110.816 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.495 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.441 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 1.23 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.97 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.545 HG13 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.82 0.343 . . . . 3.67 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.74 127.26 36.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.121 0.486 . . . . 2.47 111.382 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 2.9 mt -96.7 101.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 1.86 110.797 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.52 91.42 4.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.358 0.599 . . . . 3.54 110.642 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -89.4 131.82 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.067 -0.97 . . . . 2.63 111.589 -178.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -89.15 124.39 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.729 -0.669 . . . . 2.44 110.861 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 115.42 4.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.053 -0.521 . . . . 3.61 111.687 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.58 -162.34 11.91 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 1.79 112.419 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.01 -38.57 67.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.915 2.41 . . . . 2.89 112.305 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -89.12 -59.56 2.19 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.164 -0.471 . . . . 5.28 110.623 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.08 -152.56 19.32 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.152 -0.546 . . . . 2.53 112.054 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 mp -36.41 -62.69 0.44 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.543 0.337 . . . . 6.06 111.547 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.81 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 2.33 110.249 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 1.1 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.587 HD13 ' CD1' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 1.45 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.707 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.33 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.622 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.37 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 2.32 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 3.33 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.9 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.5 p-10 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 2.15 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.92 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.707 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 61.8 t60 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.98 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.474 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 1.27 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.54 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.77 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.622 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 1.46 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.687 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 2.17 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 1.26 109.708 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.479 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.98 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 3.18 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.87 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 2.18 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 3.27 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.548 ' HB2' ' HG ' ' A' ' 5' ' ' LEU . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.45 111.966 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.438 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 2.06 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.458 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.74 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 3.21 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 3.17 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 6.21 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 2.04 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.62 110.127 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 3.13 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.22 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.81 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.451 ' CD2' ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 2.31 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 2.39 110.254 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 1.25 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG23 HD21 ' A' ' 62' ' ' LEU . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 2.12 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 2.05 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.84 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' HG21 ' A' ' 60' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 1.23 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 1.12 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 2.37 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.624 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 1.37 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.88 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.651 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.61 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 1.28 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 1.21 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 1.27 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 1.15 112.049 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.73 ' CD1' ' HA ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 2.34 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.94 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.95 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 3.13 111.473 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.89 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 2.61 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 2.07 109.972 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 2.47 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.451 ' HG ' ' CD2' ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 2.0 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -106.54 116.09 31.33 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 2.19 109.773 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 54' ' ' LEU . 26.8 m -125.46 130.8 72.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.95 0.405 . . . . 2.51 112.051 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.14 155.17 17.6 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.788 -0.642 . . . . 2.07 110.972 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 136.18 20.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.419 -0.355 . . . . 4.7 111.075 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -71.24 123.83 9.93 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.738 2.292 . . . . 2.28 112.452 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.7 p -141.35 83.45 1.87 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.834 0.35 . . . . 4.36 110.866 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.68 14.14 4.18 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.99 -0.624 . . . . 4.69 113.457 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -67.35 -49.66 63.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.126 0.463 . . . . 7.36 111.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.383 -0.371 . . . . 8.46 110.839 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.678 0.275 . . . . 4.83 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.526 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 -136.23 123.44 21.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.361 -0.381 . . . . 4.18 111.078 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.534 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 1.23 111.502 -179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.97 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 3.67 111.469 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -103.63 155.67 18.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.079 -0.509 . . . . 2.47 111.133 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.89 134.21 16.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.412 -0.588 . . . . 1.86 109.412 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 10.8 mmtt -93.16 91.33 7.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 3.54 111.274 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.493 ' HB2' HG11 ' A' ' 81' ' ' VAL . 29.3 mt -89.47 127.89 35.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.466 -0.788 . . . . 2.63 111.564 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -93.64 127.58 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.788 -0.642 . . . . 2.44 110.981 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -75.07 107.82 7.39 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 3.61 111.282 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.76 -164.47 27.05 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.031 -0.604 . . . . 1.79 112.644 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.26 -49.75 8.67 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.004 2.469 . . . . 2.89 112.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -67.94 -66.98 0.5 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.036 -0.529 . . . . 5.28 110.115 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.87 -163.06 13.01 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.177 -0.535 . . . . 2.53 112.566 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.5 mp -37.95 -62.62 0.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.495 0.318 . . . . 6.06 111.354 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.453 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.81 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 2.33 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 1.1 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 1.45 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.726 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.33 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.503 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.37 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 2.32 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 3.33 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.9 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 2.15 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.92 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.726 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 53.5 t60 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.98 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.96 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 1.27 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.54 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.77 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.581 HD11 ' N ' ' A' ' 31' ' ' ILE . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 1.46 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 2.17 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG22 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 1.26 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.556 HG21 ' HG2' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.98 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 3.18 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.87 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 2.18 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 3.27 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.45 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 2.06 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.74 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 3.21 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 3.17 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 6.21 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 2.04 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.62 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 3.13 111.381 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.22 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.81 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 HD11 ' CD2' ' A' ' 62' ' ' LEU . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 2.31 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 2.39 110.218 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 1.25 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.462 ' CG2' HD22 ' A' ' 62' ' ' LEU . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 2.12 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 2.05 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.84 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 1.23 110.56 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 1.12 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' CD2' HD11 ' A' ' 54' ' ' LEU . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 2.37 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 1.37 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.88 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.7 t60 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.61 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 1.28 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 1.21 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 1.27 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 1.15 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.492 HD21 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 2.34 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.94 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.95 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 3.13 110.827 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.89 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.47 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 2.61 110.75 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.493 HG11 ' HB2' ' A' ' 5' ' ' LEU . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 2.07 110.051 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 2.47 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 2.0 112.556 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -116.73 140.35 49.52 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 2.19 109.358 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 84.9 t -134.23 141.1 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 2.51 111.314 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.47 138.01 31.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.154 -0.476 . . . . 2.07 110.615 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -94.15 114.21 62.67 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.448 -0.342 . . . . 4.7 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.26 142.83 42.33 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.788 2.326 . . . . 2.28 112.617 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -140.96 -62.4 0.48 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.295 -0.411 . . . . 4.36 110.602 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.4 107.74 0.37 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.921 -0.657 . . . . 4.69 112.474 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -64.25 -34.79 78.92 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.79 0.293 . . . . 7.36 111.79 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.763 0.316 . . . . 8.46 111.269 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.041 0.448 . . . . 4.83 111.343 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 -62.51 122.96 17.06 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.052 -0.522 . . . . 4.18 111.142 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.556 ' HG2' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 1.23 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 38.5 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.97 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.659 0.244 . . . . 3.67 111.659 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.76 116.17 27.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.304 0.573 . . . . 2.47 111.331 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.532 HG22 ' HG ' ' A' ' 5' ' ' LEU . 5.1 mp -96.97 103.32 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.204 -0.907 . . . . 1.86 110.815 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.87 91.41 4.36 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.405 0.621 . . . . 3.54 110.739 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.564 ' HB2' ' CG1' ' A' ' 81' ' ' VAL . 96.0 mt -89.44 130.48 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.188 -0.915 . . . . 2.63 111.558 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.25 126.03 42.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.956 -0.566 . . . . 2.44 110.596 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -57.59 118.76 5.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.085 -0.507 . . . . 3.61 111.857 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.61 -170.98 13.71 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.814 -0.63 . . . . 1.79 112.58 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.93 -35.11 99.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.987 2.458 . . . . 2.89 112.662 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -80.84 -65.57 0.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.319 -0.4 . . . . 5.28 110.732 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.05 -117.45 2.31 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.138 -0.553 . . . . 2.53 112.156 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 62.9 mt -87.6 -54.83 4.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 6.06 110.324 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.81 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 2.33 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 1.1 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.428 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 1.45 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.33 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.37 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 2.32 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 3.33 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.9 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.595 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 2.15 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.92 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.98 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG22 ' HD2' ' A' ' 26' ' ' PRO . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.96 111.274 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD2' HG22 ' A' ' 25' ' ' ILE . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 1.27 111.82 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.54 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.77 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.648 ' CG1' ' HG ' ' A' ' 62' ' ' LEU . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 1.46 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 2.17 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.26 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.548 HG21 ' HG2' ' B' ' 303' ' ' GLU . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.98 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 3.18 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 HG23 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.87 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 2.18 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 3.27 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HB3' HD22 ' A' ' 5' ' ' LEU . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.45 111.975 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 2.06 111.24 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.472 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.74 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 3.21 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 3.17 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 6.21 111.029 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 2.04 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.62 110.225 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 3.13 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.22 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.81 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 HD21 HD21 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 2.31 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 2.39 109.863 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 1.25 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 2.12 111.47 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.5 m-80 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 2.05 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.84 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 1.23 110.72 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 1.12 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.648 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 2.37 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 1.37 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.88 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.61 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 1.28 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 1.21 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 1.27 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 62' ' ' LEU . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 1.15 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 12' ' ' LEU . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 2.34 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.94 111.877 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.95 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 7' ' ' LYS . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 3.13 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.89 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 2.61 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.564 ' CG1' ' HB2' ' A' ' 5' ' ' LEU . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 2.07 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 2.47 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.516 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 2.0 111.62 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -111.34 126.34 54.81 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 2.19 110.015 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 133.94 65.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.467 -0.333 . . . . 2.51 111.395 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.13 152.11 22.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.089 -0.505 . . . . 2.07 110.993 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -108.67 128.41 25.59 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.206 -0.452 . . . . 4.7 110.861 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.04 137.68 63.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.692 2.261 . . . . 2.28 112.166 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.6 m -156.24 87.94 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.418 -0.355 . . . . 4.36 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.19 137.43 18.43 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.833 -0.699 . . . . 4.69 112.734 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t -75.25 -48.01 25.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.562 0.22 . . . . 7.36 110.842 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 8.46 110.902 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.77 0.319 . . . . 4.83 111.531 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.595 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? -155.67 132.33 10.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.085 -0.507 . . . . 4.18 110.741 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.548 ' HG2' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.42 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 1.23 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.97 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.784 0.326 . . . . 3.67 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.48 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.4 pm0 -126.81 159.31 34.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.067 -0.515 . . . . 2.47 111.014 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.67 141.47 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.706 -0.479 . . . . 1.86 109.706 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.68 91.79 5.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.109 0.48 . . . . 3.54 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.1 mt -88.34 124.86 34.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 2.63 111.863 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.659 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.5 mp -87.88 116.04 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.332 -0.849 . . . . 2.44 109.965 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 78' ' ' SER . 9.2 tptm -62.13 117.2 5.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.843 0.354 . . . . 3.61 111.657 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.22 172.75 15.28 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.743 -0.662 . . . . 1.79 112.502 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.61 -36.63 89.89 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.872 2.381 . . . . 2.89 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -68.91 0.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.262 -0.426 . . . . 5.28 110.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.73 -130.89 4.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.103 -0.57 . . . . 2.53 112.208 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 74' ' ' LEU . 17.8 mt -87.35 -52.49 5.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.153 -0.314 . . . . 6.06 110.153 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.81 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 2.33 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 1.1 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.414 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 1.45 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.729 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.33 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.651 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.37 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 2.32 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 3.33 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.9 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.547 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 2.15 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.92 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.729 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.98 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.439 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.96 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 1.27 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.54 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.77 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.651 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 1.46 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.674 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 2.17 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 1.26 109.878 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.462 HG21 ' CG ' ' B' ' 303' ' ' GLU . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.98 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 3.18 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.424 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.87 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 2.18 110.873 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 3.27 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.45 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 2.06 110.909 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.424 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.74 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 3.21 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 3.17 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 6.21 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 2.04 111.496 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.62 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 3.13 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.22 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.674 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.81 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.441 HD12 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 2.31 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 2.39 110.297 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 1.25 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.556 ' CG2' HD21 ' A' ' 62' ' ' LEU . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 2.12 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 2.05 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.84 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 1.23 110.551 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 1.12 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.614 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 2.37 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.675 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 1.37 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.88 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 14.1 t60 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.61 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.636 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 31' ' ' ILE . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 1.28 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 1.21 111.205 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.498 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 1.27 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 1.15 110.976 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' HD12 ' A' ' 12' ' ' LEU . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 2.34 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.94 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.95 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 3.13 111.304 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.422 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.89 111.619 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 2.61 111.009 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 2.07 109.616 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 2.47 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 2.0 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -113.3 109.89 19.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 2.19 109.328 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 94.9 t -107.11 135.24 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 2.51 111.457 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.5 143.78 29.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.922 -0.581 . . . . 2.07 110.738 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.92 110.4 64.05 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.276 -0.42 . . . . 4.7 111.21 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.29 149.76 57.78 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.859 2.373 . . . . 2.28 112.426 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -130.12 -62.66 0.93 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.211 -0.45 . . . . 4.36 111.008 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.06 101.04 0.15 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.841 -0.695 . . . . 4.69 112.624 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.59 -39.72 51.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.507 0.194 . . . . 7.36 111.206 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.838 0.351 . . . . 8.46 110.992 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.793 0.33 . . . . 4.83 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.547 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 -154.7 137.46 15.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.061 -0.518 . . . . 4.18 110.914 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.462 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 1.23 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.97 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.651 0.262 . . . . 3.67 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.52 123.25 37.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.328 0.585 . . . . 2.47 111.322 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mp -97.11 107.46 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.038 -0.983 . . . . 1.86 110.954 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 90.4 3.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.463 0.649 . . . . 3.54 110.29 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.4 mt -90.79 131.44 36.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.925 -1.034 . . . . 2.63 111.932 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -89.11 125.34 42.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.796 -0.638 . . . . 2.44 110.174 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 3.8 mmmt -68.56 112.12 5.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.936 0.398 . . . . 3.61 111.81 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.18 19.29 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.707 -0.679 . . . . 1.79 112.384 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.72 -43.67 47.91 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.858 2.372 . . . . 2.89 112.508 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -67.67 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.415 -0.357 . . . . 5.28 110.537 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.97 -160.13 13.41 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.04 -0.6 . . . . 2.53 112.988 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.3 mp -38.9 -62.06 0.67 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.902 0.481 . . . . 6.06 111.812 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.81 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 2.33 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 1.1 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.471 HG21 ' HA ' ' A' ' 33' ' ' VAL . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 1.45 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.33 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.37 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 2.32 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 3.33 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.9 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.451 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 2.15 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.92 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.687 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 65.8 t60 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.98 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.96 110.684 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 1.27 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.54 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.77 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.571 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 1.46 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.699 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 2.17 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' HG21 ' A' ' 16' ' ' ILE . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 1.26 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.534 HG21 ' CG ' ' B' ' 303' ' ' GLU . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.98 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 3.18 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.87 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.41 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 2.18 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 3.27 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.45 111.973 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 2.06 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.493 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.74 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 3.21 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 3.17 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 6.21 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 2.04 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.62 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 3.13 110.958 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.22 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.699 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.81 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 HD21 HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 2.31 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.569 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 2.39 110.073 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 1.25 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.613 HG23 HD23 ' A' ' 62' ' ' LEU . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 2.12 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 2.05 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.84 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 1.23 110.575 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 1.12 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.613 HD23 HG23 ' A' ' 57' ' ' VAL . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 2.37 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 1.37 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.88 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.538 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.61 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 1.28 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.417 ' HA ' HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 1.21 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 1.27 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 1.15 111.158 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 2.34 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.94 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.95 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 3.13 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.89 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 2.61 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 2.07 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 2.47 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.571 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 2.0 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -113.83 154.09 28.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 2.19 109.585 178.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 94.9 t -134.1 138.18 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.766 0.317 . . . . 2.51 111.292 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -103.23 155.48 18.4 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.984 -0.553 . . . . 2.07 111.249 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -114.78 111.21 45.88 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.337 -0.392 . . . . 4.7 110.616 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.7 120.74 8.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.712 2.274 . . . . 2.28 112.497 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 p -140.02 125.69 19.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.53 -0.304 . . . . 4.36 110.939 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.74 -145.56 4.23 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.901 -0.666 . . . . 4.69 112.771 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.7 m -82.98 -45.37 14.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.586 0.231 . . . . 7.36 111.187 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 116.43 -0.35 . . . . 8.46 110.957 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.904 0.383 . . . . 4.83 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.451 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 -134.24 110.62 9.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.011 -0.54 . . . . 4.18 110.431 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.534 ' CG ' HG21 ' A' ' 34' ' ' THR . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.538 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 1.23 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.97 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.53 0.205 . . . . 3.67 111.28 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.51 130.9 42.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.198 0.523 . . . . 2.47 111.242 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 3.6 mp -97.34 102.31 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 1.86 110.993 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -99.66 91.28 4.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.43 0.633 . . . . 3.54 110.687 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 41' ' ' ALA . 52.6 mt -97.48 131.75 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.993 -1.003 . . . . 2.63 111.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 21.2 tt -88.27 131.67 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.446 -0.343 . . . . 2.44 110.557 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.53 104.9 3.99 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.242 -0.436 . . . . 3.61 111.583 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.58 -160.27 23.02 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.763 -0.653 . . . . 1.79 112.529 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.53 -36.21 86.95 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.999 2.466 . . . . 2.89 112.752 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -79.96 -123.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.493 -0.322 . . . . 5.28 110.623 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.62 -124.98 0.74 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.576 -0.821 . . . . 2.53 112.829 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? -85.12 -50.18 7.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 6.06 110.976 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.81 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 2.33 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HB3' ' CG ' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 1.1 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.427 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 1.45 111.659 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.718 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.33 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.441 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.37 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 2.32 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 3.33 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.9 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.546 ' HA ' ' HA ' ' B' ' 301' ' ' ARG . 0.2 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 2.15 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.92 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.718 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 65.2 t60 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.98 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.96 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 1.27 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.54 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.77 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 1.46 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 2.17 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 1.26 109.205 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.54 HG22 ' CG ' ' B' ' 303' ' ' GLU . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.98 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 3.18 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.87 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 2.18 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 3.27 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB3' HD23 ' A' ' 5' ' ' LEU . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.45 112.008 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 2.06 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.74 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 3.21 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 3.17 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 6.21 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 2.04 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.62 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 3.13 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.22 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.81 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.514 ' HG ' HG22 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 2.31 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 2.39 109.607 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 1.25 111.743 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' CG2' HD23 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 2.12 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 2.05 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.84 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 1.23 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 1.12 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HG ' HG12 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 2.37 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.656 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 1.37 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.88 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.515 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.2 t60 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.61 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.656 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 1.28 110.484 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 1.21 110.712 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.621 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 1.27 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB3' HD13 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 1.15 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 2.34 109.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.94 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.95 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' HG21 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 3.13 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.89 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 2.61 112.549 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.454 HG21 ' HB ' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 2.07 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 2.47 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.562 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 2.0 111.948 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.93 120.26 41.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 2.19 109.343 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 34.4 t -103.74 135.51 41.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.917 0.389 . . . . 2.51 111.313 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.442 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.74 145.67 27.8 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.791 -0.64 . . . . 2.07 111.565 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -114.81 99.08 51.4 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.029 -0.532 . . . . 4.7 110.802 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.443 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -69.98 146.53 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.851 2.367 . . . . 2.28 112.338 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -126.8 -58.48 1.31 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.147 -0.479 . . . . 4.36 110.978 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.08 98.69 0.14 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.839 -0.696 . . . . 4.69 112.598 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.6 p -75.11 -43.94 50.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.559 0.218 . . . . 7.36 111.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.323 -0.399 . . . . 8.46 110.859 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 4.0 ptm180 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 4.83 111.499 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 -142.83 130.57 21.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.242 -0.435 . . . . 4.18 111.161 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.54 ' CG ' HG22 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.44 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 1.23 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.476 ' CG ' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.97 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.791 0.329 . . . . 3.67 111.27 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.548 ' HB3' ' CE ' ' A' ' 84' ' ' LYS . 1.2 pm0 -118.18 150.99 38.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.085 -0.507 . . . . 2.47 110.856 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.54 95.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.694 -0.484 . . . . 1.86 109.694 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -98.74 143.96 28.52 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.495 -0.557 . . . . 3.54 109.495 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.52 170.7 18.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.101 -0.333 . . . . 2.63 110.101 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -92.85 125.68 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.695 0.283 . . . . 2.44 110.899 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.528 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 33.3 tptt -65.95 133.96 51.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.286 -0.416 . . . . 3.61 111.417 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.78 178.61 17.3 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.812 -0.631 . . . . 1.79 112.647 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 -38.75 61.13 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.956 2.437 . . . . 2.89 112.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -62.61 -70.08 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.403 -0.362 . . . . 5.28 110.895 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.13 -134.29 5.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.04 -0.6 . . . . 2.53 112.396 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 74' ' ' LEU . 6.7 mt -83.31 -54.09 5.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.893 -0.41 . . . . 6.06 109.893 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.434 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.81 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 2.33 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.52 ' OG ' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 1.1 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 1.45 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.71 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.33 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.37 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 2.32 114.402 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 3.33 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.9 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.661 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.2 p-10 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 2.15 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.92 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.71 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.98 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.96 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 1.27 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.54 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.77 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.642 HG21 ' HB1' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 1.46 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 2.17 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 1.26 109.857 178.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.531 HG21 ' HG2' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.98 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 3.18 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.527 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.87 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 2.18 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 3.27 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.45 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 2.06 110.879 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.527 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.74 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 3.21 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 3.17 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 6.21 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 2.04 111.652 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.62 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 3.13 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.22 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.81 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 2.31 112.004 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 2.39 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 1.25 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 2.12 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 2.05 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.84 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 1.23 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 1.12 109.57 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 2.37 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 1.37 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.88 110.072 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.661 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.61 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 1.28 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 1.21 111.834 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 1.27 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 1.15 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.487 ' HB3' HD13 ' A' ' 12' ' ' LEU . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 2.34 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.94 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.95 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.528 ' HB ' ' HD3' ' A' ' 7' ' ' LYS . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 3.13 111.441 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.89 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 2.61 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 2.07 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 2.47 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 2.0 111.946 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.548 ' CE ' ' HB3' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -114.1 108.69 17.32 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 2.19 110.265 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 53' ' ' LYS . 99.3 t -107.99 130.53 60.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.416 -0.357 . . . . 2.51 110.72 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.23 148.72 25.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.222 -0.444 . . . . 2.07 110.92 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -102.13 131.76 22.28 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.325 -0.398 . . . . 4.7 110.829 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.82 142.11 61.79 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.708 2.272 . . . . 2.28 112.542 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 p -134.21 151.71 51.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 4.36 110.927 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.24 115.72 0.9 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.856 -0.687 . . . . 4.69 112.834 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.6 p -74.96 -36.2 62.07 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.427 0.156 . . . . 7.36 111.183 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.343 -0.39 . . . . 8.46 110.871 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.59 0.234 . . . . 4.83 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 -142.7 129.01 19.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.347 -0.388 . . . . 4.18 111.075 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.531 ' HG2' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.462 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 1.23 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.97 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.539 0.209 . . . . 3.67 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -106.58 150.65 25.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.43 -0.35 . . . . 2.47 110.731 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.36 95.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.443 -0.344 . . . . 1.86 110.758 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 82' ' ' TYR . 29.9 ttpt -98.31 147.26 24.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.339 -0.391 . . . . 3.54 110.058 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.26 170.59 18.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.074 -0.343 . . . . 2.63 110.074 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 tt -94.57 131.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.603 0.239 . . . . 2.44 111.018 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.28 129.89 15.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.326 -0.397 . . . . 3.61 111.89 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.86 -152.25 28.95 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.059 -0.591 . . . . 1.79 112.152 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.1 -80.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.845 2.363 . . . . 2.89 112.122 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.3 -73.05 0.09 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.428 0.156 . . . . 5.28 111.386 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.76 -107.99 0.23 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.776 -0.726 . . . . 2.53 112.662 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 70.8 mt -87.65 -53.2 4.91 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 6.06 111.172 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.81 113.544 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.559 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 2.33 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 1.1 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 1.45 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.33 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.639 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.37 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 2.32 113.681 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 3.33 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.9 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 2.15 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.92 113.125 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.677 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 72.0 t60 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.98 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.96 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 1.27 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.54 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.77 109.657 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.639 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 1.46 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 2.17 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 1.26 109.943 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.98 113.052 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 3.18 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.87 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 2.18 110.838 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 3.27 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.45 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 2.06 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.415 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.74 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 3.21 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 3.17 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 6.21 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 2.04 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.62 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 3.13 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.22 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.81 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.584 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' ' CG ' ' A' ' 63' ' ' GLU . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 2.39 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 1.25 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 2.12 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 2.05 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.84 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 1.23 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 1.12 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 2.37 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 1.37 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.4 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.88 110.224 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.526 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.3 t60 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.61 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.4 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.612 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 1.28 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' HA ' HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 1.21 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 1.27 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' A' ' 62' ' ' LEU . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 1.15 111.045 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.5 HD22 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 2.34 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.94 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.95 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 3.13 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.89 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 2.61 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 2.07 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 4' ' ' LYS . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 2.47 110.698 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 2.0 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.497 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.4 OUTLIER -120.29 128.39 53.26 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 2.19 109.869 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 92.6 t -121.97 137.4 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.714 0.292 . . . . 2.51 111.608 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.88 145.72 27.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.049 -0.523 . . . . 2.07 110.757 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.94 112.06 65.25 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 4.7 111.069 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 56.9 Cg_endo -71.45 117.81 5.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.701 2.267 . . . . 2.28 112.178 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 m -140.86 113.8 8.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.705 0.288 . . . . 4.36 111.174 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.79 31.58 78.73 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 116.103 -0.499 . . . . 4.69 113.251 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.6 m -54.7 -40.41 69.16 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.892 0.346 . . . . 7.36 111.489 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.873 0.368 . . . . 8.46 111.184 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.74 0.305 . . . . 4.83 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.499 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 -159.41 126.54 4.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.155 -0.475 . . . . 4.18 111.123 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 1.23 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.97 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.746 0.308 . . . . 3.67 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 156.81 38.93 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.163 -0.472 . . . . 2.47 110.762 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.412 HG12 ' HG2' ' A' ' 47' ' ' LYS . 71.2 mt -144.2 95.62 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.437 -0.347 . . . . 1.86 110.538 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -97.49 146.4 25.28 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.742 -0.466 . . . . 3.54 109.742 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 170.74 18.22 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.313 -0.255 . . . . 2.63 110.313 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 tt -95.14 125.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.748 0.309 . . . . 2.44 110.969 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.51 133.77 35.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.076 -0.511 . . . . 3.61 111.674 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.19 -157.69 33.96 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.118 -0.563 . . . . 1.79 112.364 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.34 -76.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.854 2.37 . . . . 2.89 112.235 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -59.71 3.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.309 0.115 . . . . 5.28 111.309 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.65 -164.18 37.82 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.574 -0.822 . . . . 2.53 113.143 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.612 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mp -52.75 -41.37 63.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.31 0.244 . . . . 6.06 111.466 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.81 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 2.33 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 1.1 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 1.45 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.708 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.33 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.675 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.37 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 2.32 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 3.33 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.9 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.554 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 2.15 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.92 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.708 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.98 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.96 110.995 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 1.27 113.059 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.54 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.77 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.675 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 1.46 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 2.17 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 1.26 109.806 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.405 HG22 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.98 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 3.18 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.87 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 2.18 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 3.27 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.45 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 2.06 111.142 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.74 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 3.21 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 3.17 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 6.21 111.66 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 2.04 111.296 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.62 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 3.13 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.22 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.81 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 2.31 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 2.39 109.694 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 1.25 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 HD12 ' A' ' 62' ' ' LEU . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 2.12 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 2.05 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.84 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 1.23 110.862 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 1.12 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 2.37 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 1.37 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.88 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 19.1 t60 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.61 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 1.28 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG21 HG22 ' B' ' 304' ' ' THR . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 1.21 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 1.27 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 1.15 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD23 ' N ' ' A' ' 74' ' ' LEU . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 2.34 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.94 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.95 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 3.13 110.845 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.89 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 2.61 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 2.07 110.73 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 2.47 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 2.0 111.848 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt -119.94 128.51 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 2.19 110.007 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.76 135.96 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.361 . . . . 2.51 111.058 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.65 155.17 18.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.072 -0.513 . . . . 2.07 111.017 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -101.52 139.02 20.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 4.7 110.772 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 158.3 56.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.643 2.228 . . . . 2.28 112.405 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -146.14 -74.84 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.356 -0.383 . . . . 4.36 110.804 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.12 133.83 7.81 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.94 -0.647 . . . . 4.69 112.626 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.3 p -78.84 -36.56 42.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.489 0.185 . . . . 7.36 111.305 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.391 -0.368 . . . . 8.46 111.158 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.59 0.233 . . . . 4.83 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.554 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 -124.21 128.65 49.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.364 -0.38 . . . . 4.18 110.825 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.405 ' CG ' HG22 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.562 HG22 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 1.23 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 18.0 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.97 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.72 0.295 . . . . 3.67 111.355 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.0 159.29 35.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.123 -0.489 . . . . 2.47 111.265 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 mp -139.41 137.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.409 -0.589 . . . . 1.86 109.409 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -106.72 91.44 3.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.257 0.551 . . . . 3.54 111.168 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 mt -88.79 132.85 34.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.147 -0.933 . . . . 2.63 111.698 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.597 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.4 mp -88.3 118.15 33.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.326 -0.852 . . . . 2.44 110.37 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -63.43 110.61 2.0 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.382 -0.372 . . . . 3.61 111.181 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.25 174.82 28.97 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.128 -0.558 . . . . 1.79 112.527 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.63 60.09 6.47 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.317 2.678 . . . . 2.89 112.297 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -160.95 -67.13 0.06 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 5.28 110.501 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.59 -144.36 11.57 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.099 -0.572 . . . . 2.53 112.604 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp -87.23 -50.0 6.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 6.06 110.686 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.81 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 2.33 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.523 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 1.1 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 1.45 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.33 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.37 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 2.32 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 3.33 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.9 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.594 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.7 p-10 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 2.15 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.92 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.7 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 70.0 t60 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.98 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.96 110.883 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 1.27 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.54 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.77 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 1.46 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 2.17 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 1.26 109.756 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 ' HB3' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.98 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 3.18 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.87 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 2.18 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 3.27 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.45 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 2.06 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' HB2' HG23 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.74 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 3.21 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 3.17 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 6.21 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 2.04 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.62 110.413 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 3.13 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.22 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.81 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 2.31 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 2.39 109.616 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 1.25 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 62' ' ' LEU . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 2.12 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 2.05 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.84 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 1.23 110.888 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 1.12 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.521 ' HG ' HG12 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 2.37 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 1.37 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.88 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.594 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.61 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 1.28 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 1.21 111.128 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 1.27 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 1.15 111.001 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 2.34 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.94 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.95 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 3.13 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.89 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.597 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 2.61 110.891 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 2.07 109.796 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 2.47 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 2.0 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp -119.27 132.71 55.94 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 2.19 109.914 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 78.4 t -121.21 139.73 47.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.804 0.335 . . . . 2.51 111.49 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.77 142.78 29.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.886 -0.597 . . . . 2.07 110.762 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.0 108.3 37.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 4.7 110.875 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.23 117.53 5.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.61 2.207 . . . . 2.28 112.42 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -144.08 102.3 3.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.658 0.266 . . . . 4.36 110.532 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 96.87 1.96 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.953 -0.642 . . . . 4.69 112.331 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 m -77.42 -51.03 11.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.494 0.188 . . . . 7.36 111.229 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.796 0.332 . . . . 8.46 110.89 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.676 0.274 . . . . 4.83 111.59 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 -160.94 140.33 10.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.172 -0.467 . . . . 4.18 111.034 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.461 ' HB3' HG23 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 1.23 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.97 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.89 0.376 . . . . 3.67 111.423 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pt-20 -87.16 143.71 27.17 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.098 -0.501 . . . . 2.47 110.834 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 61.8 mt -142.32 95.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.339 -0.391 . . . . 1.86 110.711 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -95.26 146.66 24.19 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.303 -0.408 . . . . 3.54 109.964 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.15 167.76 23.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.083 -0.339 . . . . 2.63 110.083 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -96.26 121.83 47.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.867 0.365 . . . . 2.44 110.747 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 107.69 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.155 -0.475 . . . . 3.61 111.107 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.54 -166.09 34.9 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.895 -0.593 . . . . 1.79 112.527 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.62 54.75 4.9 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.325 2.683 . . . . 2.89 112.538 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -143.72 -79.87 0.2 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.587 -0.279 . . . . 5.28 110.834 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.75 162.25 9.76 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.929 -0.653 . . . . 2.53 112.794 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp -44.05 -54.28 5.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.544 0.338 . . . . 6.06 111.572 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.81 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 2.33 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 1.1 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 1.45 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.739 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.33 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.723 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.37 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 2.32 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 3.33 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.9 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 2.15 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.92 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.739 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 75.0 t60 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.98 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.96 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 1.27 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.54 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.42 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.77 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.723 HD11 ' HA3' ' A' ' 18' ' ' GLY . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 1.46 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 2.17 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG21 HD23 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 1.26 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.98 113.447 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 3.18 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.87 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 2.18 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 3.27 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.45 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 2.06 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.74 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 3.21 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 3.17 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 6.21 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.499 HD23 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 2.04 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.62 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 3.13 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.22 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.81 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 2.31 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.594 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 2.39 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 1.25 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' HD13 ' A' ' 62' ' ' LEU . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 2.12 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 2.05 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.84 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 1.23 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.46 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 1.12 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.634 ' CD1' ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 2.37 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 1.37 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.88 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.569 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.61 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' HB1' ' CG2' ' A' ' 31' ' ' ILE . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 1.28 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.494 HG21 HG22 ' B' ' 304' ' ' THR . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 1.21 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.574 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 1.27 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 1.15 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.474 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 2.34 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.94 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.95 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 3.13 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.89 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 2.61 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 2.07 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.444 ' CE2' ' HB2' ' A' ' 2' ' ' GLU . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 2.47 108.829 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.453 HD12 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 2.0 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.74 143.05 47.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 2.19 109.937 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.507 ' C ' ' HB2' ' A' ' 55' ' ' LEU . 48.7 t -124.96 138.3 54.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.706 0.289 . . . . 2.51 110.744 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -94.49 148.71 21.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.225 -0.443 . . . . 2.07 111.34 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -112.65 90.33 14.74 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.042 -0.526 . . . . 4.7 110.8 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 35.3 Cg_exo -57.25 131.36 44.5 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.795 2.33 . . . . 2.28 111.9 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -144.3 113.99 7.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.825 0.345 . . . . 4.36 111.2 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.78 33.5 68.15 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.972 -0.558 . . . . 4.69 113.162 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 m -64.76 -36.49 84.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.741 0.27 . . . . 7.36 111.237 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 p80 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 8.46 111.079 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 18.6 mtt180 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.716 0.293 . . . . 4.83 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.471 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 -128.03 130.15 47.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.161 -0.472 . . . . 4.18 110.984 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.494 HG22 HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 1.23 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.97 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.477 HG11 HG12 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.749 0.309 . . . . 3.67 111.33 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.19 150.99 38.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.208 -0.451 . . . . 2.47 111.154 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.6 mt -143.23 95.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.103 -0.499 . . . . 1.86 110.381 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.23 147.59 23.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.035 -0.53 . . . . 3.54 110.285 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.22 170.41 19.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.712 -0.477 . . . . 2.63 109.712 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.8 tt -90.33 122.6 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.805 0.336 . . . . 2.44 110.789 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 28.4 tptt -76.47 121.53 23.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.24 -0.436 . . . . 3.61 111.469 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.44 168.61 28.27 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.906 -0.588 . . . . 1.79 112.662 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.26 -40.53 58.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.909 2.406 . . . . 2.89 112.638 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -52.1 -66.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.319 -0.4 . . . . 5.28 111.079 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.85 -145.98 14.46 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.959 -0.639 . . . . 2.53 112.416 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.7 mt -86.99 -54.13 4.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 6.06 110.471 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.81 113.412 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 2.33 110.708 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 1.1 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.494 ' HB ' HG21 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 1.45 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.64 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.33 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.743 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.37 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 2.32 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 3.33 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.9 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.531 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 2.15 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.92 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.64 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.98 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.96 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 1.27 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.54 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.77 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.743 HD11 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 1.46 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 2.17 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 50' ' ' ILE . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 1.26 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.414 HG23 ' HG2' ' B' ' 303' ' ' GLU . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.98 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 3.18 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.87 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 2.18 110.913 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 3.27 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.45 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 2.06 110.779 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.45 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.74 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 3.21 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 3.17 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 6.21 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 2.04 111.454 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.62 110.016 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 HG23 HG11 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 3.13 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.22 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.81 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.41 HD23 HG23 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 2.31 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.511 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 2.39 110.317 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 1.25 112.086 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.554 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 2.12 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 2.05 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.84 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 1.23 110.762 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 1.12 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD11 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 2.37 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 1.37 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.88 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.3 t60 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.61 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.445 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 1.28 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG22 ' CG2' ' B' ' 304' ' ' THR . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 1.21 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 1.27 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 1.15 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.482 HD21 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 2.34 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.94 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.95 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 3.13 112.55 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.89 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 2.61 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 2.07 110.441 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 2.47 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 2.0 112.034 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -121.47 138.4 54.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 2.19 109.582 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 53' ' ' LYS . 98.3 t -121.9 138.91 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.839 0.352 . . . . 2.51 111.256 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.511 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -85.8 143.19 28.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 2.07 111.029 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -86.52 115.14 61.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 4.7 110.811 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.484 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 30.4 Cg_endo -66.02 156.22 65.62 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.5 2.133 . . . . 2.28 112.401 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -137.52 145.87 43.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.249 -0.432 . . . . 4.36 111.09 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.39 126.68 7.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.142 -0.552 . . . . 4.69 112.469 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.5 p -75.55 -40.86 56.25 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.538 0.209 . . . . 7.36 110.969 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.231 0.13 0 CA-C-N 116.4 -0.364 . . . . 8.46 110.987 179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.82 0.343 . . . . 4.83 111.121 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.531 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -122.27 143.66 49.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.119 -0.491 . . . . 4.18 111.137 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.414 ' HG2' HG23 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.516 ' CG2' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 1.23 111.336 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.97 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 29.5 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.101 0.477 . . . . 3.67 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' HB3' ' CE ' ' A' ' 84' ' ' LYS . 1.1 pm0 -81.43 142.71 32.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.899 -0.591 . . . . 2.47 111.155 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.1 mp -144.5 111.77 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.049 -0.523 . . . . 1.86 110.593 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -103.63 149.17 25.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.003 -0.544 . . . . 3.54 110.292 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 mt -150.06 170.9 17.81 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.043 -0.355 . . . . 2.63 110.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -95.69 121.38 46.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.062 -0.347 . . . . 2.44 110.062 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -54.07 135.8 42.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.127 -0.488 . . . . 3.61 111.783 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.73 -153.73 30.44 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.006 -0.543 . . . . 1.79 112.469 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.34 -74.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.763 2.309 . . . . 2.89 112.503 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.895 -0.138 . . . . 5.28 111.36 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.94 -114.66 0.4 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.656 -0.783 . . . . 2.53 112.922 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? -87.09 -50.4 6.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 6.06 110.794 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.81 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 2.33 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.532 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 1.1 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 1.45 110.8 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.752 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.33 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.651 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.37 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 2.32 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 3.33 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.9 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 2.15 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.92 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.752 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 78.2 t60 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.98 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.96 110.85 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 1.27 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.54 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 53' ' ' LYS . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.77 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.651 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 1.46 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 2.17 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 1.26 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.456 ' CB ' ' HG2' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.98 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 3.18 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HG21 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.87 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 2.18 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 3.27 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.45 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' HB2' HD13 ' A' ' 36' ' ' ILE . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 2.06 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.435 ' HB2' HG21 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.74 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 3.21 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 3.17 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 6.21 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 2.04 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.62 110.4 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 3.13 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.22 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.533 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.81 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 2.31 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 2.39 110.46 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 1.25 112.117 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 54' ' ' LEU . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 2.12 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 72.2 m-80 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 2.05 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.84 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 1.23 110.527 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 1.12 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 2.37 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 1.37 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.88 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.575 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.5 t60 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.61 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' ILE . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 1.28 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG22 HG23 ' B' ' 304' ' ' THR . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 1.21 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.442 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 1.27 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 1.15 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' N ' HD21 ' A' ' 74' ' ' LEU . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 2.34 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.442 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.94 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.95 111.312 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 3.13 111.225 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.89 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 2.61 110.178 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 2.07 111.81 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 2.47 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 2.0 111.316 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.42 ' CE ' ' HB3' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -120.51 129.99 54.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 2.19 109.804 179.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 1' ' ' MET . 84.1 t -112.62 138.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.418 -0.355 . . . . 2.51 111.214 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.434 ' N ' HG12 ' A' ' 85' ' ' VAL . . . -97.7 149.22 22.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.234 -0.439 . . . . 2.07 111.022 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -105.98 112.76 64.19 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 4.7 111.064 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.81 168.35 10.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.836 2.358 . . . . 2.28 112.296 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.5 p -122.58 109.14 13.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.251 -0.431 . . . . 4.36 111.108 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.0 122.16 5.94 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.053 -0.594 . . . . 4.69 112.496 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -87.66 -51.52 5.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.586 0.232 . . . . 7.36 110.997 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.8 m170 . . . . . 0 N--CA 1.463 0.183 0 CA-C-N 116.268 -0.424 . . . . 8.46 110.959 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.76 0.314 . . . . 4.83 111.373 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 -143.0 115.77 8.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.161 -0.472 . . . . 4.18 110.856 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.548 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 1.23 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.516 0.198 . . . . 3.67 111.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.01 158.29 28.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.789 0.328 . . . . 2.47 111.125 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.02 141.46 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.524 -0.547 . . . . 1.86 109.524 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.14 91.14 4.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.169 0.509 . . . . 3.54 111.374 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 72.9 mt -88.76 124.16 33.87 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.414 -0.812 . . . . 2.63 111.16 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 15.2 tt -95.57 131.16 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.897 -0.592 . . . . 2.44 111.183 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.07 114.22 2.49 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.504 -0.316 . . . . 3.61 111.424 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.81 -149.68 19.56 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.014 -0.539 . . . . 1.79 112.665 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.76 4.42 4.11 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.224 2.616 . . . . 2.89 113.391 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 -69.98 0.17 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 110.442 -0.206 . . . . 5.28 110.442 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.08 18.09 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.981 -0.628 . . . . 2.53 112.965 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.453 ' HA ' ' HB1' ' A' ' 41' ' ' ALA . 28.2 mt -42.96 -58.39 2.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.694 0.398 . . . . 6.06 111.884 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.81 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 2.33 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 1.1 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.46 HD11 HG12 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 1.45 110.864 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.698 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.33 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.37 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 2.32 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 3.33 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.9 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 2.15 109.548 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.92 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.98 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.96 110.993 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 1.27 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.54 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.77 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 1.46 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 2.17 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 1.26 110.685 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.524 HG23 ' HG2' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.98 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 3.18 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.87 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 2.18 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 3.27 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.45 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 2.06 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.74 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 3.21 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 3.17 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 6.21 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 2.04 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.62 110.258 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 3.13 111.191 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.22 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.81 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.499 ' HB3' HD23 ' A' ' 62' ' ' LEU . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 2.31 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 2.39 110.088 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 1.25 111.969 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' A' ' 62' ' ' LEU . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 2.12 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 2.05 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.84 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 1.23 110.519 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 1.12 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.556 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 2.37 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 1.37 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.481 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.88 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.56 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.9 t60 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.61 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 1.28 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 1.21 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.517 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 1.27 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 1.15 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 2.34 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.94 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.95 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 3.13 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.89 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 2.61 110.678 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 2.07 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 2.47 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 2.0 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -117.66 122.47 43.63 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 2.19 110.467 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 75.8 t -114.89 132.13 65.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.663 0.268 . . . . 2.51 110.996 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -86.51 155.14 20.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.246 -0.434 . . . . 2.07 111.416 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.37 128.77 25.63 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.195 -0.457 . . . . 4.7 110.856 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.12 152.5 72.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.716 2.278 . . . . 2.28 112.84 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -130.84 138.58 49.92 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.874 -0.603 . . . . 4.36 110.735 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.72 106.16 1.79 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 4.69 112.638 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -72.45 -55.79 6.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.589 0.233 . . . . 7.36 110.933 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.832 0.349 . . . . 8.46 110.862 179.698 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.736 0.303 . . . . 4.83 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -153.13 132.4 12.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.115 -0.493 . . . . 4.18 110.844 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.446 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 1.23 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 20.0 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.97 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mmt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.815 0.34 . . . . 3.67 111.306 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 159.21 35.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.216 -0.447 . . . . 2.47 111.126 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.503 HG21 ' HD3' ' A' ' 47' ' ' LYS . 4.4 mp -131.66 140.82 47.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.236 -0.653 . . . . 1.86 109.236 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HG2' ' HE1' ' A' ' 80' ' ' PHE . 5.3 tttm -98.95 89.65 4.36 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.343 0.592 . . . . 3.54 111.388 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' HG ' HG22 ' A' ' 3' ' ' ILE . 74.2 mt -89.36 112.67 23.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.256 -0.884 . . . . 2.63 111.705 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.36 127.56 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.904 -0.589 . . . . 2.44 110.475 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -51.53 113.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.442 -0.345 . . . . 3.61 111.599 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.07 24.31 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.043 -0.599 . . . . 1.79 112.211 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.91 -81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.555 2.17 . . . . 2.89 111.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.28 -69.29 0.25 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.405 0.145 . . . . 5.28 111.287 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.59 -114.47 0.4 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.597 -0.811 . . . . 2.53 113.18 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp -87.09 -51.02 6.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 6.06 111.118 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.81 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 2.33 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 1.1 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 1.45 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.691 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.33 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.37 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 2.32 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 3.33 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.9 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 2.15 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 5.3 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.92 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.691 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 70.4 t60 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.98 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.96 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 1.27 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.54 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.77 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.623 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 1.46 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 2.17 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 50' ' ' ILE . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 1.26 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.98 113.014 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 3.18 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.87 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 2.18 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 3.27 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.45 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 2.06 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.463 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.74 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 3.21 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 3.17 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.503 ' HD3' HG21 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 6.21 111.047 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 2.04 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.62 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.401 HG22 HG13 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 3.13 111.181 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.22 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.81 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 2.31 111.989 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 2.39 109.811 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 1.25 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 62' ' ' LEU . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 2.12 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 2.05 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.84 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 1.23 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 1.12 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 57' ' ' VAL . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 2.37 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 1.37 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.88 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.563 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.5 t60 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.61 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HB1' HG23 ' A' ' 31' ' ' ILE . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 1.28 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 ' HA ' HG11 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 1.21 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 1.27 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 1.15 111.166 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.486 HD22 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 2.34 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.94 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.95 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.573 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 3.13 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.89 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' HE1' ' HG2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 2.61 111.251 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 2.07 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 2.47 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 2.0 112.014 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -115.08 113.15 23.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 2.19 109.705 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.83 133.16 65.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.969 0.414 . . . . 2.51 111.614 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.33 155.76 16.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.796 -0.638 . . . . 2.07 111.172 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.97 139.19 24.46 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.438 -0.346 . . . . 4.7 110.785 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.92 160.3 50.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.609 2.206 . . . . 2.28 112.71 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -132.13 125.7 31.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.05 -0.523 . . . . 4.36 110.772 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.28 119.25 5.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.98 -0.628 . . . . 4.69 112.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.0 p -77.54 -40.95 40.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.512 0.196 . . . . 7.36 111.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.452 -0.34 . . . . 8.46 110.944 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.66 0.267 . . . . 4.83 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 -146.32 133.19 20.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.273 -0.421 . . . . 4.18 111.136 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.97 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.826 0.345 . . . . 3.67 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -126.02 159.15 33.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.981 -0.554 . . . . 2.47 111.008 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.6 131.34 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.98 -0.748 . . . . 1.86 108.98 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 91.18 4.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.287 0.565 . . . . 3.54 111.673 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 81' ' ' VAL . 32.0 mt -94.59 129.49 41.4 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.199 -0.91 . . . . 2.63 111.224 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.562 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -89.74 127.54 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.184 -0.462 . . . . 2.44 111.037 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -59.07 124.15 19.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.043 -0.526 . . . . 3.61 111.849 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.09 -171.89 14.05 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.81 -0.632 . . . . 1.79 112.633 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.99 -40.0 81.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.901 2.4 . . . . 2.89 112.472 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -79.12 -63.11 1.49 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.272 -0.422 . . . . 5.28 110.458 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.4 -116.77 2.36 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.147 -0.549 . . . . 2.53 112.354 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt -87.54 -50.05 6.78 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 6.06 110.7 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.81 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 2.33 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.513 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 1.1 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 1.45 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.695 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.33 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.712 ' HA3' HD11 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.37 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 2.32 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 3.33 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.9 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 2.15 110.426 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.92 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.695 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 64.6 t60 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.98 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.96 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.427 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 1.27 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.54 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.77 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.712 HD11 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 1.46 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 2.17 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.427 HG21 HD23 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 1.26 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.46 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.98 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 3.18 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.87 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 2.18 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 3.27 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.45 111.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 2.06 111.279 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.44 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.74 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 3.21 111.522 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 3.17 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 6.21 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD23 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 2.04 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.62 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 3.13 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.22 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.72 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.81 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.457 HD23 HG21 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 2.31 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 2.39 110.134 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 1.25 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.474 ' CG2' HD23 ' A' ' 62' ' ' LEU . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 2.12 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 2.05 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.84 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 1.23 110.645 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 1.12 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 2.37 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 1.37 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.88 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.61 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 1.28 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG22 HG22 ' B' ' 304' ' ' THR . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 1.21 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 1.27 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 1.15 110.996 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 2.34 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.94 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.95 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.441 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 3.13 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.89 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.562 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 2.61 110.563 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 2.07 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 2.47 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 2.0 112.094 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 2.7 mmpt? -110.83 110.26 20.79 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 2.19 109.582 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 86.3 t -110.98 132.42 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.447 -0.342 . . . . 2.51 111.401 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.588 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -98.8 154.46 17.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.991 -0.55 . . . . 2.07 111.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.02 131.6 24.09 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 4.7 110.806 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.12 151.37 35.16 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.773 2.316 . . . . 2.28 112.497 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.9 p -150.45 168.39 24.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.038 -0.528 . . . . 4.36 111.034 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.54 90.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.028 -0.533 . . . . 4.69 113.194 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -75.87 -41.24 52.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.572 0.186 . . . . 7.36 111.002 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.872 0.368 . . . . 8.46 111.104 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.608 0.242 . . . . 4.83 111.273 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -147.18 157.83 43.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.3 -0.409 . . . . 4.18 111.151 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.47 HG22 HG22 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 1.23 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.97 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.534 HG22 HD11 ' A' ' 12' ' ' LEU . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.52 0.2 . . . . 3.67 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -124.85 158.73 32.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.585 -0.279 . . . . 2.47 110.952 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.91 138.53 27.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.45 -0.574 . . . . 1.86 109.45 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -102.39 91.22 4.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 3.54 110.997 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.412 HD23 ' HB1' ' A' ' 41' ' ' ALA . 10.4 mt -89.19 126.82 35.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.35 -0.841 . . . . 2.63 111.327 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -91.87 127.1 44.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 2.44 110.811 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -61.82 113.81 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.277 -0.42 . . . . 3.61 111.399 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.46 -149.59 21.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.585 -0.606 . . . . 1.79 111.585 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.27 -82.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.237 1.958 . . . . 2.89 111.028 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -65.69 -59.91 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.336 -0.246 . . . . 5.28 110.336 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.88 -138.9 10.87 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.033 -0.603 . . . . 2.53 112.851 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.4 mp -37.07 -62.15 0.51 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.866 0.466 . . . . 6.06 111.81 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.81 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 2.33 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 1.1 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 1.45 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.33 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.619 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.37 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 2.32 113.06 178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 3.33 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.9 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 2.15 109.926 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.92 112.86 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.682 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 76.4 t60 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.98 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.96 110.66 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 1.27 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.54 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.77 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.619 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 1.46 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 2.17 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG23 HD23 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.98 113.252 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 3.18 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.87 110.817 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 2.18 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 3.27 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HB1' HD23 ' A' ' 5' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.45 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 2.06 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.74 111.773 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 3.21 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 3.17 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 6.21 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 HD23 HG23 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 2.04 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.62 110.197 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 3.13 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.22 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.705 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.81 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 2.31 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 2.39 109.882 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 1.25 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 2.12 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 2.05 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.84 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 1.23 110.503 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 1.12 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 HD13 ' HB1' ' A' ' 73' ' ' ALA . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 2.37 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 1.37 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.88 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 11.9 t60 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.61 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.532 ' HB3' HG23 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 1.28 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.487 HG22 HG21 ' B' ' 304' ' ' THR . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 1.21 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 1.27 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HB1' HD13 ' A' ' 62' ' ' LEU . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 1.15 111.53 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.502 HD12 HD11 ' A' ' 54' ' ' LEU . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 2.34 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.94 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.95 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 3.13 111.122 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.89 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.425 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 2.61 110.685 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 2.07 109.934 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 2.47 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 HD22 HG12 ' A' ' 85' ' ' VAL . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 2.0 111.829 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.6 mmmt -115.67 119.46 36.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 2.19 110.0 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 83' ' ' LEU . 22.3 m -122.54 134.1 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.822 0.344 . . . . 2.51 111.454 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.93 153.94 19.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.108 -0.496 . . . . 2.07 111.383 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -98.8 129.01 30.85 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.175 -0.466 . . . . 4.7 110.802 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.17 153.41 62.33 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.791 2.328 . . . . 2.28 112.486 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 p -144.95 -70.55 0.28 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.187 -0.46 . . . . 4.36 110.907 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.82 127.85 3.89 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.064 -0.589 . . . . 4.69 112.617 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -98.23 -45.17 6.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.56 0.219 . . . . 7.36 111.109 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.6 m80 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 8.46 111.018 -179.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.682 0.277 . . . . 4.83 111.235 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 -134.71 130.98 37.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.251 -0.431 . . . . 4.18 111.002 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.487 HG21 HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 1.23 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.97 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.747 0.308 . . . . 3.67 111.468 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.38 156.59 32.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.165 -0.47 . . . . 2.47 111.282 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.42 HG12 ' HD3' ' A' ' 47' ' ' LYS . 4.1 mp -146.43 115.38 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.855 -0.611 . . . . 1.86 109.402 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -80.7 91.19 5.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.23 0.538 . . . . 3.54 111.14 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.39 137.19 32.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.309 -0.859 . . . . 2.63 112.002 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 80' ' ' PHE . 4.0 tt -89.4 153.09 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.212 -0.904 . . . . 2.44 109.939 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -84.87 133.41 34.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.651 0.262 . . . . 3.61 110.524 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.29 -170.59 36.33 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.944 -0.646 . . . . 1.79 112.383 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.3 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.579 2.186 . . . . 2.89 111.984 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -62.95 -63.88 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.49 0.186 . . . . 5.28 111.074 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.74 -136.35 2.24 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 2.53 112.802 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.579 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt -73.47 -39.47 64.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 6.06 111.343 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.81 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.579 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 2.33 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 1.1 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG22 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 1.45 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.705 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.33 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.663 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.37 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 2.32 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 3.33 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.9 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.667 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.0 p-10 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 2.15 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.92 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.705 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 55.3 t60 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.98 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.415 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.96 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 1.27 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.54 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.77 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.663 HD13 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 1.46 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 2.17 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 1.26 109.761 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.461 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.98 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 3.18 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.87 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 2.18 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 3.27 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.45 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 2.06 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.459 ' HB2' HG23 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.74 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 3.21 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 3.17 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HD3' HG12 ' A' ' 3' ' ' ILE . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 6.21 111.33 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 2.04 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.62 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.404 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 3.13 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.22 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.665 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.81 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 2.31 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 2.39 110.013 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 1.25 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 62' ' ' LEU . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 2.12 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 2.05 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.84 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 1.23 110.403 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 1.12 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' CG ' HG12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 2.37 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 1.37 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.412 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.88 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.667 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 24.6 t60 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.61 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 31' ' ' ILE . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 1.28 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 1.21 111.973 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 1.27 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 1.15 110.493 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 16' ' ' ILE . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 2.34 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.94 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.95 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 3.13 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.89 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.427 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 2.61 110.509 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 2.07 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 2.47 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 2.0 112.24 -178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -111.58 108.19 17.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 2.19 109.442 178.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 41.5 t -103.85 133.64 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.418 -0.356 . . . . 2.51 111.335 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -87.65 146.11 25.86 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.102 -0.499 . . . . 2.07 111.27 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -93.59 125.79 52.4 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 4.7 110.868 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.17 142.36 86.81 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 2.28 112.584 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.9 p -144.91 162.5 36.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 4.36 111.049 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.88 127.69 1.28 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.832 -0.699 . . . . 4.69 112.842 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m -76.29 -46.05 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.519 0.199 . . . . 7.36 110.945 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.378 -0.374 . . . . 8.46 110.846 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.818 0.342 . . . . 4.83 111.551 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 -148.38 128.87 13.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 4.18 110.734 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.537 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.476 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 1.23 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.592 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.97 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.403 HG23 HD13 ' A' ' 12' ' ' LEU . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.816 0.341 . . . . 3.67 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.505 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 1.6 mp0 -77.7 145.05 36.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.149 -0.478 . . . . 2.47 110.526 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 mt -144.11 99.18 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.301 -0.409 . . . . 1.86 110.606 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -95.08 148.92 21.84 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.122 -0.696 . . . . 3.54 109.122 178.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.29 170.12 18.62 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.705 0.288 . . . . 2.63 110.708 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.35 124.29 50.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.14 -0.482 . . . . 2.44 110.549 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -55.49 127.94 32.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.485 . . . . 3.61 111.86 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.11 -149.88 26.05 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.729 -0.668 . . . . 1.79 112.073 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.9 -78.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.63 2.22 . . . . 2.89 111.735 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -59.82 3.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.603 0.239 . . . . 5.28 110.918 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.16 -145.3 16.15 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.884 -0.674 . . . . 2.53 112.876 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.432 HD22 HG23 ' B' ' 306' ' ' VAL . 10.0 mp -36.95 -62.35 0.49 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.804 0.442 . . . . 6.06 111.742 -179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.81 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 2.33 110.356 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 1.1 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 1.45 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.699 ' HB2' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.33 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.479 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.37 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 2.32 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 3.33 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.9 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.565 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 2.15 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.92 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 58.1 t60 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.98 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.96 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 1.27 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.54 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.77 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 1.46 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 2.17 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 1.26 110.348 178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.98 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 3.18 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.87 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 2.18 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 3.27 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.45 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 2.06 110.941 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.52 ' HB2' HG21 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.74 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 3.21 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 3.17 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 6.21 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 2.04 111.236 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.62 110.479 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 3.13 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.22 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.81 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.501 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 2.31 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 2.39 110.158 179.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 1.25 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 54' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 2.12 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 2.05 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.84 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 1.23 110.758 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 1.12 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD2' HD13 ' A' ' 54' ' ' LEU . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 2.37 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 1.37 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.88 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.565 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.61 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 1.28 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 1.21 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 1.27 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 1.15 111.39 -179.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 2.34 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.94 111.839 -179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.95 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 3.13 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.89 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 2.61 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 2.07 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 2.47 110.142 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 2.0 111.879 -178.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HE3' ' HG3' ' A' ' 2' ' ' GLU . 1.9 mtpt -118.12 117.42 29.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 2.19 109.957 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 60.4 t -105.5 139.73 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 2.51 111.109 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . . . -84.85 138.08 32.77 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.156 -0.475 . . . . 2.07 110.886 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 108.43 60.58 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.249 -0.432 . . . . 4.7 111.039 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 143.01 43.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.785 2.323 . . . . 2.28 112.352 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.3 m -140.64 -69.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.424 -0.353 . . . . 4.36 110.896 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.43 98.62 0.18 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.92 -0.657 . . . . 4.69 112.674 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.8 p -76.15 -40.36 52.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.469 0.176 . . . . 7.36 111.263 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.426 -0.352 . . . . 8.46 111.044 -179.888 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 5.7 ptm180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.69 0.281 . . . . 4.83 111.465 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.1 157.76 44.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.112 -0.495 . . . . 4.18 110.968 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.644 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 1.23 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.97 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.432 HG23 HD22 ' A' ' 12' ' ' LEU . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.707 0.289 . . . . 3.67 111.42 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -106.68 148.48 28.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.239 -0.437 . . . . 2.47 110.897 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -143.75 95.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.19 -0.459 . . . . 1.86 110.455 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.06 142.81 26.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.54 -0.541 . . . . 3.54 109.54 179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.69 171.06 17.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.236 -0.283 . . . . 2.63 110.236 -179.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -89.96 139.28 17.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.747 -0.464 . . . . 2.44 109.747 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.38 134.49 44.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.793 0.33 . . . . 3.61 111.633 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.3 168.61 13.11 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.866 -0.606 . . . . 1.79 112.447 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.57 79.57 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.083 2.522 . . . . 2.89 112.498 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -173.94 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.001 -0.545 . . . . 5.28 110.837 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.16 -175.0 46.1 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.925 -0.655 . . . . 2.53 112.78 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -71.59 -38.17 70.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 6.06 111.604 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.81 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 2.33 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.537 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 1.1 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 1.45 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.67 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.33 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.37 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 2.32 112.998 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 3.33 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.9 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 2.15 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.92 113.027 -178.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.67 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 75.7 t60 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.98 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.96 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 1.27 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.54 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.77 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.631 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 1.46 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 2.17 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' CG2' HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 1.26 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.98 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 3.18 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.87 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 2.18 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 3.27 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.45 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 2.06 111.121 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.74 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 3.21 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 3.17 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 6.21 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 2.04 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 1.6 pm0 -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.62 110.279 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 3.13 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.22 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.81 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 2.31 111.95 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 2.39 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 1.25 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 2.12 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 2.05 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.84 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 1.23 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 1.12 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.497 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 2.37 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 1.37 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.88 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.1 t60 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.61 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 1.28 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG21 HG21 ' B' ' 304' ' ' THR . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 1.21 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 1.27 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 1.15 110.945 -179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.494 ' HB3' HD12 ' A' ' 12' ' ' LEU . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 2.34 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.94 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.95 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 3.13 111.476 -179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.89 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 2.61 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 2.07 110.993 179.569 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 2.47 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 2.0 112.007 -178.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -119.05 113.8 21.51 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 2.19 110.563 179.379 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 53' ' ' LYS . 22.6 t -119.93 130.82 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.141 -0.481 . . . . 2.51 110.366 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.41 ' HB1' ' HG3' ' A' ' 53' ' ' LYS . . . -84.88 150.34 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.411 -0.359 . . . . 2.07 111.019 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -100.68 119.99 57.06 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.308 -0.405 . . . . 4.7 110.959 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.11 131.19 18.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.727 2.285 . . . . 2.28 112.214 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -129.19 -64.06 0.92 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.69 -0.232 . . . . 4.36 110.876 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.37 119.59 2.73 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.013 -0.613 . . . . 4.69 112.455 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.6 m -69.58 -48.32 60.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.482 0.182 . . . . 7.36 111.144 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 CA-C-O 120.812 0.339 . . . . 8.46 110.928 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.742 0.306 . . . . 4.83 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 -95.44 143.43 26.78 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.392 -0.367 . . . . 4.18 110.908 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 1.23 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.97 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.953 0.406 . . . . 3.67 111.186 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 143.78 37.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.039 -0.528 . . . . 2.47 111.045 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -144.3 95.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.156 -0.475 . . . . 1.86 110.465 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 149.8 23.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 3.54 110.281 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.49 170.51 18.43 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.644 0.259 . . . . 2.63 110.331 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -94.42 126.11 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.529 -0.305 . . . . 2.44 110.798 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -60.82 125.36 23.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.298 -0.41 . . . . 3.61 111.288 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.4 179.79 29.54 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.878 -0.601 . . . . 1.79 112.396 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.13 46.1 2.15 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.284 2.656 . . . . 2.89 112.74 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -150.95 -60.09 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.573 -0.285 . . . . 5.28 110.894 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.16 -135.46 6.04 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.199 -0.524 . . . . 2.53 112.328 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD23 HD13 ' A' ' 74' ' ' LEU . 2.9 mp -86.41 -54.2 4.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.116 -0.327 . . . . 6.06 110.116 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.81 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 2.33 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 1.1 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 1.45 111.778 -178.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.719 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.33 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.658 ' HA3' HD13 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.37 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 2.32 113.948 177.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 3.33 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.9 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 2.15 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.92 113.012 -178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.719 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 71.9 t60 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.98 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.96 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 1.27 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.77 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.658 HD13 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 1.46 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 2.17 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 1.26 109.881 178.19 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.549 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.98 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 3.18 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.87 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 2.18 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 3.27 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.45 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 2.06 110.828 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.479 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.74 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 3.21 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 3.17 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 6.21 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 2.04 111.278 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.62 110.312 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 3.13 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.22 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.673 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.81 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 2.31 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 2.39 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 1.25 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 54' ' ' LEU . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 2.12 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 2.05 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.84 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 1.23 110.697 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 1.12 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD22 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 2.37 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 1.37 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.88 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.3 t60 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.61 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 1.28 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 1.21 111.246 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.418 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 1.27 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 1.15 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 2.34 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.94 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.95 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 3.13 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.89 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 2.61 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 2.07 110.624 179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 2.47 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.466 ' HG ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 2.0 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -119.2 110.75 17.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 2.19 110.274 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 88.0 t -104.21 135.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.291 -0.413 . . . . 2.51 110.902 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.421 ' HB2' ' HG3' ' A' ' 53' ' ' LYS . . . -88.35 144.91 26.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.365 -0.38 . . . . 2.07 111.242 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -110.46 121.04 42.45 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.236 -0.438 . . . . 4.7 110.947 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 57.1 Cg_endo -71.17 147.73 54.49 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.622 2.214 . . . . 2.28 112.512 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -142.03 -72.84 0.32 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.196 -0.456 . . . . 4.36 110.689 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.93 129.87 4.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.037 -0.602 . . . . 4.69 112.578 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.02 -43.79 8.73 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.459 0.171 . . . . 7.36 110.93 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.93 0.395 . . . . 8.46 111.229 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.653 0.263 . . . . 4.83 110.994 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 -145.66 120.98 10.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 4.18 111.037 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.549 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.454 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 1.23 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.97 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.621 0.248 . . . . 3.67 111.153 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -125.17 114.95 19.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.307 0.575 . . . . 2.47 111.335 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 33.0 mt -96.64 95.94 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.203 -0.908 . . . . 1.86 110.967 -179.095 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 92.28 8.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.715 -0.675 . . . . 3.54 110.505 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 41' ' ' ALA . 11.2 mt -87.75 146.27 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.228 -0.896 . . . . 2.63 112.453 -177.378 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.607 HG13 ' CE1' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -86.52 154.27 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.751 -1.113 . . . . 2.44 109.89 -178.367 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -112.94 120.14 40.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.816 0.341 . . . . 3.61 111.215 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -163.97 11.76 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.17 -0.538 . . . . 1.79 112.823 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.04 -38.17 95.16 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.982 2.454 . . . . 2.89 112.495 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.96 -60.02 2.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.472 -0.331 . . . . 5.28 110.283 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.77 -110.96 1.74 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.006 -0.616 . . . . 2.53 112.657 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 8.4 mp -87.4 -52.1 5.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.591 0.234 . . . . 6.06 110.869 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.81 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 2.33 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 1.1 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 1.45 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.33 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.37 115.318 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 2.32 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 3.33 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.9 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.484 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 2.15 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.92 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.676 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.98 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.96 111.368 -179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 1.27 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.54 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.77 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 1.46 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 2.17 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 HD22 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 1.26 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.98 113.139 -178.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 3.18 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.87 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 2.18 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 3.27 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.45 111.91 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 2.06 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.74 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 3.21 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 3.17 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 6.21 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 2.04 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.62 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 3.13 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.22 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.81 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 2.31 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.583 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 2.39 109.781 178.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 1.25 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 54' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 2.12 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 2.05 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.84 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 1.23 110.761 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 1.12 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 31' ' ' ILE . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 2.37 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 1.37 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.88 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.61 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 67' ' ' HIS . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 1.28 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' B' ' 304' ' ' THR . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 1.21 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 1.27 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 1.15 111.144 -179.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD2' HD23 ' A' ' 62' ' ' LEU . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 2.34 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.94 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.95 111.262 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 3.13 111.446 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.89 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.607 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 2.61 110.981 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 2.07 110.072 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 2.47 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 2.0 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -110.79 123.44 50.07 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 2.19 110.222 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 63.2 t -113.75 130.64 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.564 -0.289 . . . . 2.51 111.491 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.583 ' CB ' ' HB2' ' A' ' 55' ' ' LEU . . . -98.51 94.96 6.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.152 -0.476 . . . . 2.07 111.373 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -68.97 128.51 92.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.382 -0.372 . . . . 4.7 110.729 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 70.3 Cg_endo -71.41 155.64 59.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.034 2.489 . . . . 2.28 112.778 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.25 -69.87 0.37 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.127 -0.488 . . . . 4.36 110.895 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.28 73.71 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.813 -0.708 . . . . 4.69 112.582 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -72.46 -35.84 68.36 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.499 0.185 . . . . 7.36 111.499 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m170 . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.816 0.341 . . . . 8.46 110.928 -179.872 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.781 0.324 . . . . 4.83 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.484 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 -126.79 128.9 47.32 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.228 -0.442 . . . . 4.18 110.916 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.431 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 1.23 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.97 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.504 0.192 . . . . 3.67 111.362 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.08 157.13 35.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.391 -0.368 . . . . 2.47 111.081 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -147.11 125.84 4.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.654 -0.499 . . . . 1.86 109.654 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 91.68 8.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.101 0.477 . . . . 3.54 111.236 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -88.46 134.15 33.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.432 -0.804 . . . . 2.63 111.589 -178.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.504 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.8 mt -89.05 116.12 30.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.67 -0.696 . . . . 2.44 110.185 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.504 ' HD3' ' HA ' ' A' ' 77' ' ' THR . 0.9 OUTLIER -68.09 118.64 11.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 3.61 111.167 -179.504 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.97 -173.63 40.84 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.078 -0.582 . . . . 1.79 112.623 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.5 -57.8 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.906 2.404 . . . . 2.89 112.481 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.338 -0.392 . . . . 5.28 111.109 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.52 -140.5 3.08 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.232 -0.985 . . . . 2.53 113.686 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? -83.99 -44.83 13.76 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.783 -0.208 . . . . 6.06 111.181 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.81 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.611 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 2.33 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.643 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 1.1 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 1.45 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.33 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.37 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 2.32 112.957 178.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 3.33 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.9 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 2.15 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.92 112.756 -178.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.687 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 66.3 t60 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.98 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.96 110.563 -179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 1.27 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.54 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.687 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.77 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.623 HD12 ' HG ' ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 1.46 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 2.17 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 1.26 110.039 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.447 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.98 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 3.18 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.87 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 2.18 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 3.27 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.45 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 2.06 111.339 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.74 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 3.21 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 3.17 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 6.21 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 2.04 111.226 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.62 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 3.13 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.22 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.81 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.474 ' HB3' HD22 ' A' ' 62' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 2.31 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 2.39 109.652 178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 1.25 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 HG23 HD23 ' A' ' 62' ' ' LEU . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 2.12 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 2.05 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.84 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 1.23 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 1.12 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HG ' HD12 ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 2.37 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.687 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 1.37 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.88 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.517 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.61 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 67' ' ' HIS . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 1.28 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 1.21 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 1.27 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 1.15 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 2.34 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.94 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.95 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.504 ' HA ' ' HD3' ' A' ' 7' ' ' LYS . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 3.13 111.469 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.89 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 2.61 110.072 178.678 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 2.07 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 2.47 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 2.0 111.78 -178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -111.0 105.88 14.78 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 2.19 109.955 178.785 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 88.6 t -111.43 127.65 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.4 -0.364 . . . . 2.51 110.917 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.7 153.06 21.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.173 -0.467 . . . . 2.07 111.368 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.4 117.59 68.92 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.067 -0.515 . . . . 4.7 110.655 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.494 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -71.27 117.47 5.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.605 2.203 . . . . 2.28 112.45 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -158.03 132.83 8.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.781 0.324 . . . . 4.36 110.832 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.47 152.9 18.4 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.025 -0.607 . . . . 4.69 112.696 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 p -100.14 -50.81 3.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.635 0.255 . . . . 7.36 110.775 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 8.46 111.106 179.892 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.695 0.283 . . . . 4.83 111.235 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 -150.17 128.49 12.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 4.18 111.018 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.437 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 1.23 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.643 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.97 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.697 0.284 . . . . 3.67 111.068 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.5 pm0 -122.71 159.09 28.69 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 2.47 111.376 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 4' ' ' LYS . 4.2 mp -144.0 137.98 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.374 -0.602 . . . . 1.86 109.374 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -99.7 91.95 5.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.314 0.578 . . . . 3.54 111.189 -179.851 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mt -88.69 126.53 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.268 -0.878 . . . . 2.63 111.157 -178.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -91.33 129.72 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.699 -0.682 . . . . 2.44 111.187 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -47.73 117.79 2.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.371 -0.377 . . . . 3.61 111.362 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.08 -161.9 37.86 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.113 -0.565 . . . . 1.79 113.162 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.64 34.31 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.688 2.925 . . . . 2.89 113.025 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -176.3 -70.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.611 -0.268 . . . . 5.28 110.65 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.02 -162.82 36.61 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.014 -0.612 . . . . 2.53 112.582 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.595 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 16.2 mt -48.77 -43.42 37.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 6.06 111.512 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.81 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 2.33 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 1.1 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 1.45 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.709 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.33 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.707 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.37 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 2.32 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 3.33 110.47 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.9 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 2.15 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.92 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 68.1 t60 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.98 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.96 110.851 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 1.27 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.54 111.749 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.77 110.841 179.712 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.707 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 1.46 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 2.17 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 50' ' ' ILE . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 1.26 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.558 HG22 ' HG2' ' B' ' 303' ' ' GLU . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.98 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 3.18 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 42' ' ' ALA . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.87 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 2.18 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 3.27 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 12' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.45 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 2.06 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.74 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 3.21 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 3.17 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 6.21 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 2.04 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.62 110.403 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD13 HG11 ' A' ' 33' ' ' VAL . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 3.13 111.198 -179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.22 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.606 ' HG2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.81 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 2.31 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 2.39 109.6 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 1.25 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 2.12 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 2.05 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.84 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 1.23 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 1.12 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' HG ' ' CG1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 2.37 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 1.37 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.474 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.88 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.532 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.61 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.642 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG23 ' A' ' 31' ' ' ILE . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 1.28 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG22 HG23 ' B' ' 304' ' ' THR . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 1.21 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 1.27 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 1.15 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 2.34 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.94 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.95 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 3.13 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.89 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.401 ' CE2' ' HE3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 2.61 111.065 179.586 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 2.07 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 2.47 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 2.0 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.568 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -118.27 142.64 47.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 2.19 109.73 178.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 53' ' ' LYS . 62.0 t -127.61 138.93 53.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.778 0.323 . . . . 2.51 111.468 -179.094 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -97.01 153.09 18.12 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.079 -0.51 . . . . 2.07 111.353 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.22 89.83 18.5 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.181 -0.463 . . . . 4.7 110.785 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.483 ' HG3' ' HE2' ' A' ' 53' ' ' LYS . 59.2 Cg_endo -71.2 160.07 50.1 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.829 2.353 . . . . 2.28 112.537 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 p -97.63 -50.5 4.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.173 -0.467 . . . . 4.36 111.108 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.3 -143.72 25.18 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.062 -0.59 . . . . 4.69 112.632 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.7 m -99.9 -53.57 3.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.606 0.241 . . . . 7.36 110.864 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-N 116.313 -0.403 . . . . 8.46 110.824 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.871 0.367 . . . . 4.83 111.551 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -66.91 132.44 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.185 -0.461 . . . . 4.18 111.062 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.558 ' HG2' HG22 ' A' ' 34' ' ' THR . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.469 HG23 HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 1.23 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.97 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.453 HG12 ' HA ' ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.908 0.385 . . . . 3.67 111.098 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -130.62 159.17 37.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.919 -0.582 . . . . 2.47 111.091 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 mp -141.84 139.98 30.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.355 -0.609 . . . . 1.86 109.355 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 90.97 3.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.255 0.55 . . . . 3.54 111.37 -179.719 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.48 129.09 36.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.333 -0.849 . . . . 2.63 111.217 -179.31 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.77 127.52 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 2.44 111.071 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 107.72 5.38 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.196 -0.456 . . . . 3.61 110.762 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.66 -165.68 29.44 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.939 -0.648 . . . . 1.79 112.723 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.48 31.86 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.523 2.815 . . . . 2.89 113.205 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -132.72 -72.78 0.51 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.538 0.209 . . . . 5.28 110.797 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.47 171.74 13.18 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.071 -0.585 . . . . 2.53 112.673 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.2 mp -34.5 -62.08 0.36 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.836 0.454 . . . . 6.06 111.838 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.81 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 2.33 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 1.1 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.541 HG23 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 1.45 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.706 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.33 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.37 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 2.32 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 3.33 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.9 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 2.15 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.92 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.706 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.98 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.96 111.381 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 1.27 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.54 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.77 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.625 ' CD1' ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 1.46 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 2.17 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 1.26 110.04 178.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.98 113.043 -178.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 3.18 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.87 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 2.18 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 3.27 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.45 111.949 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 2.06 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.74 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 3.21 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 3.17 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 6.21 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 2.04 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.62 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 3.13 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.22 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.81 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 2.31 111.778 -178.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 2.39 110.184 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 1.25 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' CG2' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 2.12 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 2.05 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.84 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 1.23 110.722 179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 1.12 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 73' ' ' ALA . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 2.37 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 1.37 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.88 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.9 t60 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.61 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.581 ' HB3' ' CG2' ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 1.28 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG21 HG22 ' B' ' 304' ' ' THR . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 1.21 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 1.27 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HB2' HD13 ' A' ' 62' ' ' LEU . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 1.15 111.177 -179.497 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.541 ' CD2' HG23 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 2.34 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.94 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.95 111.334 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.502 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 3.13 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.89 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 2.61 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.502 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 2.07 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 2.47 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 2.0 111.941 -178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.1 129.02 55.3 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 2.19 110.215 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 96.0 t -122.12 134.69 64.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.899 0.38 . . . . 2.51 111.525 -179.418 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -105.76 155.54 19.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 2.07 110.491 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 19.9 tttm -113.54 104.91 55.35 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-O 120.589 0.233 . . . . 4.7 110.566 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 87' ' ' LYS . 18.7 Cg_endo -59.32 142.43 99.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.793 2.329 . . . . 2.28 112.537 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.0 t -162.69 140.63 8.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.247 -0.433 . . . . 4.36 111.048 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.24 71.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.069 -0.586 . . . . 4.69 113.326 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -76.45 -42.26 44.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.105 0.452 . . . . 7.36 111.158 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.4 m170 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.391 -0.368 . . . . 8.46 110.919 179.909 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.815 0.34 . . . . 4.83 111.156 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.558 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? -87.22 121.86 30.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.144 -0.48 . . . . 4.18 110.959 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.495 HG22 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 1.23 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.97 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.799 0.333 . . . . 3.67 111.441 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -113.18 159.12 19.6 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.19 -0.459 . . . . 2.47 111.257 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -141.5 141.23 30.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.246 -0.65 . . . . 1.86 109.246 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.41 90.9 3.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 3.54 111.064 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.483 HD22 ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.63 126.15 35.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.428 -0.805 . . . . 2.63 111.567 -178.702 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -93.51 128.81 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.646 -0.706 . . . . 2.44 110.831 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptt -54.74 116.19 2.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.863 0.363 . . . . 3.61 111.44 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.21 -170.52 45.04 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.866 -0.606 . . . . 1.79 112.811 -179.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.36 42.09 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.528 2.819 . . . . 2.89 113.41 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -171.38 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.762 -0.199 . . . . 5.28 110.586 179.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.66 -129.59 1.09 Allowed Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.867 -0.683 . . . . 2.53 112.719 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 7.0 mp -87.66 -49.37 7.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 6.06 111.195 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.81 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 2.33 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 1.1 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.41 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 1.45 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.69 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.33 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.509 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.37 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 2.32 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 3.33 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.9 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.46 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 2.15 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.92 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.69 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 66.5 t60 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.98 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.527 HG22 ' HD2' ' A' ' 26' ' ' PRO . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.96 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 25' ' ' ILE . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 1.27 112.165 -179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.54 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.77 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 1.46 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 2.17 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 50' ' ' ILE . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 1.26 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 303' ' ' GLU . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.98 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 3.18 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 HG23 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.87 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 2.18 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 3.27 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.45 111.975 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 2.06 111.015 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.453 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.74 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 3.21 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 3.17 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 6.21 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 2.04 111.006 179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.62 110.281 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.417 HG21 HG13 ' A' ' 33' ' ' VAL . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 3.13 111.327 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.22 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.642 ' HG2' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.81 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.489 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 2.31 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 2.39 109.701 178.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 1.25 110.98 179.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 2.12 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 2.05 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.84 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 1.23 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 1.12 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD21 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 2.37 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 1.37 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.451 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.88 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.538 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.61 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 67' ' ' HIS . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 1.28 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG12 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 1.21 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.594 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 1.27 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.41 ' HB2' HG13 ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 1.15 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 2.34 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.94 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.95 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 3.13 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.89 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 2.61 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 5' ' ' LEU . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 2.07 110.317 178.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 2.47 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 2.0 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.2 139.56 51.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 2.19 109.734 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG11 ' HG2' ' A' ' 53' ' ' LYS . 83.8 t -127.93 141.0 47.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.002 0.43 . . . . 2.51 111.402 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.3 139.69 32.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.765 -0.652 . . . . 2.07 110.85 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.0 107.83 25.74 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.367 -0.379 . . . . 4.7 111.054 -179.633 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.48 117.42 5.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.607 2.204 . . . . 2.28 112.396 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -138.01 -67.47 0.48 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.759 -0.2 . . . . 4.36 110.643 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.95 150.78 3.13 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.125 -0.56 . . . . 4.69 113.009 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 p -67.2 -39.04 86.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.58 0.229 . . . . 7.36 111.038 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.969 0.414 . . . . 8.46 110.907 179.806 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.769 0.319 . . . . 4.83 111.067 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.46 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 -106.02 129.3 54.16 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.121 -0.49 . . . . 4.18 110.953 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.437 ' HG2' HG22 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.479 HG21 HG23 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.97 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.86 0.362 . . . . 3.67 111.271 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.555 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.3 pm0 -131.05 159.42 37.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.026 -0.534 . . . . 2.47 110.863 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.55 136.53 35.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.43 -0.581 . . . . 1.86 109.43 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -99.98 91.22 4.7 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.351 0.596 . . . . 3.54 111.094 -179.833 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.523 ' HB2' HG13 ' A' ' 81' ' ' VAL . 8.2 mt -90.03 125.36 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.24 -0.891 . . . . 2.63 111.429 -179.186 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 tt -89.96 128.04 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.927 -0.579 . . . . 2.44 110.599 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.78 113.21 1.94 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 3.61 111.194 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 -178.98 35.12 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.054 -0.593 . . . . 1.79 112.714 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.09 48.63 2.93 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.424 2.749 . . . . 2.89 112.828 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -159.17 -61.23 0.07 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.661 0.267 . . . . 5.28 110.922 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.14 -140.43 8.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.201 -0.523 . . . . 2.53 112.1 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.5 mt -87.48 -49.6 7.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 6.06 110.444 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.81 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 2.33 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 1.1 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 1.45 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.33 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.37 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 2.32 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 3.33 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.9 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.617 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 2.15 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.92 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.699 ' HB2' ' HB1' ' A' ' 17' ' ' ALA . 57.1 t60 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.98 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.96 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 1.27 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.54 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.77 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 1.46 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 2.17 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 1.26 109.733 178.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.531 ' HB ' ' HG2' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.98 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 3.18 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.404 HD12 ' HB1' ' A' ' 42' ' ' ALA . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.87 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 2.18 111.439 -179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 3.27 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.45 112.144 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 2.06 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.74 111.201 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 3.21 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 3.17 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 6.21 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 2.04 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.62 110.206 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 3.13 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.22 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.81 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.487 HD11 ' CD2' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 2.31 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 2.39 110.122 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 1.25 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.527 ' CG2' HD23 ' A' ' 62' ' ' LEU . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 2.12 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 2.05 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.84 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 1.23 110.393 179.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 1.12 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 HD23 ' CG2' ' A' ' 57' ' ' VAL . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 2.37 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.676 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 1.37 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.88 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.61 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 1.28 110.852 178.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 1.21 110.94 179.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.63 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 1.27 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 1.15 111.148 -179.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.426 ' N ' HD21 ' A' ' 74' ' ' LEU . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 2.34 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.94 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.95 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 3.13 111.074 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.89 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.419 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 2.61 110.735 179.566 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 5' ' ' LEU . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 2.07 109.98 178.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 2.47 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 2.0 112.204 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -117.43 136.65 53.04 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 2.19 109.778 178.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' HG2' ' A' ' 53' ' ' LYS . 91.9 t -121.76 139.32 49.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.905 0.384 . . . . 2.51 111.568 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -89.69 146.33 24.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.921 -0.581 . . . . 2.07 111.221 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -92.22 118.41 68.12 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 116.326 -0.397 . . . . 4.7 110.89 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.54 156.81 62.9 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.576 2.184 . . . . 2.28 112.356 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -135.99 146.92 47.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.146 -0.479 . . . . 4.36 111.12 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.36 130.89 2.18 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.952 -0.642 . . . . 4.69 112.763 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p -79.14 -35.59 41.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.459 0.171 . . . . 7.36 111.235 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.848 0.356 . . . . 8.46 111.008 -179.948 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.8 0.334 . . . . 4.83 111.198 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 -149.74 121.04 7.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.103 -0.498 . . . . 4.18 110.547 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 1.23 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.97 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 12' ' ' LEU . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.859 0.361 . . . . 3.67 111.628 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -78.17 157.77 29.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.002 -0.544 . . . . 2.47 111.242 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.474 HG12 ' HD3' ' A' ' 47' ' ' LYS . 6.0 mt -139.6 139.91 37.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.552 -0.536 . . . . 1.86 109.552 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.596 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 4.4 tptt -103.89 90.69 3.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.226 0.536 . . . . 3.54 110.762 179.652 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.04 131.02 46.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.197 -0.91 . . . . 2.63 112.13 -178.389 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 17.2 tt -89.61 128.96 41.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.765 -0.652 . . . . 2.44 110.64 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -58.84 121.75 11.9 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.459 -0.337 . . . . 3.61 111.351 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.33 -149.88 17.46 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.842 -0.617 . . . . 1.79 112.212 179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.68 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.591 2.194 . . . . 2.89 111.555 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -60.73 -65.83 0.63 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.525 0.202 . . . . 5.28 110.618 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.79 -103.92 0.24 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.588 -0.815 . . . . 2.53 113.482 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.545 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.9 mp -87.35 -46.32 9.77 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 6.06 112.074 -178.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.81 113.012 -179.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 2.33 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 1.1 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.41 HD11 HG12 ' B' ' 306' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 1.45 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.725 ' CB ' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.33 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.37 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 2.32 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 3.33 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.9 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 2.15 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.92 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.725 ' HB2' ' CB ' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.98 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.96 111.362 -179.027 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 1.27 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.54 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.77 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 1.46 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.704 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 2.17 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 1.26 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.614 HG22 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.98 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 3.18 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.87 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 2.18 111.046 -179.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 3.27 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.45 111.751 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 2.06 111.19 179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.488 ' HB2' HG23 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.74 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 3.21 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 3.17 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HD3' HG12 ' A' ' 3' ' ' ILE . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 6.21 111.262 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 HD22 HG22 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 2.04 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.62 110.239 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.431 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 3.13 111.398 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.22 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.704 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.81 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 2.31 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 2.39 109.95 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 1.25 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 HG21 HD21 ' A' ' 54' ' ' LEU . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 2.12 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 2.05 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.84 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 1.23 110.262 179.298 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 1.12 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 31' ' ' ILE . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 2.37 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 1.37 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.88 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.545 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.1 t60 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.61 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.468 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.469 ' O ' HD22 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 1.28 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG23 HG22 ' B' ' 304' ' ' THR . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 1.21 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 1.27 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 1.15 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD11 HD21 ' A' ' 12' ' ' LEU . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 2.34 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.94 111.97 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.95 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.453 ' CG2' ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 3.13 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.89 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.596 ' CE2' ' HG3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 2.61 109.852 178.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' CG2' ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 2.07 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 2.47 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 2.0 111.761 -178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? -113.22 110.62 20.7 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 2.19 109.338 178.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.453 ' CG1' ' O ' ' A' ' 53' ' ' LYS . 39.7 t -108.67 133.57 53.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.454 -0.339 . . . . 2.51 111.157 -178.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -90.35 148.47 22.82 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.109 -0.496 . . . . 2.07 111.046 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.82 125.53 35.3 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.28 -0.418 . . . . 4.7 110.645 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.22 144.51 95.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.617 2.211 . . . . 2.28 112.236 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.61 100.44 0.58 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.234 -0.439 . . . . 4.36 110.537 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.18 129.68 49.92 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.069 -0.586 . . . . 4.69 112.934 -179.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 m -90.74 -33.68 15.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.533 0.206 . . . . 7.36 111.021 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.378 -0.373 . . . . 8.46 111.186 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 111.925 0.343 . . . . 4.83 111.925 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 302' ' ' ARG . . . . . 0.438 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 59.57 86.79 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 4.18 111.243 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 303' ' ' GLU . . . . . 0.614 ' HB3' HG22 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 304' ' ' THR . . . . . 0.458 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 1.23 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 305' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.97 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 16' ' ' ILE . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.768 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 5.6 mp . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 110.392 -0.225 . . . . 5.7 110.392 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.13 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.768 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 1.46 110.733 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 0.57 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.67 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.19 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.29 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 1.61 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 2.72 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.56 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 1.63 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.34 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.023 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.0 t-80 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.92 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.51 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.98 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.11 111.849 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.618 ' C ' HD13 ' A' ' 31' ' ' ILE . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.39 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 0.8 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 1.38 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD21 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.65 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.781 HG22 ' CD2' ' A' ' 24' ' ' HIS . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.39 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 2.54 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.4 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 2.8 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.0 111.694 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 1.82 111.051 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.39 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 2.66 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 2.49 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 5.67 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.963 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 1.68 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.54 110.098 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 2.56 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.1 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.23 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 1.72 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 1.87 109.532 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 0.67 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.889 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 1.47 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 1.49 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.74 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 0.54 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 0.72 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.827 HD13 HG12 ' A' ' 57' ' ' VAL . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.8 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.53 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.4 t-80 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.54 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 0.44 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.684 HG13 HG12 ' B' ' 306' ' ' VAL . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 0.52 111.371 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.61 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 0.41 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 1.73 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.44 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.55 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.643 HG22 ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 2.6 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.36 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 1.77 110.452 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.643 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 1.72 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 54' ' ' LEU . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 1.38 111.784 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 1.56 109.536 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.485 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.838 0.351 . . . . 3.57 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.654 ' HB3' HG21 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.633 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.65 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 74' ' ' LEU . 81.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 5.7 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.13 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 1.46 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 0.57 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 0.67 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.093 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.19 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.022 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.29 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 1.61 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 2.72 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.56 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 1.63 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.34 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.093 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.92 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.51 111.296 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 0.98 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.11 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.39 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.022 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 0.8 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 1.38 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.013 HG21 HD21 ' A' ' 48' ' ' LEU . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 0.65 110.205 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.637 HG22 ' ND1' ' A' ' 24' ' ' HIS . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.39 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 2.54 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.4 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 1.68 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 2.8 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.0 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 1.82 111.053 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 2.66 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 2.49 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 5.67 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.013 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 1.68 111.207 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.54 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 2.56 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.1 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.23 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 1.72 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 1.87 109.924 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 0.67 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.835 ' O ' HG22 ' A' ' 60' ' ' VAL . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 1.47 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 16.5 m120 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 1.49 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.74 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 0.54 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 0.72 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 1.71 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 0.8 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.53 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.54 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 0.44 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.764 HG13 HG12 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 0.52 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 0.61 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 0.41 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 1.73 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.44 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.55 112.269 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 2.6 110.678 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.36 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.13 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 1.72 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 54' ' ' LEU . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 1.38 110.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 19.9 mmmt . . . . . 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 1.56 110.55 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 32.2 ttm180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.776 0.322 . . . . 3.57 110.816 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.563 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.49 HG21 HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.65 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.67 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 6.3 mp . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.589 0.233 . . . . 5.7 111.547 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.13 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 1.46 110.249 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 0.57 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 0.67 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.19 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.076 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.29 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 1.61 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 2.72 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.56 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.561 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 7.1 p30 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 1.63 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.34 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.795 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.8 t-80 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.92 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 0.98 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.11 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.39 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.076 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 0.8 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 1.38 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 48' ' ' LEU . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 0.65 109.708 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.863 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.39 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 2.54 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.4 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 1.68 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.0 111.966 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 1.82 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.39 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 2.66 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 2.49 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 5.67 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.921 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 1.68 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.54 110.127 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 2.56 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.1 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.23 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.943 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 1.72 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 1.87 110.254 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 0.67 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 60' ' ' VAL . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 1.47 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 1.49 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.74 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 57' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 0.54 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 0.72 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 1.71 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 0.8 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.53 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.561 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.54 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.44 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.747 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 0.52 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 0.61 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.623 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 0.41 112.049 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.948 HD13 HG21 ' B' ' 306' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 1.73 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.44 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.55 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 81' ' ' VAL . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 2.6 111.473 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.36 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.77 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' HB ' HG21 ' A' ' 77' ' ' THR . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 1.58 109.972 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 1.72 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.943 ' HG ' HD21 ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 1.38 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.773 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.554 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.854 0.359 . . . . 3.57 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.863 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 0.65 111.502 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.67 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.948 HG21 HD13 ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.672 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.5 mp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.652 0.263 . . . . 5.7 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.13 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.672 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 1.46 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 0.57 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 0.67 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.046 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.19 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.29 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 1.61 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 2.72 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.56 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 1.63 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.34 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.046 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.9 t-80 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.92 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.51 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 0.98 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.11 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.39 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.755 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 0.8 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 1.38 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.951 HG21 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 0.65 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.831 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.39 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 2.54 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.4 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 14' ' ' PHE . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 1.68 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.0 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 1.82 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.525 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 2.66 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 2.49 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 5.67 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.951 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 1.68 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.54 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.415 HG22 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 2.56 111.381 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.1 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.23 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 1.72 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.218 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 0.67 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.911 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 1.47 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 1.49 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.74 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 0.54 110.56 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.72 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 31' ' ' ILE . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 1.71 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 0.8 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.53 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.618 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 61.7 t-80 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.54 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.487 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 0.52 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 0.61 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 0.41 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 1.73 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.44 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.55 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 81' ' ' VAL . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 2.6 110.827 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.36 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 1.77 110.75 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 1.58 110.051 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 1.72 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.592 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 1.38 112.556 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 1.56 109.358 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.875 0.369 . . . . 3.57 111.142 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.831 ' HB3' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 0.65 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 8.4 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.67 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 74' ' ' LEU . 62.9 mt . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 5.7 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.13 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 1.46 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 0.57 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 0.67 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.19 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.29 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 1.61 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 2.72 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.56 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.614 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 1.63 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.34 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.012 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.92 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.274 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 0.98 111.82 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.11 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.692 ' C ' HD13 ' A' ' 31' ' ' ILE . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.39 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 0.8 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 1.38 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 0.65 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.56 HG22 ' CE1' ' A' ' 24' ' ' HIS . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.39 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 2.54 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.665 HG22 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.4 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 1.68 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 2.8 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 1.82 111.24 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.39 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 2.66 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 2.49 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 5.67 111.029 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 1.68 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.54 110.225 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 2.56 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.1 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.23 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD13 HD23 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 1.72 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 1.87 109.863 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 0.67 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 1.47 111.47 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 7.2 m120 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 1.49 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.74 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 57' ' ' VAL . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 0.54 110.72 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 0.72 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.772 HD23 HD13 ' A' ' 54' ' ' LEU . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 1.71 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 0.8 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.53 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.45 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.54 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.685 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.44 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.71 HG13 HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 0.52 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 0.61 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 57' ' ' VAL . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 0.41 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 1.73 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.44 111.877 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.55 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' VAL . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 2.6 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.36 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 1.77 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 1.58 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 1.72 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CG ' HD21 ' A' ' 54' ' ' LEU . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 1.38 111.62 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 1.56 110.015 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.846 0.355 . . . . 3.57 110.741 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.502 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 0.65 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.67 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.71 HG12 HG13 ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.8 mt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 110.153 -0.314 . . . . 5.7 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.13 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 1.46 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 0.57 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 0.67 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.19 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.003 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.29 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 1.61 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 2.72 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.56 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 1.63 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.34 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.92 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.51 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 0.98 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.11 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.708 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.39 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 0.8 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 1.38 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.842 HG21 HD21 ' A' ' 48' ' ' LEU . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 0.65 109.878 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.684 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.39 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 2.54 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.4 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 1.68 110.873 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 2.8 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.0 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 1.82 110.909 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.39 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 2.66 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 2.49 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 5.67 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.842 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 1.68 111.496 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.54 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 2.56 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.1 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.23 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 1.72 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 1.87 110.297 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 0.67 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.895 ' O ' HG22 ' A' ' 60' ' ' VAL . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 1.47 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 1.49 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.74 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' VAL . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 0.54 110.551 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 0.72 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 1.71 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 0.8 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.53 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.645 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 63.9 t-80 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.54 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 0.44 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.763 HG13 HG12 ' B' ' 306' ' ' VAL . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 0.52 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 0.61 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 0.41 110.976 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 1.73 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.44 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.55 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.706 ' CG2' HG22 ' A' ' 81' ' ' VAL . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 2.6 111.304 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.36 111.619 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 1.77 111.009 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 ' CG2' ' A' ' 77' ' ' THR . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 1.72 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 1.38 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 1.56 109.328 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.567 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.798 0.332 . . . . 3.57 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.526 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.645 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 0.65 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.67 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.763 HG12 HG13 ' A' ' 71' ' ' VAL . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.577 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.3 mp . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 111.812 0.301 . . . . 5.7 111.812 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.577 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 1.46 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 0.57 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 0.67 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.086 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.19 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.29 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 1.61 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 2.72 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.56 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 1.63 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.34 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.086 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 50.0 t-80 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.92 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 32' ' ' TYR . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.51 110.684 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 0.98 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.11 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.39 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.709 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 0.8 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 1.38 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 48' ' ' LEU . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 0.65 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.477 HG21 ' CG ' ' B' ' 303' ' ' GLU . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.39 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 2.54 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.4 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 1.68 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 2.8 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.0 111.973 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 1.82 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.39 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 2.49 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 5.67 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 33' ' ' VAL . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 1.68 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.54 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 33' ' ' VAL . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 2.56 110.958 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.1 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.23 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.805 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 1.72 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 55' ' ' LEU . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 1.87 110.073 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 0.67 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.878 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 1.47 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 1.49 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.74 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 57' ' ' VAL . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 0.54 110.575 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.72 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.805 ' CD2' HD13 ' A' ' 54' ' ' LEU . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 1.71 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 0.8 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.53 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.531 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.54 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.485 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 62' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 0.44 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 0.52 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 0.61 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 0.41 111.158 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 1.73 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.44 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.55 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 2.6 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.36 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 1.77 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 77' ' ' THR . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 1.58 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 1.72 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.77 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 1.38 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 1.56 109.585 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.813 0.339 . . . . 3.57 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 0.65 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.67 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.687 HG12 HG13 ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 5.7 110.976 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.13 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 1.46 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.507 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 0.57 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.67 111.659 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.029 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.19 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.29 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 1.61 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 2.72 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.56 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 1.63 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.029 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 54.1 t-80 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.92 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.51 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 0.98 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.11 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.39 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 0.8 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 1.38 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 48' ' ' LEU . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 0.65 109.205 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.749 HG22 ' CD2' ' A' ' 24' ' ' HIS . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.39 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 2.54 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.4 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 1.68 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 2.8 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.0 112.008 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 1.82 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.39 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 2.66 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 2.49 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 5.67 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 33' ' ' VAL . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 1.68 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.54 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 2.56 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.1 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.23 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.882 HD22 HD21 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 1.72 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 1.87 109.607 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 0.67 111.743 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD22 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 1.47 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.74 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 0.54 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 0.72 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 1.71 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 0.8 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.53 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.67 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 65.6 t-80 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.54 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 0.44 110.484 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG13 HG12 ' B' ' 306' ' ' VAL . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 0.52 110.712 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 0.61 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 0.41 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.44 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.55 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.704 ' CG2' HG22 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 2.6 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.36 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 1.77 112.549 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.704 HG22 ' CG2' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 1.72 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.882 HD21 HD22 ' A' ' 54' ' ' LEU . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 1.38 111.948 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 1.56 109.343 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.889 0.376 . . . . 3.57 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.632 ' CG ' HG21 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.67 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 0.65 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.67 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.715 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.676 HD11 ' O ' ' A' ' 74' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 109.893 -0.41 . . . . 5.7 109.893 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.13 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 1.46 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 0.57 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.412 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.67 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.9 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.033 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.29 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 1.61 114.402 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 2.72 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.56 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.6 p30 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 1.63 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.34 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.9 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.92 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.51 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 0.98 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.11 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.39 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.033 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 0.8 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 1.38 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG21 HD21 ' A' ' 48' ' ' LEU . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 0.65 109.857 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.547 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 2.54 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.4 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.68 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.0 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 1.82 110.879 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 2.66 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 2.49 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 5.67 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 33' ' ' VAL . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 1.68 111.652 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.54 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 2.56 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.1 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.23 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 1.72 112.004 -178.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 1.87 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 0.67 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 1.47 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 1.49 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.74 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 0.54 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 0.72 109.57 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 1.71 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 0.8 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.53 110.072 178.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.567 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.54 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 0.44 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG21 HG21 ' B' ' 304' ' ' THR . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 0.52 111.834 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 0.41 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.805 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 1.73 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.44 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.55 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 2.6 111.441 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.36 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 1.77 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 1.58 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 1.72 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LYS . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 1.38 111.946 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.593 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 1.56 110.265 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.824 0.345 . . . . 3.57 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.547 ' HB3' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.472 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 0.65 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 12' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 HD12 ' A' ' 74' ' ' LEU . 70.8 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 5.7 111.172 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.13 113.544 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 1.46 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 0.57 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 0.67 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.19 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.031 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.29 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 1.61 113.681 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 2.72 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.56 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 1.63 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.34 113.125 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.036 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 54.5 t-80 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.92 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 0.98 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.11 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.39 109.657 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.031 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 0.8 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 1.38 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.883 HG21 HD21 ' A' ' 48' ' ' LEU . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 0.65 109.943 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.832 HG22 ' CD2' ' A' ' 24' ' ' HIS . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.39 113.052 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 2.54 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.4 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 1.68 110.838 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 2.8 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 1.82 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.39 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 2.66 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 2.49 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 5.67 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.883 HD21 HG21 ' A' ' 33' ' ' VAL . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 1.68 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.54 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 2.56 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.1 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.23 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' CD2' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 1.72 111.584 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 1.87 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 0.67 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.736 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 1.47 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 1.49 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.74 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 0.54 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.72 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.736 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 0.8 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.53 110.224 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.541 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 53.9 t-80 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.54 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.711 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 0.44 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 0.41 111.045 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 1.73 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.44 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.55 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 2.6 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.36 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 1.77 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 1.58 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 1.72 110.698 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 1.38 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.869 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.521 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.703 0.287 . . . . 3.57 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.551 ' HB3' HG21 ' A' ' 34' ' ' THR . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 0.65 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.67 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.575 HG12 HG13 ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.713 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 111.466 0.173 . . . . 5.7 111.466 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.13 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.713 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 1.46 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 0.57 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 0.67 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.19 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.979 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.29 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 1.61 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 2.72 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.56 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 1.63 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.34 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.045 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.92 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.51 110.995 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ILE . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 0.98 113.059 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.11 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.599 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.39 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.979 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 0.8 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 1.38 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG21 HD21 ' A' ' 48' ' ' LEU . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 0.65 109.806 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.611 HG21 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.39 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 2.54 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.4 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 1.68 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 2.8 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.0 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.142 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.39 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 2.66 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 2.49 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 5.67 111.66 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG21 ' A' ' 33' ' ' VAL . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 1.68 111.296 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.54 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 2.56 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.1 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.23 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 1.72 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' A' ' 84' ' ' LYS . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 1.87 109.694 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 0.67 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 1.47 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 1.49 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.74 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 57' ' ' VAL . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 0.54 110.862 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 0.72 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.709 HD13 HG12 ' A' ' 57' ' ' VAL . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 1.71 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.8 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.53 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.572 ' HE1' ' HB ' ' B' ' 304' ' ' THR . 62.5 t-80 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.54 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 0.44 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG13 HG12 ' B' ' 306' ' ' VAL . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 0.52 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.61 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 0.41 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 1.73 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.44 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.55 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 2.6 110.845 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.36 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 1.58 110.73 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 1.72 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 54' ' ' LEU . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 1.38 111.848 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 1.56 110.007 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.576 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.789 0.328 . . . . 3.57 110.825 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.611 ' CG ' HG21 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.572 ' HB ' ' HE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 0.65 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 21.7 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.67 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.654 HG12 HG13 ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 5.7 110.686 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.13 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 1.46 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 0.57 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.67 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.19 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.29 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 1.61 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 2.72 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.56 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.6 p30 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 1.63 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.34 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.4 t-80 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.92 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 32' ' ' TYR . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.51 110.883 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 0.98 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.11 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.39 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 0.8 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.38 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG21 HD21 ' A' ' 48' ' ' LEU . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.939 HG21 ' CB ' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.39 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 2.54 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.4 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 1.68 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.0 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 1.82 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.39 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 2.66 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 2.49 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 5.67 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.777 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 1.68 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.54 110.413 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 2.56 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.1 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.23 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 1.72 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 1.87 109.616 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 0.67 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.748 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 1.47 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 1.49 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.74 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 0.54 110.888 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 0.72 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 0.8 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.53 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.559 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.54 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 0.44 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.692 HG13 HG12 ' B' ' 306' ' ' VAL . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 0.52 111.128 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 0.61 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 0.41 111.001 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.44 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.55 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 2.6 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.36 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 1.77 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 1.58 109.796 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 1.72 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 1.38 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 1.56 109.914 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.828 0.347 . . . . 3.57 111.034 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.939 ' CB ' HG21 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 0.65 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.67 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.692 HG12 HG13 ' A' ' 71' ' ' VAL . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.572 0.212 . . . . 5.7 111.572 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.13 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 1.46 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 0.57 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.809 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.67 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.101 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.19 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.29 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 1.61 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 2.72 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.56 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 1.63 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.34 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.101 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 51.1 t-80 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.92 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.51 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 0.98 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.11 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' C ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.39 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 54' ' ' LEU . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 0.8 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 1.38 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 0.65 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' HB3' ' B' ' 303' ' ' GLU . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.39 113.447 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 2.54 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.4 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 1.68 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 2.8 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.0 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 1.82 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.39 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 2.66 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 2.49 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 5.67 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 1.68 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.54 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 2.56 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.1 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.23 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.103 HD22 HD11 ' A' ' 83' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 1.72 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.676 HD22 ' HD3' ' A' ' 84' ' ' LYS . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 1.87 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 0.67 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.84 HG13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 1.47 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 1.49 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.74 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 0.54 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 0.72 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 1.71 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 0.8 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.53 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.54 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 HG12 ' B' ' 306' ' ' VAL . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 0.52 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.599 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 0.61 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.84 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 0.41 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 1.73 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.44 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.55 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 2.6 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.36 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 1.58 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 57' ' ' VAL . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 1.103 HD11 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 1.38 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 1.56 109.937 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.522 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 3.57 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.67 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 74' ' ' LEU . 34.7 mt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 5.7 110.471 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.13 113.412 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 1.46 110.708 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 0.57 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 0.67 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.19 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.29 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 1.61 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 2.72 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 1.63 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.34 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.92 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 0.98 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.11 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.39 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 0.8 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 1.38 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.899 HG21 HD21 ' A' ' 48' ' ' LEU . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.758 HG22 ' CE1' ' A' ' 24' ' ' HIS . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 2.54 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.4 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 1.68 110.913 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 2.8 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.0 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 1.82 110.779 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.39 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 2.66 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 2.49 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 5.67 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 1.68 111.454 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.54 110.016 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 2.56 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.1 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.23 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.0 HD21 HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 1.72 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD23 ' CB ' ' A' ' 56' ' ' ALA . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.317 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' CB ' HD23 ' A' ' 55' ' ' LEU . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 0.67 112.086 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.0 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 1.47 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 1.49 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 0.54 110.762 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 0.72 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.75 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 1.71 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 0.8 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.579 ' HE1' ' HB ' ' B' ' 304' ' ' THR . 50.8 t-80 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.54 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 0.44 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 HG12 ' B' ' 306' ' ' VAL . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 0.61 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 0.41 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 1.73 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.44 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.55 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 2.6 112.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.36 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 1.77 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 77' ' ' THR . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 1.58 110.441 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 1.72 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 1.38 112.034 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 1.8 mmmt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 1.56 109.582 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.903 0.382 . . . . 3.57 111.137 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.579 ' HB ' ' HE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 0.65 111.336 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.67 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 5.7 110.794 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.13 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 1.46 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.57 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.8 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.19 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.29 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 1.61 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 2.72 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.56 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 1.63 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.34 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 57.1 t-80 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.92 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.51 110.85 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 0.98 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.11 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.567 ' C ' HD13 ' A' ' 31' ' ' ILE . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.39 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 0.8 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 1.38 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 0.65 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.867 HG21 ' HB3' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.39 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 2.54 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.4 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 1.68 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.0 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 1.82 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 2.66 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 2.49 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 5.67 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 1.68 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.54 110.4 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 2.56 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.1 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.23 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.708 HD13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 1.72 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 84' ' ' LYS . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 1.87 110.46 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 0.67 112.117 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 1.47 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 35.3 m120 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 1.49 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.74 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 0.54 110.527 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.72 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 57' ' ' VAL . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 0.8 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.53 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 64.8 t-80 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.54 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.44 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG13 HG12 ' B' ' 306' ' ' VAL . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 0.52 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 0.61 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 0.41 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 1.73 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HD2' HG12 ' A' ' 71' ' ' VAL . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.44 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.55 111.312 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 81' ' ' VAL . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 2.6 111.225 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 1.77 110.178 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.495 HG22 ' CG2' ' A' ' 77' ' ' THR . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 1.58 111.81 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 1.72 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 54' ' ' LEU . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 1.38 111.316 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.804 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.765 0.317 . . . . 3.57 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.867 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.508 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 0.65 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.747 HD22 ' CE2' ' A' ' 14' ' ' PHE . 28.2 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 111.884 0.327 . . . . 5.7 111.884 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.13 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.747 ' CE2' HD22 ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 1.46 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 0.57 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 0.67 110.864 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.19 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.29 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 1.61 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 2.72 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.56 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 1.63 109.548 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.34 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.038 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.92 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.993 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 0.98 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.11 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.39 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.761 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 0.8 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.696 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 1.38 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 48' ' ' LEU . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 0.65 110.685 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.757 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.39 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 2.54 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.4 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 2.8 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.0 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 1.82 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.39 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 2.66 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 2.49 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 5.67 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 1.68 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.54 110.258 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 33' ' ' VAL . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 2.56 111.191 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.1 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.23 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 57' ' ' VAL . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 1.72 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 1.87 110.088 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 0.67 111.969 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.91 ' O ' HG22 ' A' ' 60' ' ' VAL . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 1.47 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 1.49 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.74 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 0.54 110.519 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 0.72 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 1.71 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 0.8 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.53 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.66 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 64.0 t-80 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.54 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 0.44 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.727 HG13 HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.52 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 0.41 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 1.73 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.44 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.55 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 2.6 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 1.77 110.678 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 1.72 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 1.38 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 17.4 mmmt . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 1.56 110.467 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.9 ttm180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.76 0.314 . . . . 3.57 110.844 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.757 ' HB3' HG21 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.66 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.65 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.5 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.67 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.727 HG12 HG13 ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 5.7 111.118 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.13 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 1.46 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.57 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 0.67 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.19 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.027 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.29 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 1.61 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 2.72 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.56 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 1.63 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.6 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.34 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.997 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.6 t-80 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.92 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 0.98 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.11 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.39 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.027 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 0.8 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 1.38 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.909 HG21 HD21 ' A' ' 48' ' ' LEU . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 0.65 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.84 HG22 ' CD2' ' A' ' 24' ' ' HIS . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.39 113.014 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 2.54 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.4 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 2.8 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.0 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 1.82 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 2.66 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 2.49 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 5.67 111.047 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.909 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 1.68 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.54 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 2.56 111.181 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.1 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.23 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 1.72 111.989 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 1.87 109.811 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 0.67 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.882 ' O ' HG22 ' A' ' 60' ' ' VAL . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 1.47 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 1.49 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.74 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 0.54 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 0.72 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.696 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 0.8 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.53 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.6 t-80 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.54 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.44 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.823 HG13 HG12 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 0.52 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 0.61 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 0.41 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 1.73 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.44 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.55 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 2.6 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.36 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 1.77 111.251 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 1.58 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 1.72 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 48' ' ' LEU . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 1.38 112.014 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 1.56 109.705 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.776 0.322 . . . . 3.57 111.136 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.613 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.633 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.823 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 5.7 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.13 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 1.46 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 0.57 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.67 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.19 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.007 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.29 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 1.61 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 2.72 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.56 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 1.63 110.426 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.34 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.042 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.4 t-80 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.92 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.441 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.51 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 0.98 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.11 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.61 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.39 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.007 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 0.8 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 1.38 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 0.65 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.857 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.39 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 2.54 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.4 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 1.68 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' A' ' 44' ' ' LYS . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 12' ' ' LEU . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.0 111.888 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 1.82 111.279 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.39 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 2.66 111.522 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 2.49 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 5.67 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 1.68 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.54 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 2.56 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.1 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.23 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 1.72 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 1.87 110.134 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 0.67 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.902 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 1.49 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.74 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 57' ' ' VAL . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 0.54 110.645 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 0.72 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 1.71 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 0.8 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.53 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.54 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 0.44 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 0.52 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 0.61 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 0.41 110.996 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 1.73 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 71' ' ' VAL . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.44 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.55 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 2.6 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.36 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 1.77 110.563 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 1.58 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 1.72 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 54' ' ' LEU . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 1.38 112.094 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.7 mmpt? . . . . . 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 1.56 109.582 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.781 0.324 . . . . 3.57 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.462 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 0.65 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.67 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.663 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.4 mp . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 111.81 0.3 . . . . 5.7 111.81 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.13 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.663 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 1.46 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 0.57 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.544 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 0.67 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.19 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.054 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.29 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 1.61 113.06 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 2.72 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.56 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 1.63 109.926 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.34 112.86 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.6 t-80 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.92 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.66 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 0.98 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.11 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.39 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.054 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 0.8 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 0.65 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.813 HG22 ' CD2' ' A' ' 24' ' ' HIS . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.39 113.252 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 2.54 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' HIS . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.4 110.817 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 1.68 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 2.8 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.0 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 1.82 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.39 111.773 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 2.66 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 2.49 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 5.67 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 1.68 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.54 110.197 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 2.56 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.1 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.23 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 1.72 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 1.87 109.882 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 0.67 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 1.47 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.74 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 0.54 110.503 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 0.72 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 0.8 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.53 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.608 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.5 t-80 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.54 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 0.44 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG13 HG12 ' B' ' 306' ' ' VAL . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 0.52 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 0.61 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 0.41 111.53 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD23 HG21 ' B' ' 306' ' ' VAL . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 1.73 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.44 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.55 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB ' ' A' ' 81' ' ' VAL . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 2.6 111.122 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.36 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 1.77 110.685 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 77' ' ' THR . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 1.58 109.934 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 1.72 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 54' ' ' LEU . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 1.38 111.829 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.6 mmmt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 1.56 110.0 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 52.8 ttt180 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.795 0.331 . . . . 3.57 111.002 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.645 ' CG ' HG21 ' A' ' 34' ' ' THR . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.608 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 0.65 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.67 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.694 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 5.7 111.343 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.13 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 1.46 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 0.57 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.67 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.19 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.078 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.29 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 1.61 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 2.72 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.56 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.9 p30 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 1.63 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.34 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.7 t-80 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.92 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.431 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.51 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 0.98 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.11 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.619 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.39 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.078 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 0.8 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 1.38 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.931 HG21 HD21 ' A' ' 48' ' ' LEU . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 0.65 109.761 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.829 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.39 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 2.54 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.4 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 1.68 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 2.8 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.0 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 1.82 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.39 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 2.66 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 2.49 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 5.67 111.33 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 HG21 ' A' ' 33' ' ' VAL . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 1.68 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.54 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 2.56 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.1 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.684 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.23 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.628 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 1.72 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 1.87 110.013 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 0.67 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.858 ' O ' HG22 ' A' ' 60' ' ' VAL . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 1.47 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 1.49 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.74 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 0.54 110.403 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 0.72 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 1.71 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 0.8 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.53 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.684 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.3 t-80 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.54 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 0.44 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' B' ' 304' ' ' THR . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 0.52 111.973 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 0.61 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.598 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 0.41 110.493 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.44 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.55 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.641 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 2.6 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.36 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 1.77 110.509 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 1.58 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 1.72 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.501 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 1.38 112.24 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 1.56 109.442 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.61 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.778 0.323 . . . . 3.57 110.734 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.829 ' HB3' HG21 ' A' ' 34' ' ' THR . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.684 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.65 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.67 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 111.742 0.275 . . . . 5.7 111.742 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.13 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 74' ' ' LEU . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 1.46 110.356 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 0.57 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 0.67 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.967 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.19 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.29 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 1.61 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 2.72 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.56 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 1.63 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.34 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.4 t-80 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.92 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.51 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 0.98 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.11 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.39 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 0.8 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 1.38 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 0.65 110.348 178.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.782 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.39 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 2.54 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.4 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 1.68 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 2.8 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.0 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 1.82 110.941 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.39 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 2.66 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 2.49 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 5.67 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 1.68 111.236 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 2.56 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.1 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.23 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 1.72 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 84' ' ' LYS . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.158 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 0.67 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.917 HG21 HD22 ' A' ' 62' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 1.49 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.74 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 0.54 110.758 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 0.72 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 HG21 ' A' ' 57' ' ' VAL . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 1.71 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 0.8 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.53 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.568 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.54 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.62 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 0.41 111.39 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 1.73 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HD2' HG12 ' A' ' 71' ' ' VAL . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.44 111.839 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.55 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 2.6 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.36 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 1.77 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 1.58 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 1.72 110.142 179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 1.38 111.879 -178.529 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 1.9 mtpt . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 1.56 109.957 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.35 . . . . 3.57 110.968 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.782 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.67 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 71' ' ' VAL . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 5.7 111.604 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 1.46 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 0.57 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 0.67 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.067 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.19 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.016 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.29 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 1.61 112.998 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 2.72 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.56 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.588 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 1.63 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.34 113.027 -178.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.067 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 47.9 t-80 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.92 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 0.98 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.11 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.39 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.016 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 0.8 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 1.38 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.65 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.963 HG21 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.39 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 2.54 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.4 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 1.68 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 2.8 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.0 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 1.82 111.121 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.39 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 2.66 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 2.49 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 5.67 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 1.68 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.54 110.279 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 2.56 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.1 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.23 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 1.72 111.95 -178.787 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 1.87 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 0.67 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 1.47 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 1.49 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.74 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 0.54 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 0.72 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 54' ' ' LEU . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 1.71 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.8 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.53 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 49.8 t-80 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.54 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.676 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 0.44 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 HG12 ' B' ' 306' ' ' VAL . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 0.52 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.61 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 0.41 110.945 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 1.73 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.44 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.55 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 81' ' ' VAL . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 2.6 111.476 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.36 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 1.77 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 77' ' ' THR . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 1.58 110.993 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 1.72 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 1.38 112.007 -178.375 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 1.56 110.563 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.85 0.357 . . . . 3.57 110.908 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.963 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.568 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 0.65 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.67 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.622 HG12 HG13 ' A' ' 71' ' ' VAL . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 74' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.116 -0.327 . . . . 5.7 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.13 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 1.46 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.57 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 0.67 111.778 -178.357 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.13 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.19 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.29 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 1.61 113.948 177.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 2.72 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 1.63 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.34 113.012 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.13 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.7 t-80 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.51 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 0.98 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.11 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.559 ' C ' HD13 ' A' ' 31' ' ' ILE . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.39 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 0.8 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 1.38 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 48' ' ' LEU . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.65 109.881 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.903 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.39 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 2.54 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.4 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 1.68 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 2.8 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.0 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 1.82 110.828 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.39 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 2.66 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 2.49 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 5.67 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 1.68 111.278 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.54 110.312 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 2.56 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.1 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.23 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.873 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 1.72 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 0.67 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 1.47 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 1.49 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.74 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 0.54 110.697 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 0.72 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.721 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 1.71 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 0.8 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.53 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.666 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 57.3 t-80 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.54 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.659 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 0.44 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HG12 ' B' ' 306' ' ' VAL . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 0.52 111.246 179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 0.61 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 0.41 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 1.73 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.44 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.55 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 2.6 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.36 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 1.77 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 1.58 110.624 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 1.72 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.873 ' HG ' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 1.38 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 1.56 110.274 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.68 0.276 . . . . 3.57 111.037 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.666 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.65 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.67 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 74' ' ' LEU . 8.4 mp . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.591 0.234 . . . . 5.7 110.869 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.13 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 1.46 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 0.57 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 0.67 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.19 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.29 115.318 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 1.61 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 2.72 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.56 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 1.63 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.34 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.92 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.51 111.368 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 0.98 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.11 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.39 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 0.8 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 1.38 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 0.65 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.787 HG21 ' HB3' ' B' ' 303' ' ' GLU . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.39 113.139 -178.023 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 2.54 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.4 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 1.68 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 2.8 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.0 111.91 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.39 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 2.66 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 2.49 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 5.67 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 1.68 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.54 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 2.56 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.1 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.23 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.812 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 1.72 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 1.87 109.781 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 0.67 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.892 ' CG2' HD22 ' A' ' 62' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.49 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.74 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 57' ' ' VAL . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 0.54 110.761 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 0.72 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.892 HD22 ' CG2' ' A' ' 57' ' ' VAL . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 1.71 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 0.8 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.53 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.54 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.666 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.44 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.735 HG13 HG12 ' B' ' 306' ' ' VAL . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 0.52 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 0.61 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 0.41 111.144 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 1.73 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.44 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 72' ' ' THR . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.55 111.262 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 81' ' ' VAL . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 2.6 111.446 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.36 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 1.77 110.981 179.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 77' ' ' THR . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 1.58 110.072 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 1.72 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.812 ' HG ' HD21 ' A' ' 54' ' ' LEU . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 1.38 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 1.56 110.222 179.044 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.805 0.336 . . . . 3.57 110.916 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 34' ' ' THR . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 0.65 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.67 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.735 HG12 HG13 ' A' ' 71' ' ' VAL . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.495 0.188 . . . . 5.7 111.181 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.13 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 1.46 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 0.57 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 0.67 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.097 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.19 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.29 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 1.61 112.957 178.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 2.72 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.56 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 1.63 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.34 112.756 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.097 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 48.2 t-80 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.92 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 32' ' ' TYR . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.51 110.563 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 0.98 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.11 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.708 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.39 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.733 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 0.8 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 1.38 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.819 HG21 HD21 ' A' ' 48' ' ' LEU . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 0.65 110.039 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.868 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.39 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 2.54 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.4 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 1.68 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 2.8 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.0 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 1.82 111.339 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 2.66 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 2.49 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 5.67 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 1.68 111.226 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.54 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 2.56 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.1 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.23 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.724 HD13 HD21 ' A' ' 74' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 1.72 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 55' ' ' LEU . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 1.87 109.652 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 0.67 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 60' ' ' VAL . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 1.47 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 1.49 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.74 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 0.54 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 0.72 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 1.71 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 0.8 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.53 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.54 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 0.44 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.855 HG13 HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 0.52 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 0.61 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 0.41 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 1.73 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.44 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.55 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' LYS . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 2.6 111.469 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.36 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 1.77 110.072 178.678 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 1.58 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 1.72 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 1.38 111.78 -178.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 1.56 109.955 178.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.852 0.358 . . . . 3.57 111.018 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.868 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.67 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.855 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 16.2 mt . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 5.7 111.512 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.13 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.784 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 1.46 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 0.67 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.124 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.19 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.065 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.29 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 1.61 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 2.72 110.47 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.56 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 1.63 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.124 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 51.8 t-80 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.92 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.51 110.851 -179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 0.98 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.11 111.749 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.616 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.39 110.841 179.712 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.065 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.8 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 1.38 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.933 HG21 HD21 ' A' ' 48' ' ' LEU . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 24' ' ' HIS . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.39 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 2.54 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 14' ' ' PHE . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.4 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 1.68 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 2.8 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.0 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 1.82 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.39 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 2.66 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 2.49 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 5.67 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.933 HD21 HG21 ' A' ' 33' ' ' VAL . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 1.68 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.54 110.403 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 2.56 111.198 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.1 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.23 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.845 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 1.72 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 1.87 109.6 178.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 0.67 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.845 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 1.47 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 1.49 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.74 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 0.54 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 0.72 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.785 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 1.71 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 0.8 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.53 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.54 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.658 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 0.44 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.766 HG13 HG12 ' B' ' 306' ' ' VAL . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 0.52 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 0.61 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 0.41 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.746 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 1.73 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.44 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.55 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 2.6 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.36 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.065 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 1.58 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 1.72 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 1.38 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 1.56 109.73 178.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.769 0.319 . . . . 3.57 111.062 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.479 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 0.65 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.2 mp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 111.838 0.31 . . . . 5.7 111.838 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.13 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 1.46 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 0.57 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 0.67 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.19 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.29 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 1.61 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 2.72 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.56 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 1.63 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.34 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.92 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.51 111.381 -179.304 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 0.98 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.11 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.39 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 0.8 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 1.38 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.016 HG21 HD21 ' A' ' 48' ' ' LEU . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 0.65 110.04 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.663 HG21 ' HB3' ' B' ' 303' ' ' GLU . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.39 113.043 -178.203 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 2.54 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.4 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' PHE . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 1.68 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 2.8 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.0 111.949 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 1.82 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.39 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 2.66 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 2.49 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 5.67 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.016 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 1.68 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.54 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 2.56 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.1 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.679 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.23 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 1.72 111.778 -178.638 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 1.87 110.184 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 0.67 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 1.47 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 1.49 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.74 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 57' ' ' VAL . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 0.54 110.722 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 0.72 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 1.71 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 0.8 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.53 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.8 t-80 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.54 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 0.44 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.749 HG13 HG12 ' B' ' 306' ' ' VAL . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 0.52 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 0.61 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 0.41 111.177 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 1.73 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.44 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 72' ' ' THR . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.55 111.334 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 2.6 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.36 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 1.77 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 1.58 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.72 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 54' ' ' LEU . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 1.38 111.941 -178.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 1.56 110.215 179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.84 0.352 . . . . 3.57 110.959 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 0.65 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.67 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.749 HG12 HG13 ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 7.0 mp . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 5.7 111.195 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.13 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 1.46 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 0.57 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 0.67 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.998 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.19 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.52 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.29 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 1.61 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 2.72 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.56 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 1.63 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.34 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.998 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 45.5 t-80 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 0.98 112.165 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.11 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.39 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.68 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 0.8 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 1.38 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD21 ' A' ' 48' ' ' LEU . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 0.65 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.874 HG22 ' CD2' ' A' ' 24' ' ' HIS . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 2.54 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.4 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 1.68 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 2.8 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' LEU . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.015 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.39 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 2.49 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 5.67 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.003 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 1.68 111.006 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.54 110.281 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 2.56 111.327 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.1 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.23 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 1.72 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 1.87 109.701 178.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 0.67 110.98 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.833 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 1.47 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 1.49 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.74 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 0.54 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 0.72 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 1.71 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 0.8 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.53 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.54 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.873 HG13 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 0.52 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 0.61 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 0.41 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 1.73 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.44 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.55 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 2.6 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.36 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 1.58 110.317 178.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 1.72 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 1.38 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 1.56 109.734 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.483 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.893 0.378 . . . . 3.57 110.953 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.553 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 0.65 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.67 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 74' ' ' LEU . 17.5 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 5.7 110.444 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.13 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 37' ' ' ILE . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 1.46 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 0.57 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 0.67 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.929 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.19 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.29 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 1.61 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 2.72 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.56 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 1.63 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.34 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.4 t-80 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.92 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.51 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 0.98 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.11 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.39 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.8 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 1.38 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG21 HD21 ' A' ' 48' ' ' LEU . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 0.65 109.733 178.214 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.723 HG21 ' HB3' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.39 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 2.54 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.4 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 1.68 111.439 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 2.8 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.0 112.144 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 1.82 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.406 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.39 111.201 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 2.66 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 2.49 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 5.67 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.88 HD21 HG21 ' A' ' 33' ' ' VAL . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 1.68 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.54 110.206 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 2.56 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.1 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.23 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.758 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 1.72 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 1.87 110.122 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 0.67 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 60' ' ' VAL . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 1.49 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.74 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 0.54 110.393 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 0.72 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 1.71 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 0.8 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.53 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.54 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 0.44 110.852 178.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 0.52 110.94 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.61 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 0.41 111.148 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 1.73 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.44 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.55 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 81' ' ' VAL . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 2.6 111.074 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.36 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.735 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 77' ' ' THR . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 178.585 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 1.72 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.758 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 1.38 112.204 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 1.56 109.778 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.653 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.811 0.339 . . . . 3.57 110.547 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.49 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.65 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.67 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 74' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 5.7 112.074 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.13 113.012 -179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 1.46 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 0.57 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.67 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.19 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.29 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 1.61 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 2.72 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.56 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 1.63 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.34 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.92 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 32' ' ' TYR . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.51 111.362 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 0.98 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.11 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.39 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 0.8 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD21 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 0.65 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.598 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.39 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 2.54 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.4 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 1.68 111.046 -179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 2.8 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.0 111.751 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.19 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.631 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.39 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 2.66 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 2.49 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 5.67 111.262 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 1.68 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.54 110.239 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 2.56 111.398 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.1 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.23 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 1.72 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 1.87 109.95 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 0.67 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 60' ' ' VAL . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 0.54 110.262 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 0.72 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 57' ' ' VAL . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 0.8 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.53 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.689 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.6 t-80 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.54 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 0.44 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HG12 ' B' ' 306' ' ' VAL . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 0.52 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 0.61 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 0.41 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 1.73 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HD2' HG12 ' A' ' 71' ' ' VAL . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.44 111.97 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.55 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 2.6 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.36 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 1.77 109.852 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 1.58 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.72 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' HD21 ' A' ' 54' ' ' LEU . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 1.38 111.761 -178.691 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? . . . . . 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 1.56 109.338 178.607 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 302' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 3.57 111.243 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 303' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 304' ' ' THR . . . . . 0.689 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.65 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.67 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.753 0.311 . . . . 3.17 111.287 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -100.4 154.22 18.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.97 110.965 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -145.28 127.06 8.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.247 -0.649 . . . . 1.34 109.247 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 9.4 mtmt -94.33 91.32 6.65 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.261 0.553 . . . . 2.93 111.321 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 81' ' ' VAL . 2.9 mt -89.86 130.91 36.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.271 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.41 125.89 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.007 -0.542 . . . . 1.94 111.047 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.2 118.91 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 3.1 111.619 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.3 164.06 13.13 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.909 -0.587 . . . . 1.78 112.434 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.82 -42.38 66.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.86 2.374 . . . . 2.77 112.449 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -68.12 0.32 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.228 -0.442 . . . . 4.92 110.483 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.22 -140.91 8.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.943 -0.646 . . . . 2.3 112.685 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.768 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 5.6 mp -83.44 -52.2 6.72 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.392 -0.225 . . . . 5.7 110.392 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.13 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.768 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 1.46 110.733 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 0.57 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.67 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.19 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.29 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 1.61 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 2.72 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.56 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 1.63 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.34 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.023 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.0 t-80 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.92 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.51 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.98 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.11 111.849 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.618 ' C ' HD13 ' A' ' 31' ' ' ILE . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.39 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 0.8 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 1.38 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD21 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.65 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.781 HG22 ' CD2' ' A' ' 24' ' ' HIS . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.39 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 2.54 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.4 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 2.8 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.0 111.694 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 1.82 111.051 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.39 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 2.66 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 2.49 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 5.67 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.963 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 1.68 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.54 110.098 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 2.56 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.1 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.953 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.23 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 1.72 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 1.87 109.532 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 0.67 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.889 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 1.47 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 1.49 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.74 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 0.54 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 0.72 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.827 HD13 HG12 ' A' ' 57' ' ' VAL . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.8 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.53 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.4 t-80 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.54 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 0.44 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.684 HG13 HG12 ' B' ' 306' ' ' VAL . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 0.52 111.371 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.61 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 0.41 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 1.73 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.44 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.55 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.643 HG22 ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 2.6 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.36 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 1.77 110.452 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.643 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 1.72 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 54' ' ' LEU . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 1.38 111.784 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -112.77 113.76 26.0 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 1.56 109.536 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 ' O ' ' A' ' 53' ' ' LYS . 39.6 t -108.51 133.57 53.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 1.92 111.188 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -90.78 147.57 23.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.277 -0.42 . . . . 1.46 111.141 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 115.58 65.33 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.351 -0.386 . . . . 4.2 110.597 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 53.6 Cg_endo -70.12 117.68 5.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.499 2.133 . . . . 2.28 112.54 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -132.42 -64.0 0.78 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.495 -0.32 . . . . 3.88 110.467 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.64 162.31 7.67 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.229 -0.51 . . . . 4.69 113.145 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.76 -45.36 5.77 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.608 0.242 . . . . 7.06 110.846 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.978 0.418 . . . . 7.84 110.97 179.826 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.594 0.235 . . . . 4.22 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.485 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 -142.13 129.17 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 3.57 111.016 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.654 ' HB3' HG21 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.633 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.65 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.762 0.315 . . . . 3.17 111.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.55 158.55 34.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.97 110.857 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -145.99 118.35 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.436 -0.347 . . . . 1.34 110.845 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HG2' ' HD2' ' A' ' 80' ' ' PHE . 8.8 ttpt -117.16 147.6 42.32 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.804 -0.443 . . . . 2.93 109.804 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.607 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -150.23 170.45 18.93 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.27 -0.269 . . . . 2.09 110.658 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.87 139.2 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.582 -0.281 . . . . 1.94 110.459 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -56.88 133.01 54.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.81 0.338 . . . . 3.1 111.672 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.46 -150.75 27.31 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.928 -0.578 . . . . 1.78 112.064 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.65 -83.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.78 2.32 . . . . 2.77 111.681 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -61.96 -68.09 0.35 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.431 0.158 . . . . 4.92 111.287 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.53 -110.5 0.28 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.742 -0.742 . . . . 2.3 113.078 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 74' ' ' LEU . 81.3 mt -86.62 -51.8 5.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 5.7 111.29 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.13 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 1.46 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 0.57 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 0.67 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.093 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.19 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.022 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.29 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 1.61 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 2.72 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.56 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 1.63 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.34 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.093 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.92 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.51 111.296 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 0.98 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.11 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.39 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.022 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 0.8 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 1.38 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.013 HG21 HD21 ' A' ' 48' ' ' LEU . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 0.65 110.205 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.637 HG22 ' ND1' ' A' ' 24' ' ' HIS . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.39 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 2.54 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.4 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 1.68 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 2.8 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.0 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 1.82 111.053 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 2.66 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.607 ' CG ' HD11 ' A' ' 5' ' ' LEU . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 2.49 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 5.67 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.013 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 1.68 111.207 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.54 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 2.56 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.1 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.015 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.23 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 1.72 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 1.87 109.924 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 0.67 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.835 ' O ' HG22 ' A' ' 60' ' ' VAL . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 1.47 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 16.5 m120 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 1.49 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.74 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 0.54 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 0.72 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 1.71 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 0.8 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.53 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.54 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 0.44 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.764 HG13 HG12 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 0.52 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 0.61 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 0.41 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 1.73 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.44 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.55 112.269 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 2.6 110.678 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.36 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HG2' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.13 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 1.72 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 54' ' ' LEU . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 1.38 110.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 19.9 mmmt -108.22 110.98 22.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 1.56 110.55 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG13 ' O ' ' A' ' 53' ' ' LYS . 72.6 t -112.89 122.99 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.284 -0.416 . . . . 1.92 111.141 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.93 121.99 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.324 -0.398 . . . . 1.46 111.225 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 73.9 mttt -69.97 116.93 49.03 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.112 -0.495 . . . . 4.2 110.942 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HD3' ' HG3' ' A' ' 53' ' ' LYS . 32.8 Cg_exo -59.96 135.35 62.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.993 2.462 . . . . 2.28 112.134 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 p -146.01 131.39 18.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.532 -0.304 . . . . 3.88 111.167 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.79 8.45 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.078 -0.582 . . . . 4.69 113.369 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 p -70.48 -36.77 74.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.184 0.492 . . . . 7.06 111.272 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.87 0.367 . . . . 7.84 110.96 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.922 0.391 . . . . 4.22 111.523 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 32.2 ttm180 -147.42 136.31 22.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 3.57 110.816 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.563 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.49 HG21 HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.65 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.67 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.82 0.343 . . . . 3.17 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.74 127.26 36.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.121 0.486 . . . . 1.97 111.382 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 5' ' ' LEU . 2.9 mt -96.7 101.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 1.34 110.797 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.52 91.42 4.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.358 0.599 . . . . 2.93 110.642 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.75 HD13 HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -89.4 131.82 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.067 -0.97 . . . . 2.09 111.589 -178.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' ILE . 15.7 tt -89.15 124.39 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.729 -0.669 . . . . 1.94 110.861 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 115.42 4.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.053 -0.521 . . . . 3.1 111.687 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.58 -162.34 11.91 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 1.78 112.419 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.01 -38.57 67.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.915 2.41 . . . . 2.77 112.305 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -89.12 -59.56 2.19 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.164 -0.471 . . . . 4.92 110.623 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.08 -152.56 19.32 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.152 -0.546 . . . . 2.3 112.054 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 6.3 mp -36.41 -62.69 0.44 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.543 0.337 . . . . 5.7 111.547 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.13 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 1.46 110.249 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 0.57 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 0.67 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.19 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.076 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.29 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 1.61 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 2.72 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.56 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.561 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 7.1 p30 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 1.63 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.34 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.795 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.8 t-80 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.92 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 0.98 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.11 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.39 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.076 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 0.8 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 1.38 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 48' ' ' LEU . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 0.65 109.708 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.863 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.39 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 2.54 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.4 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 1.68 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 5' ' ' LEU . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.0 111.966 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 1.82 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.39 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 2.66 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 2.49 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 5.67 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.921 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 1.68 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.54 110.127 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 2.56 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.1 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.23 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.943 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 1.72 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 86' ' ' ALA . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 1.87 110.254 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 0.67 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 60' ' ' VAL . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 1.47 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 1.49 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.74 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 57' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 0.54 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 0.72 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 1.71 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 0.8 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.53 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.561 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.54 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.44 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.747 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 0.52 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 0.61 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 0.41 112.049 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.948 HD13 HG21 ' B' ' 306' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 1.73 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.44 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.55 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 81' ' ' VAL . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 2.6 111.473 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.36 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.77 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 5' ' ' LEU . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 1.58 109.972 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 1.72 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.943 ' HG ' HD21 ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 1.38 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.54 116.09 31.33 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.773 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.4 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 26.8 m -125.46 130.8 72.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.95 0.405 . . . . 1.92 112.051 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.709 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -99.14 155.17 17.6 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.788 -0.642 . . . . 1.46 110.972 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 136.18 20.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.419 -0.355 . . . . 4.2 111.075 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -71.24 123.83 9.93 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.738 2.292 . . . . 2.28 112.452 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.7 p -141.35 83.45 1.87 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.834 0.35 . . . . 3.88 110.866 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.68 14.14 4.18 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.99 -0.624 . . . . 4.69 113.457 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -67.35 -49.66 63.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.126 0.463 . . . . 7.06 111.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.383 -0.371 . . . . 7.84 110.839 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.678 0.275 . . . . 4.22 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.554 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 -136.23 123.44 21.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.361 -0.381 . . . . 3.57 111.078 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.863 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 0.65 111.502 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.67 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.948 HG21 HD13 ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 3.17 111.469 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -103.63 155.67 18.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.079 -0.509 . . . . 1.97 111.133 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.89 134.21 16.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.412 -0.588 . . . . 1.34 109.412 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 10.8 mmtt -93.16 91.33 7.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 2.93 111.274 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 81' ' ' VAL . 29.3 mt -89.47 127.89 35.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.466 -0.788 . . . . 2.09 111.564 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -93.64 127.58 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.788 -0.642 . . . . 1.94 110.981 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -75.07 107.82 7.39 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 3.1 111.282 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.76 -164.47 27.05 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.031 -0.604 . . . . 1.78 112.644 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.26 -49.75 8.67 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.004 2.469 . . . . 2.77 112.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -67.94 -66.98 0.5 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.036 -0.529 . . . . 4.92 110.115 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.87 -163.06 13.01 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.177 -0.535 . . . . 2.3 112.566 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.672 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.5 mp -37.95 -62.62 0.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.495 0.318 . . . . 5.7 111.354 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.13 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.672 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 1.46 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 0.57 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 0.67 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.046 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.19 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.29 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 1.61 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 2.72 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.56 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 1.63 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.34 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.046 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.9 t-80 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.92 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.51 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 0.98 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.11 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.39 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.755 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 0.8 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 1.38 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG21 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 0.65 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.831 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.39 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 2.54 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.4 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 14' ' ' PHE . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 1.68 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.0 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 1.82 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.525 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 2.66 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 2.49 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 5.67 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.951 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 1.68 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.54 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.415 HG22 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 2.56 111.381 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.1 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.986 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.23 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 1.72 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 86' ' ' ALA . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.218 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 0.67 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.911 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 1.47 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 1.49 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.74 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 0.54 110.56 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.72 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 31' ' ' ILE . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 1.71 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 0.8 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.53 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.618 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 61.7 t-80 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.54 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.487 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 0.52 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 0.61 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 0.41 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 1.73 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.44 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.55 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 81' ' ' VAL . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 2.6 110.827 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.36 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 1.77 110.75 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 1.58 110.051 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 1.72 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.592 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 1.38 112.556 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -116.73 140.35 49.52 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 1.56 109.358 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 53' ' ' LYS . 84.9 t -134.23 141.1 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 1.92 111.314 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -88.47 138.01 31.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.154 -0.476 . . . . 1.46 110.615 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -94.15 114.21 62.67 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.448 -0.342 . . . . 4.2 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.26 142.83 42.33 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.788 2.326 . . . . 2.28 112.617 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -140.96 -62.4 0.48 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.295 -0.411 . . . . 3.88 110.602 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.4 107.74 0.37 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.921 -0.657 . . . . 4.69 112.474 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -64.25 -34.79 78.92 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.79 0.293 . . . . 7.06 111.79 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.763 0.316 . . . . 7.84 111.269 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 301' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.041 0.448 . . . . 4.22 111.343 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 -62.51 122.96 17.06 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.57 111.142 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.831 ' HB3' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.618 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 0.65 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 8.4 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.67 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.659 0.244 . . . . 3.17 111.659 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.76 116.17 27.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.304 0.573 . . . . 1.97 111.331 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.551 HG22 ' HG ' ' A' ' 5' ' ' LEU . 5.1 mp -96.97 103.32 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.204 -0.907 . . . . 1.34 110.815 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.87 91.41 4.36 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.405 0.621 . . . . 2.93 110.739 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD22 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -89.44 130.48 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.188 -0.915 . . . . 2.09 111.558 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.25 126.03 42.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.956 -0.566 . . . . 1.94 110.596 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -57.59 118.76 5.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.085 -0.507 . . . . 3.1 111.857 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.61 -170.98 13.71 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.814 -0.63 . . . . 1.78 112.58 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.93 -35.11 99.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.987 2.458 . . . . 2.77 112.662 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -80.84 -65.57 0.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.319 -0.4 . . . . 4.92 110.732 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.05 -117.45 2.31 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.138 -0.553 . . . . 2.3 112.156 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 74' ' ' LEU . 62.9 mt -87.6 -54.83 4.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 5.7 110.324 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.13 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 1.46 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 0.57 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 0.67 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.19 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.29 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 1.61 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 2.72 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.56 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.614 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 1.63 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.34 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.012 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.92 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.274 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 0.98 111.82 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.11 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.692 ' C ' HD13 ' A' ' 31' ' ' ILE . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.39 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 0.8 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 1.38 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 0.65 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.56 HG22 ' CE1' ' A' ' 24' ' ' HIS . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.39 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 2.54 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.665 HG22 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.4 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 1.68 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 2.8 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 1.82 111.24 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.39 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 2.66 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 2.49 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' CD ' HG13 ' A' ' 3' ' ' ILE . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 5.67 111.029 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 1.68 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.54 110.225 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 2.56 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.1 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.23 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD13 HD23 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 1.72 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 1.87 109.863 179.028 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 0.67 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 1.47 111.47 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 7.2 m120 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 1.49 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.74 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 57' ' ' VAL . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 0.54 110.72 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 0.72 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD23 HD13 ' A' ' 54' ' ' LEU . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 1.71 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 0.8 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.53 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.45 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.54 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.685 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.44 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.71 HG13 HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 0.52 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 0.61 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 57' ' ' VAL . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 0.41 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 1.73 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.44 111.877 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.55 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' VAL . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 2.6 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.36 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 1.77 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 1.58 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 1.72 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 1.38 111.62 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -111.34 126.34 54.81 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 1.56 110.015 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG13 HD23 ' A' ' 83' ' ' LEU . 4.5 m -120.4 133.94 65.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.467 -0.333 . . . . 1.92 111.395 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -87.13 152.11 22.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.993 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -108.67 128.41 25.59 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.206 -0.452 . . . . 4.2 110.861 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.04 137.68 63.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.692 2.261 . . . . 2.28 112.166 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.6 m -156.24 87.94 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.418 -0.355 . . . . 3.88 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.19 137.43 18.43 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.833 -0.699 . . . . 4.69 112.734 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t -75.25 -48.01 25.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.562 0.22 . . . . 7.06 110.842 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 7.84 110.902 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.77 0.319 . . . . 4.22 111.531 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? -155.67 132.33 10.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.085 -0.507 . . . . 3.57 110.741 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.502 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 0.65 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.67 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.71 HG12 HG13 ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.784 0.326 . . . . 3.17 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.4 pm0 -126.81 159.31 34.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.067 -0.515 . . . . 1.97 111.014 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.67 141.47 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.706 -0.479 . . . . 1.34 109.706 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.68 91.79 5.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.109 0.48 . . . . 2.93 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.1 mt -88.34 124.86 34.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 2.09 111.863 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.659 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.5 mp -87.88 116.04 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.332 -0.849 . . . . 1.94 109.965 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 78' ' ' SER . 9.2 tptm -62.13 117.2 5.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.843 0.354 . . . . 3.1 111.657 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.22 172.75 15.28 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.743 -0.662 . . . . 1.78 112.502 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.61 -36.63 89.89 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.872 2.381 . . . . 2.77 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -68.91 0.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.262 -0.426 . . . . 4.92 110.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.73 -130.89 4.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.103 -0.57 . . . . 2.3 112.208 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.8 mt -87.35 -52.49 5.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.153 -0.314 . . . . 5.7 110.153 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.13 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 1.46 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 0.57 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 0.67 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.19 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.003 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.29 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 1.61 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 2.72 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.56 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 1.63 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.34 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.92 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.51 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 0.98 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.11 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.708 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.39 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 0.8 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 1.38 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.842 HG21 HD21 ' A' ' 48' ' ' LEU . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 0.65 109.878 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.684 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.39 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 2.54 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.4 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 1.68 110.873 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 2.8 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.0 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 1.82 110.909 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.39 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 2.66 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 2.49 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 5.67 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.842 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 1.68 111.496 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.54 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 2.56 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.1 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.902 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.23 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 1.72 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 1.87 110.297 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 0.67 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.895 ' O ' HG22 ' A' ' 60' ' ' VAL . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 1.47 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 1.49 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.74 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' VAL . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 0.54 110.551 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 0.72 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 1.71 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 0.8 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.53 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.645 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 63.9 t-80 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.54 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 0.44 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.763 HG13 HG12 ' B' ' 306' ' ' VAL . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 0.52 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 0.61 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 0.41 110.976 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 1.73 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.44 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.55 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.706 ' CG2' HG22 ' A' ' 81' ' ' VAL . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 2.6 111.304 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.36 111.619 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 1.77 111.009 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 ' CG2' ' A' ' 77' ' ' THR . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 1.72 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 1.38 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -113.3 109.89 19.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 1.56 109.328 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 53' ' ' LYS . 94.9 t -107.11 135.24 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.92 111.457 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.5 143.78 29.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.922 -0.581 . . . . 1.46 110.738 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.92 110.4 64.05 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.276 -0.42 . . . . 4.2 111.21 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.29 149.76 57.78 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.859 2.373 . . . . 2.28 112.426 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -130.12 -62.66 0.93 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.211 -0.45 . . . . 3.88 111.008 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.06 101.04 0.15 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.841 -0.695 . . . . 4.69 112.624 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.59 -39.72 51.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.507 0.194 . . . . 7.06 111.206 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.838 0.351 . . . . 7.84 110.992 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.793 0.33 . . . . 4.22 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.567 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 -154.7 137.46 15.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.061 -0.518 . . . . 3.57 110.914 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.526 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.645 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 0.65 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.67 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.763 HG12 HG13 ' A' ' 71' ' ' VAL . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.651 0.262 . . . . 3.17 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.52 123.25 37.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.328 0.585 . . . . 1.97 111.322 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mp -97.11 107.46 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.038 -0.983 . . . . 1.34 110.954 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 90.4 3.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.463 0.649 . . . . 2.93 110.29 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB1' ' A' ' 41' ' ' ALA . 11.4 mt -90.79 131.44 36.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.925 -1.034 . . . . 2.09 111.932 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 6' ' ' ILE . 17.1 tt -89.11 125.34 42.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.796 -0.638 . . . . 1.94 110.174 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 3.8 mmmt -68.56 112.12 5.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.936 0.398 . . . . 3.1 111.81 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.18 19.29 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.707 -0.679 . . . . 1.78 112.384 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.72 -43.67 47.91 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.858 2.372 . . . . 2.77 112.508 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -67.67 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.415 -0.357 . . . . 4.92 110.537 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.97 -160.13 13.41 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.04 -0.6 . . . . 2.3 112.988 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.3 mp -38.9 -62.06 0.67 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.902 0.481 . . . . 5.7 111.812 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.577 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 1.46 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 0.57 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 0.67 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.086 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.19 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.29 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 1.61 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 2.72 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.56 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 1.63 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.34 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.086 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 50.0 t-80 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.92 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 32' ' ' TYR . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.51 110.684 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 0.98 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.11 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.39 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.709 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 0.8 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 1.38 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 48' ' ' LEU . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 0.65 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.477 HG21 ' CG ' ' B' ' 303' ' ' GLU . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.39 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 2.54 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.4 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 1.68 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 2.8 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.0 111.973 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 1.82 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.39 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 2.49 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 5.67 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 33' ' ' VAL . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 1.68 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.54 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 33' ' ' VAL . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 2.56 110.958 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.1 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.862 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.23 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.805 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 1.72 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 86' ' ' ALA . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 1.87 110.073 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 0.67 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.878 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 1.47 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 1.49 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.74 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 57' ' ' VAL . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 0.54 110.575 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.72 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.805 ' CD2' HD13 ' A' ' 54' ' ' LEU . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 1.71 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 0.8 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.53 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.531 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.54 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.485 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 62' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 0.44 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 0.52 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 0.61 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 0.41 111.158 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 1.73 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.44 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.55 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 2.6 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.36 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 1.77 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 5' ' ' LEU . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 1.58 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 1.72 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.77 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 1.38 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -113.83 154.09 28.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 1.56 109.585 178.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 53' ' ' LYS . 94.9 t -134.1 138.18 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.766 0.317 . . . . 1.92 111.292 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -103.23 155.48 18.4 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.984 -0.553 . . . . 1.46 111.249 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -114.78 111.21 45.88 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.337 -0.392 . . . . 4.2 110.616 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.7 120.74 8.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.712 2.274 . . . . 2.28 112.497 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 p -140.02 125.69 19.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.53 -0.304 . . . . 3.88 110.939 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.74 -145.56 4.23 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.901 -0.666 . . . . 4.69 112.771 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.7 m -82.98 -45.37 14.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.586 0.231 . . . . 7.06 111.187 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 116.43 -0.35 . . . . 7.84 110.957 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.904 0.383 . . . . 4.22 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 -134.24 110.62 9.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.011 -0.54 . . . . 3.57 110.431 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 0.65 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.67 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.687 HG12 HG13 ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.53 0.205 . . . . 3.17 111.28 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.51 130.9 42.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.198 0.523 . . . . 1.97 111.242 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 3.6 mp -97.34 102.31 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 1.34 110.993 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -99.66 91.28 4.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.43 0.633 . . . . 2.93 110.687 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.774 HD13 ' HB1' ' A' ' 41' ' ' ALA . 52.6 mt -97.48 131.75 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.993 -1.003 . . . . 2.09 111.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 21.2 tt -88.27 131.67 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.446 -0.343 . . . . 1.94 110.557 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.53 104.9 3.99 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.242 -0.436 . . . . 3.1 111.583 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.58 -160.27 23.02 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.763 -0.653 . . . . 1.78 112.529 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.53 -36.21 86.95 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.999 2.466 . . . . 2.77 112.752 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -79.96 -123.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.493 -0.322 . . . . 4.92 110.623 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.62 -124.98 0.74 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.576 -0.821 . . . . 2.3 112.829 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? -85.12 -50.18 7.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 5.7 110.976 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.13 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 1.46 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 0.57 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.67 111.659 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.029 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.19 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.29 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 1.61 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 2.72 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.56 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' B' ' 301' ' ' ARG . 0.6 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 1.63 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.029 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 54.1 t-80 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.92 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.51 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 0.98 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.11 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.39 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 0.8 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 1.38 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 48' ' ' LEU . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 0.65 109.205 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.749 HG22 ' CD2' ' A' ' 24' ' ' HIS . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.39 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 2.54 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.4 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 1.68 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 2.8 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.774 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.0 112.008 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 1.82 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.39 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 2.66 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 2.49 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 5.67 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 33' ' ' VAL . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 1.68 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.54 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 2.56 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.1 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.858 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.23 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.882 HD22 HD21 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 1.72 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 1.87 109.607 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 0.67 111.743 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD22 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 1.47 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.74 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 0.54 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 0.72 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 1.71 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 0.8 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.53 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.67 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 65.6 t-80 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.54 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 0.44 110.484 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG13 HG12 ' B' ' 306' ' ' VAL . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 0.52 110.712 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 0.61 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 0.41 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.44 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.55 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.704 ' CG2' HG22 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 2.6 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.36 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.445 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 1.77 112.549 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.704 HG22 ' CG2' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 1.72 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.882 HD21 HD22 ' A' ' 54' ' ' LEU . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 1.38 111.948 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -107.93 120.26 41.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 1.56 109.343 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 53' ' ' LYS . 34.4 t -103.74 135.51 41.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.917 0.389 . . . . 1.92 111.313 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.74 145.67 27.8 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.791 -0.64 . . . . 1.46 111.565 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -114.81 99.08 51.4 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.029 -0.532 . . . . 4.2 110.802 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -69.98 146.53 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.851 2.367 . . . . 2.28 112.338 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -126.8 -58.48 1.31 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.147 -0.479 . . . . 3.88 110.978 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.08 98.69 0.14 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.839 -0.696 . . . . 4.69 112.598 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.6 p -75.11 -43.94 50.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.559 0.218 . . . . 7.06 111.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.323 -0.399 . . . . 7.84 110.859 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 301' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 4.0 ptm180 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 4.22 111.499 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 -142.83 130.57 21.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.242 -0.435 . . . . 3.57 111.161 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.632 ' CG ' HG21 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.67 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 0.65 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.67 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.715 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.791 0.329 . . . . 3.17 111.27 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' HB3' ' CE ' ' A' ' 84' ' ' LYS . 1.2 pm0 -118.18 150.99 38.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.085 -0.507 . . . . 1.97 110.856 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.54 95.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.694 -0.484 . . . . 1.34 109.694 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -98.74 143.96 28.52 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.495 -0.557 . . . . 2.93 109.495 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.52 170.7 18.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.101 -0.333 . . . . 2.09 110.101 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -92.85 125.68 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.695 0.283 . . . . 1.94 110.899 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 33.3 tptt -65.95 133.96 51.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.286 -0.416 . . . . 3.1 111.417 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.78 178.61 17.3 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.812 -0.631 . . . . 1.78 112.647 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 -38.75 61.13 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.956 2.437 . . . . 2.77 112.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -62.61 -70.08 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.403 -0.362 . . . . 4.92 110.895 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.13 -134.29 5.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.04 -0.6 . . . . 2.3 112.396 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.676 HD11 ' O ' ' A' ' 74' ' ' LEU . 6.7 mt -83.31 -54.09 5.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.893 -0.41 . . . . 5.7 109.893 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.13 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 1.46 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 0.57 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.412 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.67 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.9 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.033 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.29 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 1.61 114.402 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 2.72 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.56 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.6 p30 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 1.63 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.34 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.9 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.92 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.51 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 0.98 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.11 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.39 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.033 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 0.8 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 1.38 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG21 HD21 ' A' ' 48' ' ' LEU . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 0.65 109.857 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.547 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 2.54 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.4 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.68 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.0 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 1.82 110.879 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 2.66 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 2.49 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 5.67 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 33' ' ' VAL . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 1.68 111.652 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.54 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 2.56 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.1 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB2' HG11 ' A' ' 85' ' ' VAL . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.23 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 1.72 112.004 -178.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 1.87 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 0.67 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 1.47 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 1.49 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.74 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 0.54 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 0.72 109.57 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 1.71 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 0.8 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.53 110.072 178.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.567 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.54 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 0.44 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG21 HG21 ' B' ' 304' ' ' THR . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 0.52 111.834 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 0.41 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.805 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 1.73 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.44 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.55 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 7' ' ' LYS . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 2.6 111.441 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.36 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 1.77 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 1.58 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 1.72 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 85' ' ' VAL . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 1.38 111.946 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.593 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -114.1 108.69 17.32 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 1.56 110.265 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 53' ' ' LYS . 99.3 t -107.99 130.53 60.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.416 -0.357 . . . . 1.92 110.72 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.23 148.72 25.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.222 -0.444 . . . . 1.46 110.92 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -102.13 131.76 22.28 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.325 -0.398 . . . . 4.2 110.829 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.82 142.11 61.79 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.708 2.272 . . . . 2.28 112.542 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 p -134.21 151.71 51.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 3.88 110.927 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.24 115.72 0.9 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.856 -0.687 . . . . 4.69 112.834 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.6 p -74.96 -36.2 62.07 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.427 0.156 . . . . 7.06 111.183 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.343 -0.39 . . . . 7.84 110.871 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.59 0.234 . . . . 4.22 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 -142.7 129.01 19.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.347 -0.388 . . . . 3.57 111.075 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.547 ' HB3' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.472 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 0.65 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 12' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.539 0.209 . . . . 3.17 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -106.58 150.65 25.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.43 -0.35 . . . . 1.97 110.731 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.36 95.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.443 -0.344 . . . . 1.34 110.758 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HB2' ' CD2' ' A' ' 82' ' ' TYR . 29.9 ttpt -98.31 147.26 24.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.339 -0.391 . . . . 2.93 110.058 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.26 170.59 18.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.074 -0.343 . . . . 2.09 110.074 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 tt -94.57 131.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.603 0.239 . . . . 1.94 111.018 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.28 129.89 15.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.326 -0.397 . . . . 3.1 111.89 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.86 -152.25 28.95 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.059 -0.591 . . . . 1.78 112.152 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.1 -80.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.845 2.363 . . . . 2.77 112.122 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.3 -73.05 0.09 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.428 0.156 . . . . 4.92 111.386 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.76 -107.99 0.23 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.776 -0.726 . . . . 2.3 112.662 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 HD12 ' A' ' 74' ' ' LEU . 70.8 mt -87.65 -53.2 4.91 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 5.7 111.172 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.13 113.544 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 1.46 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 0.57 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 0.67 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.19 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.031 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.29 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 1.61 113.681 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 2.72 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.56 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 1.63 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.34 113.125 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.036 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 54.5 t-80 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.92 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 0.98 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.11 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.39 109.657 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.031 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 0.8 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 1.38 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.883 HG21 HD21 ' A' ' 48' ' ' LEU . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 0.65 109.943 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.832 HG22 ' CD2' ' A' ' 24' ' ' HIS . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.39 113.052 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 2.54 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.4 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 1.68 110.838 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 2.8 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 1.82 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.39 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 2.66 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 2.49 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 5.67 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.883 HD21 HG21 ' A' ' 33' ' ' VAL . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 1.68 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.54 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 2.56 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.1 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.962 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.23 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' CD2' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 1.72 111.584 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 86' ' ' ALA . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 1.87 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 0.67 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.736 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 1.47 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 1.49 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.74 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 0.54 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.72 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.736 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 0.8 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.53 110.224 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.541 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 53.9 t-80 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.54 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.711 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 0.44 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 0.41 111.045 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 1.73 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.44 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.55 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 2.6 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.36 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 1.77 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 1.58 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 4' ' ' LYS . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 1.72 110.698 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 1.38 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.4 OUTLIER -120.29 128.39 53.26 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.869 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.962 HG13 ' O ' ' A' ' 53' ' ' LYS . 92.6 t -121.97 137.4 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.714 0.292 . . . . 1.92 111.608 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -85.88 145.72 27.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.049 -0.523 . . . . 1.46 110.757 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.94 112.06 65.25 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 4.2 111.069 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 56.9 Cg_endo -71.45 117.81 5.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.701 2.267 . . . . 2.28 112.178 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 m -140.86 113.8 8.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.705 0.288 . . . . 3.88 111.174 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.79 31.58 78.73 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 116.103 -0.499 . . . . 4.69 113.251 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.6 m -54.7 -40.41 69.16 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.892 0.346 . . . . 7.06 111.489 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.873 0.368 . . . . 7.84 111.184 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.74 0.305 . . . . 4.22 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.521 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 -159.41 126.54 4.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.155 -0.475 . . . . 3.57 111.123 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.551 ' HB3' HG21 ' A' ' 34' ' ' THR . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.541 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 0.65 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.67 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.575 HG12 HG13 ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.746 0.308 . . . . 3.17 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 156.81 38.93 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.163 -0.472 . . . . 1.97 110.762 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 47' ' ' LYS . 71.2 mt -144.2 95.62 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.437 -0.347 . . . . 1.34 110.538 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -97.49 146.4 25.28 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.742 -0.466 . . . . 2.93 109.742 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 170.74 18.22 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.313 -0.255 . . . . 2.09 110.313 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 tt -95.14 125.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.748 0.309 . . . . 1.94 110.969 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.51 133.77 35.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.076 -0.511 . . . . 3.1 111.674 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.19 -157.69 33.96 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.118 -0.563 . . . . 1.78 112.364 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.34 -76.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.854 2.37 . . . . 2.77 112.235 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -59.71 3.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.309 0.115 . . . . 4.92 111.309 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.65 -164.18 37.82 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.574 -0.822 . . . . 2.3 113.143 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.713 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mp -52.75 -41.37 63.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.31 0.244 . . . . 5.7 111.466 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.13 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.713 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 1.46 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 0.57 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 0.67 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.19 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.979 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.29 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 1.61 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 2.72 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.56 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 1.63 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.34 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.045 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.92 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.51 110.995 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ILE . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 0.98 113.059 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.11 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.599 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.39 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.979 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 0.8 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 1.38 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG21 HD21 ' A' ' 48' ' ' LEU . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 0.65 109.806 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.611 HG21 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.39 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 2.54 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.4 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 1.68 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 2.8 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.0 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.142 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.39 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 2.66 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 2.49 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 5.67 111.66 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG21 ' A' ' 33' ' ' VAL . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 1.68 111.296 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.54 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 2.56 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.1 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.23 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 1.72 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' HB2' ' A' ' 86' ' ' ALA . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 1.87 109.694 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 0.67 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 1.47 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 1.49 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.74 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 57' ' ' VAL . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 0.54 110.862 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 0.72 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.709 HD13 HG12 ' A' ' 57' ' ' VAL . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 1.71 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.8 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.53 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.572 ' HE1' ' HB ' ' B' ' 304' ' ' THR . 62.5 t-80 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.54 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 0.44 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG13 HG12 ' B' ' 306' ' ' VAL . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 0.52 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.61 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 0.41 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 1.73 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.44 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.55 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 2.6 110.845 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.36 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 1.58 110.73 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 1.72 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 54' ' ' LEU . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 1.38 111.848 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt -119.94 128.51 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 1.56 110.007 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.76 135.96 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.361 . . . . 1.92 111.058 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -101.65 155.17 18.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.072 -0.513 . . . . 1.46 111.017 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -101.52 139.02 20.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 4.2 110.772 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 158.3 56.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.643 2.228 . . . . 2.28 112.405 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -146.14 -74.84 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.356 -0.383 . . . . 3.88 110.804 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.12 133.83 7.81 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.94 -0.647 . . . . 4.69 112.626 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.3 p -78.84 -36.56 42.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.489 0.185 . . . . 7.06 111.305 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.391 -0.368 . . . . 7.84 111.158 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.59 0.233 . . . . 4.22 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.576 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 -124.21 128.65 49.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.364 -0.38 . . . . 3.57 110.825 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.611 ' CG ' HG21 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.572 ' HB ' ' HE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 0.65 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 21.7 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.67 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.654 HG12 HG13 ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.72 0.295 . . . . 3.17 111.355 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.0 159.29 35.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.123 -0.489 . . . . 1.97 111.265 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 mp -139.41 137.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.409 -0.589 . . . . 1.34 109.409 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB3' ' HE1' ' A' ' 80' ' ' PHE . 18.7 mttp -106.72 91.44 3.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.257 0.551 . . . . 2.93 111.168 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 2.4 mt -88.79 132.85 34.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.147 -0.933 . . . . 2.09 111.698 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.592 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.4 mp -88.3 118.15 33.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.326 -0.852 . . . . 1.94 110.37 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -63.43 110.61 2.0 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.382 -0.372 . . . . 3.1 111.181 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.25 174.82 28.97 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.128 -0.558 . . . . 1.78 112.527 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.63 60.09 6.47 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.317 2.678 . . . . 2.77 112.297 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -160.95 -67.13 0.06 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 4.92 110.501 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.59 -144.36 11.57 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.099 -0.572 . . . . 2.3 112.604 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp -87.23 -50.0 6.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 5.7 110.686 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.13 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 1.46 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 0.57 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.67 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.19 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.29 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 1.61 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 2.72 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.56 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.6 p30 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 1.63 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.34 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.743 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.4 t-80 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.92 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 32' ' ' TYR . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.51 110.883 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 0.98 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.11 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.39 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 0.8 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.38 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG21 HD21 ' A' ' 48' ' ' LEU . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.939 HG21 ' CB ' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.39 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 2.54 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.4 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 1.68 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.0 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 1.82 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.39 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 2.66 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 2.49 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 5.67 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.777 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 1.68 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.54 110.413 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 2.56 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.1 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.949 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.23 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 1.72 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 1.87 109.616 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 0.67 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 1.47 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 1.49 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.74 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 0.54 110.888 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 0.72 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 0.8 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.53 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.559 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.54 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 0.44 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.692 HG13 HG12 ' B' ' 306' ' ' VAL . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 0.52 111.128 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 0.61 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 0.41 111.001 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.44 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.55 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 2.6 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.36 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 1.77 110.891 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 1.58 109.796 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 1.72 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 1.38 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp -119.27 132.71 55.94 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 1.56 109.914 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 53' ' ' LYS . 78.4 t -121.21 139.73 47.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.804 0.335 . . . . 1.92 111.49 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.77 142.78 29.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.762 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.0 108.3 37.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 4.2 110.875 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.23 117.53 5.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.61 2.207 . . . . 2.28 112.42 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -144.08 102.3 3.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.658 0.266 . . . . 3.88 110.532 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 96.87 1.96 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.953 -0.642 . . . . 4.69 112.331 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 m -77.42 -51.03 11.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.494 0.188 . . . . 7.06 111.229 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.796 0.332 . . . . 7.84 110.89 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.676 0.274 . . . . 4.22 111.59 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 -160.94 140.33 10.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.172 -0.467 . . . . 3.57 111.034 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.939 ' CB ' HG21 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 0.65 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.67 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.692 HG12 HG13 ' A' ' 71' ' ' VAL . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.89 0.376 . . . . 3.17 111.423 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pt-20 -87.16 143.71 27.17 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.098 -0.501 . . . . 1.97 110.834 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 61.8 mt -142.32 95.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.339 -0.391 . . . . 1.34 110.711 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 82' ' ' TYR . 3.6 mttt -95.26 146.66 24.19 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.303 -0.408 . . . . 2.93 109.964 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -147.15 167.76 23.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.083 -0.339 . . . . 2.09 110.083 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 6' ' ' ILE . 19.3 tt -96.26 121.83 47.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.867 0.365 . . . . 1.94 110.747 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 107.69 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.155 -0.475 . . . . 3.1 111.107 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.54 -166.09 34.9 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.895 -0.593 . . . . 1.78 112.527 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.62 54.75 4.9 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.325 2.683 . . . . 2.77 112.538 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -143.72 -79.87 0.2 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.587 -0.279 . . . . 4.92 110.834 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.75 162.25 9.76 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.929 -0.653 . . . . 2.3 112.794 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp -44.05 -54.28 5.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.544 0.338 . . . . 5.7 111.572 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.13 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 1.46 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 0.57 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.809 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.67 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.101 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.19 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.29 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 1.61 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 2.72 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.56 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 1.63 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.34 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.101 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 51.1 t-80 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.92 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.51 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 0.98 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.11 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' C ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.39 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 54' ' ' LEU . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 0.8 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 1.38 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 0.65 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' HB3' ' B' ' 303' ' ' GLU . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.39 113.447 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 2.54 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.4 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 1.68 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 2.8 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.0 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 1.82 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.39 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 2.66 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 5' ' ' LEU . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 2.49 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 5.67 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 1.68 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.54 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 2.56 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.1 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.851 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.23 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.103 HD22 HD11 ' A' ' 83' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 1.72 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD22 ' HD3' ' A' ' 84' ' ' LYS . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 1.87 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 0.67 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.84 HG13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 1.47 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 1.49 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.74 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 0.54 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 0.72 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 1.71 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 0.8 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.53 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.54 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 HG12 ' B' ' 306' ' ' VAL . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 0.52 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.599 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 0.61 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.84 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 0.41 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 1.73 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.44 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.55 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 2.6 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.36 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 1.58 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 57' ' ' VAL . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 1.103 HD11 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 1.38 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.74 143.05 47.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 1.56 109.937 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG13 ' O ' ' A' ' 53' ' ' LYS . 48.7 t -124.96 138.3 54.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.706 0.289 . . . . 1.92 110.744 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.609 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -94.49 148.71 21.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.225 -0.443 . . . . 1.46 111.34 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -112.65 90.33 14.74 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.042 -0.526 . . . . 4.2 110.8 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 35.3 Cg_exo -57.25 131.36 44.5 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.795 2.33 . . . . 2.28 111.9 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -144.3 113.99 7.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.825 0.345 . . . . 3.88 111.2 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.78 33.5 68.15 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.972 -0.558 . . . . 4.69 113.162 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 m -64.76 -36.49 84.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.741 0.27 . . . . 7.06 111.237 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 p80 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 7.84 111.079 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 301' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 18.6 mtt180 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.716 0.293 . . . . 4.22 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.522 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 -128.03 130.15 47.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.161 -0.472 . . . . 3.57 110.984 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.67 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.749 0.309 . . . . 3.17 111.33 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 84' ' ' LYS . 1.3 pm0 -118.19 150.99 38.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.154 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.6 mt -143.23 95.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.103 -0.499 . . . . 1.34 110.381 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.23 147.59 23.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.035 -0.53 . . . . 2.93 110.285 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.22 170.41 19.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.712 -0.477 . . . . 2.09 109.712 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' ILE . 17.8 tt -90.33 122.6 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.805 0.336 . . . . 1.94 110.789 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 28.4 tptt -76.47 121.53 23.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.24 -0.436 . . . . 3.1 111.469 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.44 168.61 28.27 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.906 -0.588 . . . . 1.78 112.662 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.26 -40.53 58.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.909 2.406 . . . . 2.77 112.638 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -52.1 -66.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.319 -0.4 . . . . 4.92 111.079 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.85 -145.98 14.46 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.959 -0.639 . . . . 2.3 112.416 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 74' ' ' LEU . 34.7 mt -86.99 -54.13 4.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 5.7 110.471 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.13 113.412 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 1.46 110.708 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 0.57 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 0.67 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.19 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.29 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 1.61 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 2.72 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 1.63 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.34 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.92 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 0.98 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.11 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.39 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 0.8 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 1.38 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.899 HG21 HD21 ' A' ' 48' ' ' LEU . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.758 HG22 ' CE1' ' A' ' 24' ' ' HIS . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 2.54 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.4 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 1.68 110.913 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 2.8 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.0 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 1.82 110.779 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.39 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 2.66 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 2.49 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 5.67 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 1.68 111.454 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.54 110.016 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 2.56 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.1 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.797 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.23 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.0 HD21 HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 1.72 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.317 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' CB ' HD23 ' A' ' 55' ' ' LEU . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 0.67 112.086 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.0 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 1.47 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 1.49 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 0.54 110.762 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 0.72 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.75 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 1.71 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 0.8 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.579 ' HE1' ' HB ' ' B' ' 304' ' ' THR . 50.8 t-80 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.54 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 0.44 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 HG12 ' B' ' 306' ' ' VAL . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 0.61 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 0.41 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 1.73 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.44 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.55 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 2.6 112.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.36 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 1.77 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 77' ' ' THR . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 1.58 110.441 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 1.72 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 1.38 112.034 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 2' ' ' GLU . 1.8 mmmt -121.47 138.4 54.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 1.56 109.582 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 53' ' ' LYS . 98.3 t -121.9 138.91 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.839 0.352 . . . . 1.92 111.256 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -85.8 143.19 28.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 1.46 111.029 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -86.52 115.14 61.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 4.2 110.811 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 30.4 Cg_endo -66.02 156.22 65.62 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.5 2.133 . . . . 2.28 112.401 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -137.52 145.87 43.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.249 -0.432 . . . . 3.88 111.09 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.39 126.68 7.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.142 -0.552 . . . . 4.69 112.469 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.5 p -75.55 -40.86 56.25 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.538 0.209 . . . . 7.06 110.969 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.231 0.13 0 CA-C-N 116.4 -0.364 . . . . 7.84 110.987 179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.82 0.343 . . . . 4.22 111.121 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -122.27 143.66 49.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.119 -0.491 . . . . 3.57 111.137 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.579 ' HB ' ' HE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 0.65 111.336 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.67 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 29.5 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.101 0.477 . . . . 3.17 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.1 pm0 -81.43 142.71 32.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.155 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 1' ' ' MET . 3.1 mp -144.5 111.77 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.049 -0.523 . . . . 1.34 110.593 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -103.63 149.17 25.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.003 -0.544 . . . . 2.93 110.292 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 mt -150.06 170.9 17.81 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.043 -0.355 . . . . 2.09 110.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -95.69 121.38 46.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.062 -0.347 . . . . 1.94 110.062 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -54.07 135.8 42.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.127 -0.488 . . . . 3.1 111.783 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.73 -153.73 30.44 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.006 -0.543 . . . . 1.78 112.469 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.34 -74.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.763 2.309 . . . . 2.77 112.503 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.895 -0.138 . . . . 4.92 111.36 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.94 -114.66 0.4 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.656 -0.783 . . . . 2.3 112.922 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? -87.09 -50.4 6.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 5.7 110.794 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.13 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 1.46 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.57 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.8 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.19 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.29 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 1.61 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 2.72 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.56 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 1.63 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.34 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 57.1 t-80 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.92 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.51 110.85 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 0.98 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.11 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.567 ' C ' HD13 ' A' ' 31' ' ' ILE . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.39 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 0.8 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 1.38 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 0.65 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.867 HG21 ' HB3' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.39 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 2.54 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.4 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 1.68 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.0 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 1.82 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 2.66 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 2.49 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 5.67 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 1.68 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.54 110.4 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 2.56 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.1 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.011 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.23 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.708 HD13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 1.72 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 84' ' ' LYS . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 1.87 110.46 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 0.67 112.117 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 1.47 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 35.3 m120 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 1.49 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.74 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 0.54 110.527 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.72 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 57' ' ' VAL . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 0.8 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.53 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.508 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 64.8 t-80 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.54 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.44 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG13 HG12 ' B' ' 306' ' ' VAL . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 0.52 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 0.61 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 0.41 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 1.73 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HD2' HG12 ' A' ' 71' ' ' VAL . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.44 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.55 111.312 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 81' ' ' VAL . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 2.6 111.225 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 1.77 110.178 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.495 HG22 ' CG2' ' A' ' 77' ' ' THR . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 1.58 111.81 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 1.72 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 54' ' ' LEU . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 1.38 111.316 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.51 129.99 54.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.804 179.011 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.011 HG13 ' O ' ' A' ' 53' ' ' LYS . 84.1 t -112.62 138.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.418 -0.355 . . . . 1.92 111.214 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -97.7 149.22 22.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.234 -0.439 . . . . 1.46 111.022 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -105.98 112.76 64.19 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 4.2 111.064 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.81 168.35 10.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.836 2.358 . . . . 2.28 112.296 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.5 p -122.58 109.14 13.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.251 -0.431 . . . . 3.88 111.108 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.0 122.16 5.94 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.053 -0.594 . . . . 4.69 112.496 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -87.66 -51.52 5.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.586 0.232 . . . . 7.06 110.997 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.8 m170 . . . . . 0 N--CA 1.463 0.183 0 CA-C-N 116.268 -0.424 . . . . 7.84 110.959 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.76 0.314 . . . . 4.22 111.373 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 -143.0 115.77 8.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.161 -0.472 . . . . 3.57 110.856 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.867 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.508 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 0.65 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.516 0.198 . . . . 3.17 111.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.01 158.29 28.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.789 0.328 . . . . 1.97 111.125 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.02 141.46 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.524 -0.547 . . . . 1.34 109.524 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.14 91.14 4.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.169 0.509 . . . . 2.93 111.374 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD22 ' HB1' ' A' ' 41' ' ' ALA . 72.9 mt -88.76 124.16 33.87 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.414 -0.812 . . . . 2.09 111.16 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 15.2 tt -95.57 131.16 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.897 -0.592 . . . . 1.94 111.183 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.07 114.22 2.49 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.504 -0.316 . . . . 3.1 111.424 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.81 -149.68 19.56 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.014 -0.539 . . . . 1.78 112.665 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.76 4.42 4.11 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.224 2.616 . . . . 2.77 113.391 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 -69.98 0.17 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 110.442 -0.206 . . . . 4.92 110.442 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.08 18.09 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.981 -0.628 . . . . 2.3 112.965 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.747 HD22 ' CE2' ' A' ' 14' ' ' PHE . 28.2 mt -42.96 -58.39 2.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.694 0.398 . . . . 5.7 111.884 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.13 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.747 ' CE2' HD22 ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 1.46 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 0.57 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 0.67 110.864 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.19 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.29 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 1.61 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 2.72 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.56 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 1.63 109.548 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.34 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.038 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.92 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.993 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 0.98 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.11 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.39 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.761 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 0.8 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.696 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 1.38 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 48' ' ' LEU . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 0.65 110.685 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.757 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.39 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 2.54 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.4 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 2.8 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.0 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 1.82 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.39 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 2.66 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 2.49 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 5.67 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 1.68 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.54 110.258 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 33' ' ' VAL . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 2.56 111.191 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.1 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.015 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.23 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 57' ' ' VAL . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 1.72 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 86' ' ' ALA . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 1.87 110.088 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 0.67 111.969 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.91 ' O ' HG22 ' A' ' 60' ' ' VAL . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 1.47 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 1.49 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.74 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 0.54 110.519 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 0.72 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 1.71 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 0.8 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.53 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.66 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 64.0 t-80 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.54 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 0.44 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.727 HG13 HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.52 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 0.41 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 1.73 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.44 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.55 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 2.6 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 1.77 110.678 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 1.72 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 1.38 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 17.4 mmmt -117.66 122.47 43.63 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 1.56 110.467 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG13 ' O ' ' A' ' 53' ' ' LYS . 75.8 t -114.89 132.13 65.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.663 0.268 . . . . 1.92 110.996 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -86.51 155.14 20.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.246 -0.434 . . . . 1.46 111.416 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.37 128.77 25.63 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.195 -0.457 . . . . 4.2 110.856 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.12 152.5 72.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.716 2.278 . . . . 2.28 112.84 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -130.84 138.58 49.92 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.874 -0.603 . . . . 3.88 110.735 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.72 106.16 1.79 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 4.69 112.638 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -72.45 -55.79 6.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.589 0.233 . . . . 7.06 110.933 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.832 0.349 . . . . 7.84 110.862 179.698 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.736 0.303 . . . . 4.22 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.9 ttm180 -153.13 132.4 12.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.115 -0.493 . . . . 3.57 110.844 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.757 ' HB3' HG21 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.66 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.65 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.5 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.67 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.727 HG12 HG13 ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mmt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.815 0.34 . . . . 3.17 111.306 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 159.21 35.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.126 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.68 HG23 ' HD3' ' A' ' 47' ' ' LYS . 4.4 mp -131.66 140.82 47.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.236 -0.653 . . . . 1.34 109.236 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HG2' ' HE1' ' A' ' 80' ' ' PHE . 5.3 tttm -98.95 89.65 4.36 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.343 0.592 . . . . 2.93 111.388 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -89.36 112.67 23.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.256 -0.884 . . . . 2.09 111.705 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.36 127.56 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.904 -0.589 . . . . 1.94 110.475 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -51.53 113.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.442 -0.345 . . . . 3.1 111.599 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.07 24.31 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.043 -0.599 . . . . 1.78 112.211 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.91 -81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.555 2.17 . . . . 2.77 111.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.28 -69.29 0.25 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.405 0.145 . . . . 4.92 111.287 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.59 -114.47 0.4 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.597 -0.811 . . . . 2.3 113.18 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp -87.09 -51.02 6.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 5.7 111.118 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.13 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 1.46 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.57 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 0.67 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.19 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.027 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.29 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 1.61 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 2.72 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.56 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 1.63 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.6 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.34 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.997 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.6 t-80 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.92 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 0.98 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.11 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.39 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.027 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 0.8 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 1.38 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.909 HG21 HD21 ' A' ' 48' ' ' LEU . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 0.65 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.84 HG22 ' CD2' ' A' ' 24' ' ' HIS . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.39 113.014 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 2.54 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.4 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 2.8 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.0 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 1.82 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 2.66 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 2.49 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HD3' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 5.67 111.047 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.909 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 1.68 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.54 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 2.56 111.181 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.1 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.23 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 1.72 111.989 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.696 HD13 ' HB2' ' A' ' 86' ' ' ALA . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 1.87 109.811 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 0.67 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.882 ' O ' HG22 ' A' ' 60' ' ' VAL . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 1.47 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 1.49 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.74 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 0.54 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 0.72 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.696 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 0.8 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.53 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.633 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.6 t-80 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.54 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.44 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.823 HG13 HG12 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 0.52 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 0.61 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 0.41 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 1.73 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.44 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.55 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 2.6 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.36 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.491 ' HE1' ' HG2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 1.77 111.251 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 1.58 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 1.72 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 48' ' ' LEU . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 1.38 112.014 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -115.08 113.15 23.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 1.56 109.705 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.83 133.16 65.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.969 0.414 . . . . 1.92 111.614 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.696 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -96.33 155.76 16.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.796 -0.638 . . . . 1.46 111.172 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.97 139.19 24.46 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.438 -0.346 . . . . 4.2 110.785 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.92 160.3 50.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.609 2.206 . . . . 2.28 112.71 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -132.13 125.7 31.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.05 -0.523 . . . . 3.88 110.772 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.28 119.25 5.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.98 -0.628 . . . . 4.69 112.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.0 p -77.54 -40.95 40.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.512 0.196 . . . . 7.06 111.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.452 -0.34 . . . . 7.84 110.944 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.66 0.267 . . . . 4.22 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 -146.32 133.19 20.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.273 -0.421 . . . . 3.57 111.136 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.613 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.633 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.823 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.826 0.345 . . . . 3.17 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.487 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -126.02 159.15 33.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.981 -0.554 . . . . 1.97 111.008 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.6 131.34 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.98 -0.748 . . . . 1.34 108.98 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 91.18 4.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.287 0.565 . . . . 2.93 111.673 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' VAL . 32.0 mt -94.59 129.49 41.4 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.199 -0.91 . . . . 2.09 111.224 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.573 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -89.74 127.54 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.184 -0.462 . . . . 1.94 111.037 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -59.07 124.15 19.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.043 -0.526 . . . . 3.1 111.849 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.09 -171.89 14.05 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.81 -0.632 . . . . 1.78 112.633 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.99 -40.0 81.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.901 2.4 . . . . 2.77 112.472 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -79.12 -63.11 1.49 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.272 -0.422 . . . . 4.92 110.458 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.4 -116.77 2.36 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.147 -0.549 . . . . 2.3 112.354 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt -87.54 -50.05 6.78 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 5.7 110.7 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.13 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 1.46 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 0.57 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.67 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.19 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.007 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.29 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 1.61 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 2.72 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.56 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 1.63 110.426 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.34 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.042 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.4 t-80 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.92 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.441 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.51 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 0.98 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.11 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.61 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.39 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.007 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 0.8 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 1.38 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 0.65 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.857 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.39 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 2.54 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.4 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 1.68 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' A' ' 44' ' ' LYS . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.0 111.888 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 1.82 111.279 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.39 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 2.66 111.522 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 2.49 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 5.67 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 1.68 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.54 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 2.56 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.1 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.875 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.23 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 1.72 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.811 HD12 ' HB2' ' A' ' 86' ' ' ALA . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 1.87 110.134 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 0.67 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.902 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 1.49 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.74 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 57' ' ' VAL . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 0.54 110.645 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 0.72 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 1.71 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 0.8 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.53 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.54 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 0.44 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 0.52 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 0.61 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 0.41 110.996 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 1.73 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 71' ' ' VAL . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.44 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.55 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 2.6 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.36 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 1.77 110.563 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 1.58 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 1.72 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 54' ' ' LEU . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 1.38 112.094 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.7 mmpt? -110.83 110.26 20.79 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 1.56 109.582 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 53' ' ' LYS . 86.3 t -110.98 132.42 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.447 -0.342 . . . . 1.92 111.401 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -98.8 154.46 17.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.991 -0.55 . . . . 1.46 111.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -100.02 131.6 24.09 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 4.2 110.806 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' LYS . 52.5 Cg_exo -55.12 151.37 35.16 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.773 2.316 . . . . 2.28 112.497 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.9 p -150.45 168.39 24.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.038 -0.528 . . . . 3.88 111.034 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.54 90.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.028 -0.533 . . . . 4.69 113.194 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -75.87 -41.24 52.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.572 0.186 . . . . 7.06 111.002 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.872 0.368 . . . . 7.84 111.104 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.608 0.242 . . . . 4.22 111.273 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -147.18 157.83 43.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.3 -0.409 . . . . 3.57 111.151 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.462 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 0.65 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.67 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.52 0.2 . . . . 3.17 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -124.85 158.73 32.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.585 -0.279 . . . . 1.97 110.952 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.91 138.53 27.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.45 -0.574 . . . . 1.34 109.45 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -102.39 91.22 4.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 2.93 110.997 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' HB1' ' A' ' 41' ' ' ALA . 10.4 mt -89.19 126.82 35.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.35 -0.841 . . . . 2.09 111.327 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -91.87 127.1 44.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 1.94 110.811 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -61.82 113.81 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.277 -0.42 . . . . 3.1 111.399 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.46 -149.59 21.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.585 -0.606 . . . . 1.78 111.585 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.27 -82.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.237 1.958 . . . . 2.77 111.028 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -65.69 -59.91 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.336 -0.246 . . . . 4.92 110.336 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.88 -138.9 10.87 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.033 -0.603 . . . . 2.3 112.851 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.663 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.4 mp -37.07 -62.15 0.51 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.866 0.466 . . . . 5.7 111.81 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.13 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.663 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 1.46 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 0.57 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.544 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 0.67 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.19 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.054 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.29 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 1.61 113.06 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 2.72 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.56 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 1.63 109.926 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.34 112.86 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.6 t-80 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.92 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.66 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 0.98 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.11 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.39 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.054 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 0.8 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 0.65 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.813 HG22 ' CD2' ' A' ' 24' ' ' HIS . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.39 113.252 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 2.54 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' HIS . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.4 110.817 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 1.68 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 2.8 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.0 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 1.82 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.39 111.773 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 2.66 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 2.49 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 5.67 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 1.68 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.54 110.197 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 2.56 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.1 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.23 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 1.72 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 86' ' ' ALA . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 1.87 109.882 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 0.67 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 1.47 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.74 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 0.54 110.503 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 0.72 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 0.8 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.53 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.608 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.5 t-80 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.54 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 0.44 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG13 HG12 ' B' ' 306' ' ' VAL . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 0.52 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 0.61 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 0.41 111.53 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD23 HG21 ' B' ' 306' ' ' VAL . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 1.73 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.44 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.55 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB ' ' A' ' 81' ' ' VAL . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 2.6 111.122 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.36 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.441 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 1.77 110.685 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 77' ' ' THR . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 1.58 109.934 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 1.72 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 54' ' ' LEU . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 1.38 111.829 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 19.6 mmmt -115.67 119.46 36.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 1.56 110.0 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -122.54 134.1 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.822 0.344 . . . . 1.92 111.454 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -90.93 153.94 19.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.383 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -98.8 129.01 30.85 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.175 -0.466 . . . . 4.2 110.802 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.17 153.41 62.33 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.791 2.328 . . . . 2.28 112.486 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 p -144.95 -70.55 0.28 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.187 -0.46 . . . . 3.88 110.907 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.82 127.85 3.89 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.064 -0.589 . . . . 4.69 112.617 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -98.23 -45.17 6.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.56 0.219 . . . . 7.06 111.109 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.6 m80 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 7.84 111.018 -179.942 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.682 0.277 . . . . 4.22 111.235 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 52.8 ttt180 -134.71 130.98 37.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.251 -0.431 . . . . 3.57 111.002 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.645 ' CG ' HG21 ' A' ' 34' ' ' THR . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.608 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 0.65 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.67 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.694 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.747 0.308 . . . . 3.17 111.468 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.38 156.59 32.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.165 -0.47 . . . . 1.97 111.282 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' HD3' ' A' ' 47' ' ' LYS . 4.1 mp -146.43 115.38 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.855 -0.611 . . . . 1.34 109.402 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 1.2 mptt -80.7 91.19 5.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.23 0.538 . . . . 2.93 111.14 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.39 137.19 32.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.309 -0.859 . . . . 2.09 112.002 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' CE1' ' A' ' 80' ' ' PHE . 4.0 tt -89.4 153.09 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.212 -0.904 . . . . 1.94 109.939 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -84.87 133.41 34.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.651 0.262 . . . . 3.1 110.524 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.29 -170.59 36.33 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.944 -0.646 . . . . 1.78 112.383 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.3 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.579 2.186 . . . . 2.77 111.984 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -62.95 -63.88 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.49 0.186 . . . . 4.92 111.074 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.74 -136.35 2.24 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 2.3 112.802 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt -73.47 -39.47 64.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 5.7 111.343 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.13 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 1.46 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 0.57 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.67 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.19 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.078 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.29 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 1.61 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 2.72 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.56 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.61 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 7.9 p30 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 1.63 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.34 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.7 t-80 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.92 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.431 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.51 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 0.98 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.11 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.619 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.39 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.078 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 0.8 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 1.38 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.931 HG21 HD21 ' A' ' 48' ' ' LEU . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 0.65 109.761 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.829 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.39 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 2.54 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.4 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 1.68 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 2.8 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.0 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 1.82 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.39 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 2.66 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 2.49 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD3' HG12 ' A' ' 3' ' ' ILE . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 5.67 111.33 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 HG21 ' A' ' 33' ' ' VAL . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 1.68 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.54 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 2.56 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.1 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.23 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.628 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 1.72 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.426 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 1.87 110.013 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 0.67 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.858 ' O ' HG22 ' A' ' 60' ' ' VAL . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 1.47 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 1.49 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.74 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 0.54 110.403 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 0.72 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 1.71 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 0.8 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.53 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.684 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.3 t-80 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.54 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 0.44 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' B' ' 304' ' ' THR . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 0.52 111.973 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 0.61 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 0.41 110.493 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.44 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.55 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.641 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 2.6 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.36 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 1.77 110.509 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 1.58 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 1.72 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.501 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 1.38 112.24 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -111.58 108.19 17.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 1.56 109.442 178.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 53' ' ' LYS . 41.5 t -103.85 133.64 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.418 -0.356 . . . . 1.92 111.335 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -87.65 146.11 25.86 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.102 -0.499 . . . . 1.46 111.27 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 2.4 mptt -93.59 125.79 52.4 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 4.2 110.868 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' LYS . 46.2 Cg_exo -56.17 142.36 86.81 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 2.28 112.584 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.9 p -144.91 162.5 36.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 3.88 111.049 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.88 127.69 1.28 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.832 -0.699 . . . . 4.69 112.842 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m -76.29 -46.05 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.519 0.199 . . . . 7.06 110.945 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.378 -0.374 . . . . 7.84 110.846 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 301' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.818 0.342 . . . . 4.22 111.551 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.61 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 -148.38 128.87 13.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 3.57 110.734 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.829 ' HB3' HG21 ' A' ' 34' ' ' THR . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.684 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.65 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.67 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.816 0.341 . . . . 3.17 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.513 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 1.6 mp0 -77.7 145.05 36.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.149 -0.478 . . . . 1.97 110.526 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 2' ' ' GLU . 11.3 mt -144.11 99.18 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.301 -0.409 . . . . 1.34 110.606 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -95.08 148.92 21.84 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.122 -0.696 . . . . 2.93 109.122 178.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -148.29 170.12 18.62 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.705 0.288 . . . . 2.09 110.708 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.35 124.29 50.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.14 -0.482 . . . . 1.94 110.549 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -55.49 127.94 32.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.485 . . . . 3.1 111.86 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.11 -149.88 26.05 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.729 -0.668 . . . . 1.78 112.073 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.9 -78.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.63 2.22 . . . . 2.77 111.735 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -59.82 3.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.603 0.239 . . . . 4.92 110.918 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.16 -145.3 16.15 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.884 -0.674 . . . . 2.3 112.876 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -36.95 -62.35 0.49 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.804 0.442 . . . . 5.7 111.742 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.13 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 74' ' ' LEU . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 1.46 110.356 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 0.57 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 0.67 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.967 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.19 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.29 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 1.61 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 2.72 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.56 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 1.63 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.34 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 49.4 t-80 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.92 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.51 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 0.98 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.11 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.39 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 0.8 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 1.38 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 0.65 110.348 178.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.782 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.39 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 2.54 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.4 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 1.68 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 2.8 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.0 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 1.82 110.941 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.39 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 2.66 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.547 ' CG ' HD11 ' A' ' 5' ' ' LEU . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 2.49 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 5.67 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 1.68 111.236 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 2.56 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.1 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.879 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.23 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 1.72 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 84' ' ' LYS . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.158 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 0.67 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.917 HG21 HD22 ' A' ' 62' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 1.49 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.74 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 0.54 110.758 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 0.72 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 HG21 ' A' ' 57' ' ' VAL . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 1.71 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 0.8 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.53 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.568 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.54 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.62 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 0.41 111.39 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 1.73 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HD2' HG12 ' A' ' 71' ' ' VAL . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.44 111.839 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.55 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 2.6 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.36 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 1.77 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 1.58 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.545 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 1.72 110.142 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 1.38 111.879 -178.529 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HE3' ' HG3' ' A' ' 2' ' ' GLU . 1.9 mtpt -118.12 117.42 29.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 1.56 109.957 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 53' ' ' LYS . 60.4 t -105.5 139.73 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 1.92 111.109 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.678 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.85 138.08 32.77 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.156 -0.475 . . . . 1.46 110.886 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 108.43 60.58 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.249 -0.432 . . . . 4.2 111.039 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 143.01 43.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.785 2.323 . . . . 2.28 112.352 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.3 m -140.64 -69.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.424 -0.353 . . . . 3.88 110.896 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.43 98.62 0.18 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.92 -0.657 . . . . 4.69 112.674 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.8 p -76.15 -40.36 52.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.469 0.176 . . . . 7.06 111.263 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.426 -0.352 . . . . 7.84 111.044 -179.888 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 301' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 5.7 ptm180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.69 0.281 . . . . 4.22 111.465 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.1 157.76 44.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.112 -0.495 . . . . 3.57 110.968 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.782 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.67 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 71' ' ' VAL . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.707 0.289 . . . . 3.17 111.42 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -106.68 148.48 28.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.239 -0.437 . . . . 1.97 110.897 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -143.75 95.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.19 -0.459 . . . . 1.34 110.455 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -94.06 142.81 26.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.54 -0.541 . . . . 2.93 109.54 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -150.69 171.06 17.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.236 -0.283 . . . . 2.09 110.236 -179.68 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -89.96 139.28 17.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.747 -0.464 . . . . 1.94 109.747 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.38 134.49 44.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.793 0.33 . . . . 3.1 111.633 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.3 168.61 13.11 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.866 -0.606 . . . . 1.78 112.447 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.57 79.57 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.083 2.522 . . . . 2.77 112.498 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -173.94 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.001 -0.545 . . . . 4.92 110.837 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.16 -175.0 46.1 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.925 -0.655 . . . . 2.3 112.78 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -71.59 -38.17 70.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 5.7 111.604 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 1.46 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 0.57 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 0.67 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.067 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.19 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.016 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.29 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 1.61 112.998 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 2.72 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.56 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.588 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 1.63 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.34 113.027 -178.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.067 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 47.9 t-80 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.92 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 0.98 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.11 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.39 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.016 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 0.8 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 1.38 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.65 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.963 HG21 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.39 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 2.54 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.4 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 1.68 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 2.8 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.0 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 1.82 111.121 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.39 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 2.66 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 2.49 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 5.67 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 1.68 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.54 110.279 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 2.56 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.1 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.563 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.829 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.23 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 1.72 111.95 -178.787 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 1.87 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 0.67 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 1.47 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 1.49 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.74 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 0.54 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 0.72 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 54' ' ' LEU . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 1.71 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.8 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.53 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.568 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 49.8 t-80 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.54 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.676 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 0.44 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 HG12 ' B' ' 306' ' ' VAL . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 0.52 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.61 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 0.41 110.945 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 1.73 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.44 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.55 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 81' ' ' VAL . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 2.6 111.476 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.36 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 1.77 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 77' ' ' THR . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 1.58 110.993 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 1.72 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 1.38 112.007 -178.375 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -119.05 113.8 21.51 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 1.56 110.563 179.379 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 53' ' ' LYS . 22.6 t -119.93 130.82 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.141 -0.481 . . . . 1.92 110.366 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.88 150.34 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.411 -0.359 . . . . 1.46 111.019 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -100.68 119.99 57.06 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.308 -0.405 . . . . 4.2 110.959 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.11 131.19 18.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.727 2.285 . . . . 2.28 112.214 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -129.19 -64.06 0.92 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.69 -0.232 . . . . 3.88 110.876 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.37 119.59 2.73 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.013 -0.613 . . . . 4.69 112.455 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.6 m -69.58 -48.32 60.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.482 0.182 . . . . 7.06 111.144 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 CA-C-O 120.812 0.339 . . . . 7.84 110.928 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.742 0.306 . . . . 4.22 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 -95.44 143.43 26.78 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.392 -0.367 . . . . 3.57 110.908 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.963 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.568 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 0.65 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.67 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.622 HG12 HG13 ' A' ' 71' ' ' VAL . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.953 0.406 . . . . 3.17 111.186 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 143.78 37.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.039 -0.528 . . . . 1.97 111.045 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -144.3 95.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.156 -0.475 . . . . 1.34 110.465 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 149.8 23.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 2.93 110.281 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -149.49 170.51 18.43 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.644 0.259 . . . . 2.09 110.331 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -94.42 126.11 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.529 -0.305 . . . . 1.94 110.798 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -60.82 125.36 23.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.298 -0.41 . . . . 3.1 111.288 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.4 179.79 29.54 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.878 -0.601 . . . . 1.78 112.396 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.13 46.1 2.15 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.284 2.656 . . . . 2.77 112.74 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -150.95 -60.09 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.573 -0.285 . . . . 4.92 110.894 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.16 -135.46 6.04 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.199 -0.524 . . . . 2.3 112.328 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 74' ' ' LEU . 2.9 mp -86.41 -54.2 4.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.116 -0.327 . . . . 5.7 110.116 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.13 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 1.46 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.57 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 0.67 111.778 -178.357 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.13 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.19 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.29 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 1.61 113.948 177.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 2.72 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 1.63 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.34 113.012 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.13 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.7 t-80 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.51 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 0.98 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.11 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.559 ' C ' HD13 ' A' ' 31' ' ' ILE . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.39 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 0.8 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 1.38 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 48' ' ' LEU . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.65 109.881 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.903 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.39 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 2.54 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.4 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 1.68 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 2.8 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.0 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 1.82 110.828 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.39 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 2.66 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.504 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 2.49 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 5.67 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 1.68 111.278 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.54 110.312 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 2.56 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.1 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.892 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.23 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.873 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 1.72 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 0.67 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 1.47 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 1.49 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.74 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 0.54 110.697 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 0.72 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.721 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 1.71 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 0.8 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.53 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.666 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 57.3 t-80 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.54 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.659 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 0.44 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HG12 ' B' ' 306' ' ' VAL . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 0.52 111.246 179.387 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 0.61 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 0.41 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 1.73 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.44 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.55 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 2.6 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.36 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 1.77 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 1.58 110.624 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 1.72 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.873 ' HG ' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 1.38 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.2 110.75 17.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 1.56 110.274 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 53' ' ' LYS . 88.0 t -104.21 135.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.291 -0.413 . . . . 1.92 110.902 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -88.35 144.91 26.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.365 -0.38 . . . . 1.46 111.242 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -110.46 121.04 42.45 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.236 -0.438 . . . . 4.2 110.947 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 57.1 Cg_endo -71.17 147.73 54.49 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.622 2.214 . . . . 2.28 112.512 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -142.03 -72.84 0.32 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.196 -0.456 . . . . 3.88 110.689 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.93 129.87 4.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.037 -0.602 . . . . 4.69 112.578 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.02 -43.79 8.73 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.459 0.171 . . . . 7.06 110.93 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.93 0.395 . . . . 7.84 111.229 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.653 0.263 . . . . 4.22 110.994 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 -145.66 120.98 10.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 3.57 111.037 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.666 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.65 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.67 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.621 0.248 . . . . 3.17 111.153 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -125.17 114.95 19.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.307 0.575 . . . . 1.97 111.335 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 33.0 mt -96.64 95.94 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.203 -0.908 . . . . 1.34 110.967 -179.095 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 92.28 8.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.715 -0.675 . . . . 2.93 110.505 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 41' ' ' ALA . 11.2 mt -87.75 146.27 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.228 -0.896 . . . . 2.09 112.453 -177.378 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.627 HG13 ' CE1' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -86.52 154.27 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.751 -1.113 . . . . 1.94 109.89 -178.367 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -112.94 120.14 40.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.816 0.341 . . . . 3.1 111.215 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -163.97 11.76 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.17 -0.538 . . . . 1.78 112.823 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.04 -38.17 95.16 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.982 2.454 . . . . 2.77 112.495 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.96 -60.02 2.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.472 -0.331 . . . . 4.92 110.283 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.77 -110.96 1.74 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.006 -0.616 . . . . 2.3 112.657 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 74' ' ' LEU . 8.4 mp -87.4 -52.1 5.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.591 0.234 . . . . 5.7 110.869 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.13 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 1.46 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 0.57 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 0.67 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.19 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.29 115.318 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 1.61 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 2.72 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.56 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 1.63 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.34 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.92 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.51 111.368 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 0.98 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.11 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.39 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 0.8 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 1.38 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 0.65 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.787 HG21 ' HB3' ' B' ' 303' ' ' GLU . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.39 113.139 -178.023 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 2.54 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.4 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 1.68 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 2.8 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.0 111.91 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.39 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 2.66 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 2.49 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 5.67 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 1.68 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.54 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 2.56 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.1 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.984 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.23 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.812 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 1.72 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.853 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 1.87 109.781 178.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 0.67 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.892 ' CG2' HD22 ' A' ' 62' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.49 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.74 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 57' ' ' VAL . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 0.54 110.761 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 0.72 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.892 HD22 ' CG2' ' A' ' 57' ' ' VAL . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 1.71 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 0.8 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.53 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.54 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.666 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.44 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.735 HG13 HG12 ' B' ' 306' ' ' VAL . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 0.52 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 0.61 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 0.41 111.144 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 1.73 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.44 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 72' ' ' THR . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.55 111.262 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 81' ' ' VAL . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 2.6 111.446 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.36 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 1.77 110.981 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 77' ' ' THR . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 1.58 110.072 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 1.72 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.812 ' HG ' HD21 ' A' ' 54' ' ' LEU . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 1.38 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -110.79 123.44 50.07 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 1.56 110.222 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.984 HG13 ' O ' ' A' ' 53' ' ' LYS . 63.2 t -113.75 130.64 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.564 -0.289 . . . . 1.92 111.491 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -98.51 94.96 6.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.152 -0.476 . . . . 1.46 111.373 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -68.97 128.51 92.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.382 -0.372 . . . . 4.2 110.729 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 70.3 Cg_endo -71.41 155.64 59.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.034 2.489 . . . . 2.28 112.778 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -141.25 -69.87 0.37 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.127 -0.488 . . . . 3.88 110.895 179.684 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . . . -175.28 73.71 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.813 -0.708 . . . . 4.69 112.582 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -72.46 -35.84 68.36 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.499 0.185 . . . . 7.06 111.499 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m170 . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.816 0.341 . . . . 7.84 110.928 -179.872 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.781 0.324 . . . . 4.22 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 -126.79 128.9 47.32 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.228 -0.442 . . . . 3.57 110.916 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 34' ' ' THR . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 0.65 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.67 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.735 HG12 HG13 ' A' ' 71' ' ' VAL . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.504 0.192 . . . . 3.17 111.362 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.08 157.13 35.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.391 -0.368 . . . . 1.97 111.081 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -147.11 125.84 4.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.654 -0.499 . . . . 1.34 109.654 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 91.68 8.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.101 0.477 . . . . 2.93 111.236 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -88.46 134.15 33.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.432 -0.804 . . . . 2.09 111.589 -178.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.8 mt -89.05 116.12 30.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.67 -0.696 . . . . 1.94 110.185 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD3' ' HA ' ' A' ' 77' ' ' THR . 0.9 OUTLIER -68.09 118.64 11.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 3.1 111.167 -179.504 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.97 -173.63 40.84 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.078 -0.582 . . . . 1.78 112.623 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.5 -57.8 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.906 2.404 . . . . 2.77 112.481 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.338 -0.392 . . . . 4.92 111.109 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.52 -140.5 3.08 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.232 -0.985 . . . . 2.3 113.686 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? -83.99 -44.83 13.76 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.783 -0.208 . . . . 5.7 111.181 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.13 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 1.46 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 0.57 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 0.67 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.097 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.19 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.29 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 1.61 112.957 178.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 2.72 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.56 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 1.63 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.34 112.756 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.097 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 48.2 t-80 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.92 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 32' ' ' TYR . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.51 110.563 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 0.98 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.11 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.708 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.39 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.733 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 0.8 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 1.38 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.819 HG21 HD21 ' A' ' 48' ' ' LEU . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 0.65 110.039 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.868 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.39 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 2.54 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.4 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 1.68 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 2.8 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.0 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 1.82 111.339 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 2.66 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 2.49 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 5.67 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 1.68 111.226 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.54 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 2.56 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.1 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.23 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.724 HD13 HD21 ' A' ' 74' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 1.72 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 55' ' ' LEU . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 1.87 109.652 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 0.67 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 60' ' ' VAL . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 1.47 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 1.49 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.74 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 0.54 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 0.72 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 1.71 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 0.8 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.53 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.54 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 0.44 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.855 HG13 HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 0.52 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 0.61 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 0.41 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 1.73 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.44 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.55 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' LYS . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 2.6 111.469 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.36 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 1.77 110.072 178.678 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 1.58 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 1.72 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 1.38 111.78 -178.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -111.0 105.88 14.78 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 1.56 109.955 178.785 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 53' ' ' LYS . 88.6 t -111.43 127.65 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.4 -0.364 . . . . 1.92 110.917 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.7 153.06 21.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.173 -0.467 . . . . 1.46 111.368 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.4 117.59 68.92 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.067 -0.515 . . . . 4.2 110.655 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -71.27 117.47 5.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.605 2.203 . . . . 2.28 112.45 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -158.03 132.83 8.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.781 0.324 . . . . 3.88 110.832 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.47 152.9 18.4 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.025 -0.607 . . . . 4.69 112.696 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 p -100.14 -50.81 3.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.635 0.255 . . . . 7.06 110.775 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 7.84 111.106 179.892 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.695 0.283 . . . . 4.22 111.235 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 -150.17 128.49 12.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 3.57 111.018 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.868 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.67 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.855 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.697 0.284 . . . . 3.17 111.068 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.592 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.5 pm0 -122.71 159.09 28.69 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.97 111.376 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -144.0 137.98 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.374 -0.602 . . . . 1.34 109.374 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.7 91.95 5.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.314 0.578 . . . . 2.93 111.189 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.503 HD13 ' HB1' ' A' ' 41' ' ' ALA . 3.8 mt -88.69 126.53 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.268 -0.878 . . . . 2.09 111.157 -178.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -91.33 129.72 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.699 -0.682 . . . . 1.94 111.187 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -47.73 117.79 2.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.371 -0.377 . . . . 3.1 111.362 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.08 -161.9 37.86 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.113 -0.565 . . . . 1.78 113.162 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.64 34.31 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.688 2.925 . . . . 2.77 113.025 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -176.3 -70.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.611 -0.268 . . . . 4.92 110.65 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.02 -162.82 36.61 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.014 -0.612 . . . . 2.3 112.582 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 16.2 mt -48.77 -43.42 37.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 5.7 111.512 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.13 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.784 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 1.46 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 0.67 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.124 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.19 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.065 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.29 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 1.61 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 2.72 110.47 179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.56 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 1.63 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.124 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 51.8 t-80 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.92 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.51 110.851 -179.784 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 0.98 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.11 111.749 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.616 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.39 110.841 179.712 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.065 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.8 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 1.38 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.933 HG21 HD21 ' A' ' 48' ' ' LEU . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.719 HG22 ' CD2' ' A' ' 24' ' ' HIS . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.39 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 2.54 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 14' ' ' PHE . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.4 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 1.68 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 2.8 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.0 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 1.82 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.39 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 2.66 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 2.49 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 5.67 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.933 HD21 HG21 ' A' ' 33' ' ' VAL . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 1.68 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.54 110.403 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 2.56 111.198 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.1 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.865 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.23 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.845 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 1.72 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 86' ' ' ALA . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 1.87 109.6 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 0.67 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.845 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 1.47 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 1.49 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.74 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 0.54 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 0.72 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.785 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 1.71 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 0.8 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.53 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.54 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.658 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 0.44 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.766 HG13 HG12 ' B' ' 306' ' ' VAL . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 0.52 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 0.61 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 0.41 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.746 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 1.73 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.44 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.55 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 2.6 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.36 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.065 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 1.58 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 1.72 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 1.38 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -118.27 142.64 47.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 1.56 109.73 178.859 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 53' ' ' LYS . 62.0 t -127.61 138.93 53.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.778 0.323 . . . . 1.92 111.468 -179.094 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -97.01 153.09 18.12 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.079 -0.51 . . . . 1.46 111.353 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.22 89.83 18.5 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.181 -0.463 . . . . 4.2 110.785 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 53' ' ' LYS . 59.2 Cg_endo -71.2 160.07 50.1 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.829 2.353 . . . . 2.28 112.537 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 p -97.63 -50.5 4.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.173 -0.467 . . . . 3.88 111.108 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.3 -143.72 25.18 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.062 -0.59 . . . . 4.69 112.632 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.7 m -99.9 -53.57 3.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.606 0.241 . . . . 7.06 110.864 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-N 116.313 -0.403 . . . . 7.84 110.824 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.871 0.367 . . . . 4.22 111.551 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -66.91 132.44 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.185 -0.461 . . . . 3.57 111.062 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.479 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 0.65 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.908 0.385 . . . . 3.17 111.098 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -130.62 159.17 37.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.919 -0.582 . . . . 1.97 111.091 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 mp -141.84 139.98 30.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.355 -0.609 . . . . 1.34 109.355 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 90.97 3.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.255 0.55 . . . . 2.93 111.37 -179.719 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.48 129.09 36.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.333 -0.849 . . . . 2.09 111.217 -179.31 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.77 127.52 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 1.94 111.071 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 107.72 5.38 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.196 -0.456 . . . . 3.1 110.762 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.66 -165.68 29.44 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.939 -0.648 . . . . 1.78 112.723 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.48 31.86 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.523 2.815 . . . . 2.77 113.205 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -132.72 -72.78 0.51 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.538 0.209 . . . . 4.92 110.797 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.47 171.74 13.18 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.071 -0.585 . . . . 2.3 112.673 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.2 mp -34.5 -62.08 0.36 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.836 0.454 . . . . 5.7 111.838 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.13 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 1.46 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 0.57 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 0.67 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.19 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.29 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 1.61 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 2.72 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.56 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 1.63 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.34 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.92 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.51 111.381 -179.304 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 0.98 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.11 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.39 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 0.8 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 1.38 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.016 HG21 HD21 ' A' ' 48' ' ' LEU . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 0.65 110.04 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.663 HG21 ' HB3' ' B' ' 303' ' ' GLU . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.39 113.043 -178.203 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 2.54 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.4 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' PHE . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 1.68 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 2.8 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.0 111.949 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 1.82 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.39 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 2.66 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 2.49 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 5.67 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.016 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 1.68 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.54 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 2.56 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.1 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.944 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.23 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 1.72 111.778 -178.638 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 86' ' ' ALA . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 1.87 110.184 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 0.67 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 1.47 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 1.49 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.74 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 57' ' ' VAL . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 0.54 110.722 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 0.72 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 1.71 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 0.8 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.53 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.545 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 51.8 t-80 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.54 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 0.44 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.749 HG13 HG12 ' B' ' 306' ' ' VAL . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 0.52 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 0.61 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 0.41 111.177 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 1.73 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.44 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 72' ' ' THR . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.55 111.334 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 2.6 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.36 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 1.77 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 1.58 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.72 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 54' ' ' LEU . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 1.38 111.941 -178.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.1 129.02 55.3 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 1.56 110.215 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 53' ' ' LYS . 96.0 t -122.12 134.69 64.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.899 0.38 . . . . 1.92 111.525 -179.418 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -105.76 155.54 19.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 1.46 110.491 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 19.9 tttm -113.54 104.91 55.35 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-O 120.589 0.233 . . . . 4.2 110.566 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 87' ' ' LYS . 18.7 Cg_endo -59.32 142.43 99.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.793 2.329 . . . . 2.28 112.537 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.0 t -162.69 140.63 8.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.247 -0.433 . . . . 3.88 111.048 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.24 71.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.069 -0.586 . . . . 4.69 113.326 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -76.45 -42.26 44.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.105 0.452 . . . . 7.06 111.158 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.4 m170 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.391 -0.368 . . . . 7.84 110.919 179.909 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.815 0.34 . . . . 4.22 111.156 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? -87.22 121.86 30.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.144 -0.48 . . . . 3.57 110.959 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.545 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 0.65 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.67 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.749 HG12 HG13 ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.799 0.333 . . . . 3.17 111.441 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -113.18 159.12 19.6 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.19 -0.459 . . . . 1.97 111.257 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -141.5 141.23 30.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.246 -0.65 . . . . 1.34 109.246 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.41 90.9 3.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 2.93 111.064 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.929 HD21 ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.63 126.15 35.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.428 -0.805 . . . . 2.09 111.567 -178.702 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -93.51 128.81 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.646 -0.706 . . . . 1.94 110.831 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptt -54.74 116.19 2.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.863 0.363 . . . . 3.1 111.44 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.21 -170.52 45.04 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.866 -0.606 . . . . 1.78 112.811 -179.606 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.36 42.09 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.528 2.819 . . . . 2.77 113.41 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -171.38 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.762 -0.199 . . . . 4.92 110.586 179.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.66 -129.59 1.09 Allowed Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.867 -0.683 . . . . 2.3 112.719 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 7.0 mp -87.66 -49.37 7.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 5.7 111.195 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.13 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 1.46 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 0.57 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 0.67 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.998 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.19 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.52 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.29 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 1.61 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 2.72 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.56 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 1.63 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.34 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.998 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 45.5 t-80 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 0.98 112.165 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.11 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.39 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.68 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 0.8 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 1.38 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD21 ' A' ' 48' ' ' LEU . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 0.65 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.874 HG22 ' CD2' ' A' ' 24' ' ' HIS . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 2.54 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.4 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 1.68 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 2.8 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.929 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.015 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.39 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 2.49 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 5.67 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.003 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 1.68 111.006 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.54 110.281 179.666 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 2.56 111.327 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.1 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.869 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.23 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 1.72 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' ALA . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 1.87 109.701 178.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 0.67 110.98 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.833 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 1.47 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 1.49 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.74 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 0.54 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 0.72 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 1.71 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 0.8 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.53 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.54 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.873 HG13 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 0.52 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 0.61 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 0.41 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 1.73 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.44 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.55 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 2.6 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.36 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 5' ' ' LEU . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 1.58 110.317 178.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 1.72 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 1.38 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.2 139.56 51.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 1.56 109.734 178.935 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 53' ' ' LYS . 83.8 t -127.93 141.0 47.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.002 0.43 . . . . 1.92 111.402 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -84.3 139.69 32.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.765 -0.652 . . . . 1.46 110.85 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.0 107.83 25.74 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.367 -0.379 . . . . 4.2 111.054 -179.633 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.48 117.42 5.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.607 2.204 . . . . 2.28 112.396 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -138.01 -67.47 0.48 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.759 -0.2 . . . . 3.88 110.643 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.95 150.78 3.13 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.125 -0.56 . . . . 4.69 113.009 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 p -67.2 -39.04 86.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.58 0.229 . . . . 7.06 111.038 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.969 0.414 . . . . 7.84 110.907 179.806 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.769 0.319 . . . . 4.22 111.067 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.483 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 -106.02 129.3 54.16 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.121 -0.49 . . . . 3.57 110.953 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.553 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 0.65 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.67 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.86 0.362 . . . . 3.17 111.271 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.591 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.3 pm0 -131.05 159.42 37.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.026 -0.534 . . . . 1.97 110.863 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.55 136.53 35.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.43 -0.581 . . . . 1.34 109.43 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -99.98 91.22 4.7 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.351 0.596 . . . . 2.93 111.094 -179.833 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB2' HG13 ' A' ' 81' ' ' VAL . 8.2 mt -90.03 125.36 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.24 -0.891 . . . . 2.09 111.429 -179.186 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 tt -89.96 128.04 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.927 -0.579 . . . . 1.94 110.599 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.78 113.21 1.94 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 3.1 111.194 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 -178.98 35.12 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.054 -0.593 . . . . 1.78 112.714 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.09 48.63 2.93 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.424 2.749 . . . . 2.77 112.828 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -159.17 -61.23 0.07 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.661 0.267 . . . . 4.92 110.922 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.14 -140.43 8.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.201 -0.523 . . . . 2.3 112.1 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 74' ' ' LEU . 17.5 mt -87.48 -49.6 7.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 5.7 110.444 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.13 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 37' ' ' ILE . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 1.46 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 0.57 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 0.67 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.929 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.19 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.29 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 1.61 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 2.72 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.56 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 1.63 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.34 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 52.4 t-80 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.92 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.51 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 0.98 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.11 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.39 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.8 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 1.38 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG21 HD21 ' A' ' 48' ' ' LEU . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 0.65 109.733 178.214 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.723 HG21 ' HB3' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.39 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 2.54 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.4 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 1.68 111.439 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 2.8 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.0 112.144 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 1.82 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.406 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.39 111.201 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 2.66 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 2.49 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 5.67 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.88 HD21 HG21 ' A' ' 33' ' ' VAL . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 1.68 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.54 110.206 179.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 2.56 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.1 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.922 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.23 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.758 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 1.72 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 1.87 110.122 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 0.67 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 60' ' ' VAL . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 1.49 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.74 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 0.54 110.393 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 0.72 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 1.71 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 0.8 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.53 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.54 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 0.44 110.852 178.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 0.52 110.94 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.61 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 0.41 111.148 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 1.73 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.44 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.55 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 81' ' ' VAL . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 2.6 111.074 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.36 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.427 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.735 179.566 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 5' ' ' LEU . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 178.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 1.72 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.758 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 1.38 112.204 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -117.43 136.65 53.04 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 1.56 109.778 178.984 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 53' ' ' LYS . 91.9 t -121.76 139.32 49.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.905 0.384 . . . . 1.92 111.568 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -89.69 146.33 24.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.921 -0.581 . . . . 1.46 111.221 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -92.22 118.41 68.12 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 116.326 -0.397 . . . . 4.2 110.89 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.54 156.81 62.9 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.576 2.184 . . . . 2.28 112.356 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -135.99 146.92 47.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.146 -0.479 . . . . 3.88 111.12 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.36 130.89 2.18 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.952 -0.642 . . . . 4.69 112.763 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p -79.14 -35.59 41.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.459 0.171 . . . . 7.06 111.235 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.848 0.356 . . . . 7.84 111.008 -179.948 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.8 0.334 . . . . 4.22 111.198 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.653 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 -149.74 121.04 7.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.103 -0.498 . . . . 3.57 110.547 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.49 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.65 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.67 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.859 0.361 . . . . 3.17 111.628 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -78.17 157.77 29.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.002 -0.544 . . . . 1.97 111.242 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HD3' ' A' ' 47' ' ' LYS . 6.0 mt -139.6 139.91 37.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.552 -0.536 . . . . 1.34 109.552 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.605 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 4.4 tptt -103.89 90.69 3.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.226 0.536 . . . . 2.93 110.762 179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 81' ' ' VAL . 12.4 mt -100.04 131.02 46.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.197 -0.91 . . . . 2.09 112.13 -178.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 17.2 tt -89.61 128.96 41.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.765 -0.652 . . . . 1.94 110.64 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -58.84 121.75 11.9 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.459 -0.337 . . . . 3.1 111.351 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.33 -149.88 17.46 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.842 -0.617 . . . . 1.78 112.212 179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.68 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.591 2.194 . . . . 2.77 111.555 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -60.73 -65.83 0.63 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.525 0.202 . . . . 4.92 110.618 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.79 -103.92 0.24 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.588 -0.815 . . . . 2.3 113.482 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 74' ' ' LEU . 1.9 mp -87.35 -46.32 9.77 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 5.7 112.074 -178.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.13 113.012 -179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 1.46 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 0.57 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.67 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.19 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.29 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 1.61 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 2.72 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.56 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.6 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 1.63 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.34 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.92 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 32' ' ' TYR . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.51 111.362 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 0.98 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.11 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.39 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 0.8 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD21 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 0.65 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.598 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.39 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 2.54 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.4 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 1.68 111.046 -179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 2.8 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.19 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.631 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.39 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 2.66 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 2.49 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' HG12 ' A' ' 3' ' ' ILE . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 5.67 111.262 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 1.68 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.54 110.239 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 2.56 111.398 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.1 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.889 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.23 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 1.72 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 1.87 109.95 179.141 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 0.67 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 60' ' ' VAL . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 0.54 110.262 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 0.72 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 57' ' ' VAL . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 0.8 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.53 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.689 ' CE1' ' HB ' ' B' ' 304' ' ' THR . 66.6 t-80 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.54 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 0.44 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HG12 ' B' ' 306' ' ' VAL . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 0.52 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 0.61 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 0.41 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 1.73 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HD2' HG12 ' A' ' 71' ' ' VAL . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.44 111.97 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.55 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 2.6 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.36 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CE2' ' HG3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 1.77 109.852 178.985 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 1.58 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.72 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' HD21 ' A' ' 54' ' ' LEU . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 1.38 111.761 -178.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? -113.22 110.62 20.7 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 1.56 109.338 178.607 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 53' ' ' LYS . 39.7 t -108.67 133.57 53.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.454 -0.339 . . . . 1.92 111.157 -178.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -90.35 148.47 22.82 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.109 -0.496 . . . . 1.46 111.046 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.82 125.53 35.3 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.28 -0.418 . . . . 4.2 110.645 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.22 144.51 95.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.617 2.211 . . . . 2.28 112.236 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.61 100.44 0.58 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.234 -0.439 . . . . 3.88 110.537 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.18 129.68 49.92 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.069 -0.586 . . . . 4.69 112.934 -179.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 m -90.74 -33.68 15.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.533 0.206 . . . . 7.06 111.021 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.378 -0.373 . . . . 7.84 111.186 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 111.925 0.343 . . . . 4.22 111.925 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 302' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 59.57 86.79 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 3.57 111.243 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 303' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 304' ' ' THR . . . . . 0.689 ' HB ' ' CE1' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.65 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.67 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.768 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 5.6 mp . . . . . 0 N--CA 1.462 0.159 0 N-CA-C 110.392 -0.225 . . . . 5.7 110.392 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.13 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.768 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 1.46 110.733 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 0.57 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.67 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.19 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.29 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 1.61 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 2.72 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.56 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 1.63 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.34 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.023 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.92 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.51 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.98 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.11 111.849 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.618 ' C ' HD13 ' A' ' 31' ' ' ILE . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.39 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 0.8 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 1.38 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD21 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.65 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.654 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.39 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 2.54 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.4 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 2.8 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.0 111.694 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 1.82 111.051 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.39 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 2.66 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 2.49 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 5.67 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.963 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 1.68 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.54 110.098 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 2.56 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.1 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.688 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.23 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 1.72 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 1.87 109.532 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 0.67 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.889 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 1.47 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 1.49 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.74 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 0.54 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 0.72 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.827 HD13 HG12 ' A' ' 57' ' ' VAL . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.8 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.53 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 20.2 t60 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.54 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 0.44 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.684 HG13 HG12 ' B' ' 306' ' ' VAL . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 0.52 111.371 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.61 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 0.41 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 1.73 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.44 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.55 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.643 HG22 ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 2.6 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.36 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 1.77 110.452 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.643 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 1.72 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 54' ' ' LEU . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 1.38 111.784 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 1.56 109.536 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.485 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.838 0.351 . . . . 3.57 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.654 ' HB3' HG21 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.65 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 74' ' ' LEU . 81.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 5.7 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.13 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 1.46 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 0.57 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 0.67 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.093 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.19 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.022 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.29 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 1.61 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 2.72 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.56 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 1.63 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.34 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.093 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.92 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.51 111.296 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 0.98 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.11 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.39 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.022 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 0.8 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 1.38 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.013 HG21 HD21 ' A' ' 48' ' ' LEU . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 0.65 110.205 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.637 HG22 ' ND1' ' A' ' 24' ' ' HIS . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.39 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 2.54 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.4 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 1.68 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 2.8 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.0 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 1.82 111.053 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 2.66 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 2.49 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 5.67 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.013 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 1.68 111.207 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.54 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 2.56 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.1 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.23 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 1.72 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 1.87 109.924 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 0.67 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.835 ' O ' HG22 ' A' ' 60' ' ' VAL . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 1.47 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 53.1 m-80 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 1.49 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.74 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 0.54 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 0.72 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 1.71 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 0.8 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.53 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.54 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 0.44 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.764 HG13 HG12 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 0.52 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 0.61 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 0.41 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 1.73 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.44 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.55 112.269 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 2.6 110.678 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.36 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.13 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 1.72 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 54' ' ' LEU . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 1.38 110.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 19.9 mmmt . . . . . 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 1.56 110.55 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 32.2 ttm180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.776 0.322 . . . . 3.57 110.816 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.563 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.49 HG21 HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.65 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.67 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 6.3 mp . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.589 0.233 . . . . 5.7 111.547 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.13 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 1.46 110.249 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 0.57 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 0.67 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.19 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.076 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.29 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 1.61 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 2.72 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.56 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.639 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.5 p-10 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 1.63 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.34 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.795 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.92 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 0.98 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.11 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.39 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.076 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 0.8 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 1.38 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 48' ' ' LEU . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 0.65 109.708 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.863 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.39 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 2.54 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.4 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 1.68 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.0 111.966 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 1.82 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.39 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 2.66 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 2.49 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 5.67 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.921 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 1.68 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.54 110.127 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 2.56 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.1 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.23 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.943 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 1.72 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 1.87 110.254 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 0.67 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 60' ' ' VAL . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 1.47 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 1.49 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.74 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 57' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 0.54 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 0.72 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 1.71 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 0.8 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.53 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.639 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.54 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.44 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.747 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 0.52 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 0.61 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.623 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 0.41 112.049 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.948 HD13 HG21 ' B' ' 306' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 1.73 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.44 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.55 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 81' ' ' VAL . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 2.6 111.473 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.36 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.77 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' HB ' HG21 ' A' ' 77' ' ' THR . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 1.58 109.972 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 1.72 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.943 ' HG ' HD21 ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 1.38 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.773 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.554 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.854 0.359 . . . . 3.57 111.078 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.863 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 0.65 111.502 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.67 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.948 HG21 HD13 ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.672 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.5 mp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 120.652 0.263 . . . . 5.7 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.13 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.672 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 1.46 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 0.57 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 0.67 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.046 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.19 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.29 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 1.61 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 2.72 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.56 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 1.63 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.34 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.046 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.5 t60 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.92 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.51 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 0.98 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.11 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.39 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.755 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 0.8 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 1.38 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.951 HG21 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 0.65 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.831 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.39 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 2.54 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.4 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 14' ' ' PHE . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 1.68 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.0 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 1.82 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.525 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 2.66 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 2.49 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 5.67 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.951 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 1.68 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.54 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.415 HG22 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 2.56 111.381 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.1 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.23 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 1.72 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.218 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 0.67 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.911 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 1.47 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 1.49 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.74 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 0.54 110.56 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.72 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 31' ' ' ILE . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 1.71 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 0.8 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.53 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.7 t60 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.54 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.487 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 0.52 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 0.61 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 0.41 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 1.73 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.44 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.55 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 81' ' ' VAL . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 2.6 110.827 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.36 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 1.77 110.75 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 1.58 110.051 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 1.72 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.592 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 1.38 112.556 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 1.56 109.358 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.875 0.369 . . . . 3.57 111.142 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.831 ' HB3' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.487 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 0.65 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 38.5 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.67 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 74' ' ' LEU . 62.9 mt . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 5.7 110.324 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.13 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 1.46 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 0.57 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 0.67 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.19 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.29 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 1.61 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 2.72 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.56 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.614 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 1.63 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.34 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.012 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.92 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.274 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 0.98 111.82 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.11 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.692 ' C ' HD13 ' A' ' 31' ' ' ILE . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.39 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 0.8 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 1.38 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 0.65 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.56 HG22 ' CE1' ' A' ' 24' ' ' HIS . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.39 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 2.54 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.665 HG22 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.4 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 1.68 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 2.8 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 1.82 111.24 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.39 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 2.66 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 2.49 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 5.67 111.029 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 1.68 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.54 110.225 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 2.56 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.1 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.23 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.772 HD13 HD23 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 1.72 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 1.87 109.863 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 0.67 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 1.47 111.47 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.5 m-80 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 1.49 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.74 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 57' ' ' VAL . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 0.54 110.72 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 0.72 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.772 HD23 HD13 ' A' ' 54' ' ' LEU . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 1.71 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 0.8 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.53 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.45 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.54 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.685 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.44 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.71 HG13 HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 0.52 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 0.61 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 57' ' ' VAL . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 0.41 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 1.73 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.44 111.877 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.55 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' VAL . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 2.6 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.36 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 1.77 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 1.58 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 1.72 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.413 ' CG ' HD21 ' A' ' 54' ' ' LEU . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 1.38 111.62 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 1.56 110.015 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.846 0.355 . . . . 3.57 110.741 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.502 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 0.65 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.67 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.71 HG12 HG13 ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.8 mt . . . . . 0 N--CA 1.462 0.141 0 N-CA-C 110.153 -0.314 . . . . 5.7 110.153 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.13 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 1.46 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 0.57 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 0.67 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.19 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.003 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.29 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 1.61 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 2.72 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.56 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 1.63 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.34 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.92 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.51 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 0.98 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.11 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.708 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.39 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 0.8 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 1.38 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.842 HG21 HD21 ' A' ' 48' ' ' LEU . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 0.65 109.878 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.684 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.39 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 2.54 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.4 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 1.68 110.873 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 2.8 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.0 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 1.82 110.909 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.39 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 2.66 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 2.49 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 5.67 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.842 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 1.68 111.496 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.54 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 2.56 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.1 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.23 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 1.72 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 1.87 110.297 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 0.67 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.895 ' O ' HG22 ' A' ' 60' ' ' VAL . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 1.47 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 1.49 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.74 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' VAL . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 0.54 110.551 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 0.72 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 1.71 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 0.8 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.53 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 14.1 t60 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.54 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 0.44 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.763 HG13 HG12 ' B' ' 306' ' ' VAL . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 0.52 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 0.61 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 0.41 110.976 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 1.73 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.44 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.55 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.706 ' CG2' HG22 ' A' ' 81' ' ' VAL . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 2.6 111.304 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.36 111.619 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 1.77 111.009 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 ' CG2' ' A' ' 77' ' ' THR . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 1.72 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 1.38 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 1.56 109.328 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.567 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.798 0.332 . . . . 3.57 110.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.526 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 0.65 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.67 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.763 HG12 HG13 ' A' ' 71' ' ' VAL . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.577 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.3 mp . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 111.812 0.301 . . . . 5.7 111.812 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.577 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 1.46 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 0.57 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 0.67 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.086 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.19 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.29 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 1.61 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 2.72 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.56 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 1.63 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.34 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.086 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 65.8 t60 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.92 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 32' ' ' TYR . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.51 110.684 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 0.98 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.11 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.39 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.709 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 0.8 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 1.38 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 48' ' ' LEU . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 0.65 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.481 HG22 ' CE1' ' A' ' 24' ' ' HIS . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.39 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 2.54 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.4 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 1.68 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 2.8 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.0 111.973 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 1.82 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.39 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 2.49 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 5.67 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 33' ' ' VAL . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 1.68 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.54 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 33' ' ' VAL . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 2.56 110.958 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.1 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.712 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.23 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.805 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 1.72 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 55' ' ' LEU . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 1.87 110.073 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 0.67 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.878 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 1.47 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 1.49 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.74 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 57' ' ' VAL . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 0.54 110.575 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.72 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.805 ' CD2' HD13 ' A' ' 54' ' ' LEU . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 1.71 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 0.8 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.53 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.531 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.54 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.485 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 62' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 0.44 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 0.52 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 0.61 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 0.41 111.158 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 1.73 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.44 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.55 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 2.6 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.36 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 1.77 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.439 ' HB ' HG22 ' A' ' 77' ' ' THR . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 1.58 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 1.72 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.77 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 1.38 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 1.56 109.585 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.813 0.339 . . . . 3.57 110.431 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 0.65 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.67 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.687 HG12 HG13 ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 5.7 110.976 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.13 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 1.46 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.507 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 0.57 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.422 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.67 111.659 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.029 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.19 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.29 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 1.61 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 2.72 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.56 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.467 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 1.63 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.029 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 65.2 t60 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.92 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.51 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 0.98 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.11 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.39 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 0.8 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 1.38 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 48' ' ' LEU . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 0.65 109.205 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.732 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.39 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 2.54 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.4 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 1.68 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 2.8 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.0 112.008 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 1.82 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.39 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 2.66 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 2.49 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 5.67 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 33' ' ' VAL . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 1.68 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.54 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 2.56 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.1 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.23 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.882 HD22 HD21 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 1.72 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 1.87 109.607 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 0.67 111.743 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD22 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 1.47 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.74 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 0.54 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 0.72 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 1.71 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 0.8 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.53 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.509 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.2 t60 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.54 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 0.44 110.484 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.715 HG13 HG12 ' B' ' 306' ' ' VAL . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 0.52 110.712 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 0.61 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 0.41 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.44 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.55 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.704 ' CG2' HG22 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 2.6 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.36 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 1.77 112.549 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.704 HG22 ' CG2' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 1.72 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.882 HD21 HD22 ' A' ' 54' ' ' LEU . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 1.38 111.948 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 1.56 109.343 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 120.889 0.376 . . . . 3.57 111.161 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.632 ' CG ' HG21 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 0.65 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.67 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.715 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.676 HD11 ' O ' ' A' ' 74' ' ' LEU . 6.7 mt . . . . . 0 N--CA 1.462 0.137 0 N-CA-C 109.893 -0.41 . . . . 5.7 109.893 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.13 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 1.46 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 0.57 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.412 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.67 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.9 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.033 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.29 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 1.61 114.402 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 2.72 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.56 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p-10 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 1.63 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.34 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.9 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.92 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.51 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 0.98 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.11 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.39 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.033 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 0.8 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 1.38 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.983 HG21 HD21 ' A' ' 48' ' ' LEU . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 0.65 109.857 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.547 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 2.54 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.4 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.68 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.0 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 1.82 110.879 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 2.66 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 2.49 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 5.67 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 33' ' ' VAL . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 1.68 111.652 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.54 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 2.56 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.1 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.689 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.23 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 1.72 112.004 -178.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 1.87 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 0.67 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 1.47 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 1.49 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.74 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 0.54 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 0.72 109.57 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 1.71 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 0.8 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.53 110.072 178.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.652 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.54 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 0.44 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG21 HG21 ' B' ' 304' ' ' THR . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 0.52 111.834 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 0.41 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.805 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 1.73 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.44 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.55 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 2.6 111.441 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.36 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 1.77 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 1.58 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 1.72 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 84' ' ' LYS . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 1.38 111.946 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.593 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 1.56 110.265 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 120.824 0.345 . . . . 3.57 111.075 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.547 ' HB3' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.547 ' HB ' ' HE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 0.65 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 12' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 HD12 ' A' ' 74' ' ' LEU . 70.8 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 5.7 111.172 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.13 113.544 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 1.46 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 0.57 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 0.67 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.19 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.031 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.29 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 1.61 113.681 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 2.72 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.56 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 1.63 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.34 113.125 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.036 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 72.0 t60 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.92 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 0.98 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.11 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.39 109.657 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.031 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 0.8 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 1.38 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.883 HG21 HD21 ' A' ' 48' ' ' LEU . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 0.65 109.943 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.716 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.39 113.052 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 2.54 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.4 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 1.68 110.838 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 2.8 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 1.82 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.39 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 2.66 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 2.49 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 5.67 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.883 HD21 HG21 ' A' ' 33' ' ' VAL . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 1.68 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.54 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 2.56 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.1 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.23 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.552 ' CD2' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 1.72 111.584 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 1.87 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 0.67 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.736 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 1.47 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 1.49 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.74 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 0.54 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.72 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.736 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 0.8 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.53 110.224 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.3 t60 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.54 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.711 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 0.44 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 0.41 111.045 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 1.73 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.44 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.55 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 2.6 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.36 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 1.77 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 1.58 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 1.72 110.698 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 1.38 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.869 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.521 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.703 0.287 . . . . 3.57 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.551 ' HB3' HG21 ' A' ' 34' ' ' THR . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 0.65 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.67 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.575 HG12 HG13 ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.713 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 111.466 0.173 . . . . 5.7 111.466 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.13 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.713 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 1.46 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 0.57 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 0.67 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.19 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.979 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.29 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 1.61 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 2.72 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.56 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 1.63 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.34 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.045 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.92 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.51 110.995 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ILE . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 0.98 113.059 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.11 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.599 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.39 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.979 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 0.8 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 1.38 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG21 HD21 ' A' ' 48' ' ' LEU . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 0.65 109.806 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.611 HG21 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.39 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 2.54 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.4 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 1.68 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 2.8 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.0 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.142 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.39 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 2.66 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 2.49 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 5.67 111.66 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG21 ' A' ' 33' ' ' VAL . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 1.68 111.296 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.54 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 2.56 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.1 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.23 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 1.72 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD23 ' HE2' ' A' ' 84' ' ' LYS . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 1.87 109.694 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 0.67 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 1.47 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 1.49 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.74 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 57' ' ' VAL . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 0.54 110.862 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 0.72 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.709 HD13 HG12 ' A' ' 57' ' ' VAL . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 1.71 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.8 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.53 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 19.1 t60 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.54 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 0.44 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.654 HG13 HG12 ' B' ' 306' ' ' VAL . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 0.52 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.61 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 0.41 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 1.73 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.44 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.55 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 2.6 110.845 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.36 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 1.58 110.73 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 1.72 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 54' ' ' LEU . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 1.38 111.848 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 1.56 110.007 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.576 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.789 0.328 . . . . 3.57 110.825 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.611 ' CG ' HG21 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.553 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 0.65 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 18.0 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.67 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.654 HG12 HG13 ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 5.7 110.686 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.13 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 1.46 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 0.57 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.67 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.19 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.481 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.29 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 1.61 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 2.72 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.56 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 3.7 p-10 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 1.63 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.34 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.85 ' CE1' HG22 ' A' ' 34' ' ' THR . 70.0 t60 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.92 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 32' ' ' TYR . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.51 110.883 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 0.98 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.11 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.39 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 0.8 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.38 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.777 HG21 HD21 ' A' ' 48' ' ' LEU . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.939 HG21 ' CB ' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.39 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 2.54 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.4 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 1.68 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.0 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 1.82 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.39 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 2.66 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 2.49 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 5.67 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.777 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 1.68 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.54 110.413 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 2.56 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.1 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.23 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 1.72 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 1.87 109.616 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 0.67 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.748 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 1.47 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 1.49 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.74 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 0.54 110.888 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 0.72 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 0.8 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.53 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.54 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 0.44 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.692 HG13 HG12 ' B' ' 306' ' ' VAL . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 0.52 111.128 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 0.61 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 0.41 111.001 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.44 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.55 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 2.6 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.36 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 1.77 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 1.58 109.796 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 1.72 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 1.38 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 1.56 109.914 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.828 0.347 . . . . 3.57 111.034 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.939 ' CB ' HG21 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 0.65 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.67 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.692 HG12 HG13 ' A' ' 71' ' ' VAL . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp . . . . . 0 N--CA 1.468 0.475 0 N-CA-C 111.572 0.212 . . . . 5.7 111.572 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.13 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 1.46 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 0.57 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.809 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.67 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.101 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.19 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.29 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 1.61 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 2.72 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.56 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 1.63 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.34 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.101 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 75.0 t60 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.92 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.51 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 0.98 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.11 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.435 ' C ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.39 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 54' ' ' LEU . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 0.8 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 1.38 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 0.65 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' HB3' ' B' ' 303' ' ' GLU . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.39 113.447 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 2.54 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.4 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 1.68 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 2.8 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.0 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 1.82 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.39 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 2.66 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 2.49 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 5.67 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 1.68 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.54 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 2.56 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.1 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.23 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.103 HD22 HD11 ' A' ' 83' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 1.72 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.676 HD22 ' HD3' ' A' ' 84' ' ' LYS . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 1.87 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 0.67 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.84 HG13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 1.47 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 1.49 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.74 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 0.54 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 0.72 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 1.71 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 0.8 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.53 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.54 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 HG12 ' B' ' 306' ' ' VAL . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 0.52 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.599 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 0.61 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.84 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 0.41 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 1.73 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.44 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.55 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 2.6 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.36 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 1.58 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 57' ' ' VAL . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 1.103 HD11 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 1.38 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 1.56 109.937 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.522 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.766 0.317 . . . . 3.57 110.984 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.67 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 74' ' ' LEU . 34.7 mt . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 5.7 110.471 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.13 113.412 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 1.46 110.708 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 0.57 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 0.67 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.19 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.29 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 1.61 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 2.72 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 1.63 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.34 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.92 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 0.98 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.11 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.39 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 0.8 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 1.38 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.899 HG21 HD21 ' A' ' 48' ' ' LEU . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.758 HG22 ' CE1' ' A' ' 24' ' ' HIS . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 2.54 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.4 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 1.68 110.913 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 2.8 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.0 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 1.82 110.779 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.39 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 2.66 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 2.49 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 5.67 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 1.68 111.454 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.54 110.016 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 2.56 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.1 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.23 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.0 HD21 HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 1.72 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD23 ' CB ' ' A' ' 56' ' ' ALA . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.317 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' CB ' HD23 ' A' ' 55' ' ' LEU . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 0.67 112.086 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.0 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 1.47 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 1.49 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 0.54 110.762 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 0.72 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.75 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 1.71 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 0.8 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.3 t60 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.54 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 0.44 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 HG12 ' B' ' 306' ' ' VAL . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 0.61 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 0.41 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 1.73 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.44 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.55 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 2.6 112.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.36 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 1.77 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 77' ' ' THR . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 1.58 110.441 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 1.72 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 1.38 112.034 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 1.8 mmmt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 1.56 109.582 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.903 0.382 . . . . 3.57 111.137 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 0.65 111.336 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.67 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? . . . . . 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 5.7 110.794 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.13 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 1.46 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.57 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.8 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.19 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.29 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 1.61 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 2.72 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.56 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 1.63 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.34 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 78.2 t60 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.92 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.51 110.85 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 0.98 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.11 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.567 ' C ' HD13 ' A' ' 31' ' ' ILE . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.39 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 0.8 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 1.38 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 0.65 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.867 HG21 ' HB3' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.39 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 2.54 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.4 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 1.68 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.0 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 1.82 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 2.66 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 2.49 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 5.67 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 1.68 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.54 110.4 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 2.56 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.1 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.423 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.23 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.708 HD13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 1.72 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 84' ' ' LYS . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 1.87 110.46 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 0.67 112.117 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 1.47 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 72.2 m-80 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 1.49 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.74 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 0.54 110.527 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.72 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 57' ' ' VAL . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 0.8 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.53 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.5 t60 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.54 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.44 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG13 HG12 ' B' ' 306' ' ' VAL . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 0.52 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 0.61 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 0.41 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 1.73 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HD2' HG12 ' A' ' 71' ' ' VAL . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.44 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.55 111.312 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 81' ' ' VAL . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 2.6 111.225 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 1.77 110.178 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.495 HG22 ' CG2' ' A' ' 77' ' ' THR . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 1.58 111.81 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 1.72 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 54' ' ' LEU . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 1.38 111.316 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.804 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.765 0.317 . . . . 3.57 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.867 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 0.65 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.747 HD22 ' CE2' ' A' ' 14' ' ' PHE . 28.2 mt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 111.884 0.327 . . . . 5.7 111.884 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.13 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.747 ' CE2' HD22 ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 1.46 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 0.57 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.462 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 0.67 110.864 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.19 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.29 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 1.61 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 2.72 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.56 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 1.63 109.548 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.34 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.038 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.92 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.993 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 0.98 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.11 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.39 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.761 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 0.8 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.696 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 1.38 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 48' ' ' LEU . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 0.65 110.685 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.757 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.39 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 2.54 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.4 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 2.8 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.0 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 1.82 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.39 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 2.66 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 2.49 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 5.67 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 1.68 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.54 110.258 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 33' ' ' VAL . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 2.56 111.191 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.1 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.696 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.23 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 57' ' ' VAL . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 1.72 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 1.87 110.088 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 0.67 111.969 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.91 ' O ' HG22 ' A' ' 60' ' ' VAL . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 1.47 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 1.49 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.74 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 0.54 110.519 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 0.72 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 1.71 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 0.8 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.53 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.553 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.9 t60 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.54 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 0.44 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.727 HG13 HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.52 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 0.41 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 1.73 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.44 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.55 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 2.6 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 1.77 110.678 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 1.72 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 1.38 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 17.4 mmmt . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 1.56 110.467 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.9 ttm180 . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.76 0.314 . . . . 3.57 110.844 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.757 ' HB3' HG21 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.46 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.65 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 20.0 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.67 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.727 HG12 HG13 ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 5.7 111.118 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.13 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 1.46 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.57 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 0.67 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.19 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.027 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.29 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 1.61 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 2.72 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.56 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 1.63 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 5.3 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.34 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.997 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 70.4 t60 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.92 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 0.98 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.11 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.39 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.027 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 0.8 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 1.38 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.909 HG21 HD21 ' A' ' 48' ' ' LEU . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 0.65 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.728 HG22 ' CE1' ' A' ' 24' ' ' HIS . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.39 113.014 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 2.54 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.4 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 2.8 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.0 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 1.82 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 2.66 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 2.49 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 5.67 111.047 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.909 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 1.68 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.54 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 2.56 111.181 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.1 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.23 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 1.72 111.989 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 1.87 109.811 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 0.67 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.882 ' O ' HG22 ' A' ' 60' ' ' VAL . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 1.47 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 1.49 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.74 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 0.54 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 0.72 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.696 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 0.8 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.53 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.5 t60 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.54 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.44 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.823 HG13 HG12 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 0.52 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 0.61 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 0.41 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 1.73 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.44 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.55 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 2.6 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.36 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 1.77 111.251 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 1.58 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 1.72 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 48' ' ' LEU . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 1.38 112.014 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 1.56 109.705 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.776 0.322 . . . . 3.57 111.136 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.613 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.426 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.823 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 5.7 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.13 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 1.46 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 0.57 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.67 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.19 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.007 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.29 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 1.61 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 2.72 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.56 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 1.63 110.426 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.34 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.042 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 64.6 t60 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.92 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.441 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.51 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 0.98 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.11 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.61 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.39 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.007 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 0.8 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 1.38 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 0.65 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.857 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.39 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 2.54 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.4 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 1.68 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' A' ' 44' ' ' LYS . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 12' ' ' LEU . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.0 111.888 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 1.82 111.279 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.39 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 2.66 111.522 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 2.49 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 5.67 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 1.68 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.54 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 2.56 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.1 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.23 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 1.72 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 1.87 110.134 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 0.67 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.902 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 1.49 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.74 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 57' ' ' VAL . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 0.54 110.645 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 0.72 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 1.71 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 0.8 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.53 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.54 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 0.44 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 0.52 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 0.61 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 0.41 110.996 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 1.73 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 71' ' ' VAL . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.44 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.55 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 2.6 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.36 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 1.77 110.563 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 1.58 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 1.72 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 54' ' ' LEU . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 1.38 112.094 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.7 mmpt? . . . . . 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 1.56 109.582 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 . . . . . 0 C--O 1.233 0.228 0 CA-C-O 120.781 0.324 . . . . 3.57 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.462 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 0.65 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.67 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.663 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.4 mp . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 111.81 0.3 . . . . 5.7 111.81 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.13 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.663 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 1.46 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 0.57 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.544 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 0.67 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.19 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.054 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.29 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 1.61 113.06 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 2.72 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.56 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 1.63 109.926 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.34 112.86 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 76.4 t60 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.92 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.66 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 0.98 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.11 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.39 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.054 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 0.8 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 0.65 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.802 HG22 ' CE1' ' A' ' 24' ' ' HIS . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.39 113.252 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 2.54 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' HIS . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.4 110.817 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 1.68 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 2.8 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.0 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 1.82 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.39 111.773 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 2.66 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 2.49 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 5.67 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 1.68 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.54 110.197 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 2.56 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.1 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.23 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 1.72 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 1.87 109.882 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 0.67 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 1.47 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.74 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 0.54 110.503 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 0.72 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 0.8 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.53 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.556 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 11.9 t60 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.54 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 0.44 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.694 HG13 HG12 ' B' ' 306' ' ' VAL . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 0.52 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 0.61 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 0.41 111.53 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD23 HG21 ' B' ' 306' ' ' VAL . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 1.73 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.44 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.55 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB ' ' A' ' 81' ' ' VAL . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 2.6 111.122 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.36 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 1.77 110.685 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 77' ' ' THR . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 1.58 109.934 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 1.72 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 54' ' ' LEU . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 1.38 111.829 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 19.6 mmmt . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 1.56 110.0 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 52.8 ttt180 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.795 0.331 . . . . 3.57 111.002 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.645 ' CG ' HG21 ' A' ' 34' ' ' THR . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.506 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 0.65 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.67 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.694 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt . . . . . 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 5.7 111.343 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.13 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 1.46 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 0.57 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.67 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.19 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.078 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.29 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 1.61 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 2.72 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.56 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.656 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.0 p-10 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 1.63 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.34 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.3 t60 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.92 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.431 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.51 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 0.98 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.11 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.619 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.39 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.078 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 0.8 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 1.38 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.931 HG21 HD21 ' A' ' 48' ' ' LEU . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 0.65 109.761 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.829 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.39 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 2.54 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.4 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 1.68 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 2.8 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.0 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 1.82 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.39 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 2.66 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 2.49 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 5.67 111.33 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 HG21 ' A' ' 33' ' ' VAL . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 1.68 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.54 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 2.56 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.1 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.684 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.23 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.628 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 1.72 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 1.87 110.013 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 0.67 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.858 ' O ' HG22 ' A' ' 60' ' ' VAL . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 1.47 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 1.49 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.74 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 0.54 110.403 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 0.72 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 1.71 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 0.8 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.53 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 24.6 t60 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.54 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 0.44 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' B' ' 304' ' ' THR . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 0.52 111.973 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 0.61 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.598 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 0.41 110.493 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.44 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.55 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.641 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 2.6 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.36 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 1.77 110.509 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 1.58 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 1.72 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.501 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 1.38 112.24 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 1.56 109.442 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.61 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.778 0.323 . . . . 3.57 110.734 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.829 ' HB3' HG21 ' A' ' 34' ' ' THR . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.542 ' HB ' ' HE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.65 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.67 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 111.742 0.275 . . . . 5.7 111.742 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.13 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 74' ' ' LEU . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 1.46 110.356 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 0.57 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 0.67 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.967 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.19 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.29 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 1.61 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 2.72 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.56 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 1.63 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.34 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 58.1 t60 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.92 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.51 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 0.98 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.11 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.39 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 0.8 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 1.38 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 0.65 110.348 178.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.782 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.39 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.559 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 2.54 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.4 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 1.68 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 2.8 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.0 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 1.82 110.941 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.39 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 2.66 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 2.49 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 5.67 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 1.68 111.236 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.479 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 2.56 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.1 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.23 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 1.72 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 84' ' ' LYS . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.158 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 0.67 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.917 HG21 HD22 ' A' ' 62' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 1.49 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.74 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 0.54 110.758 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 0.72 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 HG21 ' A' ' 57' ' ' VAL . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 1.71 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 0.8 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.53 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.568 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.54 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.62 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 0.41 111.39 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 1.73 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HD2' HG12 ' A' ' 71' ' ' VAL . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.44 111.839 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.55 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 2.6 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.36 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 1.77 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 1.58 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 1.72 110.142 179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 1.38 111.879 -178.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 1.9 mtpt . . . . . 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 1.56 109.957 178.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.836 0.35 . . . . 3.57 110.968 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.782 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.67 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 71' ' ' VAL . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 5.7 111.604 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 1.46 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 0.57 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 0.67 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.067 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.19 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.016 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.29 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 1.61 112.998 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 2.72 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.56 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.588 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 1.63 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.34 113.027 -178.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.067 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 75.7 t60 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.92 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 0.98 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.11 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.39 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.016 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 0.8 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 1.38 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.65 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.963 HG21 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.39 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 2.54 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.4 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 1.68 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 2.8 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.0 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 1.82 111.121 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.39 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 2.66 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 2.49 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 5.67 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 1.68 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 1.6 pm0 -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.54 110.279 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 2.56 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.1 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.23 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 1.72 111.95 -178.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 1.87 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 0.67 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 1.47 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 1.49 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.74 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 0.54 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 0.72 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 54' ' ' LEU . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 1.71 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.8 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.53 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.1 t60 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.54 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.676 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 0.44 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 HG12 ' B' ' 306' ' ' VAL . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 0.52 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.61 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 0.41 110.945 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 1.73 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.44 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.55 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 81' ' ' VAL . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 2.6 111.476 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.36 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 1.77 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 77' ' ' THR . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 1.58 110.993 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 1.72 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 1.38 112.007 -178.375 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 1.56 110.563 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.85 0.357 . . . . 3.57 110.908 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.963 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 0.65 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.67 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.622 HG12 HG13 ' A' ' 71' ' ' VAL . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 74' ' ' LEU . 2.9 mp . . . . . 0 N--CA 1.461 0.123 0 N-CA-C 110.116 -0.327 . . . . 5.7 110.116 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.13 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 1.46 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.57 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 0.67 111.778 -178.357 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.13 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.19 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.29 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 1.61 113.948 177.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 2.72 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 1.63 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.34 113.012 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.13 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.9 t60 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.51 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 0.98 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.11 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.559 ' C ' HD13 ' A' ' 31' ' ' ILE . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.39 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 0.8 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 1.38 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 48' ' ' LEU . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.65 109.881 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.903 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.39 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 2.54 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.4 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 1.68 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 2.8 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.0 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 1.82 110.828 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.39 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 2.66 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 2.49 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 5.67 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 1.68 111.278 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.54 110.312 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 2.56 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.1 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.691 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.23 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.873 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 1.72 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 0.67 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 1.47 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 1.49 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.74 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 0.54 110.697 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 0.72 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.721 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 1.71 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 0.8 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.53 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.3 t60 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.54 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.659 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 0.44 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HG12 ' B' ' 306' ' ' VAL . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 0.52 111.246 179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 0.61 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 0.41 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 1.73 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.44 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.55 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 2.6 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.36 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 1.77 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 1.58 110.624 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 1.72 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.873 ' HG ' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 1.38 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 1.56 110.274 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.68 0.276 . . . . 3.57 111.037 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.473 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.65 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.67 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 74' ' ' LEU . 8.4 mp . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.591 0.234 . . . . 5.7 110.869 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.13 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 1.46 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 0.57 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 0.67 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.19 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.29 115.318 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 1.61 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 2.72 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.56 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 1.63 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.34 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.92 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.51 111.368 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 0.98 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.11 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.39 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 0.8 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 1.38 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 0.65 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.787 HG21 ' HB3' ' B' ' 303' ' ' GLU . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.39 113.139 -178.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 2.54 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.4 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 1.68 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 2.8 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.0 111.91 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.39 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 2.66 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 2.49 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 5.67 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 1.68 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.54 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 2.56 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.1 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.23 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.812 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 1.72 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 1.87 109.781 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 0.67 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.892 ' CG2' HD22 ' A' ' 62' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.49 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.74 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 57' ' ' VAL . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 0.54 110.761 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 0.72 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.892 HD22 ' CG2' ' A' ' 57' ' ' VAL . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 1.71 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 0.8 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.53 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.54 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.666 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.44 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.735 HG13 HG12 ' B' ' 306' ' ' VAL . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 0.52 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 0.61 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 0.41 111.144 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 1.73 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.44 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 72' ' ' THR . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.55 111.262 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 81' ' ' VAL . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 2.6 111.446 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.36 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 1.77 110.981 179.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 77' ' ' THR . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 1.58 110.072 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 1.72 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.812 ' HG ' HD21 ' A' ' 54' ' ' LEU . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 1.38 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm . . . . . 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 1.56 110.222 179.044 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.805 0.336 . . . . 3.57 110.916 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 34' ' ' THR . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 0.65 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.67 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.735 HG12 HG13 ' A' ' 71' ' ' VAL . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? . . . . . 0 N--CA 1.463 0.183 0 CA-C-O 120.495 0.188 . . . . 5.7 111.181 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.13 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 1.46 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 0.57 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 0.67 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.097 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.19 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.29 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 1.61 112.957 178.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 2.72 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.56 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 1.63 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.34 112.756 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.097 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 66.3 t60 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.92 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 32' ' ' TYR . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.51 110.563 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 0.98 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.11 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.708 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.39 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.733 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 0.8 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 1.38 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.819 HG21 HD21 ' A' ' 48' ' ' LEU . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 0.65 110.039 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.868 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.39 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 2.54 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.4 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 1.68 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 2.8 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.0 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 1.82 111.339 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 2.66 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 2.49 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 5.67 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 1.68 111.226 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.54 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 2.56 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.1 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.23 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.724 HD13 HD21 ' A' ' 74' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 1.72 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 55' ' ' LEU . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 1.87 109.652 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 0.67 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 60' ' ' VAL . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 1.47 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 1.49 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.74 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 0.54 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 0.72 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 1.71 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 0.8 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.53 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.54 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 0.44 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.855 HG13 HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 0.52 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 0.61 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 0.41 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 1.73 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.44 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.55 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' LYS . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 2.6 111.469 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.36 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 1.77 110.072 178.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 1.58 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 1.72 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 1.38 111.78 -178.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER . . . . . 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 1.56 109.955 178.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 120.852 0.358 . . . . 3.57 111.018 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.868 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.67 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.855 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 16.2 mt . . . . . 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 5.7 111.512 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.13 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.784 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 1.46 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 0.67 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.124 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.19 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.065 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.29 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 1.61 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG22 ' ND2' ' A' ' 29' ' ' ASN . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 2.72 110.47 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.56 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 1.63 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.124 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.1 t60 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.92 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.51 110.851 -179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 0.98 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' ND2' HG22 ' A' ' 20' ' ' VAL . 5.9 m120 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.11 111.749 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.616 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.39 110.841 179.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.065 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.8 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 1.38 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.933 HG21 HD21 ' A' ' 48' ' ' LEU . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.716 HG22 ' CE1' ' A' ' 24' ' ' HIS . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.39 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 2.54 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 14' ' ' PHE . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.4 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 1.68 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 2.8 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.0 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 1.82 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.39 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 2.66 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 2.49 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 5.67 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.933 HD21 HG21 ' A' ' 33' ' ' VAL . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 1.68 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.54 110.403 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 2.56 111.198 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.1 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.23 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.845 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 1.72 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 1.87 109.6 178.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 0.67 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.845 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 1.47 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 1.49 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.74 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 0.54 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 0.72 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.785 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 1.71 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 0.8 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.53 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.54 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.658 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 0.44 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.766 HG13 HG12 ' B' ' 306' ' ' VAL . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 0.52 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 0.61 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 0.41 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.746 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 1.73 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.44 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.55 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 2.6 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.36 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.065 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 1.58 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 1.72 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 1.38 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 1.56 109.73 178.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.769 0.319 . . . . 3.57 111.062 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.479 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 0.65 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.2 mp . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 111.838 0.31 . . . . 5.7 111.838 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.13 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 1.46 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 0.57 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 0.67 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.19 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.29 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 1.61 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 2.72 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.56 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 1.63 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.34 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.92 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.51 111.381 -179.304 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 0.98 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.11 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.39 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 0.8 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 1.38 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.016 HG21 HD21 ' A' ' 48' ' ' LEU . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 0.65 110.04 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.663 HG21 ' HB3' ' B' ' 303' ' ' GLU . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.39 113.043 -178.203 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 2.54 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.4 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' PHE . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 1.68 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 2.8 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.0 111.949 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 1.82 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.39 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 2.66 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 2.49 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 5.67 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.016 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 1.68 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.54 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 2.56 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.1 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.679 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.23 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 1.72 111.778 -178.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 1.87 110.184 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 0.67 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 1.47 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 1.49 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.74 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 57' ' ' VAL . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 0.54 110.722 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 0.72 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 1.71 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 0.8 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.53 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.9 t60 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.54 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 0.44 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.749 HG13 HG12 ' B' ' 306' ' ' VAL . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 0.52 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 0.61 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 0.41 111.177 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 1.73 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.44 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 72' ' ' THR . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.55 111.334 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 2.6 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.36 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 1.77 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 1.58 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.72 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 54' ' ' LEU . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 1.38 111.941 -178.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 1.56 110.215 179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.84 0.352 . . . . 3.57 110.959 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.474 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 0.65 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.67 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.749 HG12 HG13 ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 7.0 mp . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 5.7 111.195 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.13 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 1.46 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 0.57 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 0.67 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.998 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.19 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.52 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.29 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 1.61 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 2.72 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.56 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 1.63 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.34 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.998 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 66.5 t60 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 0.98 112.165 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.11 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.39 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.68 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 0.8 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 1.38 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD21 ' A' ' 48' ' ' LEU . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 0.65 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.844 HG22 ' CE1' ' A' ' 24' ' ' HIS . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 2.54 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.4 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 1.68 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 2.8 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 12' ' ' LEU . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.015 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.39 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 2.49 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 5.67 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.003 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 1.68 111.006 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.54 110.281 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 2.56 111.327 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.1 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.23 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 1.72 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 1.87 109.701 178.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 0.67 110.98 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.833 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 1.47 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 1.49 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.74 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 0.54 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 0.72 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 1.71 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 0.8 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.53 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.54 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.873 HG13 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 0.52 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 0.61 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 0.41 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 1.73 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.44 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.55 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 2.6 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.36 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 81' ' ' VAL . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 1.58 110.317 178.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 1.72 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 1.38 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 1.56 109.734 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.483 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.893 0.378 . . . . 3.57 110.953 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.553 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 0.65 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.67 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 74' ' ' LEU . 17.5 mt . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 5.7 110.444 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.13 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 37' ' ' ILE . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 1.46 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 0.57 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 0.67 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.929 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.19 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.29 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 1.61 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 2.72 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.56 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 1.63 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.34 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 57.1 t60 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.92 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.51 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 0.98 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.11 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.39 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.8 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 1.38 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.88 HG21 HD21 ' A' ' 48' ' ' LEU . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 0.65 109.733 178.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.723 HG21 ' HB3' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.39 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 2.54 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.4 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 1.68 111.439 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 2.8 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.0 112.144 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 1.82 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.406 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.39 111.201 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 2.66 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 2.49 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 5.67 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.88 HD21 HG21 ' A' ' 33' ' ' VAL . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 1.68 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.54 110.206 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 2.56 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.1 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.23 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.758 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 1.72 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 1.87 110.122 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 0.67 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 60' ' ' VAL . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 1.49 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.74 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 0.54 110.393 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 0.72 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 1.71 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 0.8 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.53 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.54 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 0.44 110.852 178.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 0.52 110.94 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.61 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 0.41 111.148 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 1.73 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.44 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.55 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 81' ' ' VAL . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 2.6 111.074 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.36 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.735 179.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 77' ' ' THR . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 178.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 1.72 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.758 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 1.38 112.204 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 1.56 109.778 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.653 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.811 0.339 . . . . 3.57 110.547 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.49 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.65 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.67 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 74' ' ' LEU . 1.9 mp . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 5.7 112.074 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.13 113.012 -179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 1.46 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 0.57 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.67 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.19 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.29 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 1.61 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 2.72 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.56 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 1.63 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.34 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.92 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 32' ' ' TYR . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.51 111.362 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 0.98 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.11 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.39 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 0.8 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD21 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 0.65 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.598 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.39 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 2.54 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.4 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 1.68 111.046 -179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 2.8 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.0 111.751 -179.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.19 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.631 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.39 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 2.66 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 2.49 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 5.67 111.262 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 1.68 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.54 110.239 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 2.56 111.398 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.1 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.23 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 1.72 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 1.87 109.95 179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 0.67 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 60' ' ' VAL . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 0.54 110.262 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 0.72 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 57' ' ' VAL . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 0.8 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.53 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.1 t60 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.54 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 0.44 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HG12 ' B' ' 306' ' ' VAL . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 0.52 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 0.61 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 0.41 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 1.73 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HD2' HG12 ' A' ' 71' ' ' VAL . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.44 111.97 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.55 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 2.6 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.36 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 1.77 109.852 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 1.58 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.72 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' HD21 ' A' ' 54' ' ' LEU . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 1.38 111.761 -178.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? . . . . . 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 1.56 109.338 178.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 302' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 3.57 111.243 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 303' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 304' ' ' THR . . . . . 0.485 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.65 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.67 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.753 0.311 . . . . 3.17 111.287 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -100.4 154.22 18.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 1.97 110.965 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -145.28 127.06 8.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 109.247 -0.649 . . . . 1.34 109.247 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 9.4 mtmt -94.33 91.32 6.65 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.261 0.553 . . . . 2.93 111.321 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 81' ' ' VAL . 2.9 mt -89.86 130.91 36.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.211 -0.904 . . . . 2.09 111.271 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.41 125.89 42.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.007 -0.542 . . . . 1.94 111.047 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -61.2 118.91 7.45 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.186 -0.461 . . . . 3.1 111.619 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.3 164.06 13.13 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.909 -0.587 . . . . 1.78 112.434 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.82 -42.38 66.88 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.86 2.374 . . . . 2.77 112.449 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -68.12 0.32 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.228 -0.442 . . . . 4.92 110.483 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.22 -140.91 8.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.943 -0.646 . . . . 2.3 112.685 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.768 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 5.6 mp -83.44 -52.2 6.72 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 110.392 -0.225 . . . . 5.7 110.392 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.24 31.93 21.36 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.11 -0.567 . . . . 1.13 114.152 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.768 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 29.3 p90 -161.05 -174.71 4.51 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 117.31 0.555 . . . . 1.46 110.733 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 41.1 p -129.92 172.9 11.21 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.096 -0.335 . . . . 0.57 110.096 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.94 169.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.67 110.983 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.023 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.46 164.12 28.89 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.589 -1.263 . . . . 1.19 107.589 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.87 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.36 134.49 1.67 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 117.839 -2.124 . . . . 1.29 115.803 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 104.08 160.51 24.49 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 120.351 -0.928 . . . . 1.61 113.883 177.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.11 137.55 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 110.364 -0.236 . . . . 2.72 110.364 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.21 -20.12 18.69 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.938 -0.649 . . . . 1.56 112.842 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -133.2 17.71 4.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.035 0.534 . . . . 1.63 110.647 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -55.25 143.85 26.59 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.207 0.817 . . . . 2.34 113.207 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.023 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.75 -29.33 18.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.393 -0.821 . . . . 0.92 110.968 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 mm -137.24 129.05 16.68 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.003 -0.544 . . . . 1.51 110.765 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -57.34 125.13 17.88 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.599 2.199 . . . . 0.98 112.264 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.35 -11.72 71.42 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.067 -0.587 . . . . 1.06 113.416 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.28 110.32 11.44 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.36 0.58 . . . . 1.68 110.608 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -88.23 17.24 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.41 -0.359 . . . . 2.11 111.849 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.618 ' C ' HD13 ' A' ' 31' ' ' ILE . 56.5 m -69.99 -179.61 1.95 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.695 0.283 . . . . 1.39 110.84 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.87 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.7 mm -100.28 109.8 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.993 0.425 . . . . 0.8 111.399 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 16.8 m-85 -110.31 145.43 37.47 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.021 -0.536 . . . . 1.38 111.479 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD21 ' A' ' 48' ' ' LEU . 58.5 t -79.61 126.24 39.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.171 -0.468 . . . . 0.65 109.826 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.654 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.9 OUTLIER -99.47 -25.86 14.31 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.473 0.916 . . . . 1.39 113.473 -177.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.11 120.29 2.56 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.607 0.225 . . . . 2.54 111.607 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.7 mt -101.77 124.62 55.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.706 0.288 . . . . 1.4 111.053 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.79 148.16 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.687 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.6 148.78 45.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.339 -0.391 . . . . 3.11 111.004 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.35 17.94 41.16 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 116.011 -0.541 . . . . 3.15 113.775 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.85 168.33 35.69 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 120.931 -0.652 . . . . 2.8 112.818 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -48.51 -54.71 13.31 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.694 0.257 . . . . 3.0 111.694 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.2 -50.92 59.13 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.579 0.228 . . . . 1.82 111.051 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.4 t-80 -51.24 -45.6 62.05 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.188 -0.46 . . . . 1.39 111.552 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -70.85 -38.58 73.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.344 -0.389 . . . . 2.66 111.37 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -61.98 -50.43 72.11 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.446 -0.343 . . . . 3.24 110.964 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.15 -26.31 13.82 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.131 -0.557 . . . . 2.49 113.133 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -65.1 -41.34 95.05 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.906 0.353 . . . . 5.67 111.268 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.963 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -87.77 123.85 33.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.114 0.483 . . . . 1.68 111.278 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -136.62 147.69 47.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.437 -0.801 . . . . 1.54 110.098 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -42.15 138.82 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.505 0.193 . . . . 2.56 111.33 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.87 -21.75 37.37 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.008 -0.615 . . . . 1.1 113.744 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -71.73 152.45 42.76 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 117.946 0.873 . . . . 1.56 111.22 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.953 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -112.85 148.33 35.12 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.584 -0.734 . . . . 3.23 110.772 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.677 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -95.76 102.7 14.52 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.332 -0.849 . . . . 1.72 111.807 -178.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.723 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.2 tt -66.49 -52.12 49.44 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.211 -0.904 . . . . 1.87 109.532 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.85 159.41 38.17 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.328 -0.397 . . . . 0.67 111.419 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.889 ' O ' HG22 ' A' ' 60' ' ' VAL . 7.7 p -149.45 117.08 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.858 0.361 . . . . 1.47 111.025 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.7 m120 67.82 38.87 2.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.134 -0.484 . . . . 1.49 110.929 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 82.66 -13.38 0.83 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.733 -0.667 . . . . 1.74 112.697 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.8 m -94.73 143.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.768 0.258 . . . . 0.54 111.018 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.3 p -82.59 129.92 35.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.866 -0.42 . . . . 0.72 109.866 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.827 HD13 HG12 ' A' ' 57' ' ' VAL . 1.3 tp -103.89 27.32 7.68 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.874 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 49.7 mt-10 -110.28 -18.0 13.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.564 0.579 . . . . 1.96 112.564 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -126.12 44.28 2.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.924 0.392 . . . . 2.93 111.262 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 15.7 m -134.01 160.23 41.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.111 -0.495 . . . . 0.8 111.952 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.435 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 59.5 p -70.87 -171.84 0.58 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.564 -0.744 . . . . 1.53 109.915 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 20.2 t60 -73.44 -39.79 64.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.223 -0.591 . . . . 0.54 110.167 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -51.3 -45.92 62.36 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.22 -0.445 . . . . 2.9 110.3 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.1 OUTLIER -65.48 -37.39 86.7 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.168 -0.469 . . . . 1.84 110.691 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.64 -42.27 92.35 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.907 0.384 . . . . 0.44 110.82 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.684 HG13 HG12 ' B' ' 306' ' ' VAL . 45.1 t -80.73 -37.15 16.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.987 -0.551 . . . . 0.52 111.371 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 22.9 m -62.82 -38.64 91.55 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.417 -0.356 . . . . 0.61 111.281 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.687 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -76.34 -36.56 58.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.542 -0.299 . . . . 0.41 111.007 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -69.66 -31.51 69.62 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.714 -0.476 . . . . 1.73 109.714 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.619 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 4.5 ptpt -86.04 -17.37 35.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.61 -0.723 . . . . 1.44 111.899 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -79.09 62.21 3.44 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.0 0.429 . . . . 1.55 110.991 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.643 HG22 ' HB ' ' A' ' 81' ' ' VAL . 33.6 p -121.61 118.14 28.48 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.092 -0.504 . . . . 2.6 111.205 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.9 m -91.31 -86.09 0.22 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.094 -0.503 . . . . 3.36 110.447 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.34 -44.07 6.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.741 0.305 . . . . 2.23 110.324 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.7 170.85 13.79 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.071 -0.513 . . . . 1.77 110.452 179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.643 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.5 p -142.23 120.05 7.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.14 99.01 10.51 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.234 0.54 . . . . 1.72 110.564 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 54' ' ' LEU . 2.3 tp -88.48 128.28 35.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.233 -0.894 . . . . 1.38 111.784 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -112.77 113.76 26.0 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.748 -0.66 . . . . 1.56 109.536 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.953 HG13 ' O ' ' A' ' 53' ' ' LYS . 39.6 t -108.51 133.57 53.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 1.92 111.188 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -90.78 147.57 23.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.277 -0.42 . . . . 1.46 111.141 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 115.58 65.33 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.351 -0.386 . . . . 4.2 110.597 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 53.6 Cg_endo -70.12 117.68 5.25 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.499 2.133 . . . . 2.28 112.54 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.2 m -132.42 -64.0 0.78 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.495 -0.32 . . . . 3.88 110.467 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.64 162.31 7.67 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.229 -0.51 . . . . 4.69 113.145 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.76 -45.36 5.77 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.608 0.242 . . . . 7.06 110.846 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.1 t60 . . . . . 0 N--CA 1.463 0.177 0 CA-C-O 120.978 0.418 . . . . 7.84 110.97 179.826 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 61.3 mtm180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.594 0.235 . . . . 4.22 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.485 ' NH2' ' HB3' ' A' ' 67' ' ' HIS . 50.2 ttp85 -142.13 129.17 20.81 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.34 -0.391 . . . . 3.57 111.016 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.654 ' HB3' HG21 ' A' ' 34' ' ' THR . 17.9 mt-10 -125.23 110.06 13.6 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.953 -0.567 . . . . 2.08 110.307 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.433 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.48 144.98 41.92 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.191 -0.459 . . . . 0.65 111.236 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.2 mt-30 -79.99 152.34 29.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.498 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.684 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.644 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.762 0.315 . . . . 3.17 111.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.55 158.55 34.27 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.188 -0.46 . . . . 1.97 110.857 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -145.99 118.35 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.436 -0.347 . . . . 1.34 110.845 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HG2' ' HD2' ' A' ' 80' ' ' PHE . 8.8 ttpt -117.16 147.6 42.32 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.804 -0.443 . . . . 2.93 109.804 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.607 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -150.23 170.45 18.93 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 122.27 -0.269 . . . . 2.09 110.658 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.5 tt -98.87 139.2 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.582 -0.281 . . . . 1.94 110.459 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -56.88 133.01 54.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.81 0.338 . . . . 3.1 111.672 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.46 -150.75 27.31 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.928 -0.578 . . . . 1.78 112.064 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -72.65 -83.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.78 2.32 . . . . 2.77 111.681 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -61.96 -68.09 0.35 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.431 0.158 . . . . 4.92 111.287 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.53 -110.5 0.28 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.742 -0.742 . . . . 2.3 113.078 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 74' ' ' LEU . 81.3 mt -86.62 -51.8 5.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.408 0.147 . . . . 5.7 111.29 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 84.2 33.92 18.96 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.024 -0.608 . . . . 1.13 113.421 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 15.2 p90 -159.34 -175.28 5.13 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.091 0.446 . . . . 1.46 110.729 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.9 p -130.64 174.28 10.07 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.724 0.297 . . . . 0.57 110.463 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.91 170.39 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.198 -0.456 . . . . 0.67 110.844 179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.093 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.16 164.06 28.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.439 -1.319 . . . . 1.19 107.439 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.022 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.07 133.22 1.48 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 117.605 -2.236 . . . . 1.29 116.057 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.84 156.47 22.0 Favored Glycine 0 C--O 1.222 -0.616 0 C-N-CA 120.772 -0.728 . . . . 1.61 113.054 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.09 136.59 26.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 110.194 -0.299 . . . . 2.72 110.194 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.81 -19.35 16.34 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 120.952 -0.642 . . . . 1.56 113.157 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 6.2 p30 -139.98 25.85 2.29 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.12 0.568 . . . . 1.63 110.501 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -74.8 160.57 30.53 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.308 0.575 . . . . 2.34 112.311 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.093 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.1 t60 -89.49 -26.02 21.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.241 -0.89 . . . . 0.92 112.122 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.422 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.1 mt -146.05 132.71 9.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.559 0.219 . . . . 1.51 111.296 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -56.08 128.1 28.81 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.883 2.389 . . . . 0.98 112.049 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.79 -55.28 1.38 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.05 -0.595 . . . . 1.06 112.208 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -89.03 105.83 18.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.868 0.366 . . . . 1.68 110.666 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -87.09 17.76 4.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.998 -0.546 . . . . 2.11 112.373 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 m -82.81 155.84 23.98 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.722 -0.474 . . . . 1.39 109.722 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.022 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.12 124.92 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.865 0.691 . . . . 0.8 112.865 -177.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 50.6 m-85 -119.97 149.43 42.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 115.531 -0.758 . . . . 1.38 110.338 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.013 HG21 HD21 ' A' ' 48' ' ' LEU . 23.1 t -77.76 126.2 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.722 0.296 . . . . 0.65 110.205 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.637 HG22 ' ND1' ' A' ' 24' ' ' HIS . 2.3 p -97.33 -29.24 13.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.666 0.987 . . . . 1.39 113.666 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 80.9 mttt -160.69 124.83 3.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.635 0.235 . . . . 2.54 111.635 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.9 mt -102.04 122.29 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.679 0.276 . . . . 1.4 111.046 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.4 mp -78.96 149.26 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.303 -0.408 . . . . 1.68 110.718 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.25 148.44 44.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.356 -0.384 . . . . 3.11 111.143 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.83 17.81 44.22 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.921 -0.581 . . . . 3.15 113.694 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.65 167.12 36.58 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 2.8 112.891 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.2 -52.51 20.57 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 122.339 0.256 . . . . 3.0 111.655 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.566 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.01 -51.53 38.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.498 -0.319 . . . . 1.82 111.053 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.0 t-80 -51.86 -45.55 64.11 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.943 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.27 -38.24 68.87 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.359 -0.382 . . . . 2.66 111.688 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.607 ' CG ' HD11 ' A' ' 5' ' ' LEU . 8.9 t70 -65.85 -55.35 17.5 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.755 -0.202 . . . . 3.24 111.329 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.43 -29.88 11.57 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.941 -0.647 . . . . 2.49 113.181 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -62.87 -42.66 99.84 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.935 0.368 . . . . 5.67 111.52 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.013 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -88.24 117.48 27.18 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.919 0.39 . . . . 1.68 111.207 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -131.16 144.81 51.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.68 -0.691 . . . . 1.54 110.417 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.7 mp -42.15 131.35 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 116.928 -0.124 . . . . 2.56 110.704 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.46 -20.61 15.63 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.81 -0.71 . . . . 1.1 112.815 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.31 147.43 49.66 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.369 0.584 . . . . 1.56 111.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.015 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.33 149.63 27.61 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.329 -0.85 . . . . 3.23 111.05 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -104.55 127.88 52.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.644 -0.707 . . . . 1.72 111.952 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 55' ' ' LEU . 3.5 tm? -94.72 -53.88 3.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.338 -0.846 . . . . 1.87 109.924 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.85 158.88 44.6 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.843 0.354 . . . . 0.67 111.808 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.835 ' O ' HG22 ' A' ' 60' ' ' VAL . 60.4 t -135.65 112.88 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.314 -0.403 . . . . 1.47 110.203 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 53.1 m-80 59.54 38.25 22.43 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.532 -0.303 . . . . 1.49 111.54 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 90.05 -17.82 0.2 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.152 0.581 . . . . 1.74 112.507 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.7 m -87.01 140.48 15.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 110.326 -0.25 . . . . 0.54 110.326 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.6 p -80.92 128.66 33.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.501 -0.479 . . . . 0.72 110.744 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.763 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.5 tp -103.24 21.01 16.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.884 -0.598 . . . . 1.71 111.018 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -103.01 -22.47 13.79 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.43 0.53 . . . . 1.96 112.43 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.29 53.57 1.88 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.035 0.445 . . . . 2.93 111.257 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 5.4 m -143.03 153.55 16.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.909 -0.587 . . . . 0.8 111.944 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -62.64 161.5 12.13 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.736 -0.665 . . . . 1.53 110.18 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.3 t60 -52.07 -37.57 54.31 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.834 -0.347 . . . . 0.54 110.82 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -50.83 -47.3 60.18 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.512 0.196 . . . . 2.9 110.572 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 6.9 mm-40 -62.4 -35.67 79.95 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.287 -0.415 . . . . 1.84 110.959 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.54 -42.13 95.88 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.169 0.509 . . . . 0.44 110.557 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.764 HG13 HG12 ' B' ' 306' ' ' VAL . 33.0 t -80.28 -38.24 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.665 -0.698 . . . . 0.52 111.5 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 87.4 m -64.39 -32.13 73.62 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.611 0.226 . . . . 0.61 111.611 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -81.0 -36.53 30.55 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.764 -0.198 . . . . 0.41 111.348 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.1 mm? -75.6 -35.8 60.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.11 0.481 . . . . 1.73 109.851 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 20.3 ttpt -73.09 -29.25 62.79 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.309 -0.859 . . . . 1.44 112.244 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.92 76.63 2.16 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.123 0.487 . . . . 1.55 112.269 -178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 t -126.57 141.56 51.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.601 -0.727 . . . . 2.6 110.678 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.1 m -128.67 -79.98 0.57 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.379 -0.373 . . . . 3.36 110.987 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -99.38 -58.16 1.99 Allowed 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 110.013 -0.365 . . . . 2.23 110.013 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' HD2' ' HG2' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -122.87 169.56 11.0 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.13 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.83 144.16 28.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -130.05 98.5 4.77 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.354 0.597 . . . . 1.72 111.141 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.976 HD11 HD11 ' A' ' 54' ' ' LEU . 2.6 tp -93.12 130.15 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.038 -0.983 . . . . 1.38 110.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 19.9 mmmt -108.22 110.98 22.73 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.269 -0.423 . . . . 1.56 110.55 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG13 ' O ' ' A' ' 53' ' ' LYS . 72.6 t -112.89 122.99 68.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.284 -0.416 . . . . 1.92 111.141 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.93 121.99 43.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.324 -0.398 . . . . 1.46 111.225 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 73.9 mttt -69.97 116.93 49.03 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.112 -0.495 . . . . 4.2 110.942 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.601 ' HD3' ' HG3' ' A' ' 53' ' ' LYS . 32.8 Cg_exo -59.96 135.35 62.4 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.993 2.462 . . . . 2.28 112.134 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 p -146.01 131.39 18.61 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.532 -0.304 . . . . 3.88 111.167 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.79 8.45 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.078 -0.582 . . . . 4.69 113.369 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 72.5 p -70.48 -36.77 74.05 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.184 0.492 . . . . 7.06 111.272 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.6 m80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.87 0.367 . . . . 7.84 110.96 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.922 0.391 . . . . 4.22 111.523 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 32.2 ttm180 -147.42 136.31 22.14 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.977 -0.556 . . . . 3.57 110.816 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.563 ' CG ' HG21 ' A' ' 34' ' ' THR . 6.3 mp0 -119.4 145.68 46.01 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.946 -0.57 . . . . 2.08 110.798 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.49 HG21 HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -150.75 145.95 26.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.65 111.126 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 12.3 mt-30 -77.81 155.14 31.26 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.072 -0.513 . . . . 1.67 111.301 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 71' ' ' VAL . 6.3 m . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.495 -0.764 . . . . 1.47 111.739 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.82 0.343 . . . . 3.17 111.098 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.74 127.26 36.42 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.121 0.486 . . . . 1.97 111.382 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 5' ' ' LEU . 2.9 mt -96.7 101.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 1.34 110.797 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.52 91.42 4.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.358 0.599 . . . . 2.93 110.642 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.75 HD13 HG22 ' A' ' 3' ' ' ILE . 0.7 OUTLIER -89.4 131.82 35.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.067 -0.97 . . . . 2.09 111.589 -178.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 6' ' ' ILE . 15.7 tt -89.15 124.39 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.729 -0.669 . . . . 1.94 110.861 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.04 115.42 4.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.053 -0.521 . . . . 3.1 111.687 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.58 -162.34 11.91 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.887 -0.597 . . . . 1.78 112.419 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.01 -38.57 67.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.915 2.41 . . . . 2.77 112.305 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.1 mtmm -89.12 -59.56 2.19 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.164 -0.471 . . . . 4.92 110.623 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.08 -152.56 19.32 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.152 -0.546 . . . . 2.3 112.054 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.896 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 6.3 mp -36.41 -62.69 0.44 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.543 0.337 . . . . 5.7 111.547 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.18 47.63 57.73 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.047 -0.597 . . . . 1.13 113.053 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.896 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 14.0 p90 -162.93 -173.5 3.49 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 110.249 -0.278 . . . . 1.46 110.249 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -130.3 169.63 15.17 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.804 -0.443 . . . . 0.57 109.804 179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.81 168.75 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.999 0.428 . . . . 0.67 111.489 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.795 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.33 166.86 22.15 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.409 -1.33 . . . . 1.19 107.409 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.076 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.43 124.83 0.73 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 118.629 -1.748 . . . . 1.29 115.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 154.84 11.87 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 118.771 1.286 . . . . 1.61 114.055 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.79 148.96 11.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 110.027 -0.36 . . . . 2.72 110.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.96 -18.11 18.2 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.629 -0.796 . . . . 1.56 112.208 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.639 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.5 p-10 -138.87 19.07 2.65 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.098 0.559 . . . . 1.63 109.561 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -46.96 138.55 6.36 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.514 0.931 . . . . 2.34 113.514 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.795 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -95.79 -31.45 13.18 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.342 -0.844 . . . . 0.92 111.395 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.492 HG13 ' CE2' ' A' ' 32' ' ' TYR . 30.3 mm -131.26 128.88 22.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 116.217 -0.447 . . . . 1.51 110.945 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.06 114.23 1.83 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.792 2.328 . . . . 0.98 112.476 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.28 -46.78 1.13 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.105 -0.569 . . . . 1.06 112.96 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.45 108.62 20.27 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.834 0.349 . . . . 1.68 111.605 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -84.2 21.63 1.36 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.955 -0.566 . . . . 2.11 111.568 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -67.16 -179.4 0.96 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.662 0.268 . . . . 1.39 110.99 179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.076 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -98.92 109.54 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.078 0.466 . . . . 0.8 110.897 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 21.7 m-85 -109.48 146.23 34.92 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.836 -0.62 . . . . 1.38 112.369 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.921 HG21 HD21 ' A' ' 48' ' ' LEU . 90.7 t -84.8 125.35 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.033 -0.53 . . . . 0.65 109.708 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.863 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.6 t -100.1 -25.69 14.21 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.793 1.034 . . . . 1.39 113.793 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.0 mttt -157.55 119.77 3.8 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.988 0.366 . . . . 2.54 111.988 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.93 121.46 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.56 -0.291 . . . . 1.4 110.742 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.5 mp -74.95 147.56 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.34 -0.391 . . . . 1.68 110.929 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -62.32 144.55 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.262 -0.427 . . . . 3.11 111.18 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.82 18.61 59.81 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.987 -0.551 . . . . 3.15 113.564 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.05 166.8 31.25 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.806 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.638 ' HB1' ' HG ' ' A' ' 5' ' ' LEU . . . -46.13 -54.5 8.51 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.966 0.358 . . . . 3.0 111.966 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.15 -49.81 63.45 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.505 -0.316 . . . . 1.82 111.421 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -53.02 -50.6 63.91 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.224 -0.443 . . . . 1.39 111.612 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -66.2 -39.88 89.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.249 -0.432 . . . . 2.66 111.322 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.2 -49.21 76.68 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.528 -0.305 . . . . 3.24 111.035 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.42 -27.04 11.24 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.068 -0.587 . . . . 2.49 113.314 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -45.97 90.89 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.854 0.327 . . . . 5.67 111.251 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.921 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -82.83 122.66 28.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.034 0.445 . . . . 1.68 111.374 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.32 145.01 51.72 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.63 -0.714 . . . . 1.54 110.127 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mt -47.47 122.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.636 0.255 . . . . 2.56 111.368 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -23.39 7.88 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.169 -0.538 . . . . 1.1 113.343 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -67.8 154.82 40.7 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.571 0.686 . . . . 1.56 111.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -112.09 148.6 33.59 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.837 -0.62 . . . . 3.23 110.933 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.943 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.4 OUTLIER -97.8 114.47 26.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.028 -0.987 . . . . 1.72 111.703 -179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 86' ' ' ALA . 6.3 tp -75.91 -51.83 11.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.027 -0.988 . . . . 1.87 110.254 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.69 160.73 41.56 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.177 0.436 . . . . 0.67 112.177 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.903 ' O ' HG22 ' A' ' 60' ' ' VAL . 90.8 t -144.23 109.3 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.892 0.377 . . . . 1.47 111.557 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 0.5 OUTLIER 64.5 50.34 2.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.158 -0.473 . . . . 1.49 111.303 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 11.2 m120 77.58 -12.79 1.02 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.171 0.804 . . . . 1.74 113.171 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' O ' ' A' ' 57' ' ' VAL . 8.5 m -97.18 142.74 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 118.173 0.442 . . . . 0.54 110.753 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.8 p -79.3 136.25 36.97 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.605 -0.438 . . . . 0.72 110.247 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.734 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -102.58 29.68 5.13 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.992 -0.549 . . . . 1.71 111.603 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -121.71 -19.72 6.71 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.745 0.646 . . . . 1.96 112.745 -179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.76 43.21 2.3 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.756 0.312 . . . . 2.93 111.646 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.9 m -142.82 159.59 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 112.763 0.653 . . . . 0.8 112.763 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.1 p -70.91 -172.77 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.091 -0.958 . . . . 1.53 109.998 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.639 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 36.0 t60 -70.46 -41.7 72.43 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 120.318 -0.553 . . . . 0.54 111.707 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -53.56 -40.91 65.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 121.28 -0.168 . . . . 2.9 110.85 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -67.79 -37.72 82.39 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.417 -0.356 . . . . 1.84 110.736 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' CB ' HG13 ' A' ' 31' ' ' ILE . . . -60.84 -48.68 80.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.44 110.675 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.747 ' HA ' ' CD1' ' A' ' 74' ' ' LEU . 12.3 t -71.93 -41.32 68.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.157 -0.928 . . . . 0.52 111.746 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 18.5 m -63.22 -31.5 72.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.452 -0.34 . . . . 0.61 111.412 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -74.24 -42.5 59.58 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 112.049 0.388 . . . . 0.41 112.049 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.948 HD13 HG21 ' B' ' 306' ' ' VAL . 0.0 OUTLIER -73.69 -26.84 60.91 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 119.98 -0.688 . . . . 1.73 110.351 179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -85.01 -24.78 28.07 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.978 0.362 . . . . 1.44 111.978 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -71.07 70.48 0.53 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.969 0.414 . . . . 1.55 111.116 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.451 HG21 ' HB ' ' A' ' 81' ' ' VAL . 48.8 p -133.42 161.09 35.48 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.059 -0.519 . . . . 2.6 111.473 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.83 -75.43 0.54 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.703 -0.68 . . . . 3.36 110.344 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.38 -43.33 5.7 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.537 -0.301 . . . . 2.23 110.532 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.13 170.98 13.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.77 110.929 179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 5' ' ' LEU . 3.3 p -142.21 119.81 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 109.972 -0.381 . . . . 1.58 109.972 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -96.76 99.4 10.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.229 0.537 . . . . 1.72 111.119 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.943 ' HG ' HD21 ' A' ' 54' ' ' LEU . 3.0 tp -92.24 124.15 36.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.203 -0.908 . . . . 1.38 111.722 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -106.54 116.09 31.33 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.773 178.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.4 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 26.8 m -125.46 130.8 72.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.95 0.405 . . . . 1.92 112.051 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.709 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -99.14 155.17 17.6 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.788 -0.642 . . . . 1.46 110.972 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.66 136.18 20.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.419 -0.355 . . . . 4.2 111.075 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -71.24 123.83 9.93 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.738 2.292 . . . . 2.28 112.452 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.7 p -141.35 83.45 1.87 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.834 0.35 . . . . 3.88 110.866 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.68 14.14 4.18 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.99 -0.624 . . . . 4.69 113.457 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.3 m -67.35 -49.66 63.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 117.126 0.463 . . . . 7.06 111.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 . . . . . 0 C--O 1.231 0.128 0 CA-C-N 116.383 -0.371 . . . . 7.84 110.839 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.678 0.275 . . . . 4.22 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.554 ' CB ' ' HB2' ' A' ' 22' ' ' ASN . 20.7 ttm-85 -136.23 123.44 21.76 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.361 -0.381 . . . . 3.57 111.078 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.863 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.5 mp0 -121.89 109.63 14.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.876 -0.602 . . . . 2.08 110.277 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.417 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -113.98 146.76 39.68 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.855 0.36 . . . . 0.65 111.502 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 23.3 mt-30 -79.44 153.17 29.85 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.991 -0.55 . . . . 1.67 110.867 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.948 HG21 HD13 ' A' ' 74' ' ' LEU . 17.2 m . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.621 -0.704 . . . . 1.47 111.826 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtm . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.885 0.374 . . . . 3.17 111.469 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -103.63 155.67 18.38 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.079 -0.509 . . . . 1.97 111.133 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.89 134.21 16.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.412 -0.588 . . . . 1.34 109.412 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 10.8 mmtt -93.16 91.33 7.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.112 0.482 . . . . 2.93 111.274 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 81' ' ' VAL . 29.3 mt -89.47 127.89 35.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.466 -0.788 . . . . 2.09 111.564 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -93.64 127.58 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.788 -0.642 . . . . 1.94 110.981 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -75.07 107.82 7.39 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.817 0.341 . . . . 3.1 111.282 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.76 -164.47 27.05 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 121.031 -0.604 . . . . 1.78 112.644 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.26 -49.75 8.67 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.004 2.469 . . . . 2.77 112.111 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -67.94 -66.98 0.5 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.036 -0.529 . . . . 4.92 110.115 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.87 -163.06 13.01 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.177 -0.535 . . . . 2.3 112.566 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.672 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.5 mp -37.95 -62.62 0.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.495 0.318 . . . . 5.7 111.354 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 65.81 50.94 50.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.012 -0.613 . . . . 1.13 112.739 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.672 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 9.7 p90 -164.48 -173.3 3.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 110.185 -0.302 . . . . 1.46 110.185 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.62 171.66 11.94 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 110.115 -0.328 . . . . 0.57 110.115 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -158.37 174.12 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.229 0.538 . . . . 0.67 110.9 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.046 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -140.06 169.4 17.77 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.363 -1.347 . . . . 1.19 107.363 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.79 126.3 0.82 Allowed Glycine 0 C--O 1.228 -0.266 0 C-N-CA 118.31 -1.9 . . . . 1.29 115.167 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 107.53 160.93 21.24 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 120.363 -0.923 . . . . 1.61 114.177 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.03 140.37 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.596 0.236 . . . . 2.72 110.783 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.51 -23.41 6.46 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.926 -0.654 . . . . 1.56 112.788 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -129.76 17.77 5.73 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.852 0.461 . . . . 1.63 110.52 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -55.44 142.04 34.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.998 0.74 . . . . 2.34 112.998 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.046 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 53.5 t60 -89.4 -25.45 21.53 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.415 -0.812 . . . . 0.92 111.732 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 mm -141.11 125.9 10.71 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.669 -0.241 . . . . 1.51 111.105 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -52.13 124.44 14.84 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.804 2.336 . . . . 0.98 112.672 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.59 -47.3 1.33 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.041 -0.6 . . . . 1.06 112.466 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.21 114.24 25.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.835 0.35 . . . . 1.68 110.753 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -89.89 15.31 10.12 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.163 -0.471 . . . . 2.11 111.579 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 8.9 t -70.75 -178.98 2.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.709 0.29 . . . . 1.39 110.412 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.755 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.6 mp -97.17 117.91 42.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.025 0.441 . . . . 0.8 111.104 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 17.6 m-85 -116.64 144.32 44.55 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 1.38 111.455 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG21 HD21 ' A' ' 48' ' ' LEU . 40.1 t -74.07 137.51 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.336 -0.393 . . . . 0.65 110.264 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.831 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.3 p -107.22 -32.69 7.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.008 0.744 . . . . 1.39 113.008 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -159.84 121.99 3.34 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.567 0.223 . . . . 2.54 111.515 -179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.8 mt -96.07 121.22 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.623 0.249 . . . . 1.4 110.933 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' A' ' 14' ' ' PHE . 1.7 mp -78.84 145.77 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.449 -0.341 . . . . 1.68 110.754 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -59.67 145.09 46.05 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.304 -0.407 . . . . 3.11 111.172 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.32 23.27 64.23 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 116.102 -0.499 . . . . 3.15 113.277 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.72 166.94 26.66 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.831 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -47.38 -54.06 12.22 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.871 0.323 . . . . 3.0 111.871 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.648 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.17 -50.96 51.03 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.648 -0.251 . . . . 1.82 111.169 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.525 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.13 -47.96 53.84 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.55 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -70.79 -38.34 73.38 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.383 -0.372 . . . . 2.66 111.481 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -61.97 -51.83 66.5 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.639 -0.255 . . . . 3.24 110.973 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 -21.06 42.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.964 -0.636 . . . . 2.49 113.486 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.13 -35.65 66.55 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 117.026 0.413 . . . . 5.67 111.379 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.951 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -90.24 127.72 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.931 0.396 . . . . 1.68 111.147 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.02 143.61 49.52 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.72 -0.673 . . . . 1.54 110.17 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.415 HG22 HG12 ' A' ' 33' ' ' VAL . 0.9 OUTLIER -48.55 121.99 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.713 0.292 . . . . 2.56 111.381 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.62 -20.98 8.67 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.207 -0.521 . . . . 1.1 113.265 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -68.53 161.1 28.6 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 117.676 0.738 . . . . 1.56 110.742 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.986 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.12 149.13 32.59 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.553 0.692 . . . . 3.23 111.629 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 2.0 mt -101.83 103.35 14.05 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.199 -0.91 . . . . 1.72 111.323 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 86' ' ' ALA . 13.6 tp -71.62 -48.18 49.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.276 -0.875 . . . . 1.87 110.218 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -153.92 151.68 29.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.987 0.366 . . . . 0.67 111.987 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.911 ' O ' HG22 ' A' ' 60' ' ' VAL . 41.8 t -138.53 113.48 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.281 -0.418 . . . . 1.47 110.85 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 80.7 m-20 64.85 44.36 3.65 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.803 0.335 . . . . 1.49 111.29 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 62.5 m-80 80.72 -14.5 0.83 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.972 0.73 . . . . 1.74 112.972 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 57' ' ' VAL . 13.3 m -94.79 147.35 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 118.0 0.364 . . . . 0.54 110.56 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.45 131.09 35.04 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.946 -0.302 . . . . 0.72 110.299 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.755 ' O ' HD13 ' A' ' 31' ' ' ILE . 4.8 tp -101.87 33.99 2.83 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.26 -0.427 . . . . 1.71 111.903 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 24.7 mt-10 -97.46 -102.65 0.19 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.361 -0.382 . . . . 1.96 110.8 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -63.56 55.74 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.184 1.179 . . . . 2.93 114.184 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.4 m -131.07 151.55 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.368 -0.378 . . . . 0.8 110.076 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 75.1 p -65.86 -169.66 0.06 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.226 -0.286 . . . . 1.53 110.226 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.7 t60 -76.68 -34.06 58.24 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 119.927 -0.709 . . . . 0.54 110.138 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.04 -48.13 61.58 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.555 0.217 . . . . 2.9 110.45 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.3 mp0 -68.26 -36.64 79.76 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.321 -0.4 . . . . 1.84 110.277 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.27 -47.33 86.51 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.957 -0.565 . . . . 0.44 111.459 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.487 HG21 HG21 ' B' ' 304' ' ' THR . 0.8 OUTLIER -74.78 -36.88 41.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.531 -0.758 . . . . 0.52 111.845 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 m -67.78 -39.26 84.11 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.647 -0.251 . . . . 0.61 111.545 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.11 88.68 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 120.475 0.178 . . . . 0.41 111.055 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.0 mm? -69.88 -33.66 72.53 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.506 -0.553 . . . . 1.73 109.506 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -75.41 -25.91 57.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.424 -0.807 . . . . 1.44 112.059 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -78.74 63.12 3.42 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.963 0.411 . . . . 1.55 111.817 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 81' ' ' VAL . 5.0 p -119.76 116.51 26.06 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.16 -0.473 . . . . 2.6 110.827 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -102.41 -84.86 0.45 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.043 -0.526 . . . . 3.36 110.716 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -95.35 -54.27 3.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.762 0.315 . . . . 2.23 110.215 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.86 165.77 21.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.946 -0.57 . . . . 1.77 110.75 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.677 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.1 p -142.12 125.25 14.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 110.051 -0.352 . . . . 1.58 110.051 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -94.98 98.77 10.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.247 0.546 . . . . 1.72 110.569 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.592 ' CD1' HD21 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -86.26 128.27 34.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.142 -0.936 . . . . 1.38 112.556 -178.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.6 OUTLIER -116.73 140.35 49.52 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.355 -0.838 . . . . 1.56 109.358 178.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.986 HG13 ' O ' ' A' ' 53' ' ' LYS . 84.9 t -134.23 141.1 44.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.793 0.33 . . . . 1.92 111.314 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.677 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -88.47 138.01 31.81 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.154 -0.476 . . . . 1.46 110.615 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -94.15 114.21 62.67 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.448 -0.342 . . . . 4.2 111.014 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.26 142.83 42.33 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.788 2.326 . . . . 2.28 112.617 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -140.96 -62.4 0.48 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.295 -0.411 . . . . 3.88 110.602 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.4 107.74 0.37 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.921 -0.657 . . . . 4.69 112.474 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -64.25 -34.79 78.92 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.79 0.293 . . . . 7.06 111.79 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 . . . . . 0 N--CA 1.465 0.318 0 CA-C-O 120.763 0.316 . . . . 7.84 111.269 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.041 0.448 . . . . 4.22 111.343 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 22' ' ' ASN . 11.1 tpp85 -62.51 122.96 17.06 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.052 -0.522 . . . . 3.57 111.142 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.831 ' HB3' HG21 ' A' ' 34' ' ' THR . 12.1 mt-10 -119.16 110.31 16.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.807 -0.633 . . . . 2.08 110.08 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.487 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -107.53 153.65 22.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.097 -0.501 . . . . 0.65 111.68 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.608 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 38.5 mt-30 -85.14 151.15 24.34 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.871 -0.604 . . . . 1.67 110.937 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.065 -0.969 . . . . 1.47 111.675 -179.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.659 0.244 . . . . 3.17 111.659 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.76 116.17 27.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.304 0.573 . . . . 1.97 111.331 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.551 HG22 ' HG ' ' A' ' 5' ' ' LEU . 5.1 mp -96.97 103.32 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.204 -0.907 . . . . 1.34 110.815 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.87 91.41 4.36 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.405 0.621 . . . . 2.93 110.739 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.652 HD22 ' HB1' ' A' ' 41' ' ' ALA . 96.0 mt -89.44 130.48 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.188 -0.915 . . . . 2.09 111.558 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 tt -89.25 126.03 42.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.956 -0.566 . . . . 1.94 110.596 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -57.59 118.76 5.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.085 -0.507 . . . . 3.1 111.857 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.61 -170.98 13.71 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.814 -0.63 . . . . 1.78 112.58 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.93 -35.11 99.16 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.987 2.458 . . . . 2.77 112.662 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -80.84 -65.57 0.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.319 -0.4 . . . . 4.92 110.732 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.05 -117.45 2.31 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.138 -0.553 . . . . 2.3 112.156 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 74' ' ' LEU . 62.9 mt -87.6 -54.83 4.06 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.709 0.29 . . . . 5.7 110.324 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.23 34.36 20.76 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.206 -0.521 . . . . 1.13 113.975 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.486 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 25.7 p90 -159.66 -174.94 4.88 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.205 0.502 . . . . 1.46 110.716 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 7.1 p -130.69 172.96 11.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.018 -0.364 . . . . 0.57 110.018 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -154.52 167.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.935 0.398 . . . . 0.67 111.476 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -132.94 162.32 31.95 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.883 -1.525 . . . . 1.19 106.883 177.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.21 132.99 1.43 Allowed Glycine 0 C--O 1.226 -0.359 0 C-N-CA 117.766 -2.159 . . . . 1.29 116.024 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.59 158.48 20.52 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 120.484 -0.865 . . . . 1.61 113.463 177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.4 t -66.23 137.57 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 110.184 -0.302 . . . . 2.72 110.184 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.7 -17.51 20.29 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.936 -0.649 . . . . 1.56 112.959 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.614 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p30 -140.72 26.64 2.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.125 0.57 . . . . 1.63 109.949 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.27 157.08 36.46 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.093 0.775 . . . . 2.34 113.093 -177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.012 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 61.8 t60 -94.67 -33.86 12.8 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.631 -1.168 . . . . 0.92 111.855 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.3 mm -129.97 130.36 23.12 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.274 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 123.47 13.57 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.873 2.382 . . . . 0.98 111.82 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.71 -49.79 1.42 Allowed Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.905 -0.664 . . . . 1.06 111.912 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.52 100.68 12.39 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.768 0.318 . . . . 1.68 110.81 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -81.84 24.29 0.62 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.148 -0.478 . . . . 2.11 112.003 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.692 ' C ' HD13 ' A' ' 31' ' ' ILE . 7.3 m -69.18 -178.38 1.29 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 109.884 -0.413 . . . . 1.39 109.884 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.0 mm -104.7 108.13 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 119.892 -0.723 . . . . 0.8 111.096 179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 14.9 m-85 -103.55 147.86 26.66 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.08 -0.964 . . . . 1.38 111.654 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 72.7 t -79.45 125.42 38.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.015 -0.539 . . . . 0.65 109.94 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.56 HG22 ' CE1' ' A' ' 24' ' ' HIS . 10.4 p -97.08 -27.42 14.59 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.445 0.906 . . . . 1.39 113.445 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 11.9 mttt -161.85 123.9 2.88 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.853 0.316 . . . . 2.54 111.853 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.665 HG22 ' HB2' ' A' ' 43' ' ' HIS . 3.1 mt -100.72 121.53 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.676 0.274 . . . . 1.4 110.86 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.42 147.6 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.325 -0.398 . . . . 1.68 110.841 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.59 146.86 50.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.254 -0.43 . . . . 3.11 110.999 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.54 17.14 47.19 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.03 -0.532 . . . . 3.15 113.521 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.85 166.5 35.71 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.96 -0.638 . . . . 2.8 112.893 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.652 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.6 -56.95 5.27 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.12 -49.57 60.26 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.618 -0.264 . . . . 1.82 111.24 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.63 -45.92 48.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.23 -0.441 . . . . 1.39 111.644 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -74.91 -35.99 62.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.38 -0.373 . . . . 2.66 111.512 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.08 -52.07 64.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.668 -0.242 . . . . 3.24 110.9 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.8 -31.41 7.27 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.148 -0.549 . . . . 2.49 113.099 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' CD ' HG13 ' A' ' 3' ' ' ILE . 9.8 ttmt -56.27 -50.63 70.83 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.843 0.321 . . . . 5.67 111.029 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -82.32 120.05 24.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.034 0.445 . . . . 1.68 111.191 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -131.76 147.59 52.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.622 -0.717 . . . . 1.54 110.225 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pt -41.33 139.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.639 0.257 . . . . 2.56 111.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.56 -20.27 47.18 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 120.876 -0.678 . . . . 1.1 114.018 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -73.63 152.73 40.43 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.11 0.955 . . . . 1.56 111.361 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.1 148.6 31.43 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.514 -0.766 . . . . 3.23 110.545 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.772 HD13 HD23 ' A' ' 62' ' ' LEU . 1.3 mt -92.24 112.57 24.56 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.123 -0.944 . . . . 1.72 111.786 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 86' ' ' ALA . 0.7 OUTLIER -75.2 -51.77 12.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.482 -0.781 . . . . 1.87 109.863 179.028 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.62 158.59 34.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.8 -0.36 . . . . 0.67 111.779 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -145.27 114.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.871 0.367 . . . . 1.47 111.47 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.5 m-80 65.88 41.68 3.7 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.105 -0.498 . . . . 1.49 111.281 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.3 t30 84.13 -16.71 0.51 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.018 0.747 . . . . 1.74 113.018 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 57' ' ' VAL . 23.8 m -93.78 146.01 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 118.039 0.381 . . . . 0.54 110.72 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.7 p -82.0 134.53 35.37 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.056 -0.35 . . . . 0.72 110.056 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.772 HD23 HD13 ' A' ' 54' ' ' LEU . 1.9 tp -103.38 27.43 7.32 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.189 -0.459 . . . . 1.71 111.79 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 35.8 mt-10 -111.93 -21.86 11.37 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.579 0.585 . . . . 1.96 112.579 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -122.35 51.79 1.35 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.958 0.409 . . . . 2.93 111.319 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -143.27 154.62 16.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.028 -0.533 . . . . 0.8 112.274 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.7 p -68.34 -179.7 1.38 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.414 -0.812 . . . . 1.53 109.594 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.45 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 21.0 t60 -65.23 -41.6 94.24 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.176 -0.61 . . . . 0.54 110.705 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -49.21 -55.27 13.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.462 0.172 . . . . 2.9 110.598 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -58.22 -32.54 68.4 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.452 -0.34 . . . . 1.84 111.078 179.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.685 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.73 -44.04 94.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.44 110.763 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.71 HG13 HG12 ' B' ' 306' ' ' VAL . 37.4 t -78.16 -40.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.783 -0.644 . . . . 0.52 111.022 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 m -64.25 -34.76 78.84 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.446 -0.343 . . . . 0.61 111.25 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB1' HG23 ' A' ' 57' ' ' VAL . . . -73.16 -38.35 66.25 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.598 -0.274 . . . . 0.41 110.627 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.3 mm? -72.3 -35.93 68.79 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 109.54 -0.541 . . . . 1.73 109.54 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 71' ' ' VAL . 0.7 OUTLIER -73.55 -28.12 61.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.397 -0.819 . . . . 1.44 111.877 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -70.99 69.18 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.988 0.423 . . . . 1.55 111.814 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' VAL . 20.5 p -126.14 136.9 53.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 2.6 111.204 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.1 m -116.72 -82.18 0.62 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.014 -0.539 . . . . 3.36 110.555 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -96.84 -48.83 5.3 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.915 0.388 . . . . 2.23 110.169 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.78 170.28 14.58 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.767 -0.651 . . . . 1.77 110.534 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.63 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.5 p -142.28 119.8 7.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 110.091 -0.337 . . . . 1.58 110.091 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -96.18 99.29 11.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.343 0.592 . . . . 1.72 110.412 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 2.0 tt -93.93 125.15 38.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.054 -0.976 . . . . 1.38 111.62 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -111.34 126.34 54.81 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 115.724 -0.671 . . . . 1.56 110.015 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.495 HG13 HD23 ' A' ' 83' ' ' LEU . 4.5 m -120.4 133.94 65.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.467 -0.333 . . . . 1.92 111.395 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -87.13 152.11 22.63 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.089 -0.505 . . . . 1.46 110.993 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -108.67 128.41 25.59 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 116.206 -0.452 . . . . 4.2 110.861 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.04 137.68 63.36 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.692 2.261 . . . . 2.28 112.166 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.6 m -156.24 87.94 1.07 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.418 -0.355 . . . . 3.88 110.449 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.19 137.43 18.43 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.833 -0.699 . . . . 4.69 112.734 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.7 t -75.25 -48.01 25.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.562 0.22 . . . . 7.06 110.842 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-N 116.367 -0.379 . . . . 7.84 110.902 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.77 0.319 . . . . 4.22 111.531 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.614 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 3.0 tmm_? -155.67 132.33 10.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.085 -0.507 . . . . 3.57 110.741 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.502 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -121.6 127.88 51.35 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.037 -0.528 . . . . 2.08 110.636 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -135.35 144.83 46.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.347 -0.388 . . . . 0.65 111.143 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.0 mt-30 -76.58 153.59 35.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 1.67 110.97 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.71 HG12 HG13 ' A' ' 71' ' ' VAL . 10.5 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.615 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.784 0.326 . . . . 3.17 111.377 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.508 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.4 pm0 -126.81 159.31 34.23 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.067 -0.515 . . . . 1.97 111.014 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.67 141.47 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.706 -0.479 . . . . 1.34 109.706 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.68 91.79 5.57 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.109 0.48 . . . . 2.93 110.862 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 38.1 mt -88.34 124.86 34.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.527 -0.761 . . . . 2.09 111.863 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.659 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.5 mp -87.88 116.04 29.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.332 -0.849 . . . . 1.94 109.965 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 78' ' ' SER . 9.2 tptm -62.13 117.2 5.71 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.843 0.354 . . . . 3.1 111.657 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.22 172.75 15.28 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.743 -0.662 . . . . 1.78 112.502 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.61 -36.63 89.89 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.872 2.381 . . . . 2.77 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.07 -68.91 0.32 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.262 -0.426 . . . . 4.92 110.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.73 -130.89 4.72 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.103 -0.57 . . . . 2.3 112.208 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 17.8 mt -87.35 -52.49 5.35 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 110.153 -0.314 . . . . 5.7 110.153 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.24 35.91 22.39 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.215 -0.517 . . . . 1.13 113.68 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.5 p90 -160.31 -174.59 4.58 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.044 0.422 . . . . 1.46 110.691 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.5 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 1.2 p -129.85 171.69 12.46 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.959 -0.385 . . . . 0.57 109.959 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.18 168.92 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.082 0.467 . . . . 0.67 111.455 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.006 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.14 163.84 29.01 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 107.033 -1.469 . . . . 1.19 107.033 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.003 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 133.6 1.53 Allowed Glycine 0 C--O 1.225 -0.459 0 C-N-CA 117.727 -2.178 . . . . 1.29 116.023 178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.62 160.46 23.97 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.406 -0.902 . . . . 1.61 113.411 177.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.02 140.15 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.435 -0.209 . . . . 2.72 110.435 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.1 -17.88 25.37 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.96 -0.638 . . . . 1.56 112.675 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -136.57 21.9 3.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.076 0.55 . . . . 1.63 110.828 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 14.0 mp0 -57.41 143.05 41.68 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.046 0.758 . . . . 2.34 113.046 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.006 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.3 t60 -91.06 -29.49 17.3 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.411 -0.813 . . . . 0.92 110.726 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG13 ' CE2' ' A' ' 32' ' ' TYR . 16.8 mm -138.72 126.9 13.79 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 115.872 -0.604 . . . . 1.51 110.371 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.61 125.89 19.66 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.569 2.179 . . . . 0.98 112.309 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.26 -43.91 1.59 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.963 -0.637 . . . . 1.06 112.919 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.69 115.08 28.52 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.993 0.425 . . . . 1.68 111.574 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.51 21.02 1.01 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.702 -0.681 . . . . 2.11 111.773 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.708 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.42 -179.35 1.64 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.698 0.285 . . . . 1.39 111.004 179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.003 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -103.54 109.11 26.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 121.171 0.51 . . . . 0.8 110.861 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 7.3 m-85 -105.78 146.25 30.09 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.701 -0.682 . . . . 1.38 111.88 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.842 HG21 HD21 ' A' ' 48' ' ' LEU . 46.9 t -79.46 128.0 38.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.051 -0.522 . . . . 0.65 109.878 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.684 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.4 p -100.04 -28.61 12.97 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.507 0.929 . . . . 1.39 113.507 -177.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 39.9 mttp -159.96 122.5 3.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.74 0.274 . . . . 2.54 111.74 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -98.56 120.99 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.615 -0.266 . . . . 1.4 110.897 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.9 mp -76.69 147.85 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.309 -0.405 . . . . 1.68 110.873 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -62.25 144.35 55.69 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.231 -0.44 . . . . 3.11 111.008 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.5 19.02 61.91 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.688 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.13 166.63 31.05 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.959 -0.639 . . . . 2.8 112.929 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.22 -55.07 9.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.847 0.314 . . . . 3.0 111.847 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.84 -49.79 64.6 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.671 -0.24 . . . . 1.82 110.909 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.4 t-80 -50.07 -48.47 53.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.069 -0.514 . . . . 1.39 111.511 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -69.23 -37.16 77.86 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.282 -0.417 . . . . 2.66 111.243 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.22 -55.17 31.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.469 -0.332 . . . . 3.24 110.787 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.16 -23.01 35.33 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.163 -0.541 . . . . 2.49 113.278 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -41.04 80.95 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.93 0.365 . . . . 5.67 111.391 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.842 HD21 HG21 ' A' ' 33' ' ' VAL . 2.5 tt -86.93 128.16 35.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.921 0.391 . . . . 1.68 111.496 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -136.97 146.89 45.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.667 -0.697 . . . . 1.54 110.157 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.29 124.75 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.868 0.366 . . . . 2.56 111.667 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.24 -23.9 7.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.175 -0.536 . . . . 1.1 113.051 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -70.89 157.49 38.05 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 117.617 0.708 . . . . 1.56 110.359 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.902 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.71 147.86 35.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.423 0.63 . . . . 3.23 111.039 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -96.1 103.58 15.48 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.187 -0.915 . . . . 1.72 111.758 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.4 tt -65.62 -47.9 74.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.229 -0.896 . . . . 1.87 110.297 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -156.29 158.49 37.56 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.415 0.524 . . . . 0.67 112.415 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.895 ' O ' HG22 ' A' ' 60' ' ' VAL . 65.7 t -140.5 109.74 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.153 -0.476 . . . . 1.47 111.2 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 64.29 46.77 3.38 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.263 -0.426 . . . . 1.49 111.392 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.1 t30 81.61 -14.8 0.77 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.085 0.772 . . . . 1.74 113.085 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.895 HG22 ' O ' ' A' ' 57' ' ' VAL . 5.7 m -94.63 146.43 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 117.981 0.355 . . . . 0.54 110.551 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.7 p -82.22 133.34 35.25 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.684 -0.407 . . . . 0.72 110.392 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -102.95 27.92 6.66 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.878 -0.601 . . . . 1.71 111.626 179.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 5.6 tt0 -117.25 -19.21 9.71 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.385 0.513 . . . . 1.96 112.385 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.5 41.16 3.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.864 0.364 . . . . 2.93 111.471 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.3 m -137.84 157.4 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.126 0.488 . . . . 0.8 112.27 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 173.65 6.35 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.425 -0.807 . . . . 1.53 110.067 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 14.1 t60 -58.72 -41.01 85.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.519 -0.472 . . . . 0.54 111.029 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -49.43 -52.04 31.5 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.444 0.164 . . . . 2.9 110.645 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -59.14 -34.62 72.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.295 -0.411 . . . . 1.84 111.213 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.74 -43.35 99.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.052 0.453 . . . . 0.44 110.819 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.763 HG13 HG12 ' B' ' 306' ' ' VAL . 39.9 t -79.62 -39.35 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.728 -0.669 . . . . 0.52 111.205 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 89.9 m -64.08 -34.59 78.38 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.4 -0.364 . . . . 0.61 111.565 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -77.87 -37.56 47.94 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.528 0.204 . . . . 0.41 110.976 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.5 mm? -69.93 -36.23 75.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.213 0.53 . . . . 1.73 109.94 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -82.4 -21.84 35.64 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.1 -0.954 . . . . 1.44 112.086 -179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -77.09 67.43 3.07 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.046 0.45 . . . . 1.55 111.067 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.706 ' CG2' HG22 ' A' ' 81' ' ' VAL . 44.8 p -128.67 144.17 51.1 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.031 -0.531 . . . . 2.6 111.304 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' LYS . 45.3 t -121.38 -80.58 0.63 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.227 -0.442 . . . . 3.36 111.619 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -95.32 -52.12 4.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.695 0.283 . . . . 2.23 111.105 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.659 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.76 171.28 9.29 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.239 -0.437 . . . . 1.77 111.009 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.706 HG22 ' CG2' ' A' ' 77' ' ' THR . 91.6 t -141.07 119.55 10.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 109.616 -0.513 . . . . 1.58 109.616 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.55 98.72 8.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.311 0.577 . . . . 1.72 110.822 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.01 123.99 31.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.141 -0.936 . . . . 1.38 111.584 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -113.3 109.89 19.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 115.828 -0.624 . . . . 1.56 109.328 178.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 53' ' ' LYS . 94.9 t -107.11 135.24 46.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.92 111.457 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.5 143.78 29.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.922 -0.581 . . . . 1.46 110.738 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.92 110.4 64.05 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 116.276 -0.42 . . . . 4.2 111.21 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.29 149.76 57.78 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.859 2.373 . . . . 2.28 112.426 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.6 m -130.12 -62.66 0.93 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.211 -0.45 . . . . 3.88 111.008 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.06 101.04 0.15 Allowed Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.841 -0.695 . . . . 4.69 112.624 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.59 -39.72 51.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.507 0.194 . . . . 7.06 111.206 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.838 0.351 . . . . 7.84 110.992 -179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.793 0.33 . . . . 4.22 111.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.567 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.2 ttm-85 -154.7 137.46 15.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.061 -0.518 . . . . 3.57 110.914 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.526 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -123.04 148.05 46.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.04 -0.527 . . . . 2.08 110.772 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -151.78 140.89 21.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.249 -0.432 . . . . 0.65 110.907 -179.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 46.8 mt-30 -78.46 151.68 32.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.2 -0.455 . . . . 1.67 111.214 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.763 HG12 HG13 ' A' ' 71' ' ' VAL . 13.7 m . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.602 -0.713 . . . . 1.47 111.625 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mtp . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.651 0.262 . . . . 3.17 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.52 123.25 37.35 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.328 0.585 . . . . 1.97 111.322 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 4.5 mp -97.11 107.46 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.038 -0.983 . . . . 1.34 110.954 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.38 90.4 3.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.463 0.649 . . . . 2.93 110.29 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.511 HD22 ' HB1' ' A' ' 41' ' ' ALA . 11.4 mt -90.79 131.44 36.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.925 -1.034 . . . . 2.09 111.932 -178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 6' ' ' ILE . 17.1 tt -89.11 125.34 42.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.796 -0.638 . . . . 1.94 110.174 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 3.8 mmmt -68.56 112.12 5.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.936 0.398 . . . . 3.1 111.81 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.18 19.29 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.707 -0.679 . . . . 1.78 112.384 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.72 -43.67 47.91 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.858 2.372 . . . . 2.77 112.508 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -67.67 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.415 -0.357 . . . . 4.92 110.537 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.97 -160.13 13.41 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.04 -0.6 . . . . 2.3 112.988 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.577 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.3 mp -38.9 -62.06 0.67 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.902 0.481 . . . . 5.7 111.812 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 69.29 50.26 34.08 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.396 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.577 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 6.2 p90 -162.1 -174.05 3.93 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.755 0.277 . . . . 1.46 110.523 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -127.55 169.8 13.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.556 -0.535 . . . . 0.57 109.556 178.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.474 HG23 ' O ' ' A' ' 15' ' ' SER . 0.7 OUTLIER -160.15 172.36 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.015 0.436 . . . . 0.67 111.494 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.086 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.33 167.7 21.07 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.102 -1.444 . . . . 1.19 107.102 177.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.586 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.49 129.02 1.01 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 117.98 -2.057 . . . . 1.29 115.702 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.46 158.16 19.28 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.414 -0.898 . . . . 1.61 113.293 177.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -65.55 142.19 17.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 120.439 0.162 . . . . 2.72 110.567 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 -16.75 23.25 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.901 -0.666 . . . . 1.56 112.666 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.474 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -140.32 26.66 2.16 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.189 0.595 . . . . 1.63 110.102 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -63.82 148.11 50.12 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.535 0.569 . . . . 2.34 112.535 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.086 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 65.8 t60 -89.49 -23.6 22.03 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.247 -0.888 . . . . 0.92 111.584 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.503 HD12 ' CE2' ' A' ' 32' ' ' TYR . 11.9 mt -149.66 127.32 5.66 Favored Pre-proline 0 CA--C 1.53 0.19 0 CA-C-N 116.414 -0.357 . . . . 1.51 110.684 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 124.98 15.96 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.718 2.278 . . . . 0.98 112.517 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.33 -58.54 0.53 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.992 -0.623 . . . . 1.06 112.392 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.99 109.26 19.26 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.927 0.394 . . . . 1.68 110.797 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -87.46 13.75 9.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.864 -0.607 . . . . 2.11 112.078 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -82.43 157.23 23.75 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.674 -0.491 . . . . 1.39 109.674 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.709 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.89 128.01 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.713 0.635 . . . . 0.8 112.713 -177.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.6 m-85 -119.24 147.11 44.62 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.768 -0.651 . . . . 1.38 110.772 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG21 HD21 ' A' ' 48' ' ' LEU . 73.3 t -80.22 130.03 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.373 -0.376 . . . . 0.65 110.497 178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.481 HG22 ' CE1' ' A' ' 24' ' ' HIS . 0.2 OUTLIER -100.64 -28.64 12.75 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.204 0.816 . . . . 1.39 113.204 -178.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 19.8 mttt -163.47 125.7 2.53 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 117.668 0.213 . . . . 2.54 111.375 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 40.1 mt -100.3 125.32 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.776 0.322 . . . . 1.4 110.75 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.9 mp -78.03 147.55 7.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.121 -0.491 . . . . 1.68 110.828 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -61.0 144.41 53.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.405 . . . . 3.11 111.385 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.51 20.69 59.35 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.828 -0.624 . . . . 3.15 113.57 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 169.55 30.66 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.978 -0.629 . . . . 2.8 112.792 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -44.97 -60.0 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 111.973 0.36 . . . . 3.0 111.973 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -63.82 -48.99 74.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.499 -0.319 . . . . 1.82 111.42 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.5 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.8 t-80 -51.89 -50.99 59.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.183 -0.462 . . . . 1.39 111.709 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -67.9 -39.97 83.54 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.545 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -61.82 -52.46 64.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.547 -0.297 . . . . 3.24 111.24 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.99 -26.41 14.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 121.161 -0.542 . . . . 2.49 113.02 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -64.23 -41.59 96.94 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.736 0.268 . . . . 5.67 111.081 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.864 HD21 HG21 ' A' ' 33' ' ' VAL . 1.2 tt -87.48 128.01 35.23 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.943 0.401 . . . . 1.68 111.14 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.52 146.5 49.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.627 -0.715 . . . . 1.54 110.494 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 33' ' ' VAL . 19.2 mm -48.32 122.29 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.567 -0.288 . . . . 2.56 110.958 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.93 -22.97 7.92 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.956 -0.64 . . . . 1.1 113.662 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -69.14 157.88 36.0 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 117.85 0.825 . . . . 1.56 111.13 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.862 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -108.36 149.75 28.27 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.661 -0.699 . . . . 3.23 111.288 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.805 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -100.3 117.11 33.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.323 -0.853 . . . . 1.72 111.898 -178.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 86' ' ' ALA . 9.4 tt -85.76 -57.43 3.05 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.495 -0.775 . . . . 1.87 110.073 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -142.96 145.49 33.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.114 0.413 . . . . 0.67 112.114 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.878 ' O ' HG22 ' A' ' 60' ' ' VAL . 9.7 t -126.5 110.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.255 -0.43 . . . . 1.47 111.098 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.1 m120 63.3 43.88 5.92 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.819 0.343 . . . . 1.49 111.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.3 t-20 85.53 -20.15 0.28 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.974 0.731 . . . . 1.74 112.974 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 57' ' ' VAL . 18.6 m -90.82 154.15 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.025 0.375 . . . . 0.54 110.575 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.3 p -88.44 128.87 35.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.72 110.571 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.805 ' CD2' HD13 ' A' ' 54' ' ' LEU . 5.3 tp -102.71 30.42 4.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.181 -0.463 . . . . 1.71 111.433 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.96 -21.3 11.19 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.731 0.641 . . . . 1.96 112.731 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.63 50.69 1.47 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.08 0.467 . . . . 2.93 111.021 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 12.9 m -145.91 151.78 14.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.935 -0.575 . . . . 0.8 112.296 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 p -64.81 169.14 5.4 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.642 -0.708 . . . . 1.53 109.858 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.531 ' NE2' ' HB ' ' B' ' 304' ' ' THR . 22.8 t60 -55.89 -39.37 71.48 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.287 -0.565 . . . . 0.54 110.945 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -46.53 -54.52 9.18 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 110.16 -0.311 . . . . 2.9 110.16 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.485 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -59.52 -32.33 70.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.118 -0.492 . . . . 1.84 111.248 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' HA ' HD11 ' A' ' 62' ' ' LEU . . . -58.14 -44.77 88.03 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.196 0.522 . . . . 0.44 110.531 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.687 HG13 HG12 ' B' ' 306' ' ' VAL . 66.5 t -80.74 -35.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.518 -0.764 . . . . 0.52 111.074 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 94.9 m -62.97 -39.11 93.71 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.368 -0.378 . . . . 0.61 111.303 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -76.3 -37.15 57.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.637 -0.256 . . . . 0.41 111.158 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -70.12 -29.52 66.48 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.965 -0.383 . . . . 1.73 109.965 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.556 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.4 ptpt -89.99 -19.68 24.16 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.972 -0.558 . . . . 1.44 112.199 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -79.6 63.97 4.34 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.208 0.528 . . . . 1.55 110.824 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 81' ' ' VAL . 23.5 p -125.54 137.47 53.93 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.779 -0.646 . . . . 2.6 110.953 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.1 m -110.04 -80.61 0.58 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.121 -0.491 . . . . 3.36 110.697 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.92 -46.91 5.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.645 -0.252 . . . . 2.23 110.708 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 169.29 16.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.567 -0.288 . . . . 1.77 111.157 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 5' ' ' LEU . 2.7 p -142.48 122.22 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.343 -0.39 . . . . 1.58 109.96 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -98.79 99.3 10.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.214 0.53 . . . . 1.72 110.866 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.77 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.5 tt -94.18 127.51 40.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.29 -0.868 . . . . 1.38 111.764 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -113.83 154.09 28.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.55 -0.75 . . . . 1.56 109.585 178.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 53' ' ' LYS . 94.9 t -134.1 138.18 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-O 120.766 0.317 . . . . 1.92 111.292 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.733 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -103.23 155.48 18.4 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.984 -0.553 . . . . 1.46 111.249 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -114.78 111.21 45.88 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.337 -0.392 . . . . 4.2 110.616 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.7 120.74 8.38 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.712 2.274 . . . . 2.28 112.497 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 p -140.02 125.69 19.3 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.53 -0.304 . . . . 3.88 110.939 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.74 -145.56 4.23 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.901 -0.666 . . . . 4.69 112.771 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.7 m -82.98 -45.37 14.19 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.586 0.231 . . . . 7.06 111.187 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 N--CA 1.463 0.177 0 CA-C-N 116.43 -0.35 . . . . 7.84 110.957 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.904 0.383 . . . . 4.22 111.417 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.474 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 31.4 ttm180 -134.24 110.62 9.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.011 -0.54 . . . . 3.57 110.431 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.536 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 3.3 mp0 -104.27 141.45 36.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.029 -0.532 . . . . 2.08 110.783 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.531 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 1.1 m -148.43 148.27 30.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.018 -0.537 . . . . 0.65 111.092 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.4 OUTLIER -79.48 155.98 28.03 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.348 -0.387 . . . . 1.67 110.965 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.687 HG12 HG13 ' A' ' 71' ' ' VAL . 15.6 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.148 -0.93 . . . . 1.47 111.427 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.53 0.205 . . . . 3.17 111.28 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -131.51 130.9 42.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.198 0.523 . . . . 1.97 111.242 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 3.6 mp -97.34 102.31 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.264 -0.88 . . . . 1.34 110.993 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -99.66 91.28 4.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.43 0.633 . . . . 2.93 110.687 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.774 HD13 ' HB1' ' A' ' 41' ' ' ALA . 52.6 mt -97.48 131.75 43.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.993 -1.003 . . . . 2.09 111.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 21.2 tt -88.27 131.67 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.446 -0.343 . . . . 1.94 110.557 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.53 104.9 3.99 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.242 -0.436 . . . . 3.1 111.583 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.58 -160.27 23.02 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.763 -0.653 . . . . 1.78 112.529 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.53 -36.21 86.95 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.999 2.466 . . . . 2.77 112.752 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -79.96 -123.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.493 -0.322 . . . . 4.92 110.623 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.62 -124.98 0.74 Allowed Glycine 0 C--N 1.341 0.824 0 C-N-CA 120.576 -0.821 . . . . 2.3 112.829 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.449 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.2 mm? -85.12 -50.18 7.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.646 0.26 . . . . 5.7 110.976 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.9 35.5 31.03 Favored Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.108 -0.567 . . . . 1.13 113.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 21.6 p90 -162.43 -173.9 3.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.692 0.246 . . . . 1.46 110.469 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 8.6 p -131.39 170.98 13.92 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.535 -0.543 . . . . 0.57 109.535 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.422 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.01 169.37 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.054 0.454 . . . . 0.67 111.659 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.029 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -133.75 163.88 28.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.011 -1.477 . . . . 1.19 107.011 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.34 129.06 1.01 Allowed Glycine 0 C--O 1.226 -0.399 0 C-N-CA 118.306 -1.902 . . . . 1.29 115.168 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 109.43 156.98 17.22 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.373 -0.918 . . . . 1.61 113.274 178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.2 m -65.25 144.42 14.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.567 0.222 . . . . 2.72 110.516 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.41 -18.29 11.31 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.814 -0.708 . . . . 1.56 112.485 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' B' ' 301' ' ' ARG . 0.2 OUTLIER -138.48 25.23 2.65 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.299 0.639 . . . . 1.63 110.09 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -61.55 146.2 49.52 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.029 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 65.2 t60 -89.31 -21.96 22.89 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.537 -0.756 . . . . 0.92 111.504 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 tt -148.64 130.97 7.71 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.73 -0.214 . . . . 1.51 110.796 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.04 120.5 7.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.631 2.221 . . . . 0.98 112.538 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.59 -54.73 0.71 Allowed Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.02 -0.61 . . . . 1.06 112.912 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.4 109.42 20.33 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.894 0.378 . . . . 1.68 110.858 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -87.19 15.9 5.74 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.998 -0.547 . . . . 2.11 111.917 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.9 OUTLIER -66.29 -179.36 0.78 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.605 0.241 . . . . 1.39 110.525 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.686 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -101.74 109.64 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 121.472 0.653 . . . . 0.8 110.766 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 12.0 m-85 -104.55 144.12 32.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.047 -0.978 . . . . 1.38 112.018 -179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.866 HG21 HD21 ' A' ' 48' ' ' LEU . 55.0 t -78.56 129.46 37.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.205 -0.665 . . . . 0.65 109.205 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.732 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.6 p -103.26 -27.51 12.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.489 0.922 . . . . 1.39 113.489 -177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.06 117.81 2.94 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.842 0.312 . . . . 2.54 111.842 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 43' ' ' HIS . 7.1 mt -98.38 121.65 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.606 -0.27 . . . . 1.4 111.092 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -78.56 147.61 6.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.298 -0.41 . . . . 1.68 110.706 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -64.49 145.97 55.28 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.428 -0.351 . . . . 3.11 111.113 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.79 16.96 59.93 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.009 -0.541 . . . . 3.15 113.75 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.16 167.6 30.5 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.889 -0.672 . . . . 2.8 112.812 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.774 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -45.52 -58.32 3.47 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.008 0.373 . . . . 3.0 112.008 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.58 -48.93 73.14 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.575 -0.284 . . . . 1.82 111.329 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.42 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.6 t-80 -53.28 -51.57 61.86 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.256 -0.429 . . . . 1.39 111.556 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -64.06 -40.47 96.33 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.363 -0.381 . . . . 2.66 111.134 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -60.31 -48.23 82.64 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.363 -0.38 . . . . 3.24 110.781 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.74 -23.38 13.48 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 121.214 -0.517 . . . . 2.49 113.573 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.74 86.87 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 117.105 0.453 . . . . 5.67 110.902 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.866 HD21 HG21 ' A' ' 33' ' ' VAL . 2.6 tt -83.06 131.28 35.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.976 0.417 . . . . 1.68 111.071 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.65 146.46 49.55 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.595 -0.73 . . . . 1.54 110.438 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.67 121.66 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.765 0.316 . . . . 2.56 111.452 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.03 -24.82 7.72 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 121.165 -0.54 . . . . 1.1 113.592 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -65.54 159.81 23.74 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 117.755 0.777 . . . . 1.56 110.935 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.858 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -109.3 147.21 33.04 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-O 121.357 0.598 . . . . 3.23 110.695 179.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.882 HD22 HD21 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -96.13 104.56 16.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.238 -0.892 . . . . 1.72 112.006 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.1 tm? -68.57 -52.73 28.57 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.413 -0.812 . . . . 1.87 109.607 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -151.59 153.06 33.76 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 120.909 -0.316 . . . . 0.67 111.743 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.642 HG21 HD22 ' A' ' 62' ' ' LEU . 88.5 t -141.4 115.03 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.839 0.352 . . . . 1.47 111.199 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 23.2 m120 63.51 51.42 2.56 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.071 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 1.0 OUTLIER 76.0 -19.12 0.42 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.505 0.928 . . . . 1.74 113.505 179.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.2 m -96.04 153.53 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 118.406 0.548 . . . . 0.54 111.175 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.5 p -84.47 133.89 34.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.707 0.289 . . . . 0.72 110.33 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.8 tp -102.89 31.82 3.99 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.37 -0.377 . . . . 1.71 111.773 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 1.3 tm-20 -118.1 -22.25 7.88 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.445 0.535 . . . . 1.96 112.445 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.81 50.46 1.07 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.759 0.314 . . . . 2.93 111.703 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.684 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 17.9 m -148.83 155.33 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 112.71 0.633 . . . . 0.8 112.71 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 48.4 p -68.89 -170.63 0.24 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.183 -0.917 . . . . 1.53 109.575 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.509 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.2 t60 -72.25 -42.15 65.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.903 -0.719 . . . . 0.54 110.413 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.09 -53.59 12.41 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.777 -0.453 . . . . 2.9 109.777 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.684 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.1 -34.99 75.82 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.89 -0.596 . . . . 1.84 111.243 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.625 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.35 -43.68 92.77 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.182 0.515 . . . . 0.44 110.484 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.715 HG13 HG12 ' B' ' 306' ' ' VAL . 42.2 t -79.96 -37.55 17.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.316 -0.857 . . . . 0.52 110.712 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.655 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 60.9 m -62.52 -38.06 88.49 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.255 -0.429 . . . . 0.61 111.228 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.412 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.82 -38.3 62.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.708 -0.224 . . . . 0.41 110.947 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.6 mm? -67.7 -36.46 80.69 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.474 -0.565 . . . . 1.73 109.474 178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.655 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.07 -17.52 42.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.065 -0.97 . . . . 1.44 111.986 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 72' ' ' THR . 24.7 t30 -82.3 59.97 4.79 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.55 110.686 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.704 ' CG2' HG22 ' A' ' 81' ' ' VAL . 5.3 p -119.17 107.33 13.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.873 -0.603 . . . . 2.6 110.325 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.9 t -88.54 -91.16 0.12 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.037 -0.528 . . . . 3.36 111.567 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.44 -67.38 0.7 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 111.943 0.349 . . . . 2.23 111.943 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.445 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.85 137.64 54.88 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.549 0.574 . . . . 1.77 112.549 -179.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.704 HG22 ' CG2' ' A' ' 77' ' ' THR . 39.9 t -90.81 119.44 37.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.23 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.993 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -115.1 99.5 7.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.119 0.485 . . . . 1.72 110.614 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.882 HD21 HD22 ' A' ' 54' ' ' LEU . 2.8 tt -94.24 124.02 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.417 -0.811 . . . . 1.38 111.948 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -107.93 120.26 41.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.31 -0.859 . . . . 1.56 109.343 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 53' ' ' LYS . 34.4 t -103.74 135.51 41.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.917 0.389 . . . . 1.92 111.313 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.455 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.74 145.67 27.8 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.791 -0.64 . . . . 1.46 111.565 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -114.81 99.08 51.4 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.029 -0.532 . . . . 4.2 110.802 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 56.5 Cg_endo -69.98 146.53 59.13 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.851 2.367 . . . . 2.28 112.338 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.6 m -126.8 -58.48 1.31 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.147 -0.479 . . . . 3.88 110.978 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.08 98.69 0.14 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.839 -0.696 . . . . 4.69 112.598 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.6 p -75.11 -43.94 50.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.559 0.218 . . . . 7.06 111.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 116.323 -0.399 . . . . 7.84 110.859 179.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . 0.574 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 4.0 ptm180 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.721 0.296 . . . . 4.22 111.499 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.467 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 30.5 ttt85 -142.83 130.57 21.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.242 -0.435 . . . . 3.57 111.161 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.632 ' CG ' HG21 ' A' ' 34' ' ' THR . 14.9 mp0 -125.48 111.48 15.13 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.871 -0.604 . . . . 2.08 110.125 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.47 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -118.33 148.43 42.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.342 -0.39 . . . . 0.65 111.548 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 17.6 mt-30 -81.81 151.39 27.41 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.002 -0.545 . . . . 1.67 110.677 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.715 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.557 -0.735 . . . . 1.47 111.611 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.791 0.329 . . . . 3.17 111.27 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.561 ' HB3' ' CE ' ' A' ' 84' ' ' LYS . 1.2 pm0 -118.18 150.99 38.47 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.085 -0.507 . . . . 1.97 110.856 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.54 95.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.694 -0.484 . . . . 1.34 109.694 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -98.74 143.96 28.52 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.495 -0.557 . . . . 2.93 109.495 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -150.52 170.7 18.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.101 -0.333 . . . . 2.09 110.101 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -92.85 125.68 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 120.695 0.283 . . . . 1.94 110.899 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 33.3 tptt -65.95 133.96 51.95 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.286 -0.416 . . . . 3.1 111.417 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.78 178.61 17.3 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 115.812 -0.631 . . . . 1.78 112.647 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -61.46 -38.75 61.13 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.956 2.437 . . . . 2.77 112.628 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -62.61 -70.08 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.403 -0.362 . . . . 4.92 110.895 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.13 -134.29 5.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.04 -0.6 . . . . 2.3 112.396 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.676 HD11 ' O ' ' A' ' 74' ' ' LEU . 6.7 mt -83.31 -54.09 5.26 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.893 -0.41 . . . . 5.7 109.893 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.0 30.45 23.07 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.256 -0.497 . . . . 1.13 113.876 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 11.7 p90 -156.54 -177.27 6.48 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.298 0.549 . . . . 1.46 110.738 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -124.0 168.79 12.36 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.552 -0.294 . . . . 0.57 110.326 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.412 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -155.37 168.19 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.301 -0.409 . . . . 0.67 110.7 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.9 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.44 168.4 19.85 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.577 -1.268 . . . . 1.19 107.577 177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.033 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.22 127.8 0.92 Allowed Glycine 0 C--O 1.227 -0.339 0 C-N-CA 118.044 -2.027 . . . . 1.29 115.971 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.09 154.44 21.02 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.217 -0.992 . . . . 1.61 114.402 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.0 t -64.0 147.91 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.356 -0.422 . . . . 2.72 110.434 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.12 -20.01 18.92 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.832 -0.699 . . . . 1.56 112.251 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 3.2 p-10 -138.85 15.8 2.68 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.918 0.487 . . . . 1.63 110.296 178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -43.93 140.44 1.99 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.749 1.018 . . . . 2.34 113.749 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.9 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 77.2 t60 -89.53 -29.94 18.58 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.475 -0.784 . . . . 0.92 111.847 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 mt -141.42 126.25 10.6 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.476 -0.329 . . . . 1.51 111.011 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.96 121.68 7.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.927 2.418 . . . . 0.98 112.482 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.95 -48.17 1.16 Allowed Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.969 -0.634 . . . . 1.06 113.075 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -96.27 113.45 25.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.896 0.379 . . . . 1.68 111.541 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -92.37 15.34 14.11 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.804 -0.634 . . . . 2.11 112.215 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.409 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 11.6 t -80.87 160.57 24.72 Favored 'General case' 0 C--N 1.338 0.099 0 N-CA-C 110.463 -0.199 . . . . 1.39 110.463 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.033 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -74.53 121.73 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.766 0.317 . . . . 0.8 111.815 -177.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.689 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 48.2 m-85 -120.57 146.54 46.22 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.381 -0.372 . . . . 1.38 111.52 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.983 HG21 HD21 ' A' ' 48' ' ' LEU . 41.0 t -75.73 121.52 27.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.04 -0.527 . . . . 0.65 109.857 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.547 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.1 p -90.2 -24.49 20.99 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 19.8 tttt -172.1 133.52 0.7 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 111.742 0.275 . . . . 2.54 111.742 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 10.7 mt -104.88 126.57 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 120.805 0.336 . . . . 1.4 110.898 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.9 mp -82.21 152.1 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.68 110.752 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.73 145.85 51.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.173 -0.467 . . . . 3.11 110.864 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.72 18.56 53.0 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.341 -0.457 . . . . 3.15 113.757 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.02 165.15 35.9 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.685 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.19 -54.1 14.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 122.286 0.234 . . . . 3.0 111.475 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.17 -51.2 60.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.389 -0.368 . . . . 1.82 110.879 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.6 t-80 -50.6 -44.56 57.0 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.052 -0.522 . . . . 1.39 111.766 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -72.83 -38.58 67.08 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.239 -0.437 . . . . 2.66 111.554 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -65.71 -55.16 18.82 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.581 -0.281 . . . . 3.24 111.194 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.69 -27.26 21.01 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.928 -0.653 . . . . 2.49 113.131 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.0 -42.05 97.3 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.892 0.346 . . . . 5.67 111.842 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 33' ' ' VAL . 3.2 tt -90.1 124.49 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.901 0.381 . . . . 1.68 111.652 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -134.58 144.7 48.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.768 -0.651 . . . . 1.54 110.292 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pt -45.8 126.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 120.481 0.182 . . . . 2.56 111.071 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.28 -21.99 8.03 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.148 -0.549 . . . . 1.1 112.731 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' HB2' HG11 ' A' ' 85' ' ' VAL . 4.5 p30 -73.56 153.41 40.26 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 117.307 0.554 . . . . 1.56 111.107 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.789 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -106.02 148.15 28.06 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 115.682 -0.69 . . . . 3.23 110.228 179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -94.92 107.5 19.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.707 -0.679 . . . . 1.72 112.004 -178.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.14 -53.84 18.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.329 -0.851 . . . . 1.87 109.613 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -162.82 165.78 24.93 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.336 -0.393 . . . . 0.67 111.45 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.738 ' CG1' ' HB1' ' A' ' 73' ' ' ALA . 12.5 p -156.24 120.79 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.827 0.346 . . . . 1.47 110.963 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.8 m120 57.19 64.81 1.52 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.15 0.5 . . . . 1.49 110.516 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.9 m120 65.4 -21.2 0.09 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.491 1.293 . . . . 1.74 114.491 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 57' ' ' VAL . 21.0 m -95.36 137.48 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 118.837 0.744 . . . . 0.54 112.119 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.3 p -81.51 135.58 35.6 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.57 -0.529 . . . . 0.72 109.57 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -104.36 19.41 20.3 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.399 -0.364 . . . . 1.71 111.706 179.031 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -89.15 -26.95 21.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.873 0.694 . . . . 1.96 112.873 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -132.73 68.06 1.51 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.97 0.414 . . . . 2.93 111.577 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.4 m -150.33 154.18 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 112.341 0.497 . . . . 0.8 112.341 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.403 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -65.03 -171.13 0.06 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.428 -0.806 . . . . 1.53 110.072 178.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.652 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 26.3 t60 -75.61 -36.22 60.33 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 119.845 -0.742 . . . . 0.54 110.357 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.3 -41.49 62.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.539 0.209 . . . . 2.9 110.443 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -71.52 -39.19 70.91 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.384 -0.371 . . . . 1.84 110.991 179.363 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.805 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.55 -42.0 98.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.16 0.505 . . . . 0.44 110.516 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG21 HG21 ' B' ' 304' ' ' THR . 0.3 OUTLIER -79.28 -39.02 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.549 -0.751 . . . . 0.52 111.834 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.7 m -68.02 -33.66 75.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.524 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.738 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -75.22 -38.72 60.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.5 0.19 . . . . 0.41 110.796 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.805 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.4 mm? -68.31 -32.02 71.86 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.114 0.483 . . . . 1.73 109.97 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 2.9 ptpt -84.37 -18.45 36.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.285 -0.87 . . . . 1.44 112.125 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -74.2 68.86 1.5 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.935 0.398 . . . . 1.55 111.703 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 7' ' ' LYS . 16.6 p -129.91 152.62 49.19 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.247 -0.433 . . . . 2.6 111.441 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.4 p -135.26 -80.5 0.43 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.224 -0.444 . . . . 3.36 111.157 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.16 -56.44 2.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.875 0.369 . . . . 2.23 110.264 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -124.35 163.8 20.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.904 -0.589 . . . . 1.77 109.491 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.88 125.27 15.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 121.238 -0.185 . . . . 1.58 110.759 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -107.21 98.56 8.19 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.213 0.53 . . . . 1.72 110.223 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.622 HD22 HG23 ' A' ' 85' ' ' VAL . 2.3 tt -91.16 137.42 32.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.306 -0.861 . . . . 1.38 111.946 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.593 ' N ' HD23 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -114.1 108.69 17.32 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.597 -0.729 . . . . 1.56 110.265 179.174 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.789 HG13 ' O ' ' A' ' 53' ' ' LYS . 99.3 t -107.99 130.53 60.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.416 -0.357 . . . . 1.92 110.72 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.23 148.72 25.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.222 -0.444 . . . . 1.46 110.92 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -102.13 131.76 22.28 Favored Pre-proline 0 C--O 1.233 0.217 0 CA-C-N 116.325 -0.398 . . . . 4.2 110.829 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.82 142.11 61.79 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.708 2.272 . . . . 2.28 112.542 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 p -134.21 151.71 51.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 3.88 110.927 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.24 115.72 0.9 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.856 -0.687 . . . . 4.69 112.834 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.6 p -74.96 -36.2 62.07 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.427 0.156 . . . . 7.06 111.183 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 62.8 t-80 . . . . . 0 N--CA 1.463 0.2 0 CA-C-N 116.343 -0.39 . . . . 7.84 110.871 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.59 0.234 . . . . 4.22 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 55.4 ttm-85 -142.7 129.01 19.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.347 -0.388 . . . . 3.57 111.075 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.547 ' HB3' HG21 ' A' ' 34' ' ' THR . 8.3 mt-10 -121.62 128.01 51.46 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.829 -0.623 . . . . 2.08 110.44 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.547 ' HB ' ' HE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -127.94 147.29 50.47 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.977 0.417 . . . . 0.65 111.492 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 25.5 mt-30 -84.05 150.8 25.35 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.784 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 12' ' ' LEU . 15.5 m . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.072 -0.966 . . . . 1.47 111.709 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.539 0.209 . . . . 3.17 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.9 OUTLIER -106.58 150.65 25.96 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.43 -0.35 . . . . 1.97 110.731 179.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -145.36 95.94 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.443 -0.344 . . . . 1.34 110.758 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HB2' ' CD2' ' A' ' 82' ' ' TYR . 29.9 ttpt -98.31 147.26 24.85 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.339 -0.391 . . . . 2.93 110.058 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.26 170.59 18.62 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 110.074 -0.343 . . . . 2.09 110.074 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 tt -94.57 131.63 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.603 0.239 . . . . 1.94 111.018 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -48.28 129.89 15.82 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.326 -0.397 . . . . 3.1 111.89 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.86 -152.25 28.95 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.059 -0.591 . . . . 1.78 112.152 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.1 -80.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.845 2.363 . . . . 2.77 112.122 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -59.3 -73.05 0.09 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.428 0.156 . . . . 4.92 111.386 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -179.76 -107.99 0.23 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.776 -0.726 . . . . 2.3 112.662 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 HD12 ' A' ' 74' ' ' LEU . 70.8 mt -87.65 -53.2 4.91 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.655 0.264 . . . . 5.7 111.172 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 85.34 36.56 10.69 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.049 -0.596 . . . . 1.13 113.544 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 14.4 p90 -160.37 -175.02 4.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 117.194 0.497 . . . . 1.46 110.842 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 98.7 p -127.56 174.31 9.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.365 -0.235 . . . . 0.57 110.365 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.89 169.69 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.046 0.451 . . . . 0.67 111.17 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.66 164.59 27.51 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.8 -1.556 . . . . 1.19 106.8 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.031 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.46 133.67 1.54 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 117.115 -2.469 . . . . 1.29 116.732 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 103.57 159.87 24.91 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.715 -0.755 . . . . 1.61 113.681 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.45 138.9 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 120.448 0.166 . . . . 2.72 110.782 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.93 -18.26 27.64 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.907 -0.663 . . . . 1.56 112.742 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.9 20.9 2.65 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.233 0.613 . . . . 1.63 110.603 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 70.1 mt-30 -58.87 147.08 35.13 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.125 0.787 . . . . 2.34 113.125 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.036 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 72.0 t60 -90.01 -31.22 17.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.201 -0.908 . . . . 0.92 111.101 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.4 mm -132.31 128.5 21.23 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.981 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.31 122.44 10.72 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.811 2.341 . . . . 0.98 112.322 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -45.71 2.36 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 121.009 -0.615 . . . . 1.06 112.705 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.55 107.31 19.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.896 0.379 . . . . 1.68 110.973 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -87.98 17.8 4.68 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.085 -0.507 . . . . 2.11 112.126 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' O ' ' HD1' ' A' ' 32' ' ' TYR . 18.7 m -82.2 155.45 24.93 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.657 -0.497 . . . . 1.39 109.657 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.031 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.4 mm -74.68 126.02 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.443 0.534 . . . . 0.8 112.443 -177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -120.27 147.57 44.81 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.939 -0.573 . . . . 1.38 110.701 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.883 HG21 HD21 ' A' ' 48' ' ' LEU . 79.1 t -79.28 120.83 31.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.943 -0.391 . . . . 0.65 109.943 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.716 HG22 ' CE1' ' A' ' 24' ' ' HIS . 1.5 p -95.09 -23.58 17.26 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.052 0.76 . . . . 1.39 113.052 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -163.55 122.59 2.04 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.783 0.29 . . . . 2.54 111.783 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.6 mt -101.95 126.06 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.557 -0.292 . . . . 1.4 111.05 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.2 mp -77.76 145.68 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.205 -0.452 . . . . 1.68 110.838 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -59.64 149.1 31.38 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.378 -0.373 . . . . 3.11 111.098 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.56 20.92 40.29 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.949 -0.569 . . . . 3.15 113.576 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.11 171.27 36.96 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.012 -0.613 . . . . 2.8 112.907 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.24 -51.36 45.15 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.819 0.303 . . . . 3.0 111.819 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.53 -52.99 15.33 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.652 -0.249 . . . . 1.82 110.964 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.3 t-80 -50.1 -44.74 52.17 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.15 -0.477 . . . . 1.39 111.809 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -73.26 -36.81 66.44 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.454 -0.339 . . . . 2.66 111.419 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -65.22 -55.06 20.65 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 3.24 111.167 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -26.7 23.5 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.989 -0.624 . . . . 2.49 113.026 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -65.73 -41.06 92.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.802 0.301 . . . . 5.67 111.696 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.883 HD21 HG21 ' A' ' 33' ' ' VAL . 2.9 tt -90.2 125.48 35.49 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.936 0.398 . . . . 1.68 111.404 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -131.23 142.33 50.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.716 -0.675 . . . . 1.54 110.101 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.45 123.5 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-O 120.679 0.276 . . . . 2.56 111.348 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.03 -19.76 8.71 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.225 -0.512 . . . . 1.1 113.151 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.13 160.01 33.17 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 117.565 0.682 . . . . 1.56 110.634 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.962 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -108.5 149.7 28.46 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 121.602 0.715 . . . . 3.23 111.54 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.552 ' CD2' HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -101.42 102.85 13.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.146 -0.934 . . . . 1.72 111.584 -178.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 86' ' ' ALA . 3.9 tt -71.71 -51.11 24.6 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.414 -0.812 . . . . 1.87 110.05 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.51 151.24 27.44 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.527 -0.306 . . . . 0.67 111.659 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.736 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -143.95 125.45 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.666 -0.243 . . . . 1.47 111.099 179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.1 m120 66.11 31.19 9.02 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.395 -0.366 . . . . 1.49 111.037 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.4 t-20 88.29 -20.12 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.803 -0.635 . . . . 1.74 112.54 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 29.2 m -88.67 149.49 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 117.71 0.232 . . . . 0.54 110.889 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -85.34 130.12 34.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.866 0.365 . . . . 0.72 110.256 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.736 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.6 tp -102.48 24.61 10.14 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.922 -0.581 . . . . 1.71 111.722 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 28.3 mt-10 -106.17 -20.96 13.25 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.611 0.597 . . . . 1.96 112.611 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.78 54.12 1.43 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.811 0.338 . . . . 2.93 111.325 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.8 m -149.11 151.47 12.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 112.364 0.505 . . . . 0.8 112.364 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.76 165.6 8.23 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.487 -0.779 . . . . 1.53 110.224 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.3 t60 -53.15 -38.9 63.13 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 120.784 -0.366 . . . . 0.54 111.052 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -50.19 -47.47 54.63 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.513 0.197 . . . . 2.9 110.873 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 5.3 mp0 -62.93 -35.86 81.49 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.402 -0.363 . . . . 1.84 111.057 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.711 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.47 -41.97 86.45 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.207 0.527 . . . . 0.44 110.552 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HG12 ' B' ' 306' ' ' VAL . 44.0 t -80.93 -36.39 15.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.338 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 90.4 m -63.85 -35.33 80.28 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.654 -0.248 . . . . 0.61 111.634 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.15 -35.7 36.22 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.771 -0.195 . . . . 0.41 111.045 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.4 mm? -74.84 -33.12 62.1 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.887 0.375 . . . . 1.73 110.285 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -78.55 -24.84 45.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.788 -0.642 . . . . 1.44 111.983 -179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.86 71.06 2.66 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.195 0.521 . . . . 1.55 111.518 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.9 t -82.77 156.96 23.42 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.758 -0.656 . . . . 2.6 111.484 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.9 m -136.4 -123.67 0.15 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.805 -0.634 . . . . 3.36 109.71 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -94.32 -46.44 7.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.883 -0.784 . . . . 2.23 108.883 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.92 171.09 9.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.237 -0.892 . . . . 1.77 109.139 178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.2 t -141.54 133.22 27.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 110.081 -0.34 . . . . 1.58 110.081 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 4' ' ' LYS . 6.2 t80 -120.75 98.74 6.15 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.222 0.534 . . . . 1.72 110.698 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 tt -85.16 138.23 32.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.311 -0.859 . . . . 1.38 111.959 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.4 OUTLIER -120.29 128.39 53.26 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 115.626 -0.716 . . . . 1.56 109.869 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.962 HG13 ' O ' ' A' ' 53' ' ' LYS . 92.6 t -121.97 137.4 55.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.714 0.292 . . . . 1.92 111.608 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -85.88 145.72 27.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.049 -0.523 . . . . 1.46 110.757 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.94 112.06 65.25 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 4.2 111.069 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 56.9 Cg_endo -71.45 117.81 5.34 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.701 2.267 . . . . 2.28 112.178 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.0 m -140.86 113.8 8.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.705 0.288 . . . . 3.88 111.174 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.79 31.58 78.73 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 116.103 -0.499 . . . . 4.69 113.251 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.6 m -54.7 -40.41 69.16 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.892 0.346 . . . . 7.06 111.489 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 120.873 0.368 . . . . 7.84 111.184 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.74 0.305 . . . . 4.22 111.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.521 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 55.7 ttm-85 -159.41 126.54 4.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.155 -0.475 . . . . 3.57 111.123 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.551 ' HB3' HG21 ' A' ' 34' ' ' THR . 5.0 pt-20 -117.94 144.8 45.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.155 -0.475 . . . . 2.08 110.823 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.421 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -150.8 142.3 23.49 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.509 . . . . 0.65 110.962 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 3.3 mt-30 -70.1 156.22 39.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.257 -0.428 . . . . 1.67 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.575 HG12 HG13 ' A' ' 71' ' ' VAL . 3.9 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.083 -0.96 . . . . 1.47 111.522 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.746 0.308 . . . . 3.17 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.81 156.81 38.93 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.163 -0.472 . . . . 1.97 110.762 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.426 HG12 ' HG2' ' A' ' 47' ' ' LYS . 71.2 mt -144.2 95.62 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 116.437 -0.347 . . . . 1.34 110.538 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -97.49 146.4 25.28 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.742 -0.466 . . . . 2.93 109.742 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 170.74 18.22 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 110.313 -0.255 . . . . 2.09 110.313 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 tt -95.14 125.36 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.748 0.309 . . . . 1.94 110.969 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.51 133.77 35.42 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.076 -0.511 . . . . 3.1 111.674 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.19 -157.69 33.96 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.118 -0.563 . . . . 1.78 112.364 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.34 -76.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.854 2.37 . . . . 2.77 112.235 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.1 -59.71 3.23 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.309 0.115 . . . . 4.92 111.309 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.65 -164.18 37.82 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.574 -0.822 . . . . 2.3 113.143 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.713 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 1.1 mp -52.75 -41.37 63.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.31 0.244 . . . . 5.7 111.466 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 76.17 48.77 9.18 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.037 -0.602 . . . . 1.13 113.642 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.713 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 1.7 p90 -162.62 -174.13 3.84 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.792 0.296 . . . . 1.46 110.612 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.05 175.16 8.91 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.29 -0.263 . . . . 0.57 110.29 179.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.8 171.72 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.926 0.394 . . . . 0.67 111.046 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.045 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.1 165.6 25.68 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.467 -1.309 . . . . 1.19 107.467 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.979 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.78 132.37 1.36 Allowed Glycine 0 C--O 1.224 -0.476 0 C-N-CA 117.844 -2.122 . . . . 1.29 116.137 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 104.56 158.19 23.72 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.577 -0.82 . . . . 1.61 113.714 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.34 141.69 17.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.55 0.214 . . . . 2.72 110.663 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 -19.54 13.49 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.802 -0.713 . . . . 1.56 112.537 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.54 21.7 2.92 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.226 0.61 . . . . 1.63 110.269 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -59.65 147.99 35.41 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.007 0.744 . . . . 2.34 113.007 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.045 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.7 t60 -89.79 -25.21 21.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.173 -0.921 . . . . 0.92 111.398 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 1.1 tp -145.94 135.45 11.51 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.346 -0.388 . . . . 1.51 110.995 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 25' ' ' ILE . 51.0 Cg_exo -52.84 119.91 6.77 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.914 2.409 . . . . 0.98 113.059 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.4 -50.32 1.64 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.945 -0.645 . . . . 1.06 113.295 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 107.82 17.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.949 0.404 . . . . 1.68 111.307 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.67 16.06 6.11 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.809 -0.632 . . . . 2.11 111.781 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.599 ' C ' HD13 ' A' ' 31' ' ' ILE . 3.5 m -71.26 -179.14 2.29 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.64 0.257 . . . . 1.39 110.965 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.979 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -99.77 109.47 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 121.044 0.449 . . . . 0.8 111.196 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.1 m-85 -107.27 143.77 35.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.878 -0.601 . . . . 1.38 111.737 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG21 HD21 ' A' ' 48' ' ' LEU . 53.8 t -73.75 127.43 35.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.198 -0.455 . . . . 0.65 109.806 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.611 HG21 ' CG ' ' B' ' 303' ' ' GLU . 17.8 p -97.23 -31.48 12.41 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.315 0.857 . . . . 1.39 113.315 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 29.0 mttt -160.34 123.89 3.53 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.525 0.202 . . . . 2.54 111.431 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.2 mt -101.62 122.37 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.684 0.278 . . . . 1.4 110.695 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mt -73.01 143.47 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.194 -0.457 . . . . 1.68 111.187 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -51.85 144.29 11.72 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 3.11 111.157 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.98 41.98 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 116.119 -0.491 . . . . 3.15 113.408 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.9 172.84 42.63 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.01 -0.614 . . . . 2.8 112.674 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.28 -47.61 55.28 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.644 0.239 . . . . 3.0 111.644 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.9 -53.45 11.31 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.142 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -53.02 -45.22 67.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.211 -0.45 . . . . 1.39 111.902 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 16.6 mmtt -72.4 -39.43 67.97 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.49 -0.323 . . . . 2.66 111.615 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -66.2 -52.28 49.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.522 -0.308 . . . . 3.24 111.238 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.76 -30.54 9.82 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.899 -0.667 . . . . 2.49 113.146 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG12 ' A' ' 3' ' ' ILE . 0.1 OUTLIER -63.32 -43.75 96.89 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.855 0.328 . . . . 5.67 111.66 -179.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG21 ' A' ' 33' ' ' VAL . 4.3 tt -89.95 121.49 32.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.996 0.426 . . . . 1.68 111.296 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -133.85 144.81 49.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.525 -0.761 . . . . 1.54 110.129 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 pp -40.77 141.73 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.408 0.147 . . . . 2.56 110.824 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.71 -21.15 37.29 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.741 -0.742 . . . . 1.1 113.255 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -74.14 153.77 39.4 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 117.764 0.782 . . . . 1.56 111.374 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -114.06 149.05 36.07 Favored 'General case' 0 N--CA 1.458 -0.072 0 CA-C-N 115.427 -0.806 . . . . 3.23 111.053 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -97.46 113.63 25.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.182 -0.917 . . . . 1.72 111.87 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD13 ' HB2' ' A' ' 86' ' ' ALA . 30.6 tp -79.37 -51.34 9.52 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.204 -0.907 . . . . 1.87 109.694 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -158.7 158.67 34.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.477 -0.328 . . . . 0.67 111.446 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.859 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.9 p -151.11 123.47 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.707 0.289 . . . . 1.47 110.674 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 32.9 m120 65.65 33.82 8.12 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.387 -0.37 . . . . 1.49 110.829 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.516 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 17.7 m120 85.23 -16.4 0.48 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.627 0.771 . . . . 1.74 112.672 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.859 HG22 ' O ' ' A' ' 57' ' ' VAL . 26.6 m -90.14 144.88 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 117.749 0.25 . . . . 0.54 110.862 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.3 p -84.32 129.55 34.87 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.88 0.372 . . . . 0.72 110.542 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.709 HD13 HG12 ' A' ' 57' ' ' VAL . 1.1 tp -103.63 27.13 7.71 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.854 -0.612 . . . . 1.71 111.406 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 tt0 -110.25 -22.31 11.81 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.339 0.496 . . . . 1.96 112.339 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -126.49 46.87 2.38 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.948 0.404 . . . . 2.93 111.676 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.0 m -136.3 159.8 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.191 -0.459 . . . . 0.8 112.135 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.29 172.73 7.74 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.703 -0.68 . . . . 1.53 109.817 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.552 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 19.1 t60 -60.0 -39.49 85.94 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.514 -0.475 . . . . 0.54 111.157 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -52.39 -45.78 66.0 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.495 0.188 . . . . 2.9 110.72 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.1 mm-40 -63.26 -35.5 80.54 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.362 -0.381 . . . . 1.84 110.949 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -41.85 96.6 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.038 0.447 . . . . 0.44 110.645 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.654 HG13 HG12 ' B' ' 306' ' ' VAL . 40.6 t -80.31 -37.73 17.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.618 -0.719 . . . . 0.52 111.387 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.559 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 80.0 m -63.63 -35.06 79.27 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.61 111.24 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -79.05 -36.27 41.24 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.578 -0.283 . . . . 0.41 111.216 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -70.87 -34.85 72.02 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.188 0.518 . . . . 1.73 109.746 178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.559 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 14.3 ptpt -78.51 -20.63 50.35 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.151 -0.931 . . . . 1.44 111.858 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.1 64.08 3.2 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.398 . . . . 1.55 111.507 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -126.23 141.71 51.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.151 -0.477 . . . . 2.6 110.845 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.8 m -125.25 -75.95 0.59 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.232 -0.44 . . . . 3.36 111.138 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -104.47 -53.45 2.71 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.762 0.315 . . . . 2.23 110.56 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -126.37 162.71 24.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.01 -0.541 . . . . 1.77 110.249 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.4 p -142.03 119.78 8.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 116.752 -0.203 . . . . 1.58 110.73 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.51 98.71 10.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.194 0.521 . . . . 1.72 110.619 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 54' ' ' LEU . 1.3 tp -89.52 138.2 31.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.176 -0.92 . . . . 1.38 111.848 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.7 mmmt -119.94 128.51 53.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.676 -0.693 . . . . 1.56 110.007 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.76 135.96 54.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 120.857 0.361 . . . . 1.92 111.058 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.51 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -101.65 155.17 18.27 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.072 -0.513 . . . . 1.46 111.017 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -101.52 139.02 20.05 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.28 -0.418 . . . . 4.2 110.772 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.77 158.3 56.02 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.643 2.228 . . . . 2.28 112.405 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.4 p -146.14 -74.84 0.21 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.356 -0.383 . . . . 3.88 110.804 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.12 133.83 7.81 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.94 -0.647 . . . . 4.69 112.626 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.3 p -78.84 -36.56 42.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.489 0.185 . . . . 7.06 111.305 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.464 0.227 0 CA-C-N 116.391 -0.368 . . . . 7.84 111.158 -179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.59 0.233 . . . . 4.22 111.342 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.576 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 20.0 tpp180 -124.21 128.65 49.52 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.364 -0.38 . . . . 3.57 110.825 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.611 ' CG ' HG21 ' A' ' 34' ' ' THR . 4.9 mp0 -123.91 120.71 33.32 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.892 -0.594 . . . . 2.08 110.303 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.553 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -129.78 145.98 51.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.873 0.368 . . . . 0.65 111.475 -179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 18.0 mt-30 -76.51 152.39 36.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.016 -0.538 . . . . 1.67 111.194 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.654 HG12 HG13 ' A' ' 71' ' ' VAL . 16.3 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.046 -0.978 . . . . 1.47 111.377 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 tpp . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.72 0.295 . . . . 3.17 111.355 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.0 159.29 35.47 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.123 -0.489 . . . . 1.97 111.265 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.5 mp -139.41 137.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.409 -0.589 . . . . 1.34 109.409 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HB3' ' HE1' ' A' ' 80' ' ' PHE . 18.7 mttp -106.72 91.44 3.68 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.257 0.551 . . . . 2.93 111.168 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 2.4 mt -88.79 132.85 34.45 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.147 -0.933 . . . . 2.09 111.698 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.592 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.4 mp -88.3 118.15 33.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.326 -0.852 . . . . 1.94 110.37 -178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -63.43 110.61 2.0 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.382 -0.372 . . . . 3.1 111.181 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.25 174.82 28.97 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.128 -0.558 . . . . 1.78 112.527 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.63 60.09 6.47 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.317 2.678 . . . . 2.77 112.297 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -160.95 -67.13 0.06 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 4.92 110.501 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 151.59 -144.36 11.57 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 121.099 -0.572 . . . . 2.3 112.604 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 3.7 mp -87.23 -50.0 6.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.489 0.185 . . . . 5.7 110.686 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.1 36.2 13.56 Favored Glycine 0 C--N 1.335 0.513 0 C-N-CA 121.064 -0.589 . . . . 1.13 113.69 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.4 p90 -163.41 -174.1 3.62 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.949 0.375 . . . . 1.46 110.654 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.5 OUTLIER -126.84 171.57 11.14 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 109.741 -0.466 . . . . 0.57 109.741 178.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.441 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -154.61 169.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.67 110.888 179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.42 166.58 23.14 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.498 -1.297 . . . . 1.19 107.498 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.481 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.72 125.08 0.75 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.797 -1.668 . . . . 1.29 115.432 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.37 155.39 17.88 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 119.973 -1.108 . . . . 1.61 114.779 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.17 150.05 10.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.436 -0.382 . . . . 2.72 110.751 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.44 -20.09 9.59 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.788 -0.72 . . . . 1.56 112.528 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 3.7 p-10 -136.7 18.83 3.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.861 0.464 . . . . 1.63 109.914 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -46.54 138.68 5.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.371 0.878 . . . . 2.34 113.371 -178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.85 ' CE1' HG22 ' A' ' 34' ' ' THR . 70.0 t60 -89.25 -24.08 22.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.343 -0.844 . . . . 0.92 111.764 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 32' ' ' TYR . 9.1 mt -147.44 127.26 6.62 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 116.519 -0.309 . . . . 1.51 110.883 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.48 123.35 12.6 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.692 2.261 . . . . 0.98 112.36 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.29 -6.44 82.45 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.937 -0.649 . . . . 1.06 113.466 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.1 112.69 13.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.447 0.624 . . . . 1.68 110.524 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.29 9.65 39.03 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.398 0.518 . . . . 2.11 112.398 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.4 OUTLIER -67.49 -179.86 1.16 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.466 0.174 . . . . 1.39 110.543 179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -98.45 115.7 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-O 120.997 0.427 . . . . 0.8 110.592 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 36.1 m-85 -114.64 142.41 46.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.865 -0.607 . . . . 1.38 112.317 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.777 HG21 HD21 ' A' ' 48' ' ' LEU . 38.4 t -73.65 131.01 35.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 109.756 -0.461 . . . . 0.65 109.756 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.939 HG21 ' CB ' ' B' ' 303' ' ' GLU . 6.4 p -101.88 -31.3 10.78 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.232 0.827 . . . . 1.39 113.232 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 3.4 mtpm? -159.35 121.8 3.5 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.558 0.218 . . . . 2.54 111.556 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 43' ' ' HIS . 14.5 mt -99.36 121.19 49.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.65 0.262 . . . . 1.4 110.765 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.73 145.22 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.362 -0.381 . . . . 1.68 110.744 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -59.07 147.91 33.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.347 -0.388 . . . . 3.11 111.212 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA2' ' HE3' ' A' ' 44' ' ' LYS . . . 57.87 20.34 40.35 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.894 -0.594 . . . . 3.15 113.664 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.02 170.84 38.23 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.906 -0.664 . . . . 2.8 112.866 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.69 28.48 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.884 0.327 . . . . 3.0 111.884 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.16 -51.84 22.6 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.586 -0.279 . . . . 1.82 111.136 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.4 t-80 -51.03 -46.74 61.7 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.133 -0.485 . . . . 1.39 111.525 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 39' ' ' GLY . 6.2 mmtp -69.24 -37.94 78.24 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.323 -0.398 . . . . 2.66 111.295 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -62.65 -53.75 49.77 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.553 -0.294 . . . . 3.24 110.84 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.94 -25.77 25.37 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.043 -0.598 . . . . 2.49 112.904 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.8 mmtm -67.83 -39.02 83.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.732 0.266 . . . . 5.67 111.357 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.777 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.21 125.94 35.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.918 0.39 . . . . 1.68 111.288 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -130.31 142.61 50.53 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.718 -0.674 . . . . 1.54 110.413 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.8 mt -47.58 121.67 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.653 0.263 . . . . 2.56 111.084 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.55 -21.04 8.69 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.127 -0.558 . . . . 1.1 113.436 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -66.09 160.58 23.61 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 117.868 0.834 . . . . 1.56 110.613 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.949 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.72 148.96 31.21 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.555 0.693 . . . . 3.23 111.563 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -102.77 102.92 13.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.133 -0.939 . . . . 1.72 111.551 -179.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.3 tt -70.65 -52.43 21.3 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.452 -0.794 . . . . 1.87 109.616 178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.84 153.24 30.85 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.417 -0.356 . . . . 0.67 111.444 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.8 p -147.18 123.36 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.725 0.297 . . . . 1.47 111.275 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 11.6 m120 66.78 33.21 6.31 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.113 -0.494 . . . . 1.49 111.185 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.8 t-20 87.42 -18.09 0.3 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.774 0.657 . . . . 1.74 112.774 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 57' ' ' VAL . 19.4 m -93.05 149.22 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 117.883 0.31 . . . . 0.54 110.888 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.0 p -84.17 131.3 34.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.866 0.365 . . . . 0.72 110.337 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 1.9 tp -102.44 31.33 4.1 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.709 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -118.76 -19.39 8.66 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.471 0.545 . . . . 1.96 112.471 -179.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -121.31 42.36 3.09 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.813 0.339 . . . . 2.93 111.619 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 16.9 m -138.88 157.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.425 0.528 . . . . 0.8 112.425 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -69.84 -172.61 0.53 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.47 -0.786 . . . . 1.53 109.841 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.586 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 37.5 t60 -71.98 -39.16 69.5 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 119.853 -0.739 . . . . 0.54 111.095 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.0 -45.47 61.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.524 -0.176 . . . . 2.9 110.524 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -68.05 -34.23 76.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.495 -0.321 . . . . 1.84 110.726 179.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -43.65 87.04 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.189 0.518 . . . . 0.44 110.556 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.692 HG13 HG12 ' B' ' 306' ' ' VAL . 43.9 t -80.84 -33.77 13.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.576 -0.738 . . . . 0.52 111.128 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 17.1 m -63.47 -41.9 98.59 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.484 -0.325 . . . . 0.61 110.993 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.748 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -73.52 -36.9 65.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.445 -0.343 . . . . 0.41 111.001 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -68.62 -29.88 68.48 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.791 -0.448 . . . . 1.73 109.791 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 9.4 ptpt -89.27 -12.62 40.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.732 -0.667 . . . . 1.44 112.113 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.78 59.5 3.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.937 0.398 . . . . 1.55 110.953 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.7 p -124.15 134.56 53.29 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.099 -0.501 . . . . 2.6 110.991 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.9 m -114.91 -81.08 0.6 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.189 -0.459 . . . . 3.36 111.005 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.74 -48.94 5.28 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.658 0.266 . . . . 2.23 110.802 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.592 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -127.37 170.49 12.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.18 -0.464 . . . . 1.77 110.891 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 5' ' ' LEU . 1.3 m -141.36 128.71 21.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.796 -0.446 . . . . 1.58 109.796 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -111.45 98.86 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.236 0.541 . . . . 1.72 110.623 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -90.27 133.75 34.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.354 -0.839 . . . . 1.38 112.169 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 6.1 mtpp -119.27 132.71 55.94 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.34 -0.845 . . . . 1.56 109.914 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 53' ' ' LYS . 78.4 t -121.21 139.73 47.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.804 0.335 . . . . 1.92 111.49 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -84.77 142.78 29.56 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.886 -0.597 . . . . 1.46 110.762 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.0 108.3 37.28 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.301 -0.409 . . . . 4.2 110.875 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.23 117.53 5.21 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.61 2.207 . . . . 2.28 112.42 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.4 m -144.08 102.3 3.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.658 0.266 . . . . 3.88 110.532 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 96.87 1.96 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.953 -0.642 . . . . 4.69 112.331 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 m -77.42 -51.03 11.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.494 0.188 . . . . 7.06 111.229 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 t60 . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.796 0.332 . . . . 7.84 110.89 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.676 0.274 . . . . 4.22 111.59 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.626 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 15.4 ttm180 -160.94 140.33 10.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.172 -0.467 . . . . 3.57 111.034 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.939 ' CB ' HG21 ' A' ' 34' ' ' THR . 1.1 pm0 -135.27 144.96 47.1 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.914 -0.585 . . . . 2.08 110.993 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.34 147.25 52.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.203 -0.453 . . . . 0.65 111.149 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.3 mt-30 -78.83 144.73 34.76 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.185 -0.461 . . . . 1.67 110.523 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.692 HG12 HG13 ' A' ' 71' ' ' VAL . 19.7 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.128 -0.939 . . . . 1.47 111.409 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 120.89 0.376 . . . . 3.17 111.423 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pt-20 -87.16 143.71 27.17 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.098 -0.501 . . . . 1.97 110.834 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 61.8 mt -142.32 95.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.339 -0.391 . . . . 1.34 110.711 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 82' ' ' TYR . 3.6 mttt -95.26 146.66 24.19 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.303 -0.408 . . . . 2.93 109.964 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -147.15 167.76 23.35 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.083 -0.339 . . . . 2.09 110.083 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 6' ' ' ILE . 19.3 tt -96.26 121.83 47.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.867 0.365 . . . . 1.94 110.747 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.6 107.69 19.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.155 -0.475 . . . . 3.1 111.107 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.54 -166.09 34.9 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.895 -0.593 . . . . 1.78 112.527 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -77.62 54.75 4.9 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.325 2.683 . . . . 2.77 112.538 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -143.72 -79.87 0.2 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.587 -0.279 . . . . 4.92 110.834 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.75 162.25 9.76 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.929 -0.653 . . . . 2.3 112.794 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 2.6 mp -44.05 -54.28 5.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.544 0.338 . . . . 5.7 111.572 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.64 48.97 11.72 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.961 -0.638 . . . . 1.13 113.84 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 3.9 p90 -161.42 -174.65 4.38 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.849 0.324 . . . . 1.46 110.25 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.2 p -129.14 175.54 8.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.597 0.237 . . . . 0.57 110.635 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.809 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.36 172.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.67 110.787 179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.101 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.38 165.63 26.29 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.529 -1.285 . . . . 1.19 107.529 177.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.606 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.16 135.94 1.92 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 117.751 -2.166 . . . . 1.29 116.065 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.75 160.44 25.75 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.556 -0.83 . . . . 1.61 113.777 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 p -66.35 136.6 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.595 0.236 . . . . 2.72 110.383 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.51 -20.85 20.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.959 -0.638 . . . . 1.56 112.572 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.8 OUTLIER -131.46 16.24 4.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.951 0.5 . . . . 1.63 110.726 179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.5 mt-30 -53.8 145.13 16.56 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.266 0.839 . . . . 2.34 113.266 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.101 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 75.0 t60 -88.52 -23.56 23.16 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.319 -0.855 . . . . 0.92 111.13 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.2 mt -149.89 130.73 7.11 Favored Pre-proline 0 C--O 1.232 0.134 0 CA-C-N 116.422 -0.354 . . . . 1.51 110.902 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.71 128.98 32.59 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.741 2.294 . . . . 0.98 112.131 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.45 -11.73 71.31 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.854 -0.689 . . . . 1.06 113.478 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.39 112.19 13.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.461 0.631 . . . . 1.68 110.752 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.44 13.24 20.16 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.082 0.401 . . . . 2.11 112.082 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.435 ' C ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -70.73 -179.11 2.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.572 0.225 . . . . 1.39 110.584 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 54' ' ' LEU . 3.0 mm -99.82 114.43 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 120.726 -0.39 . . . . 0.8 110.487 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' A' ' 53' ' ' LYS . 41.8 m-85 -114.06 144.01 43.82 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.159 -0.473 . . . . 1.38 111.031 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG21 HD21 ' A' ' 48' ' ' LEU . 25.5 t -78.64 124.85 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.364 -0.38 . . . . 0.65 110.192 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' HB3' ' B' ' 303' ' ' GLU . 7.3 t -96.88 -27.36 14.71 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.447 0.906 . . . . 1.39 113.447 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 15.1 mtpt -159.61 123.25 3.71 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.976 0.362 . . . . 2.54 111.976 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.437 HG22 ' HB2' ' A' ' 43' ' ' HIS . 52.4 mt -103.33 125.27 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.594 -0.276 . . . . 1.4 110.941 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.3 mp -80.11 147.41 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.288 -0.415 . . . . 1.68 110.687 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -58.32 150.15 22.73 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.174 -0.466 . . . . 3.11 111.482 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.3 22.72 45.27 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.879 -0.6 . . . . 3.15 113.462 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.96 170.49 34.71 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.04 -0.6 . . . . 2.8 112.95 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.6 -48.97 57.66 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.919 0.34 . . . . 3.0 111.919 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.701 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -72.7 -54.22 9.59 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.673 0.273 . . . . 1.82 111.301 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.437 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.76 -45.04 66.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.957 -0.565 . . . . 1.39 112.062 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -70.38 -38.77 74.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.549 -0.296 . . . . 2.66 111.749 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' CG ' HD11 ' A' ' 5' ' ' LEU . 9.2 t70 -66.4 -57.25 7.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.792 -0.185 . . . . 3.24 111.43 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.76 -27.43 16.44 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.837 -0.697 . . . . 2.49 112.952 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -66.45 -40.04 89.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.815 0.308 . . . . 5.67 111.5 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.75 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -90.21 125.39 35.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.641 0.257 . . . . 1.68 110.896 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.07 147.61 35.33 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.346 -0.388 . . . . 1.54 110.866 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -33.74 141.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 111.696 0.258 . . . . 2.56 111.696 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.41 -7.28 81.7 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.61 . . . . 1.1 113.783 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -71.04 145.68 49.8 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 117.953 0.876 . . . . 1.56 110.977 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.851 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.3 148.81 31.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.532 -0.758 . . . . 3.23 110.868 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.103 HD22 HD11 ' A' ' 83' ' ' LEU . 54.3 mt -106.32 127.24 53.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.348 -0.842 . . . . 1.72 112.311 -178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.676 HD22 ' HD3' ' A' ' 84' ' ' LYS . 9.9 tt -89.55 -51.45 5.53 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.404 -0.817 . . . . 1.87 109.765 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' CB ' ' HA ' ' A' ' 61' ' ' CYS . . . -167.5 161.32 13.78 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.126 0.266 . . . . 0.67 111.595 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.84 HG13 ' HB1' ' A' ' 73' ' ' ALA . 12.2 p -156.24 124.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.771 0.319 . . . . 1.47 111.258 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.8 m120 55.81 65.56 1.43 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.165 0.507 . . . . 1.49 110.75 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.11 -21.6 0.07 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.614 1.338 . . . . 1.74 114.614 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.23 133.66 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 118.872 0.76 . . . . 0.54 111.797 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 56' ' ' ALA . 30.4 p -72.87 143.62 47.71 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.238 0.542 . . . . 0.72 111.396 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 54' ' ' LEU . 14.9 mt -102.69 10.88 38.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.271 -0.877 . . . . 1.71 111.735 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.68 -20.98 11.92 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.27 0.47 . . . . 1.96 112.27 -178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.32 53.0 1.46 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 2.93 111.267 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 18.1 m -148.04 152.46 12.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.097 0.475 . . . . 0.8 112.08 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -171.86 0.14 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.256 -0.884 . . . . 1.53 109.76 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.9 t60 -72.78 -38.78 67.18 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.347 -0.541 . . . . 0.54 110.323 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -44.78 70.26 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.518 -0.31 . . . . 2.9 111.132 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -68.18 -36.09 79.05 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.511 0.196 . . . . 1.84 110.793 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.46 -42.01 91.03 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.888 HG13 HG12 ' B' ' 306' ' ' VAL . 39.8 t -80.84 -36.58 15.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.661 -0.7 . . . . 0.52 111.635 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.599 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 22.7 m -64.25 -34.13 77.41 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.465 -0.334 . . . . 0.61 111.444 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.84 ' HB1' HG13 ' A' ' 57' ' ' VAL . . . -81.54 -35.71 29.97 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.716 -0.22 . . . . 0.41 111.468 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -70.85 -31.25 67.89 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-O 121.019 0.438 . . . . 1.73 110.186 178.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.46 -17.58 26.9 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.44 -0.8 . . . . 1.44 112.475 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -77.53 71.72 4.03 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.995 0.426 . . . . 1.55 112.026 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 t -133.8 159.21 41.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.052 -0.522 . . . . 2.6 111.083 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 p -133.84 -74.43 0.48 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.465 -0.334 . . . . 3.36 111.631 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -106.36 -55.92 2.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.707 0.289 . . . . 2.23 110.704 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 165.04 14.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.014 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.54 147.68 21.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.853 0.359 . . . . 1.58 111.209 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.628 ' O ' HG23 ' A' ' 57' ' ' VAL . 30.6 t80 -131.0 130.54 43.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.829 -0.804 . . . . 1.72 108.829 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 1.103 HD11 HD22 ' A' ' 54' ' ' LEU . 2.8 tp -130.2 147.44 51.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.129 0.49 . . . . 1.38 111.574 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.676 ' HD3' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -118.74 143.05 47.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.448 -0.796 . . . . 1.56 109.937 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG13 ' O ' ' A' ' 53' ' ' LYS . 48.7 t -124.96 138.3 54.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.706 0.289 . . . . 1.92 110.744 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.609 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -94.49 148.71 21.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.225 -0.443 . . . . 1.46 111.34 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -112.65 90.33 14.74 Favored Pre-proline 0 C--O 1.235 0.3 0 CA-C-N 116.042 -0.526 . . . . 4.2 110.8 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD2' ' HE2' ' A' ' 53' ' ' LYS . 35.3 Cg_exo -57.25 131.36 44.5 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.795 2.33 . . . . 2.28 111.9 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.5 p -144.3 113.99 7.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.825 0.345 . . . . 3.88 111.2 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 57.78 33.5 68.15 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.972 -0.558 . . . . 4.69 113.162 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.5 m -64.76 -36.49 84.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.741 0.27 . . . . 7.06 111.237 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.3 p80 . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.885 0.374 . . . . 7.84 111.079 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 18.6 mtt180 . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.716 0.293 . . . . 4.22 111.193 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.522 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 16.3 tpp180 -128.03 130.15 47.82 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.161 -0.472 . . . . 3.57 110.984 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.886 ' HB3' HG21 ' A' ' 34' ' ' THR . 2.5 mp0 -130.39 95.47 3.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.938 -0.574 . . . . 2.08 110.132 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.534 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -105.19 150.72 24.84 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.205 -0.452 . . . . 0.65 111.598 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 9.7 mt-30 -83.0 150.26 26.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.964 -0.562 . . . . 1.67 110.59 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.888 HG12 HG13 ' A' ' 71' ' ' VAL . 16.4 m . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.107 -0.949 . . . . 1.47 111.566 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 tpt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.749 0.309 . . . . 3.17 111.33 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 84' ' ' LYS . 1.3 pm0 -118.19 150.99 38.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.208 -0.451 . . . . 1.97 111.154 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 90.6 mt -143.23 95.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.103 -0.499 . . . . 1.34 110.381 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.23 147.59 23.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.035 -0.53 . . . . 2.93 110.285 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.2 tp -150.22 170.41 19.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.712 -0.477 . . . . 2.09 109.712 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 6' ' ' ILE . 17.8 tt -90.33 122.6 41.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.805 0.336 . . . . 1.94 110.789 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 28.4 tptt -76.47 121.53 23.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.24 -0.436 . . . . 3.1 111.469 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.44 168.61 28.27 Favored Glycine 0 CA--C 1.522 0.488 0 CA-C-N 115.906 -0.588 . . . . 1.78 112.662 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.26 -40.53 58.49 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.909 2.406 . . . . 2.77 112.638 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -52.1 -66.08 0.45 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.319 -0.4 . . . . 4.92 111.079 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 150.85 -145.98 14.46 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.959 -0.639 . . . . 2.3 112.416 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 74' ' ' LEU . 34.7 mt -86.99 -54.13 4.5 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.704 0.287 . . . . 5.7 110.471 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 89.43 32.33 10.52 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.051 -0.595 . . . . 1.13 113.412 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 15.9 p90 -161.04 -175.32 4.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 117.113 0.456 . . . . 1.46 110.708 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 2.8 p -128.17 177.27 7.03 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.719 -0.219 . . . . 0.57 110.462 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.528 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.61 170.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.086 0.47 . . . . 0.67 111.157 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.21 165.58 26.31 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.93 -1.507 . . . . 1.19 106.93 177.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.12 135.26 1.8 Allowed Glycine 0 C--O 1.223 -0.571 0 C-N-CA 117.358 -2.353 . . . . 1.29 116.322 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.74 158.42 25.61 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 120.642 -0.79 . . . . 1.61 113.545 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.52 139.79 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 120.548 0.213 . . . . 2.72 110.606 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.78 -21.02 12.09 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.815 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -136.33 18.86 3.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.268 0.627 . . . . 1.63 110.564 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -58.13 146.94 31.61 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.119 0.785 . . . . 2.34 113.119 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 69.9 t60 -89.99 -30.13 17.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.139 -0.937 . . . . 0.92 111.202 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 tt -136.98 130.04 17.38 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.202 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 123.79 14.34 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.715 2.277 . . . . 0.98 112.809 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.08 -46.38 1.59 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.984 -0.627 . . . . 1.06 113.314 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.41 108.12 20.52 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.839 0.352 . . . . 1.68 111.466 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -86.28 21.17 2.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.88 -0.6 . . . . 2.11 112.242 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 m -82.0 157.08 24.34 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.715 -0.476 . . . . 1.39 109.715 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.719 HD12 ' HA3' ' A' ' 18' ' ' GLY . 2.5 mm -74.16 120.05 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 113.303 0.853 . . . . 0.8 113.303 -176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 33.4 m-85 -115.58 146.03 42.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.646 -0.706 . . . . 1.38 110.286 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.899 HG21 HD21 ' A' ' 48' ' ' LEU . 53.7 t -75.47 126.07 35.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.051 -0.351 . . . . 0.65 110.051 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.758 HG22 ' CE1' ' A' ' 24' ' ' HIS . 25.3 p -95.68 -28.72 14.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.311 0.856 . . . . 1.39 113.311 -178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.2 mtpp -160.71 123.37 3.25 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.597 0.221 . . . . 2.54 111.597 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 43' ' ' HIS . 17.7 mt -101.25 123.4 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.714 0.292 . . . . 1.4 110.641 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 3.1 mp -78.04 146.07 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.229 -0.441 . . . . 1.68 110.913 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -57.72 149.13 22.73 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.333 -0.394 . . . . 3.11 111.178 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.26 21.94 27.91 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 116.008 -0.542 . . . . 3.15 113.56 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.61 171.15 41.22 Favored Glycine 0 C--N 1.338 0.642 0 C-N-CA 121.006 -0.616 . . . . 2.8 112.797 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.8 -48.61 63.76 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 111.633 0.235 . . . . 3.0 111.633 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.547 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -71.99 -54.11 10.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.596 -0.275 . . . . 1.82 110.779 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.478 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -50.59 -42.2 55.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.509 . . . . 1.39 111.878 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -75.49 -37.57 60.09 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.433 -0.348 . . . . 2.66 111.619 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.85 -52.19 52.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.652 -0.249 . . . . 3.24 111.233 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.72 -27.7 18.52 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.944 -0.646 . . . . 2.49 113.164 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -65.46 -42.14 92.63 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.921 0.341 . . . . 5.67 111.921 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.899 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -90.21 123.66 34.2 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.854 0.359 . . . . 1.68 111.454 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -129.94 140.97 50.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 1.54 110.016 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 33' ' ' VAL . 1.1 pt -46.2 123.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.657 0.265 . . . . 2.56 111.456 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.5 -18.04 8.82 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.31 -0.471 . . . . 1.1 112.94 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 4.3 p30 -72.34 158.52 35.64 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 117.415 0.608 . . . . 1.56 110.464 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.797 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.31 153.02 26.55 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.432 0.634 . . . . 3.23 111.811 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.0 HD21 HG13 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -107.18 102.88 12.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.142 -0.935 . . . . 1.72 111.766 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.4 tt -74.74 -48.85 23.42 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.317 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' CB ' HD23 ' A' ' 55' ' ' LEU . . . -154.07 152.59 30.65 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.086 0.402 . . . . 0.67 112.086 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.0 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -140.62 122.64 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.599 -0.273 . . . . 1.47 110.799 179.34 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 1.9 m120 60.71 33.48 20.2 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.573 -0.285 . . . . 1.49 111.36 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.9 t-20 89.69 -18.35 0.2 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.917 HG22 ' O ' ' A' ' 57' ' ' VAL . 12.5 m -87.91 145.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 117.794 0.27 . . . . 0.54 110.762 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.2 p -84.44 125.77 32.65 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.063 0.458 . . . . 0.72 110.541 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.75 HD13 ' CG2' ' A' ' 57' ' ' VAL . 1.5 tp -103.09 17.37 24.24 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.757 -0.656 . . . . 1.71 111.291 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.1 -18.21 15.68 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.234 0.457 . . . . 1.96 112.234 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.24 46.7 2.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.99 0.424 . . . . 2.93 111.065 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 9.6 m -139.74 155.56 25.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.172 -0.467 . . . . 0.8 112.059 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -68.14 166.16 16.72 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.55 -0.75 . . . . 1.53 110.274 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.564 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 12.3 t60 -53.1 -39.43 63.4 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.813 -0.355 . . . . 0.54 111.163 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -50.28 -47.83 55.26 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.468 0.175 . . . . 2.9 110.973 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -62.59 -35.96 81.21 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.292 -0.413 . . . . 1.84 111.149 179.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.687 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.94 -39.52 78.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.105 0.479 . . . . 0.44 111.026 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.513 HG13 HG12 ' B' ' 306' ' ' VAL . 86.9 t -80.56 -35.36 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.773 -0.649 . . . . 0.52 111.431 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.488 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 79.0 m -62.87 -38.27 90.21 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.558 -0.292 . . . . 0.61 111.425 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.64 -35.86 44.81 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.607 -0.269 . . . . 0.41 111.447 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -71.54 -30.91 66.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.856 -0.424 . . . . 1.73 109.856 178.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.9 OUTLIER -86.85 -18.52 30.74 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.634 -0.712 . . . . 1.44 111.831 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -59.97 -28.34 67.58 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.674 0.25 . . . . 1.55 111.674 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' HB ' ' A' ' 81' ' ' VAL . 14.2 p -37.45 139.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.55 0.574 . . . . 2.6 112.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 31.9 m -135.14 -81.53 0.43 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.536 -0.756 . . . . 3.36 110.768 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 7' ' ' LYS . 6.2 m-20 -94.64 -60.1 1.78 Allowed 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.618 -0.512 . . . . 2.23 109.618 179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.5 167.37 13.97 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.781 -0.645 . . . . 1.77 109.605 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.456 ' HB ' HG22 ' A' ' 77' ' ' THR . 10.9 p -141.3 144.26 26.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 110.441 -0.207 . . . . 1.58 110.441 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -125.29 98.19 5.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.308 0.575 . . . . 1.72 110.284 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -89.59 136.6 32.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.147 -0.933 . . . . 1.38 112.034 -178.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 2' ' ' GLU . 1.8 mmmt -121.47 138.4 54.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.556 -0.747 . . . . 1.56 109.582 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 53' ' ' LYS . 98.3 t -121.9 138.91 50.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.839 0.352 . . . . 1.92 111.256 -179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -85.8 143.19 28.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.942 -0.572 . . . . 1.46 111.029 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -86.52 115.14 61.13 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 4.2 110.811 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.465 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 30.4 Cg_endo -66.02 156.22 65.62 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.5 2.133 . . . . 2.28 112.401 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.1 t -137.52 145.87 43.47 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.249 -0.432 . . . . 3.88 111.09 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -113.39 126.68 7.53 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.142 -0.552 . . . . 4.69 112.469 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.5 p -75.55 -40.86 56.25 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.538 0.209 . . . . 7.06 110.969 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 C--O 1.231 0.13 0 CA-C-N 116.4 -0.364 . . . . 7.84 110.987 179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.82 0.343 . . . . 4.22 111.121 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 0.2 OUTLIER -122.27 143.66 49.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.119 -0.491 . . . . 3.57 111.137 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.552 ' CG ' HG21 ' A' ' 34' ' ' THR . 2.6 mp0 -114.8 150.01 36.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.835 -0.62 . . . . 2.08 110.526 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.3 139.86 24.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.375 -0.375 . . . . 0.65 111.336 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.9 mt-30 -75.2 153.81 37.93 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.966 -0.561 . . . . 1.67 111.218 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 71' ' ' VAL . 6.0 m . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.477 -0.773 . . . . 1.47 111.271 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 29.5 ttm . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.101 0.477 . . . . 3.17 111.065 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.1 pm0 -81.43 142.71 32.71 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.899 -0.591 . . . . 1.97 111.155 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.457 HD11 ' HG2' ' A' ' 1' ' ' MET . 3.1 mp -144.5 111.77 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.049 -0.523 . . . . 1.34 110.593 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttt -103.63 149.17 25.18 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.003 -0.544 . . . . 2.93 110.292 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 mt -150.06 170.9 17.81 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.043 -0.355 . . . . 2.09 110.043 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -95.69 121.38 46.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.062 -0.347 . . . . 1.94 110.062 178.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -54.07 135.8 42.74 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.127 -0.488 . . . . 3.1 111.783 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.73 -153.73 30.44 Favored Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.006 -0.543 . . . . 1.78 112.469 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.34 -74.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.763 2.309 . . . . 2.77 112.503 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -76.43 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.895 -0.138 . . . . 4.92 111.36 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.94 -114.66 0.4 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.656 -0.783 . . . . 2.3 112.922 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 14' ' ' PHE . 4.5 mm? -87.09 -50.4 6.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.594 0.235 . . . . 5.7 110.794 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 86.58 36.22 9.7 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.086 -0.578 . . . . 1.13 113.422 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 12' ' ' LEU . 10.6 p90 -161.13 -174.82 4.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.999 0.399 . . . . 1.46 110.459 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -127.39 175.02 8.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.779 0.323 . . . . 0.57 110.611 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.564 HD11 HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -156.89 171.87 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.109 -0.496 . . . . 0.67 110.8 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.034 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -139.65 167.21 22.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.524 -1.288 . . . . 1.19 107.524 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.026 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.03 132.43 1.38 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 117.952 -2.07 . . . . 1.29 116.235 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 159.48 26.68 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 120.773 -0.727 . . . . 1.61 114.036 177.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.96 142.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 110.234 -0.284 . . . . 2.72 110.234 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 -23.88 5.52 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.914 -0.66 . . . . 1.56 112.768 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -130.79 17.61 5.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.126 0.57 . . . . 1.63 110.367 178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -57.01 147.63 23.57 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 113.664 0.987 . . . . 2.34 113.664 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.034 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 78.2 t60 -88.54 -24.88 22.78 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 114.903 -1.044 . . . . 0.92 112.431 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.795 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -157.88 144.15 12.82 Favored Pre-proline 0 C--N 1.33 -0.281 0 O-C-N 122.976 0.173 . . . . 1.51 110.85 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.71 129.36 19.72 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.274 1.983 . . . . 0.98 112.376 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.66 -30.68 8.52 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.846 -0.692 . . . . 1.06 113.495 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.6 116.46 18.91 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 117.355 0.577 . . . . 1.68 111.778 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -87.88 16.83 5.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.793 -0.64 . . . . 2.11 111.815 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.567 ' C ' HD13 ' A' ' 31' ' ' ILE . 29.1 m -73.04 -178.36 2.8 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.644 0.259 . . . . 1.39 110.846 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.026 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -97.86 113.67 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.044 0.449 . . . . 0.8 110.989 179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.795 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 27.2 m-85 -111.52 141.55 44.95 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.103 -0.499 . . . . 1.38 112.155 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.869 HG21 HD21 ' A' ' 48' ' ' LEU . 54.3 t -77.77 120.35 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.172 -0.467 . . . . 0.65 109.883 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.867 HG21 ' HB3' ' B' ' 303' ' ' GLU . 15.1 t -95.69 -26.32 15.76 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 114.319 1.229 . . . . 1.39 114.319 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 12.5 mttt -160.29 124.92 3.78 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.318 0.508 . . . . 2.54 111.997 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 43' ' ' HIS . 18.0 mt -101.8 121.83 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.628 -0.26 . . . . 1.4 110.865 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.8 mp -72.48 143.85 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.372 -0.377 . . . . 1.68 110.769 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.41 146.39 15.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.772 0.32 . . . . 3.11 110.996 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 55.04 23.46 31.86 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 116.045 -0.525 . . . . 3.15 113.562 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.93 172.97 44.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.974 -0.631 . . . . 2.8 112.807 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.23 -47.13 65.85 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.613 0.227 . . . . 3.0 111.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -74.09 -53.62 9.55 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.687 -0.233 . . . . 1.82 110.726 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.544 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.2 t-80 -48.89 -42.86 38.23 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.223 -0.444 . . . . 1.39 111.575 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -75.13 -34.29 61.64 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.395 -0.366 . . . . 2.66 110.992 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -65.11 -55.54 18.13 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.464 -0.335 . . . . 3.24 111.085 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.52 -26.9 22.0 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.919 -0.657 . . . . 2.49 112.992 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.99 -38.92 72.71 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.083 0.401 . . . . 5.67 112.083 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.869 HD21 HG21 ' A' ' 33' ' ' VAL . 2.3 tt -90.26 119.93 30.98 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.773 0.321 . . . . 1.68 111.432 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -125.34 138.88 54.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.059 -0.519 . . . . 1.54 110.4 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -44.17 121.32 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.799 0.333 . . . . 2.56 111.755 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -16.45 9.61 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 116.171 -0.468 . . . . 1.1 113.157 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -67.68 160.55 27.79 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.491 0.645 . . . . 1.56 110.242 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.011 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.9 ttpt -108.68 147.13 32.38 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 121.443 0.639 . . . . 3.23 111.283 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.708 HD13 HD23 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -100.19 115.12 29.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.31 -0.859 . . . . 1.72 111.985 -178.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.654 HD23 ' HD3' ' A' ' 84' ' ' LYS . 40.5 tp -81.71 -52.46 7.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.128 -0.942 . . . . 1.87 110.46 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -155.76 153.1 29.34 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.117 0.414 . . . . 0.67 112.117 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 5.9 t -136.58 118.06 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.49 -0.323 . . . . 1.47 110.679 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 72.2 m-80 61.49 40.58 13.61 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.516 -0.311 . . . . 1.49 111.174 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 15.2 m120 84.39 -18.83 0.39 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.496 0.718 . . . . 1.74 112.915 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.5 m -87.83 149.5 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 117.916 0.325 . . . . 0.54 110.527 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.4 p -86.13 128.64 34.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.944 0.402 . . . . 0.72 111.035 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.712 HD22 HG21 ' A' ' 57' ' ' VAL . 1.1 tp -103.04 24.92 10.05 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.97 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -105.74 -22.92 12.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.32 -0.4 . . . . 1.96 111.957 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.73 48.66 2.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.975 0.416 . . . . 2.93 111.262 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.8 m -137.7 156.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.07 -0.514 . . . . 0.8 111.869 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -177.3 0.96 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.555 -0.748 . . . . 1.53 110.189 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.5 t60 -67.98 -38.75 83.07 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.41 -0.516 . . . . 0.54 110.372 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -51.22 -49.09 61.76 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.677 -0.238 . . . . 2.9 110.972 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -64.68 -33.36 75.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.599 -0.273 . . . . 1.84 110.988 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.56 -43.38 97.34 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.44 110.797 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG13 HG12 ' B' ' 306' ' ' VAL . 44.7 t -80.19 -34.59 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.705 -0.68 . . . . 0.52 110.933 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.453 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 54.8 m -64.25 -35.98 82.59 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.43 -0.35 . . . . 0.61 111.34 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -78.69 -36.37 43.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.843 -0.162 . . . . 0.41 111.205 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -71.3 -33.9 70.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.153 0.501 . . . . 1.73 109.903 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.512 ' HD2' HG12 ' A' ' 71' ' ' VAL . 1.2 ptmm? -83.69 -20.19 33.95 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.326 -0.852 . . . . 1.44 112.199 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' THR . 35.1 t30 -85.35 63.7 8.23 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.908 0.385 . . . . 1.55 111.312 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 81' ' ' VAL . 25.4 p -129.98 148.1 51.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.297 -0.411 . . . . 2.6 111.225 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.4 m -111.52 -148.12 0.43 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.179 -0.464 . . . . 3.36 111.136 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -47.82 -39.76 19.23 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.986 0.365 . . . . 2.23 111.986 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -117.51 167.63 11.13 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 110.178 -0.305 . . . . 1.77 110.178 178.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.495 HG22 ' CG2' ' A' ' 77' ' ' THR . 2.9 t -136.84 147.32 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.996 0.427 . . . . 1.58 111.81 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -139.34 126.64 21.41 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.038 -0.727 . . . . 1.72 109.038 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 54' ' ' LEU . 5.4 tt -133.08 149.66 52.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.925 0.393 . . . . 1.38 111.316 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.654 ' HD3' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.51 129.99 54.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.944 -0.571 . . . . 1.56 109.804 179.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.011 HG13 ' O ' ' A' ' 53' ' ' LYS . 84.1 t -112.62 138.69 40.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.418 -0.355 . . . . 1.92 111.214 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . . . -97.7 149.22 22.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.234 -0.439 . . . . 1.46 111.022 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -105.98 112.76 64.19 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-N 116.219 -0.446 . . . . 4.2 111.064 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.81 168.35 10.44 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.836 2.358 . . . . 2.28 112.296 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.5 p -122.58 109.14 13.94 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.251 -0.431 . . . . 3.88 111.108 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.0 122.16 5.94 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.053 -0.594 . . . . 4.69 112.496 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -87.66 -51.52 5.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.586 0.232 . . . . 7.06 110.997 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.8 m170 . . . . . 0 N--CA 1.463 0.183 0 CA-C-N 116.268 -0.424 . . . . 7.84 110.959 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 120.76 0.314 . . . . 4.22 111.373 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 12.4 ttt85 -143.0 115.77 8.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.161 -0.472 . . . . 3.57 110.856 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.867 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.1 mp0 -125.4 105.87 9.39 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.957 -0.565 . . . . 2.08 110.432 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.452 HG21 HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -110.27 147.4 33.92 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.08 -0.509 . . . . 0.65 111.382 -179.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.9 mt-30 -80.55 150.92 29.4 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.128 -0.487 . . . . 1.67 110.606 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.661 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.611 -0.709 . . . . 1.47 111.753 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.516 0.198 . . . . 3.17 111.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.01 158.29 28.11 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.789 0.328 . . . . 1.97 111.125 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.02 141.46 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.524 -0.547 . . . . 1.34 109.524 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -101.14 91.14 4.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.169 0.509 . . . . 2.93 111.374 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD22 ' HB1' ' A' ' 41' ' ' ALA . 72.9 mt -88.76 124.16 33.87 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.414 -0.812 . . . . 2.09 111.16 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 15.2 tt -95.57 131.16 43.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.897 -0.592 . . . . 1.94 111.183 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -59.07 114.22 2.49 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.504 -0.316 . . . . 3.1 111.424 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.81 -149.68 19.56 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 116.014 -0.539 . . . . 1.78 112.665 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.76 4.42 4.11 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.224 2.616 . . . . 2.77 113.391 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 -69.98 0.17 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 110.442 -0.206 . . . . 4.92 110.442 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.54 -146.08 18.09 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.981 -0.628 . . . . 2.3 112.965 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.747 HD22 ' CE2' ' A' ' 14' ' ' PHE . 28.2 mt -42.96 -58.39 2.43 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 122.694 0.398 . . . . 5.7 111.884 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.522 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 67.96 52.71 26.83 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.95 -0.643 . . . . 1.13 113.357 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.747 ' CE2' HD22 ' A' ' 12' ' ' LEU . 4.6 p90 -162.67 -173.84 3.7 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.253 -0.277 . . . . 1.46 110.253 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -125.29 168.76 13.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.917 -0.401 . . . . 0.57 109.917 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.462 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.83 171.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.922 0.391 . . . . 0.67 110.864 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.038 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -136.31 168.11 20.04 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.021 -1.474 . . . . 1.19 107.021 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.76 124.57 0.72 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 117.722 -2.18 . . . . 1.29 115.689 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.48 155.79 13.51 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.529 -0.843 . . . . 1.61 113.369 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -64.69 142.59 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.149 -0.315 . . . . 2.72 110.149 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.36 -17.2 25.41 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.834 -0.698 . . . . 1.56 112.973 -179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -141.92 25.01 1.98 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.216 0.606 . . . . 1.63 109.548 179.064 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -64.1 150.44 45.52 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.856 0.687 . . . . 2.34 112.856 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.038 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 63.0 t60 -89.68 -29.11 19.0 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.956 -1.02 . . . . 0.92 111.49 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -146.18 129.11 8.08 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 116.349 -0.387 . . . . 1.51 110.993 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 126.21 21.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.744 2.296 . . . . 0.98 112.283 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.58 -56.41 0.48 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.127 -0.559 . . . . 1.06 112.515 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -94.13 109.92 21.67 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.788 0.328 . . . . 1.68 111.007 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -85.78 16.48 4.0 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.562 0.578 . . . . 2.11 112.562 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.6 m -85.65 161.1 19.4 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.464 -0.569 . . . . 1.39 109.464 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.761 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -74.17 129.95 36.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.715 0.635 . . . . 0.8 112.715 -177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.696 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 35.4 m-85 -121.18 147.93 44.92 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 116.012 -0.54 . . . . 1.38 110.801 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 48' ' ' LEU . 54.8 t -77.46 125.17 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.384 -0.371 . . . . 0.65 110.685 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.757 HG21 ' HB3' ' B' ' 303' ' ' GLU . 1.4 p -95.11 -28.28 15.15 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.354 0.872 . . . . 1.39 113.354 -178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.8 OUTLIER -165.76 128.65 2.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.415 0.15 . . . . 2.54 111.166 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 33.0 mt -99.8 123.33 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.647 0.261 . . . . 1.4 111.083 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.7 mp -76.13 146.18 9.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.528 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.45 145.37 44.09 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.374 -0.376 . . . . 3.11 111.509 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.11 21.66 53.66 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.746 -0.661 . . . . 3.15 113.558 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.73 171.13 34.28 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.018 -0.61 . . . . 2.8 112.808 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.59 -57.46 4.74 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.922 0.342 . . . . 3.0 111.922 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.74 -50.07 66.13 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.562 -0.29 . . . . 1.82 111.187 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 55.9 t-80 -50.81 -48.87 59.57 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.215 -0.448 . . . . 1.39 111.572 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -70.03 -38.98 76.03 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.287 -0.415 . . . . 2.66 111.458 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.27 -56.38 16.99 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.511 -0.313 . . . . 3.24 110.995 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 -26.07 24.52 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.04 -0.6 . . . . 2.49 113.11 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.6 mtpt -67.83 -37.36 81.81 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.818 0.309 . . . . 5.67 111.406 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -90.2 122.49 33.18 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.906 0.384 . . . . 1.68 111.324 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -128.83 142.32 51.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.841 -0.618 . . . . 1.54 110.258 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.565 HG22 HG12 ' A' ' 33' ' ' VAL . 1.4 pt -46.96 124.66 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.649 0.261 . . . . 2.56 111.191 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.21 -20.65 8.41 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 121.146 -0.55 . . . . 1.1 112.972 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -72.42 159.4 34.05 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 117.487 0.644 . . . . 1.56 110.575 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.015 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.77 147.97 30.12 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.466 0.65 . . . . 3.23 111.41 179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 57' ' ' VAL . 1.2 mt -96.21 105.06 17.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.383 -0.826 . . . . 1.72 111.698 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.615 HD12 ' HB2' ' A' ' 86' ' ' ALA . 5.0 tt -71.82 -54.15 11.07 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.581 -0.736 . . . . 1.87 110.088 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 60' ' ' VAL . . . -148.69 148.9 30.59 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.648 -0.421 . . . . 0.67 111.969 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.91 ' O ' HG22 ' A' ' 60' ' ' VAL . 29.6 t -127.37 111.91 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.279 -0.418 . . . . 1.47 110.975 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.5 m120 62.18 43.57 8.48 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.409 -0.36 . . . . 1.49 111.256 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.405 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.7 t30 85.04 -20.48 0.28 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.69 -0.686 . . . . 1.74 112.819 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.91 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 m -86.56 151.43 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 117.878 0.308 . . . . 0.54 110.519 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.9 p -89.0 132.44 34.73 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 0.72 110.236 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.761 HD23 ' HB ' ' A' ' 31' ' ' ILE . 6.5 tp -100.9 35.08 2.28 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.731 0.641 . . . . 1.71 112.731 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -88.64 -110.95 0.07 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 119.46 -0.305 . . . . 1.96 110.574 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.77 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.953 0.723 . . . . 2.93 112.953 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 69' ' ' GLU . 15.6 m -148.94 144.84 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.248 -0.887 . . . . 0.8 111.37 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.518 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 11.5 m -66.14 159.05 27.06 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.787 -0.82 . . . . 1.53 108.787 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.553 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.9 t60 -51.99 -35.82 47.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.153 -0.619 . . . . 0.54 111.402 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.518 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 6.4 pt-20 -50.89 -47.87 60.5 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.505 -0.183 . . . . 2.9 110.505 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -63.2 -33.39 75.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.404 -0.362 . . . . 1.84 110.558 179.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.63 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.43 -42.18 91.27 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.038 0.447 . . . . 0.44 110.736 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.727 HG13 HG12 ' B' ' 306' ' ' VAL . 61.0 t -81.01 -35.01 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.869 -0.605 . . . . 0.52 111.284 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.54 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 88.6 m -64.0 -37.45 87.48 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.43 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.82 -35.85 43.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.597 -0.274 . . . . 0.41 111.289 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.83 -29.09 62.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.851 0.357 . . . . 1.73 110.108 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 11.0 ptpt -86.32 -20.6 28.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.842 -0.617 . . . . 1.44 111.959 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -75.1 70.67 2.1 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.159 0.504 . . . . 1.55 111.82 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 t -126.64 137.71 53.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.756 -0.657 . . . . 2.6 111.071 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.3 t -122.19 -81.85 0.64 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.128 -0.487 . . . . 3.36 110.66 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -96.76 -54.38 3.23 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.653 0.263 . . . . 2.23 110.538 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' CZ ' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -128.38 167.87 16.38 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.224 -0.444 . . . . 1.77 110.678 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.4 t -141.74 119.94 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 110.069 -0.345 . . . . 1.58 110.069 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -96.23 98.84 10.62 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.113 0.482 . . . . 1.72 110.362 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.97 127.5 34.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.404 -0.817 . . . . 1.38 111.767 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 17.4 mmmt -117.66 122.47 43.63 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 115.701 -0.681 . . . . 1.56 110.467 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.015 HG13 ' O ' ' A' ' 53' ' ' LYS . 75.8 t -114.89 132.13 65.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 120.663 0.268 . . . . 1.92 110.996 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.615 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -86.51 155.14 20.62 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.246 -0.434 . . . . 1.46 111.416 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.37 128.77 25.63 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.195 -0.457 . . . . 4.2 110.856 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.12 152.5 72.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.716 2.278 . . . . 2.28 112.84 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -130.84 138.58 49.92 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.874 -0.603 . . . . 3.88 110.735 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.72 106.16 1.79 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.951 -0.642 . . . . 4.69 112.638 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -72.45 -55.79 6.45 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.589 0.233 . . . . 7.06 110.933 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.832 0.349 . . . . 7.84 110.862 179.698 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.736 0.303 . . . . 4.22 111.275 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.9 ttm180 -153.13 132.4 12.77 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.115 -0.493 . . . . 3.57 110.844 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.757 ' HB3' HG21 ' A' ' 34' ' ' THR . 18.7 mt-10 -125.56 135.14 51.92 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.054 -0.521 . . . . 2.08 110.842 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.46 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -142.61 148.92 38.26 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.318 -0.401 . . . . 0.65 111.249 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 20.0 mt-30 -79.29 150.83 31.4 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.062 -0.517 . . . . 1.67 111.416 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.727 HG12 HG13 ' A' ' 71' ' ' VAL . 15.9 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.011 -0.995 . . . . 1.47 111.6 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mmt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.815 0.34 . . . . 3.17 111.306 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.35 159.21 35.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.216 -0.447 . . . . 1.97 111.126 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.68 HG23 ' HD3' ' A' ' 47' ' ' LYS . 4.4 mp -131.66 140.82 47.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 109.236 -0.653 . . . . 1.34 109.236 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.491 ' HG2' ' HE1' ' A' ' 80' ' ' PHE . 5.3 tttm -98.95 89.65 4.36 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.343 0.592 . . . . 2.93 111.388 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.2 mt -89.36 112.67 23.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.256 -0.884 . . . . 2.09 111.705 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -93.36 127.56 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.904 -0.589 . . . . 1.94 110.475 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -51.53 113.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.442 -0.345 . . . . 3.1 111.599 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 -151.07 24.31 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.043 -0.599 . . . . 1.78 112.211 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.91 -81.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.555 2.17 . . . . 2.77 111.947 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.28 -69.29 0.25 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.405 0.145 . . . . 4.92 111.287 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -177.59 -114.47 0.4 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.597 -0.811 . . . . 2.3 113.18 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.0 mp -87.09 -51.02 6.24 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.491 0.186 . . . . 5.7 111.118 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 83.09 36.76 14.06 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.997 -0.621 . . . . 1.13 113.625 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -161.56 -174.38 4.22 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.209 0.504 . . . . 1.46 110.831 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 5.7 p -130.18 173.02 11.16 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.357 -0.238 . . . . 0.57 110.357 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.439 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.06 169.9 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.927 0.394 . . . . 0.67 111.406 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.997 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.93 163.94 28.73 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 107.235 -1.395 . . . . 1.19 107.235 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.027 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.65 1.39 Allowed Glycine 0 C--O 1.224 -0.495 0 C-N-CA 117.599 -2.239 . . . . 1.29 116.034 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 107.82 155.52 18.91 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.479 -0.867 . . . . 1.61 113.149 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.54 141.87 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 110.478 -0.193 . . . . 2.72 110.478 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.87 -16.22 28.06 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.964 -0.636 . . . . 1.56 112.517 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.41 26.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.551 0.741 . . . . 1.63 110.012 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 5.3 mt-30 -64.36 149.54 48.05 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.537 0.569 . . . . 2.34 112.537 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.997 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 70.4 t60 -91.13 -30.22 16.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.378 -0.828 . . . . 0.92 111.128 179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.6 mm -135.93 124.74 15.66 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 116.02 -0.536 . . . . 1.51 110.863 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.72 122.61 10.01 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.772 2.315 . . . . 0.98 112.404 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.38 -50.47 1.44 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.96 -0.638 . . . . 1.06 112.546 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.05 106.93 18.81 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.789 0.328 . . . . 1.68 110.92 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -86.9 17.37 4.12 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.162 -0.472 . . . . 2.11 111.79 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 m -79.54 153.67 29.36 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.678 -0.49 . . . . 1.39 109.678 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.027 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.17 122.03 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 N-CA-C 112.595 0.591 . . . . 0.8 112.595 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 31.4 m-85 -114.88 147.54 39.78 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.47 -0.787 . . . . 1.38 110.766 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.909 HG21 HD21 ' A' ' 48' ' ' LEU . 46.2 t -77.43 125.88 37.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.483 -0.562 . . . . 0.65 109.483 177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.728 HG22 ' CE1' ' A' ' 24' ' ' HIS . 21.5 p -95.05 -26.43 16.06 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.014 0.746 . . . . 1.39 113.014 -178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 12.7 tttm -165.66 125.65 1.77 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.648 0.261 . . . . 2.54 111.597 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 43' ' ' HIS . 19.1 mt -102.65 125.05 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.565 -0.289 . . . . 1.4 111.009 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.6 mp -79.08 148.82 5.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.698 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -60.87 146.88 44.88 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.341 -0.39 . . . . 3.11 111.125 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.86 19.59 50.42 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.931 -0.577 . . . . 3.15 113.734 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.73 168.18 35.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.891 -0.671 . . . . 2.8 112.837 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.44 -52.84 20.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.828 0.307 . . . . 3.0 111.828 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.57 -51.54 41.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.548 -0.296 . . . . 1.82 111.179 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.546 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.8 t-80 -52.87 -47.09 68.09 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.06 -0.518 . . . . 1.39 111.981 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 mmtp -71.19 -39.65 71.69 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.449 -0.342 . . . . 2.66 111.59 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -63.93 -53.32 52.24 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.629 -0.259 . . . . 3.24 111.027 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.0 -30.27 10.15 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.027 -0.606 . . . . 2.49 113.191 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.68 ' HD3' HG23 ' A' ' 3' ' ' ILE . 0.5 OUTLIER -60.59 -41.93 95.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.93 0.365 . . . . 5.67 111.047 179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.909 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.36 123.76 33.82 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.992 0.425 . . . . 1.68 110.979 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -130.18 143.2 50.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.646 -0.706 . . . . 1.54 110.126 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.86 122.9 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.583 0.23 . . . . 2.56 111.181 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.05 -21.79 8.19 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.102 -0.57 . . . . 1.1 113.296 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.53 154.82 39.37 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 117.676 0.738 . . . . 1.56 110.842 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -110.0 149.13 30.42 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.856 -0.611 . . . . 3.23 110.844 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -101.39 124.54 47.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.573 -0.74 . . . . 1.72 111.989 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.696 HD13 ' HB2' ' A' ' 86' ' ' ALA . 55.5 tp -90.61 -52.95 4.64 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.032 -0.985 . . . . 1.87 109.811 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.49 155.31 40.16 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.811 0.338 . . . . 0.67 111.595 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.882 ' O ' HG22 ' A' ' 60' ' ' VAL . 51.2 t -136.12 112.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.357 -0.383 . . . . 1.47 110.715 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 5.4 m120 61.76 41.0 12.36 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.354 -0.385 . . . . 1.49 111.277 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t-20 86.05 -16.95 0.41 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.906 -0.588 . . . . 1.74 112.584 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.882 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.2 m -89.14 146.28 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 117.76 0.254 . . . . 0.54 110.449 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.5 p -84.6 128.61 34.69 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.688 -0.405 . . . . 0.72 110.415 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.696 ' CD2' HD13 ' A' ' 54' ' ' LEU . 1.8 tp -102.61 25.47 9.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.361 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -106.56 -20.19 13.44 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.608 0.596 . . . . 1.96 112.608 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.0 56.27 1.52 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.053 0.454 . . . . 2.93 111.305 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 m -147.12 152.98 12.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 112.35 0.5 . . . . 0.8 112.35 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 p -65.62 165.21 12.82 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.583 -0.735 . . . . 1.53 109.949 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.546 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.5 t60 -54.33 -38.73 66.34 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.723 -0.391 . . . . 0.54 111.513 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -52.13 -43.76 64.17 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.579 0.228 . . . . 2.9 110.667 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.9 OUTLIER -64.48 -36.67 84.94 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.263 -0.426 . . . . 1.84 110.766 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.698 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.25 -39.98 84.54 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.11 0.481 . . . . 0.44 110.536 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.823 HG13 HG12 ' B' ' 306' ' ' VAL . 43.4 t -80.47 -36.76 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 115.759 -0.655 . . . . 0.52 111.128 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 87.9 m -63.35 -36.61 84.26 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.437 -0.347 . . . . 0.61 111.353 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -78.0 -36.81 48.4 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.677 -0.238 . . . . 0.41 111.166 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.3 mm? -72.65 -32.67 66.04 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.863 0.364 . . . . 1.73 110.03 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 1.2 ptpp? -81.6 -22.63 37.58 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.747 -0.66 . . . . 1.44 111.949 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -75.52 68.79 2.21 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.089 0.471 . . . . 1.55 111.455 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 0.5 OUTLIER -128.04 139.19 52.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.054 -0.521 . . . . 2.6 111.129 -179.188 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.5 m -128.27 -79.07 0.57 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.828 -0.624 . . . . 3.36 110.605 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.35 -58.15 2.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.585 0.231 . . . . 2.23 110.869 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.491 ' HE1' ' HG2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.4 170.24 13.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.353 -0.385 . . . . 1.77 111.251 179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.553 ' CG2' ' HB ' ' A' ' 77' ' ' THR . 92.2 t -141.63 119.79 9.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.361 -0.382 . . . . 1.58 109.977 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -102.73 99.32 9.28 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.264 0.554 . . . . 1.72 110.704 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 48' ' ' LEU . 4.7 tp -82.12 129.71 34.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.25 -0.886 . . . . 1.38 112.014 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -115.08 113.15 23.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.745 -0.661 . . . . 1.56 109.705 178.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.9 m -117.83 133.16 65.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.969 0.414 . . . . 1.92 111.614 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.696 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -96.33 155.76 16.62 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.796 -0.638 . . . . 1.46 111.172 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.97 139.19 24.46 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.438 -0.346 . . . . 4.2 110.785 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.92 160.3 50.39 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.609 2.206 . . . . 2.28 112.71 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.1 m -132.13 125.7 31.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.05 -0.523 . . . . 3.88 110.772 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.28 119.25 5.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.98 -0.628 . . . . 4.69 112.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.0 p -77.54 -40.95 40.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.512 0.196 . . . . 7.06 111.118 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 . . . . . 0 N--CA 1.462 0.161 0 CA-C-N 116.452 -0.34 . . . . 7.84 110.944 179.919 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.66 0.267 . . . . 4.22 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 37.5 ttm180 -146.32 133.19 20.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.273 -0.421 . . . . 3.57 111.136 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.613 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.3 mt-10 -124.5 138.46 54.34 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.087 -0.506 . . . . 2.08 110.668 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.426 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -146.75 143.95 29.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.267 -0.424 . . . . 0.65 110.98 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.8 mt-30 -77.42 151.67 34.66 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.13 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.823 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.533 -0.746 . . . . 1.47 111.405 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.826 0.345 . . . . 3.17 111.196 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.487 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 pm0 -126.02 159.15 33.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.981 -0.554 . . . . 1.97 111.008 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 mp -142.6 131.34 21.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.98 -0.748 . . . . 1.34 108.98 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.75 91.18 4.28 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.287 0.565 . . . . 2.93 111.673 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' VAL . 32.0 mt -94.59 129.49 41.4 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.199 -0.91 . . . . 2.09 111.224 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.573 ' HB ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -89.74 127.54 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.184 -0.462 . . . . 1.94 111.037 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -59.07 124.15 19.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.043 -0.526 . . . . 3.1 111.849 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.09 -171.89 14.05 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.81 -0.632 . . . . 1.78 112.633 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.99 -40.0 81.39 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.901 2.4 . . . . 2.77 112.472 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -79.12 -63.11 1.49 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.272 -0.422 . . . . 4.92 110.458 179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.4 -116.77 2.36 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.147 -0.549 . . . . 2.3 112.354 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.607 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 10.2 mt -87.54 -50.05 6.78 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.599 0.238 . . . . 5.7 110.7 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.69 38.48 14.0 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.113 -0.565 . . . . 1.13 113.473 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.1 p90 -162.1 -174.12 3.96 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.901 0.351 . . . . 1.46 110.683 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -129.27 173.45 10.49 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.9 -0.407 . . . . 0.57 109.9 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.473 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.0 170.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.095 0.474 . . . . 0.67 111.286 179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.69 164.93 26.74 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.141 -1.429 . . . . 1.19 107.141 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.007 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.4 132.95 1.43 Allowed Glycine 0 C--O 1.225 -0.453 0 C-N-CA 117.769 -2.157 . . . . 1.29 115.888 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.44 160.01 24.09 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.415 -0.898 . . . . 1.61 113.508 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.63 139.57 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 110.513 -0.18 . . . . 2.72 110.513 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.41 -18.89 21.55 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.766 -0.73 . . . . 1.56 112.766 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 0.7 OUTLIER -135.77 18.91 3.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.078 0.551 . . . . 1.63 110.426 179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -56.39 144.56 30.31 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.097 0.777 . . . . 2.34 113.097 -178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.042 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 64.6 t60 -90.97 -28.69 17.86 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.24 -0.891 . . . . 0.92 111.105 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.441 HG12 ' HD2' ' A' ' 26' ' ' PRO . 2.7 tt -137.49 136.64 20.65 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.203 -0.453 . . . . 1.51 110.929 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' HG12 ' A' ' 25' ' ' ILE . 22.4 Cg_endo -61.45 120.64 8.39 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.739 2.292 . . . . 0.98 112.571 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.36 -46.39 1.25 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.989 -0.624 . . . . 1.06 112.951 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.54 110.21 22.84 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.868 0.366 . . . . 1.68 111.662 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -84.01 19.92 1.66 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.956 -0.565 . . . . 2.11 111.507 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.61 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -69.48 -179.34 1.66 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.705 0.288 . . . . 1.39 110.887 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.007 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -101.14 108.81 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-O 121.118 0.485 . . . . 0.8 110.754 178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 8.8 m-85 -107.89 146.97 31.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.846 -0.615 . . . . 1.38 111.533 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 55.2 t -77.48 130.8 35.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.175 -0.466 . . . . 0.65 110.341 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.857 HG21 ' HB3' ' B' ' 303' ' ' GLU . 16.7 p -101.09 -31.05 11.25 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.301 0.852 . . . . 1.39 113.301 -178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 17.9 mtpp -159.21 122.2 3.64 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.581 0.229 . . . . 2.54 111.554 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.2 mt -98.46 120.54 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 120.733 0.302 . . . . 1.4 110.846 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.16 144.34 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.222 -0.445 . . . . 1.68 110.763 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.54 147.37 37.21 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.825 0.345 . . . . 3.11 111.211 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA2' ' HE2' ' A' ' 44' ' ' LYS . . . 58.09 20.14 41.18 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.877 -0.601 . . . . 3.15 113.62 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.04 171.09 36.84 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 121.025 -0.607 . . . . 2.8 112.83 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -48.03 -54.44 13.0 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.888 0.329 . . . . 3.0 111.888 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.95 -51.12 43.1 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.611 0.243 . . . . 1.82 111.279 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 36' ' ' ILE . 60.7 t-80 -50.99 -47.0 61.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.197 -0.456 . . . . 1.39 111.645 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' HE2' ' HA2' ' A' ' 39' ' ' GLY . 22.9 mmtt -72.34 -38.15 68.67 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.35 -0.386 . . . . 2.66 111.522 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -63.86 -56.09 17.96 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.62 -0.264 . . . . 3.24 110.998 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.89 -28.61 15.22 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.978 -0.629 . . . . 2.49 113.037 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -59.97 -46.79 88.3 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.769 0.284 . . . . 5.67 111.336 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 4.7 tt -85.06 121.59 28.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.043 0.449 . . . . 1.68 111.442 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.41 146.66 50.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.555 -0.748 . . . . 1.54 110.011 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -41.91 137.5 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.495 0.188 . . . . 2.56 111.357 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.62 -21.33 32.7 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.9 -0.667 . . . . 1.1 113.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -75.72 152.85 37.38 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 117.736 0.768 . . . . 1.56 111.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.875 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.57 148.26 34.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.52 -0.764 . . . . 3.23 110.506 178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.72 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -94.21 104.04 16.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.209 -0.905 . . . . 1.72 111.978 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.811 HD12 ' HB2' ' A' ' 86' ' ' ALA . 8.2 tt -64.12 -52.06 60.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.251 -0.886 . . . . 1.87 110.134 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -155.88 159.68 39.53 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.151 0.426 . . . . 0.67 112.151 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.902 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.7 t -142.21 111.76 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.234 -0.439 . . . . 1.47 111.126 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 11.1 m120 64.26 47.6 3.13 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.27 -0.423 . . . . 1.49 111.221 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 58' ' ' ASN . 9.8 m120 79.16 -13.99 0.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.18 0.807 . . . . 1.74 113.18 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 57' ' ' VAL . 9.3 m -95.08 144.45 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 118.096 0.407 . . . . 0.54 110.645 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -81.48 133.74 35.44 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 120.714 -0.394 . . . . 0.72 110.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -103.22 28.43 6.35 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.942 -0.572 . . . . 1.71 111.32 179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.1 mt-10 -115.43 -21.41 9.82 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.45 0.537 . . . . 1.96 112.45 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.86 43.61 2.72 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.831 0.348 . . . . 2.93 111.476 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 14.5 m -140.22 157.59 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 112.414 0.524 . . . . 0.8 112.414 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -69.72 176.0 3.88 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.444 -0.798 . . . . 1.53 110.248 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.0 t60 -60.27 -40.88 91.94 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 120.435 -0.506 . . . . 0.54 111.042 -179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -49.54 -49.19 47.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.59 0.233 . . . . 2.9 110.688 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.4 mp0 -61.5 -35.25 77.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.204 -0.453 . . . . 1.84 111.155 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -61.34 -42.81 99.29 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.039 0.447 . . . . 0.44 110.903 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 42.4 t -80.31 -38.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.707 -0.679 . . . . 0.52 111.073 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.456 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 52.6 m -62.61 -34.75 77.66 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.44 -0.345 . . . . 0.61 111.299 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.33 -35.71 40.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.723 -0.217 . . . . 0.41 110.996 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 70' ' ' ALA . 2.6 mm? -72.97 -35.45 66.92 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.934 0.397 . . . . 1.73 109.986 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 71' ' ' VAL . 13.0 ptmt -81.1 -24.84 37.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.637 -0.711 . . . . 1.44 112.256 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 72' ' ' THR . 11.9 t30 -75.34 68.07 2.0 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.08 0.467 . . . . 1.55 111.028 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.583 HG22 ' HB ' ' A' ' 81' ' ' VAL . 16.6 p -121.91 115.39 22.49 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.894 -0.593 . . . . 2.6 111.101 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 t -87.33 -87.26 0.15 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 3.36 110.496 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -98.13 -43.89 6.84 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.669 0.271 . . . . 2.23 110.563 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' CE1' ' HB ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.55 171.65 12.79 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.117 -0.492 . . . . 1.77 110.563 179.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 77' ' ' THR . 8.4 p -141.76 119.97 9.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 110.119 -0.326 . . . . 1.58 110.119 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -97.85 99.13 10.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.318 0.58 . . . . 1.72 110.368 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 54' ' ' LEU . 5.0 tp -87.95 125.87 34.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.232 -0.895 . . . . 1.38 112.094 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' O ' HD23 ' A' ' 54' ' ' LEU . 2.7 mmpt? -110.83 110.26 20.79 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.707 -0.679 . . . . 1.56 109.582 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 53' ' ' LYS . 86.3 t -110.98 132.42 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.447 -0.342 . . . . 1.92 111.401 -178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.811 ' HB2' HD12 ' A' ' 55' ' ' LEU . . . -98.8 154.46 17.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.991 -0.55 . . . . 1.46 111.326 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -100.02 131.6 24.09 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.128 -0.487 . . . . 4.2 110.806 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 87' ' ' LYS . 52.5 Cg_exo -55.12 151.37 35.16 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.773 2.316 . . . . 2.28 112.497 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.9 p -150.45 168.39 24.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.038 -0.528 . . . . 3.88 111.034 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.54 90.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-N 116.028 -0.533 . . . . 4.69 113.194 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.1 t -75.87 -41.24 52.82 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.572 0.186 . . . . 7.06 111.002 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-O 120.872 0.368 . . . . 7.84 111.104 179.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 41.0 mtm105 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 120.608 0.242 . . . . 4.22 111.273 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -147.18 157.83 43.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.3 -0.409 . . . . 3.57 111.151 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.857 ' HB3' HG21 ' A' ' 34' ' ' THR . 0.5 OUTLIER -130.58 156.52 44.72 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.029 -0.532 . . . . 2.08 111.255 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.462 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -149.71 143.0 25.18 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.081 -0.509 . . . . 0.65 110.902 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.8 mt-30 -73.64 151.13 40.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.237 -0.438 . . . . 1.67 111.33 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 9.2 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.458 -0.782 . . . . 1.47 111.575 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mtm . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 120.52 0.2 . . . . 3.17 111.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -124.85 158.73 32.72 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.585 -0.279 . . . . 1.97 110.952 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 mp -142.91 138.53 27.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.45 -0.574 . . . . 1.34 109.45 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -102.39 91.22 4.16 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 2.93 110.997 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.55 HD22 ' HB1' ' A' ' 41' ' ' ALA . 10.4 mt -89.19 126.82 35.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.35 -0.841 . . . . 2.09 111.327 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.4 tt -91.87 127.1 44.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 1.94 110.811 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.1 tptt -61.82 113.81 2.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.277 -0.42 . . . . 3.1 111.399 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.46 -149.59 21.97 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.585 -0.606 . . . . 1.78 111.585 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.27 -82.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.237 1.958 . . . . 2.77 111.028 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -65.69 -59.91 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 110.336 -0.246 . . . . 4.92 110.336 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.88 -138.9 10.87 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 121.033 -0.603 . . . . 2.3 112.851 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.663 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.4 mp -37.07 -62.15 0.51 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.866 0.466 . . . . 5.7 111.81 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 70.37 47.73 41.71 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.993 -0.622 . . . . 1.13 113.04 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.663 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 15.0 p90 -163.96 -173.6 3.26 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.187 -0.301 . . . . 1.46 110.187 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.5 p -131.01 174.12 10.32 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.133 -0.321 . . . . 0.57 110.133 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.544 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -156.97 173.05 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.953 0.406 . . . . 0.67 110.876 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.5 164.52 27.29 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.786 -1.561 . . . . 1.19 106.786 177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.054 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.16 130.41 1.15 Allowed Glycine 0 C--O 1.225 -0.409 0 C-N-CA 117.224 -2.417 . . . . 1.29 116.329 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 108.04 157.11 19.4 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 120.568 -0.825 . . . . 1.61 113.06 178.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.92 140.55 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 110.079 -0.341 . . . . 2.72 110.079 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 -17.68 26.29 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.905 -0.664 . . . . 1.56 112.599 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.7 OUTLIER -137.19 21.07 2.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.35 0.66 . . . . 1.63 109.926 179.139 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 33.5 mt-30 -58.67 146.93 34.6 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.86 0.689 . . . . 2.34 112.86 -178.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 76.4 t60 -89.59 -26.96 20.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.273 -0.876 . . . . 0.92 111.101 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.2 mt -147.18 130.26 8.03 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.66 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -57.54 125.98 20.47 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.758 2.306 . . . . 0.98 112.212 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.25 0.58 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.043 -0.599 . . . . 1.06 112.516 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.46 110.09 22.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.826 0.345 . . . . 1.68 111.134 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -86.18 17.55 3.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 2.11 111.885 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -83.57 158.59 21.88 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.072 -0.344 . . . . 1.39 110.072 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.054 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.5 mm -74.13 125.83 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 113.03 0.752 . . . . 0.8 113.03 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 34.5 m-85 -119.5 148.66 43.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.452 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.011 HG21 HD21 ' A' ' 48' ' ' LEU . 48.3 t -77.09 129.11 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 110.26 -0.274 . . . . 0.65 110.26 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.802 HG22 ' CE1' ' A' ' 24' ' ' HIS . 26.9 p -100.33 -30.31 11.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.252 0.834 . . . . 1.39 113.252 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 10.2 mtpp -159.58 122.41 3.54 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.557 0.218 . . . . 2.54 111.478 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 43' ' ' HIS . 8.2 mt -98.94 122.03 50.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.695 0.284 . . . . 1.4 110.817 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 mp -78.94 147.85 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.277 -0.419 . . . . 1.68 110.682 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -64.02 148.03 50.68 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.337 -0.392 . . . . 3.11 111.204 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.68 17.37 53.9 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.834 -0.621 . . . . 3.15 113.593 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.59 168.73 32.13 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 120.945 -0.645 . . . . 2.8 112.962 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.55 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.25 -59.06 3.14 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.025 0.38 . . . . 3.0 112.025 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -65.07 -49.62 69.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.622 0.248 . . . . 1.82 111.284 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.464 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.7 t-80 -51.4 -48.78 62.51 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.09 -0.504 . . . . 1.39 111.773 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -70.59 -38.22 74.0 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.481 -0.327 . . . . 2.66 111.541 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.25 -50.79 68.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.609 -0.269 . . . . 3.24 110.98 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -27.16 13.16 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.127 -0.559 . . . . 2.49 113.184 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -62.18 -44.9 95.56 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.867 0.333 . . . . 5.67 111.33 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.011 HD21 HG21 ' A' ' 33' ' ' VAL . 3.9 tt -84.55 122.48 29.08 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.892 0.377 . . . . 1.68 111.29 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -130.78 144.72 51.65 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.736 -0.665 . . . . 1.54 110.197 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 mp -47.07 125.13 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.708 -0.224 . . . . 2.56 111.047 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.89 -22.32 8.12 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.107 -0.568 . . . . 1.1 112.969 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -70.46 152.72 43.73 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.553 0.677 . . . . 1.56 111.264 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -108.79 149.19 29.41 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.62 -0.718 . . . . 3.23 110.638 179.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.76 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -98.33 111.99 24.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.586 -0.734 . . . . 1.72 111.94 -178.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 86' ' ' ALA . 27.6 tp -79.75 -53.01 7.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.125 -0.943 . . . . 1.87 109.882 178.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -152.33 156.01 38.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.811 0.3 . . . . 0.67 111.811 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -138.62 114.82 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.674 0.273 . . . . 1.47 111.048 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.408 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 63.14 41.29 8.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.414 -0.357 . . . . 1.49 111.306 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 0.8 OUTLIER 84.65 -16.87 0.48 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.668 0.618 . . . . 1.74 112.668 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.4 m -90.57 148.13 4.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 CA-C-N 117.821 0.282 . . . . 0.54 110.503 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.5 p -86.53 130.82 34.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.876 -0.33 . . . . 0.72 110.388 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.8 tp -101.68 30.28 4.42 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.896 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 65' ' ' VAL . 8.3 mt-10 -89.07 -106.25 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.512 -0.28 . . . . 1.96 110.56 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -62.02 65.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.415 0.894 . . . . 2.93 113.415 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 6.9 m -134.32 156.12 40.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.692 -0.686 . . . . 0.8 110.668 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -73.02 160.01 32.74 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.535 -0.543 . . . . 1.53 109.535 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.556 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 11.9 t60 -51.59 -37.71 51.18 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.658 -0.417 . . . . 0.54 111.145 -178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -54.88 -41.11 70.46 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.888 -0.142 . . . . 2.9 110.935 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -64.01 -37.25 86.72 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.455 -0.202 . . . . 1.84 110.455 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.514 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -60.54 -40.1 90.31 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.128 0.49 . . . . 0.44 110.655 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.694 HG13 HG12 ' B' ' 306' ' ' VAL . 48.4 t -80.34 -39.51 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 115.491 -0.777 . . . . 0.52 111.596 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 77.2 m -64.87 -36.81 85.57 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.925 0.343 . . . . 0.61 111.925 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.78 -39.44 44.07 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 111.53 0.196 . . . . 0.41 111.53 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD23 HG21 ' B' ' 306' ' ' VAL . 8.5 mp -72.55 -31.34 65.19 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.372 . . . . 1.73 110.785 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.31 -24.12 40.18 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.643 -0.708 . . . . 1.44 111.753 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -76.92 69.34 3.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.039 0.447 . . . . 1.55 111.137 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB ' ' A' ' 81' ' ' VAL . 18.4 p -123.67 130.6 52.89 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.993 -0.549 . . . . 2.6 111.122 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.1 t -106.43 -82.06 0.54 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.197 -0.456 . . . . 3.36 110.631 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -99.51 -48.56 4.72 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 2.23 110.584 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.441 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.28 168.33 17.05 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.193 -0.458 . . . . 1.77 110.685 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.43 ' HB ' HG22 ' A' ' 77' ' ' THR . 13.9 p -142.06 120.0 8.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.934 -0.395 . . . . 1.58 109.934 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -96.91 98.97 10.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.26 0.553 . . . . 1.72 110.833 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD11 HD11 ' A' ' 54' ' ' LEU . 2.9 tp -87.48 128.87 35.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.25 -0.887 . . . . 1.38 111.829 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 2' ' ' GLU . 19.6 mmmt -115.67 119.46 36.16 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.76 -0.655 . . . . 1.56 110.0 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.3 m -122.54 134.1 66.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.822 0.344 . . . . 1.92 111.454 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -90.93 153.94 19.82 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.108 -0.496 . . . . 1.46 111.383 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -98.8 129.01 30.85 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.175 -0.466 . . . . 4.2 110.802 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.17 153.41 62.33 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.791 2.328 . . . . 2.28 112.486 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.6 p -144.95 -70.55 0.28 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.187 -0.46 . . . . 3.88 110.907 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.82 127.85 3.89 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.064 -0.589 . . . . 4.69 112.617 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.4 m -98.23 -45.17 6.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.56 0.219 . . . . 7.06 111.109 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.6 m80 . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 7.84 111.018 -179.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.682 0.277 . . . . 4.22 111.235 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.441 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 52.8 ttt180 -134.71 130.98 37.09 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.251 -0.431 . . . . 3.57 111.002 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.645 ' CG ' HG21 ' A' ' 34' ' ' THR . 5.1 mp0 -123.82 122.39 37.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.965 -0.562 . . . . 2.08 110.433 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.506 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -133.17 147.44 52.06 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.372 -0.376 . . . . 0.65 111.21 -179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.5 mt-30 -80.37 150.75 29.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.061 -0.518 . . . . 1.67 111.123 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.694 HG12 HG13 ' A' ' 71' ' ' VAL . 16.8 m . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.139 -0.934 . . . . 1.47 111.463 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.747 0.308 . . . . 3.17 111.468 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.38 156.59 32.31 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.165 -0.47 . . . . 1.97 111.282 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.451 HG12 ' HD3' ' A' ' 47' ' ' LYS . 4.1 mp -146.43 115.38 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.855 -0.611 . . . . 1.34 109.402 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 1.2 mptt -80.7 91.19 5.84 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.23 0.538 . . . . 2.93 111.14 -179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 mt -88.39 137.19 32.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.309 -0.859 . . . . 2.09 112.002 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.424 HG13 ' CE1' ' A' ' 80' ' ' PHE . 4.0 tt -89.4 153.09 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.212 -0.904 . . . . 1.94 109.939 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -84.87 133.41 34.31 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.651 0.262 . . . . 3.1 110.524 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.29 -170.59 36.33 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.944 -0.646 . . . . 1.78 112.383 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -62.3 -73.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.579 2.186 . . . . 2.77 111.984 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -62.95 -63.88 1.08 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.49 0.186 . . . . 4.92 111.074 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.74 -136.35 2.24 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 2.3 112.802 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 5.7 mt -73.47 -39.47 64.89 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.434 0.159 . . . . 5.7 111.343 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.9 34.56 21.27 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 121.046 -0.597 . . . . 1.13 113.48 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.594 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 8.0 p90 -161.84 -174.24 4.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.939 0.37 . . . . 1.46 110.628 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.32 172.44 11.49 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.754 -0.462 . . . . 0.57 109.754 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 HG21 ' HG ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -155.32 170.06 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.061 0.458 . . . . 0.67 110.912 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.864 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.7 166.99 22.61 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.492 -1.299 . . . . 1.19 107.492 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.078 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.95 126.54 0.83 Allowed Glycine 0 C--O 1.225 -0.407 0 C-N-CA 118.455 -1.831 . . . . 1.29 115.251 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 110.34 154.91 14.49 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.835 -1.174 . . . . 1.61 114.262 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t -64.89 148.53 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 110.225 -0.287 . . . . 2.72 110.225 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.66 -20.17 9.82 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.77 -0.729 . . . . 1.56 112.643 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.656 ' ND2' ' HB2' ' A' ' 67' ' ' HIS . 3.0 p-10 -136.9 17.99 3.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.811 -0.44 . . . . 1.63 109.811 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -48.83 139.97 9.25 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.837 1.051 . . . . 2.34 113.837 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 55.3 t60 -92.48 -31.74 15.15 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.104 -0.953 . . . . 0.92 111.168 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.431 HG13 ' CE2' ' A' ' 32' ' ' TYR . 28.4 mm -133.6 128.31 19.97 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 115.99 -0.55 . . . . 1.51 110.883 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.67 120.88 9.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.762 2.308 . . . . 0.98 112.334 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.11 -47.65 1.09 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 121.021 -0.609 . . . . 1.06 112.861 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.12 112.55 24.86 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.871 0.367 . . . . 1.68 111.252 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.93 18.51 2.95 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.991 -0.55 . . . . 2.11 111.574 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.619 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -67.45 -179.73 1.12 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.776 0.322 . . . . 1.39 110.953 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.078 HD12 ' HA3' ' A' ' 18' ' ' GLY . 0.8 OUTLIER -98.94 109.94 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-O 120.985 0.421 . . . . 0.8 110.641 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -109.46 144.0 38.3 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.476 0.546 . . . . 1.38 112.476 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.931 HG21 HD21 ' A' ' 48' ' ' LEU . 55.9 t -78.21 127.26 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.925 -0.58 . . . . 0.65 109.761 178.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.829 HG21 ' HB3' ' B' ' 303' ' ' GLU . 11.4 t -100.68 -29.21 12.42 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.677 0.992 . . . . 1.39 113.677 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 28.1 mmtp -157.25 120.31 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 117.837 0.29 . . . . 2.54 111.748 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.594 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.8 mt -99.85 121.96 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.623 -0.262 . . . . 1.4 110.7 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.47 146.88 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.326 -0.397 . . . . 1.68 110.937 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -60.0 146.17 43.63 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.267 -0.424 . . . . 3.11 110.758 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.85 20.2 56.88 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.269 -0.491 . . . . 3.15 113.494 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.28 166.81 33.65 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.948 -0.644 . . . . 2.8 112.679 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.58 -51.23 28.84 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.76 0.282 . . . . 3.0 111.76 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -70.34 -51.71 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.628 -0.26 . . . . 1.82 111.133 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 36' ' ' ILE . 58.5 t-80 -51.09 -47.41 61.9 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 1.39 111.624 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -69.24 -38.03 78.29 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.377 -0.374 . . . . 2.66 111.375 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.21 -52.25 63.01 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.545 -0.298 . . . . 3.24 111.119 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.34 -26.74 20.05 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.993 -0.622 . . . . 2.49 112.982 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HD3' HG12 ' A' ' 3' ' ' ILE . 15.2 mttp -65.03 -40.94 95.57 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.785 0.292 . . . . 5.67 111.33 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 HG21 ' A' ' 33' ' ' VAL . 2.4 tt -89.07 125.56 35.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.97 0.414 . . . . 1.68 111.306 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -131.64 143.68 50.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.572 -0.74 . . . . 1.54 110.143 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 HG13 HG13 ' A' ' 36' ' ' ILE . 8.1 mt -48.37 122.18 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.708 0.29 . . . . 2.56 111.148 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.51 -22.15 8.38 Favored Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.072 -0.513 . . . . 1.1 113.483 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -66.78 158.58 29.99 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 117.662 0.731 . . . . 1.56 110.6 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.896 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -112.1 147.76 35.38 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.541 0.686 . . . . 3.23 111.084 179.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.628 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -98.93 102.78 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.03 -0.987 . . . . 1.72 111.815 -179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.426 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 3.3 tt -64.98 -50.52 66.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.21 -0.905 . . . . 1.87 110.013 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -153.09 158.13 41.44 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.173 0.434 . . . . 0.67 112.173 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.858 ' O ' HG22 ' A' ' 60' ' ' VAL . 73.8 t -137.51 108.62 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.253 -0.431 . . . . 1.47 111.092 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 63.25 48.97 3.43 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.188 -0.46 . . . . 1.49 111.46 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 80.68 -14.96 0.79 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.133 0.79 . . . . 1.74 113.133 179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.858 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.4 m -93.34 146.72 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.87 0.305 . . . . 0.54 110.403 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.22 131.48 34.74 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.652 -0.419 . . . . 0.72 110.334 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.743 HD22 ' CG2' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -103.11 30.74 4.65 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 115.873 -0.603 . . . . 1.71 111.85 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -116.08 -18.71 10.56 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 48.92 1.68 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.859 0.362 . . . . 2.93 111.44 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.8 m -143.85 158.53 16.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 112.682 0.623 . . . . 0.8 112.682 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -71.28 -167.3 0.22 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.456 -0.793 . . . . 1.53 109.656 178.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.656 ' HB2' ' ND2' ' A' ' 22' ' ' ASN . 24.6 t60 -77.17 -38.77 51.04 Favored 'General case' 0 C--O 1.23 0.065 0 C-N-CA 119.795 -0.762 . . . . 0.54 110.687 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -51.05 -39.4 55.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.687 0.28 . . . . 2.9 110.337 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.67 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.1 mp0 -73.84 -38.29 64.57 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.8 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -63.83 -47.42 80.83 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.262 0.553 . . . . 0.44 110.748 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' B' ' 304' ' ' THR . 1.4 p -71.37 -41.51 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.174 -0.921 . . . . 0.52 111.973 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.5 m -69.03 -34.53 75.38 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 111.682 0.253 . . . . 0.61 111.682 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' CB ' HD11 ' A' ' 62' ' ' LEU . . . -66.36 -41.72 89.07 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 120.689 0.281 . . . . 0.41 110.493 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -72.89 -38.64 66.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.175 -0.676 . . . . 1.73 109.175 177.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -31.21 72.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.15 -0.932 . . . . 1.44 111.704 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -72.33 67.98 0.73 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.969 0.414 . . . . 1.55 111.666 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.641 HG22 ' HB ' ' A' ' 81' ' ' VAL . 2.9 p -124.03 131.03 53.51 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.046 -0.524 . . . . 2.6 111.072 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.0 m -116.14 -80.26 0.6 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 3.36 110.497 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -105.07 -48.68 3.66 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.919 -0.401 . . . . 2.23 109.919 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.424 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -130.0 165.15 22.75 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.106 -0.497 . . . . 1.77 110.509 179.344 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.641 ' HB ' HG22 ' A' ' 77' ' ' THR . 7.2 p -142.03 125.92 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.774 -0.454 . . . . 1.58 109.774 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -94.62 98.58 10.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.319 0.58 . . . . 1.72 110.247 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.501 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.0 tp -87.59 123.57 32.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.078 -0.965 . . . . 1.38 112.24 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -111.58 108.19 17.6 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.758 -0.656 . . . . 1.56 109.442 178.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 53' ' ' LYS . 41.5 t -103.85 133.64 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.418 -0.356 . . . . 1.92 111.335 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -87.65 146.11 25.86 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.102 -0.499 . . . . 1.46 111.27 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 2.4 mptt -93.59 125.79 52.4 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.089 -0.505 . . . . 4.2 110.868 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 87' ' ' LYS . 46.2 Cg_exo -56.17 142.36 86.81 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 2.28 112.584 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.9 p -144.91 162.5 36.7 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.388 -0.369 . . . . 3.88 111.049 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -175.88 127.69 1.28 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.832 -0.699 . . . . 4.69 112.842 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.1 m -76.29 -46.05 29.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.519 0.199 . . . . 7.06 110.945 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 . . . . . 0 N--CA 1.462 0.169 0 CA-C-N 116.378 -0.374 . . . . 7.84 110.846 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.818 0.342 . . . . 4.22 111.551 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.61 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 8.7 ttm180 -148.38 128.87 13.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.062 -0.517 . . . . 3.57 110.734 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.829 ' HB3' HG21 ' A' ' 34' ' ' THR . 7.2 mp0 -114.34 147.05 39.73 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 2.08 110.78 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.542 ' HB ' ' HE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -145.26 149.36 34.74 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.38 -0.373 . . . . 0.65 111.27 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -81.51 160.18 23.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.145 -0.48 . . . . 1.67 111.447 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.498 -0.763 . . . . 1.47 111.426 -179.647 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ptt? . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.816 0.341 . . . . 3.17 111.532 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.513 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 1.6 mp0 -77.7 145.05 36.83 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.149 -0.478 . . . . 1.97 110.526 179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 2' ' ' GLU . 11.3 mt -144.11 99.18 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.301 -0.409 . . . . 1.34 110.606 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' HG2' ' CD2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -95.08 148.92 21.84 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.122 -0.696 . . . . 2.93 109.122 178.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.7 OUTLIER -148.29 170.12 18.62 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.705 0.288 . . . . 2.09 110.708 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.0 tt -97.35 124.29 50.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.14 -0.482 . . . . 1.94 110.549 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -55.49 127.94 32.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.132 -0.485 . . . . 3.1 111.86 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.11 -149.88 26.05 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.729 -0.668 . . . . 1.78 112.073 179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -68.9 -78.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.63 2.22 . . . . 2.77 111.735 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -59.82 3.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.603 0.239 . . . . 4.92 110.918 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 140.16 -145.3 16.15 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.884 -0.674 . . . . 2.3 112.876 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -36.95 -62.35 0.49 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.804 0.442 . . . . 5.7 111.742 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 74.46 46.12 21.01 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.887 -0.673 . . . . 1.13 113.062 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CE1' HD12 ' A' ' 74' ' ' LEU . 15.3 p90 -163.97 -173.66 3.29 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.356 -0.239 . . . . 1.46 110.356 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.37 173.5 10.13 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.186 -0.302 . . . . 0.57 110.186 179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -159.31 173.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.268 0.556 . . . . 0.67 111.325 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.967 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.26 168.39 19.71 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.027 -1.471 . . . . 1.19 107.027 177.132 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.5 123.52 0.66 Allowed Glycine 0 C--O 1.226 -0.365 0 C-N-CA 118.315 -1.898 . . . . 1.29 115.51 179.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 106.85 160.84 21.89 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.341 -0.933 . . . . 1.61 113.941 177.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.8 145.33 14.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.564 -0.318 . . . . 2.72 110.632 179.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 -20.91 15.15 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.791 -0.719 . . . . 1.56 112.612 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' CG ' ' HB2' ' A' ' 67' ' ' HIS . 6.9 p30 -133.95 13.58 3.96 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.553 0.341 . . . . 1.63 110.506 179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -44.29 138.29 3.16 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 113.389 0.885 . . . . 2.34 113.389 -178.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.967 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 58.1 t60 -89.64 -24.9 21.53 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.493 -0.776 . . . . 0.92 111.31 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -148.0 127.06 6.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.563 -0.29 . . . . 1.51 110.98 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.73 125.6 18.51 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.845 2.363 . . . . 0.98 112.712 -179.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.87 -52.9 0.74 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 121.096 -0.573 . . . . 1.06 112.756 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.91 110.37 22.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.766 0.317 . . . . 1.68 111.193 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -85.65 18.99 2.58 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.196 -0.456 . . . . 2.11 111.586 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 71.2 m -71.48 -178.68 2.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.692 0.282 . . . . 1.39 110.744 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.74 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -97.71 116.72 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-O 120.962 0.41 . . . . 0.8 110.872 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 18.9 m-85 -114.22 142.35 46.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.974 -0.557 . . . . 1.38 111.821 -179.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG21 ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -78.31 126.81 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.214 -0.448 . . . . 0.65 110.348 178.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.782 HG21 ' HB3' ' B' ' 303' ' ' GLU . 14.3 t -100.99 -28.1 12.92 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.671 0.989 . . . . 1.39 113.671 -178.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.559 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 5.4 mmtt -156.05 118.55 4.12 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 117.959 0.345 . . . . 2.54 111.836 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 43' ' ' HIS . 6.0 mt -97.54 120.94 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.691 -0.231 . . . . 1.4 110.486 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.1 mp -76.85 145.01 10.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.48 -0.327 . . . . 1.68 110.785 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.82 149.4 31.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.344 -0.389 . . . . 3.11 111.503 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.2 21.18 38.58 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 115.798 -0.637 . . . . 3.15 113.54 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.9 171.87 36.33 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 121.056 -0.592 . . . . 2.8 112.995 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.95 -50.09 58.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.878 0.325 . . . . 3.0 111.878 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -73.24 -53.39 11.02 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.681 0.277 . . . . 1.82 110.941 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.5 t-80 -48.92 -44.79 40.66 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.946 -0.57 . . . . 1.39 111.829 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -74.07 -35.03 64.23 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.563 -0.289 . . . . 2.66 111.21 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.547 ' CG ' HD11 ' A' ' 5' ' ' LEU . 25.3 t0 -62.08 -51.87 66.19 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.431 -0.35 . . . . 3.24 110.872 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.71 -24.27 26.83 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.088 -0.577 . . . . 2.49 113.669 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -72.4 -36.37 68.64 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 117.256 0.528 . . . . 5.67 111.546 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' CD2' HG21 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -90.62 129.01 36.79 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.817 0.342 . . . . 1.68 111.236 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -134.18 142.8 47.56 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.011 -0.54 . . . . 1.54 110.479 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.71 122.44 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.635 0.255 . . . . 2.56 111.363 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 121.07 -19.97 8.64 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.077 -0.582 . . . . 1.1 113.561 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -68.72 161.23 28.76 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 118.01 0.905 . . . . 1.56 110.451 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.879 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.81 147.64 35.28 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.432 0.634 . . . . 3.23 110.971 179.678 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.705 HD22 ' CG2' ' A' ' 57' ' ' VAL . 1.8 mt -99.23 105.06 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.202 -0.908 . . . . 1.72 112.016 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 HD23 ' HE2' ' A' ' 84' ' ' LYS . 4.0 tp -70.43 -51.24 30.89 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.158 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.871 0.367 . . . . 0.67 111.963 179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.917 HG21 HD22 ' A' ' 62' ' ' LEU . 32.5 t -139.71 113.46 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.327 -0.397 . . . . 1.47 110.898 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 80.0 m-20 65.6 40.52 4.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.336 -0.393 . . . . 1.49 111.276 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.411 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 1.5 t30 84.88 -16.54 0.49 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.738 0.644 . . . . 1.74 112.738 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.89 HG22 ' O ' ' A' ' 57' ' ' VAL . 10.3 m -92.83 149.53 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 117.81 0.277 . . . . 0.54 110.758 179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.6 p -84.29 129.65 34.87 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.856 0.36 . . . . 0.72 110.48 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.917 HD22 HG21 ' A' ' 57' ' ' VAL . 3.0 tp -102.91 28.8 5.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.02 -0.536 . . . . 1.71 111.513 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 2.8 pt-20 -114.08 -18.26 11.73 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.331 0.493 . . . . 1.96 112.331 -179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -125.4 40.47 3.73 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.785 0.326 . . . . 2.93 111.672 -179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.2 m -135.11 159.23 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.927 0.394 . . . . 0.8 111.908 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -69.51 -170.63 0.3 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.773 -0.649 . . . . 1.53 110.113 179.121 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.568 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 19.8 t60 -75.17 -37.23 61.34 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.207 -0.597 . . . . 0.54 110.624 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -50.97 -46.28 61.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.659 0.266 . . . . 2.9 110.305 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.586 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.7 mp0 -67.99 -35.93 79.17 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.619 178.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.62 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -57.85 -44.28 86.46 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.93 178.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG13 HG12 ' B' ' 306' ' ' VAL . 41.4 t -80.34 -33.11 13.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.791 -0.641 . . . . 0.52 111.338 179.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -63.29 -38.57 91.69 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.568 -0.287 . . . . 0.61 111.163 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.645 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.92 -35.86 50.08 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.702 -0.227 . . . . 0.41 111.39 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.62 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -73.66 -31.41 63.47 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.933 0.397 . . . . 1.73 110.135 178.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HD2' HG12 ' A' ' 71' ' ' VAL . 8.5 ptmm? -84.08 -20.29 32.88 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.768 -0.651 . . . . 1.44 111.839 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -82.81 62.55 6.46 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.96 0.41 . . . . 1.55 111.108 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.3 p -121.71 127.48 50.78 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.218 -0.447 . . . . 2.6 111.303 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -106.71 -143.95 0.38 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.916 -0.583 . . . . 3.36 110.11 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -48.22 -49.4 33.18 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.572 0.169 . . . . 2.23 110.948 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.01 162.57 22.1 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.267 -0.271 . . . . 1.77 110.267 178.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.31 148.37 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.543 0.211 . . . . 1.58 110.998 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.545 ' CD2' ' HG2' ' A' ' 4' ' ' LYS . 21.5 t80 -127.11 98.31 5.26 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.285 0.564 . . . . 1.72 110.142 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' CG ' HD21 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -92.8 139.3 30.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.205 -0.907 . . . . 1.38 111.879 -178.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.513 ' HE3' ' HG3' ' A' ' 2' ' ' GLU . 1.9 mtpt -118.12 117.42 29.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.974 -0.557 . . . . 1.56 109.957 178.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.879 HG13 ' O ' ' A' ' 53' ' ' LYS . 60.4 t -105.5 139.73 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 1.92 111.109 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.678 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.85 138.08 32.77 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.156 -0.475 . . . . 1.46 110.886 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.03 108.43 60.58 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.249 -0.432 . . . . 4.2 111.039 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 143.01 43.36 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.785 2.323 . . . . 2.28 112.352 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.3 m -140.64 -69.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.424 -0.353 . . . . 3.88 110.896 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.43 98.62 0.18 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.92 -0.657 . . . . 4.69 112.674 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.8 p -76.15 -40.36 52.82 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.469 0.176 . . . . 7.06 111.263 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 . . . . . 0 N--CA 1.464 0.248 0 CA-C-N 116.426 -0.352 . . . . 7.84 111.044 -179.888 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . 0.558 ' HA ' ' HA ' ' A' ' 22' ' ' ASN . 5.7 ptm180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.69 0.281 . . . . 4.22 111.465 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.1 157.76 44.23 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.112 -0.495 . . . . 3.57 110.968 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.782 ' HB3' HG21 ' A' ' 34' ' ' THR . 1.2 mp0 -132.96 143.2 49.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.12 -0.491 . . . . 2.08 111.035 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.45 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -133.6 146.48 50.99 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.193 -0.458 . . . . 0.65 111.212 -179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 24.6 mt-30 -74.58 153.12 39.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.054 -0.521 . . . . 1.67 111.23 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.643 HG12 HG13 ' A' ' 71' ' ' VAL . 12.4 m . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.585 -0.721 . . . . 1.47 111.63 -179.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.707 0.289 . . . . 3.17 111.42 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.499 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.5 OUTLIER -106.68 148.48 28.33 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.239 -0.437 . . . . 1.97 110.897 179.724 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -143.75 95.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 116.19 -0.459 . . . . 1.34 110.455 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -94.06 142.81 26.97 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.54 -0.541 . . . . 2.93 109.54 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -150.69 171.06 17.74 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 110.236 -0.283 . . . . 2.09 110.236 -179.68 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 tt -89.96 139.28 17.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.747 -0.464 . . . . 1.94 109.747 178.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.38 134.49 44.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.793 0.33 . . . . 3.1 111.633 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -110.3 168.61 13.11 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.866 -0.606 . . . . 1.78 112.447 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.57 79.57 1.84 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.083 2.522 . . . . 2.77 112.498 -179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -173.94 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.001 -0.545 . . . . 4.92 110.837 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 173.16 -175.0 46.1 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.925 -0.655 . . . . 2.3 112.78 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 1.1 mt -71.59 -38.17 70.91 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.604 0.224 . . . . 5.7 111.604 -179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 90.33 27.58 20.01 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.947 -0.644 . . . . 1.13 113.668 179.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.5 p90 -157.8 -176.76 6.11 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.408 0.604 . . . . 1.46 111.133 179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 35' ' ' LYS . 2.0 p -125.66 172.43 9.78 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.506 -0.315 . . . . 0.57 110.476 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.427 ' HB ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -156.15 168.88 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.89 0.376 . . . . 0.67 111.289 179.757 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.067 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.64 165.22 26.06 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 107.174 -1.417 . . . . 1.19 107.174 177.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.016 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 166.08 132.26 1.36 Allowed Glycine 0 C--O 1.225 -0.439 0 C-N-CA 117.455 -2.307 . . . . 1.29 116.291 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.4 155.73 22.31 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.616 -0.802 . . . . 1.61 112.998 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.0 t -64.23 139.82 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 110.506 -0.183 . . . . 2.72 110.506 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.45 -16.28 40.84 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.961 -0.638 . . . . 1.56 112.703 -179.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.588 ' HB3' ' HG2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.71 24.25 1.89 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.274 0.629 . . . . 1.63 110.493 179.466 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 35.1 mt-30 -62.42 152.3 34.64 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.027 0.751 . . . . 2.34 113.027 -178.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.067 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 75.7 t60 -89.63 -28.75 19.3 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.181 -0.918 . . . . 0.92 110.868 179.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.9 mt -146.51 124.57 6.18 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 116.226 -0.443 . . . . 1.51 110.761 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.47 129.93 27.9 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.935 2.423 . . . . 0.98 112.473 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.25 -55.44 0.85 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.008 -0.615 . . . . 1.06 112.286 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.9 106.75 18.7 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.884 0.373 . . . . 1.68 110.945 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -85.57 18.63 2.71 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.928 -0.578 . . . . 2.11 112.06 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.0 m -85.97 158.23 19.94 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.848 -0.427 . . . . 1.39 109.848 178.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.016 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.3 mm -74.66 126.87 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 112.39 0.515 . . . . 0.8 112.39 -177.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 27.2 m-85 -122.49 150.55 42.38 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.154 -0.476 . . . . 1.38 110.528 179.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 48' ' ' LEU . 74.9 t -81.66 118.46 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.917 0.389 . . . . 0.65 110.483 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.963 HG21 ' HB3' ' B' ' 303' ' ' GLU . 8.0 t -89.95 -23.64 21.51 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.503 0.927 . . . . 1.39 113.503 -178.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 9.1 mttt -163.38 127.26 2.82 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 117.86 0.3 . . . . 2.54 111.588 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.513 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 3.9 mt -106.7 128.26 61.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.726 0.298 . . . . 1.4 110.965 179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.2 mp -83.19 150.22 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.168 -0.469 . . . . 1.68 110.788 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.69 150.0 28.98 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.336 -0.393 . . . . 3.11 111.118 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.86 18.71 11.98 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 116.063 -0.517 . . . . 3.15 114.048 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.6 169.48 45.08 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.901 -0.666 . . . . 2.8 112.726 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.4 23.99 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 111.598 0.221 . . . . 3.0 111.598 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.8 -52.35 31.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.423 -0.353 . . . . 1.82 111.121 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.513 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 59.0 t-80 -52.12 -41.66 62.67 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.077 -0.511 . . . . 1.39 112.11 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -77.16 -38.75 51.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.518 -0.31 . . . . 2.66 111.559 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.9 t0 -64.82 -55.7 18.0 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.585 -0.28 . . . . 3.24 111.021 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.61 -32.52 7.46 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.016 -0.612 . . . . 2.49 113.185 179.67 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -59.58 -43.68 93.57 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.815 0.308 . . . . 5.67 111.135 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 33' ' ' VAL . 1.7 tt -90.36 126.68 35.95 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.605 -0.271 . . . . 1.68 110.689 179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' ILE . 1.6 pm0 -144.42 147.02 32.83 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 116.36 -0.382 . . . . 1.54 110.279 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 49' ' ' GLN . 2.7 mp -36.76 135.65 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.419 0.152 . . . . 2.56 110.887 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.83 -14.09 53.01 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.727 -0.749 . . . . 1.1 113.461 -179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.563 ' HB2' HG11 ' A' ' 85' ' ' VAL . 3.3 p30 -80.29 148.63 30.65 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 117.741 0.77 . . . . 1.56 111.149 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.829 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -106.44 148.09 28.55 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.718 -0.674 . . . . 3.23 110.395 178.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -95.15 104.63 16.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.6 -0.727 . . . . 1.72 111.95 -178.787 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.48 -53.11 31.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.429 -0.805 . . . . 1.87 110.019 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -160.96 162.76 32.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.054 0.391 . . . . 0.67 112.054 179.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.731 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -150.68 118.13 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.43 -0.35 . . . . 1.47 110.93 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 56.2 67.12 1.05 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.142 0.496 . . . . 1.49 110.57 -179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.48 -21.15 0.09 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.506 1.299 . . . . 1.74 114.506 178.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 57' ' ' VAL . 36.0 m -95.32 140.1 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 118.927 0.785 . . . . 0.54 112.148 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.4 p -82.39 136.17 35.02 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.374 -0.602 . . . . 0.72 109.374 178.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.756 HD22 HD22 ' A' ' 54' ' ' LEU . 1.3 tp -103.01 22.45 13.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.488 -0.324 . . . . 1.71 111.731 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -100.15 -24.13 14.66 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.592 0.59 . . . . 1.96 112.592 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.61 62.09 1.48 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.01 0.433 . . . . 2.93 111.333 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 9.4 m -149.64 152.12 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.999 -0.546 . . . . 0.8 112.307 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.8 p -63.92 165.64 8.5 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.435 -0.802 . . . . 1.53 109.795 178.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.1 t60 -55.86 -38.35 70.0 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.413 -0.515 . . . . 0.54 111.388 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -52.94 -43.52 66.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.48 0.181 . . . . 2.9 110.627 179.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.615 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -63.93 -36.09 82.82 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.413 -0.358 . . . . 1.84 110.952 179.297 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.676 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.8 -41.9 92.21 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.105 0.479 . . . . 0.44 110.52 178.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 HG12 ' B' ' 306' ' ' VAL . 51.4 t -80.72 -37.72 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.585 -0.734 . . . . 0.52 111.185 179.444 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 46.5 m -63.78 -33.44 75.67 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.419 -0.355 . . . . 0.61 111.298 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.71 -36.58 37.28 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.637 -0.256 . . . . 0.41 110.945 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.676 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.5 mm? -72.81 -33.91 66.53 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.411 . . . . 1.73 110.102 178.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -80.11 -24.26 40.64 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.654 -0.703 . . . . 1.44 111.82 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -82.41 66.62 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.056 0.455 . . . . 1.55 110.662 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 81' ' ' VAL . 22.4 p -125.01 133.63 52.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.963 -0.562 . . . . 2.6 111.476 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.23 -147.59 0.39 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.788 -0.642 . . . . 3.36 109.982 179.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -48.6 -49.93 34.78 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.427 0.156 . . . . 2.23 110.717 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -120.1 157.97 27.85 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 110.111 -0.329 . . . . 1.77 110.111 178.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.424 ' CG2' HG22 ' A' ' 77' ' ' THR . 4.2 p -142.18 123.75 12.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.456 0.17 . . . . 1.58 110.993 179.569 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -99.58 98.51 9.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.214 0.53 . . . . 1.72 110.031 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -91.08 139.02 31.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.215 -0.902 . . . . 1.38 112.007 -178.375 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 2' ' ' GLU . 0.2 OUTLIER -119.05 113.8 21.51 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.811 -0.631 . . . . 1.56 110.563 179.379 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.829 HG13 ' O ' ' A' ' 53' ' ' LYS . 22.6 t -119.93 130.82 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.141 -0.481 . . . . 1.92 110.366 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -84.88 150.34 25.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.411 -0.359 . . . . 1.46 111.019 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -100.68 119.99 57.06 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.308 -0.405 . . . . 4.2 110.959 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.479 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 58.9 Cg_endo -71.11 131.19 18.88 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.727 2.285 . . . . 2.28 112.214 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -129.19 -64.06 0.92 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.69 -0.232 . . . . 3.88 110.876 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.37 119.59 2.73 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 121.013 -0.613 . . . . 4.69 112.455 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 62.6 m -69.58 -48.32 60.61 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.482 0.182 . . . . 7.06 111.144 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.334 -0.102 0 CA-C-O 120.812 0.339 . . . . 7.84 110.928 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 78.7 mtm-85 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.742 0.306 . . . . 4.22 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.588 ' HG2' ' HB3' ' A' ' 22' ' ' ASN . 4.8 ptp180 -95.44 143.43 26.78 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.392 -0.367 . . . . 3.57 110.908 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.963 ' HB3' HG21 ' A' ' 34' ' ' THR . 9.8 mp0 -124.96 127.63 47.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.965 -0.561 . . . . 2.08 110.448 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.476 HG21 HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -123.64 146.47 48.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.329 -0.396 . . . . 0.65 111.486 -179.318 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 19.7 mt-30 -82.29 151.88 26.57 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.948 -0.569 . . . . 1.67 110.786 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.622 HG12 HG13 ' A' ' 71' ' ' VAL . 16.0 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.668 -0.682 . . . . 1.47 111.654 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.953 0.406 . . . . 3.17 111.186 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 143.78 37.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.039 -0.528 . . . . 1.97 111.045 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 87.7 mt -144.3 95.89 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.156 -0.475 . . . . 1.34 110.465 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 149.8 23.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 2.93 110.281 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.504 HD11 ' CG ' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -149.49 170.51 18.43 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.644 0.259 . . . . 2.09 110.331 -179.786 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 tt -94.42 126.11 46.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.529 -0.305 . . . . 1.94 110.798 179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -60.82 125.36 23.43 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.298 -0.41 . . . . 3.1 111.288 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.4 179.79 29.54 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.878 -0.601 . . . . 1.78 112.396 179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.13 46.1 2.15 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.284 2.656 . . . . 2.77 112.74 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.0 tttt -150.95 -60.09 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.573 -0.285 . . . . 4.92 110.894 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 145.16 -135.46 6.04 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.199 -0.524 . . . . 2.3 112.328 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD11 ' O ' ' A' ' 74' ' ' LEU . 2.9 mp -86.41 -54.2 4.56 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.116 -0.327 . . . . 5.7 110.116 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 88.13 31.68 13.92 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.018 -0.611 . . . . 1.13 113.79 179.145 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 74' ' ' LEU . 9.5 p90 -157.17 -177.03 6.3 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.274 0.537 . . . . 1.46 111.14 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.9 OUTLIER -121.99 170.5 9.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.685 -0.487 . . . . 0.57 109.685 179.29 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.472 HD11 HG22 ' A' ' 71' ' ' VAL . 1.0 OUTLIER -157.88 166.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.06 0.457 . . . . 0.67 111.778 -178.357 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.13 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -138.83 167.67 21.51 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.569 -1.271 . . . . 1.19 107.569 177.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.31 132.51 1.37 Allowed Glycine 0 C--O 1.225 -0.464 0 C-N-CA 117.935 -2.079 . . . . 1.29 115.938 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 102.99 159.17 25.41 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.492 -0.861 . . . . 1.61 113.948 177.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.08 140.13 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 120.705 0.288 . . . . 2.72 110.975 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.45 -20.77 10.07 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.018 -0.61 . . . . 1.56 112.819 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.53 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.31 18.77 3.68 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.167 0.587 . . . . 1.63 110.641 179.192 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 67.0 mt-30 -57.05 147.56 24.0 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.012 0.745 . . . . 2.34 113.012 -178.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.13 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 71.9 t60 -89.01 -23.21 22.66 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.725 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.22 140.63 14.39 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-O 120.653 0.263 . . . . 1.51 111.017 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 127.09 17.14 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.669 2.246 . . . . 0.98 112.243 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.58 -18.87 56.6 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.835 -0.698 . . . . 1.06 113.468 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.19 113.02 13.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 117.431 0.615 . . . . 1.68 110.859 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.71 16.63 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.189 -0.46 . . . . 2.11 111.895 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.559 ' C ' HD13 ' A' ' 31' ' ' ILE . 68.8 m -71.5 -179.0 2.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.672 0.272 . . . . 1.39 110.776 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.2 mm -98.01 110.87 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.988 0.423 . . . . 0.8 111.0 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.691 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.2 m-85 -109.96 143.12 40.37 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.066 -0.516 . . . . 1.38 112.274 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 48' ' ' LEU . 77.7 t -80.4 119.43 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 116.028 -0.533 . . . . 0.65 109.881 178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.903 HG21 ' HB2' ' B' ' 303' ' ' GLU . 14.1 t -89.91 -23.05 21.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.632 0.975 . . . . 1.39 113.632 -178.092 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -164.43 127.37 2.41 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.022 0.374 . . . . 2.54 111.75 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.485 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 20.5 mt -101.65 124.82 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 120.614 0.245 . . . . 1.4 110.609 179.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.8 mp -78.99 147.21 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.344 -0.389 . . . . 1.68 110.869 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -59.38 148.66 31.71 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.332 -0.395 . . . . 3.11 111.184 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.27 20.54 29.42 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.953 -0.567 . . . . 3.15 113.683 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 171.28 38.24 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.99 -0.624 . . . . 2.8 112.793 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -54.29 17.9 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.75 0.278 . . . . 3.0 111.75 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.509 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.91 -51.66 37.57 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.557 -0.292 . . . . 1.82 110.828 179.727 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 60.3 t-80 -49.53 -44.64 46.58 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.047 -0.524 . . . . 1.39 111.944 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 mttt -74.76 -36.18 62.59 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.484 -0.325 . . . . 2.66 111.105 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.504 ' CG ' HD11 ' A' ' 5' ' ' LEU . 28.4 t70 -64.05 -53.41 50.22 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.455 -0.339 . . . . 3.24 111.093 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.67 18.99 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.07 -0.586 . . . . 2.49 113.073 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -40.8 88.99 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.717 0.259 . . . . 5.67 111.661 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD21 HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -90.14 125.87 35.6 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.93 0.395 . . . . 1.68 111.278 -179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -128.25 140.42 51.9 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.806 -0.634 . . . . 1.54 110.312 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.46 122.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.79 0.329 . . . . 2.56 111.492 -179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.92 -18.47 9.06 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-O 119.717 -0.491 . . . . 1.1 113.217 -179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -71.13 163.2 28.09 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 117.634 0.717 . . . . 1.56 110.323 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.892 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -113.21 147.81 36.73 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 121.451 0.644 . . . . 3.23 110.824 179.097 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.873 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.9 OUTLIER -98.01 105.17 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.01 -0.996 . . . . 1.72 111.836 -178.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.79 -50.34 57.53 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.247 -0.888 . . . . 1.87 110.47 179.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -154.95 157.61 37.97 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.156 0.428 . . . . 0.67 112.156 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.893 ' O ' HG22 ' A' ' 60' ' ' VAL . 91.9 t -142.28 116.84 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.511 -0.313 . . . . 1.47 110.993 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 85.0 m-20 63.64 38.26 9.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.421 -0.354 . . . . 1.49 111.392 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.0 t30 86.6 -16.61 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.86 0.689 . . . . 1.74 112.86 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG22 ' O ' ' A' ' 57' ' ' VAL . 14.9 m -91.92 147.04 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 117.896 0.317 . . . . 0.54 110.697 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 29.4 p -82.29 131.45 35.23 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.007 0.432 . . . . 0.72 110.638 179.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.721 ' CD2' HD13 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -102.56 26.36 8.01 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.751 -0.658 . . . . 1.71 111.56 179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -117.44 -18.03 9.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.242 0.46 . . . . 1.96 112.242 -179.507 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.74 38.35 4.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.78 0.324 . . . . 2.93 111.187 179.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 11.7 m -135.48 160.36 40.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.029 0.442 . . . . 0.8 112.048 -179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -72.01 168.1 18.76 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.603 -0.726 . . . . 1.53 110.35 179.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 22.3 t60 -55.26 -39.09 69.38 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 120.653 -0.419 . . . . 0.54 111.075 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -50.72 -47.1 59.26 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.544 0.211 . . . . 2.9 110.893 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 mm-40 -63.17 -35.48 80.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.265 -0.425 . . . . 1.84 111.267 179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.659 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.69 -42.29 88.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.029 0.442 . . . . 0.44 111.044 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG13 HG12 ' B' ' 306' ' ' VAL . 47.8 t -80.78 -34.51 14.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.836 -0.62 . . . . 0.52 111.246 179.387 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.431 ' HA ' ' CD ' ' A' ' 75' ' ' LYS . 61.0 m -63.37 -37.17 86.24 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.483 -0.326 . . . . 0.61 111.528 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -79.66 -36.33 37.91 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 111.57 0.211 . . . . 0.41 111.57 -179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -72.69 -30.47 64.26 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.819 0.342 . . . . 1.73 110.165 178.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HD2' HG12 ' A' ' 71' ' ' VAL . 0.1 OUTLIER -85.11 -20.55 30.15 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.813 -0.63 . . . . 1.44 112.04 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -76.84 66.49 2.73 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.869 0.366 . . . . 1.55 111.502 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.5 p -129.24 148.51 51.18 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.225 -0.443 . . . . 2.6 111.186 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -134.75 -74.53 0.47 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.149 -0.478 . . . . 3.36 110.937 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.15 -57.52 2.14 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.733 0.301 . . . . 2.23 110.2 179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.95 162.63 25.51 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.007 -0.542 . . . . 1.77 110.211 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 81' ' ' VAL . 7.2 p -141.92 119.97 8.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.764 -0.198 . . . . 1.58 110.624 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -98.95 98.41 9.47 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.28 0.562 . . . . 1.72 110.533 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.873 ' HG ' HD21 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -88.55 140.35 29.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.14 -0.936 . . . . 1.38 111.794 -178.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.2 110.75 17.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.976 -0.556 . . . . 1.56 110.274 179.415 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.892 HG13 ' O ' ' A' ' 53' ' ' LYS . 88.0 t -104.21 135.83 40.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.291 -0.413 . . . . 1.92 110.902 -179.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' HB3' ' HG3' ' A' ' 53' ' ' LYS . . . -88.35 144.91 26.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.365 -0.38 . . . . 1.46 111.242 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -110.46 121.04 42.45 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.236 -0.438 . . . . 4.2 110.947 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB3' ' HE2' ' A' ' 53' ' ' LYS . 57.1 Cg_endo -71.17 147.73 54.49 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.622 2.214 . . . . 2.28 112.512 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -142.03 -72.84 0.32 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.196 -0.456 . . . . 3.88 110.689 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.93 129.87 4.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.037 -0.602 . . . . 4.69 112.578 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.02 -43.79 8.73 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.459 0.171 . . . . 7.06 110.93 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 120.93 0.395 . . . . 7.84 111.229 179.893 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.653 0.263 . . . . 4.22 110.994 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.53 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 25.3 ttm180 -145.66 120.98 10.25 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 3.57 111.037 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HB2' HG21 ' A' ' 34' ' ' THR . 1.4 pm0 -126.91 96.82 4.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.077 -0.511 . . . . 2.08 110.519 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.473 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -90.54 149.15 22.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.645 -0.707 . . . . 0.65 111.168 -179.562 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 6.0 mt-30 -85.06 142.75 29.34 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.265 -0.425 . . . . 1.67 110.396 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.493 HG12 HG13 ' A' ' 71' ' ' VAL . 17.8 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.612 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.621 0.248 . . . . 3.17 111.153 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -125.17 114.95 19.69 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.307 0.575 . . . . 1.97 111.335 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 83' ' ' LEU . 33.0 mt -96.64 95.94 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.203 -0.908 . . . . 1.34 110.967 -179.095 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 92.28 8.79 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.715 -0.675 . . . . 2.93 110.505 179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 41' ' ' ALA . 11.2 mt -87.75 146.27 25.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.228 -0.896 . . . . 2.09 112.453 -177.378 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.627 HG13 ' CE1' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -86.52 154.27 3.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 114.751 -1.113 . . . . 1.94 109.89 -178.367 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -112.94 120.14 40.39 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.816 0.341 . . . . 3.1 111.215 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.07 -163.97 11.76 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.17 -0.538 . . . . 1.78 112.823 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.04 -38.17 95.16 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.982 2.454 . . . . 2.77 112.495 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.96 -60.02 2.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.472 -0.331 . . . . 4.92 110.283 179.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.77 -110.96 1.74 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.006 -0.616 . . . . 2.3 112.657 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 HD12 ' A' ' 74' ' ' LEU . 8.4 mp -87.4 -52.1 5.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.591 0.234 . . . . 5.7 110.869 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.66 36.33 23.13 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.163 -0.541 . . . . 1.13 113.527 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 25.2 p90 -161.51 -174.26 4.17 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.94 0.37 . . . . 1.46 110.448 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.4 p -131.13 171.51 13.19 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.965 -0.383 . . . . 0.57 109.965 179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -155.41 170.31 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.039 0.447 . . . . 0.67 111.419 179.76 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.033 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.59 165.15 25.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.516 -1.291 . . . . 1.19 107.516 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.58 128.5 0.97 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.313 -1.899 . . . . 1.29 115.318 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.5 157.85 19.09 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 120.362 -0.923 . . . . 1.61 113.516 177.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.18 141.06 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 110.53 -0.174 . . . . 2.72 110.53 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.98 -18.66 12.01 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.985 -0.626 . . . . 1.56 112.934 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.507 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -139.36 23.68 2.52 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.068 0.547 . . . . 1.63 110.04 179.331 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -67.86 153.16 44.31 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.392 0.615 . . . . 2.34 112.635 -178.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.033 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 60.6 t60 -89.74 -25.67 21.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.915 -1.039 . . . . 0.92 112.11 -179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 32' ' ' TYR . 6.8 mt -149.09 129.06 6.56 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-O 120.649 0.261 . . . . 1.51 111.368 -179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.04 128.84 27.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.882 2.388 . . . . 0.98 112.093 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.67 -48.06 0.98 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.08 -0.581 . . . . 1.06 112.189 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.01 112.0 19.02 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.75 0.309 . . . . 1.68 110.907 179.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -80.74 25.05 0.45 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.077 -0.51 . . . . 2.11 112.135 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.21 -179.09 1.47 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.367 -0.234 . . . . 1.39 110.367 179.19 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.677 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -102.53 119.47 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.599 -0.441 . . . . 0.8 110.708 178.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 11.6 m-85 -117.16 147.91 42.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.845 -0.616 . . . . 1.38 111.439 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.979 HG21 HD21 ' A' ' 48' ' ' LEU . 41.7 t -78.43 127.67 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.661 -0.496 . . . . 0.65 109.661 178.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.787 HG21 ' HB3' ' B' ' 303' ' ' GLU . 2.7 p -99.06 -28.04 13.57 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.139 0.792 . . . . 1.39 113.139 -178.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 23.2 ttpt -163.29 123.12 2.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 111.793 0.294 . . . . 2.54 111.793 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.557 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.7 mt -100.7 122.06 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.511 -0.313 . . . . 1.4 110.814 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -74.3 147.24 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.238 -0.437 . . . . 1.68 110.765 179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.93 145.71 52.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.352 -0.385 . . . . 3.11 110.775 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.05 17.73 55.98 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.278 -0.487 . . . . 3.15 113.513 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.94 166.91 34.21 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 120.978 -0.63 . . . . 2.8 112.85 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -46.91 -55.59 7.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.91 0.337 . . . . 3.0 111.91 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -66.71 -49.7 65.22 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.647 -0.251 . . . . 1.82 111.218 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.1 t-80 -51.15 -48.35 61.86 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.244 -0.434 . . . . 1.39 111.593 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -68.16 -37.55 81.13 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.315 -0.402 . . . . 2.66 111.282 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -62.9 -52.7 62.07 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.452 -0.34 . . . . 3.24 111.001 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.6 -27.63 13.5 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.044 -0.598 . . . . 2.49 113.131 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -64.01 -42.79 97.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.756 0.278 . . . . 5.67 111.19 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD21 HG21 ' A' ' 33' ' ' VAL . 2.8 tt -86.05 123.95 31.93 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.971 0.415 . . . . 1.68 111.323 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.83 145.08 50.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.679 -0.691 . . . . 1.54 110.245 179.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -47.06 122.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.782 0.325 . . . . 2.56 111.673 -179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.52 -22.62 8.23 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 116.068 -0.515 . . . . 1.1 113.239 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -66.94 155.1 39.4 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 117.678 0.739 . . . . 1.56 110.243 179.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.984 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -109.51 147.35 33.06 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 121.404 0.621 . . . . 3.23 110.816 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.812 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.3 OUTLIER -96.44 109.68 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.303 -0.862 . . . . 1.72 112.56 -178.183 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.853 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.3 tt -72.02 -54.12 10.87 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.047 -0.979 . . . . 1.87 109.781 178.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 153.61 34.45 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.321 0.489 . . . . 0.67 112.321 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.892 ' CG2' HD22 ' A' ' 62' ' ' LEU . 40.9 t -134.9 108.26 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.171 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.9 m120 64.14 47.42 3.28 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.231 -0.441 . . . . 1.49 111.3 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 82.28 -16.77 0.58 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.231 0.826 . . . . 1.74 113.231 179.298 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.872 HG22 ' O ' ' A' ' 57' ' ' VAL . 11.7 m -94.39 149.25 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 118.141 0.428 . . . . 0.54 110.761 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 32.0 p -83.66 134.12 34.79 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.849 -0.34 . . . . 0.72 110.199 179.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.892 HD22 ' CG2' ' A' ' 57' ' ' VAL . 6.1 tp -102.86 31.59 4.1 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.223 0.453 . . . . 1.71 112.223 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 17.2 tt0 -120.81 -19.71 7.23 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.319 0.489 . . . . 1.96 112.319 -179.334 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.6 44.2 2.07 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.82 0.343 . . . . 2.93 111.455 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 18.5 m -143.3 155.72 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.55 0.574 . . . . 0.8 112.55 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -67.77 -170.55 0.16 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.268 -0.878 . . . . 1.53 109.688 178.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 16.9 t60 -73.47 -40.67 63.96 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.038 -0.665 . . . . 0.54 110.591 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -48.72 -52.13 25.21 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 110.115 -0.328 . . . . 2.9 110.115 179.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 0.2 OUTLIER -62.78 -33.97 76.27 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.982 -0.554 . . . . 1.84 110.978 179.09 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.666 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.84 -43.87 97.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.097 0.475 . . . . 0.44 110.71 178.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.735 HG13 HG12 ' B' ' 306' ' ' VAL . 38.7 t -80.12 -37.55 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-N 115.649 -0.705 . . . . 0.52 111.091 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.659 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 62.2 m -62.54 -35.24 78.82 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.447 -0.342 . . . . 0.61 111.125 179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 57' ' ' VAL . . . -77.76 -37.24 49.52 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.516 -0.311 . . . . 0.41 111.144 -179.601 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 70' ' ' ALA . 3.9 mm? -71.07 -35.65 71.97 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.138 0.495 . . . . 1.73 109.746 178.373 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 6.5 ptpt -79.89 -22.09 43.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.299 -0.864 . . . . 1.44 112.027 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 72' ' ' THR . 9.8 t30 -69.79 68.87 0.28 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.059 0.457 . . . . 1.55 111.262 -179.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.698 ' CG2' HG22 ' A' ' 81' ' ' VAL . 30.2 p -128.94 147.25 50.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.97 -0.559 . . . . 2.6 111.446 -179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 p -121.53 -79.64 0.61 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.89 -0.596 . . . . 3.36 110.241 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.71 -41.07 6.04 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.395 -0.366 . . . . 2.23 110.287 179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.627 ' CE1' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -129.58 175.02 9.13 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.954 -0.567 . . . . 1.77 110.981 179.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG22 ' CG2' ' A' ' 77' ' ' THR . 89.5 t -141.31 119.81 9.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 116.367 -0.379 . . . . 1.58 110.072 -179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -101.71 98.81 9.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.311 0.577 . . . . 1.72 110.272 179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.812 ' HG ' HD21 ' A' ' 54' ' ' LEU . 1.3 tt -96.59 125.79 41.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.099 -0.955 . . . . 1.38 112.012 -178.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.5 mmmm -110.79 123.44 50.07 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.723 -0.671 . . . . 1.56 110.222 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.984 HG13 ' O ' ' A' ' 53' ' ' LYS . 63.2 t -113.75 130.64 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.564 -0.289 . . . . 1.92 111.491 -179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.853 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -98.51 94.96 6.98 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.152 -0.476 . . . . 1.46 111.373 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -68.97 128.51 92.75 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.382 -0.372 . . . . 4.2 110.729 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HE2' ' A' ' 53' ' ' LYS . 70.3 Cg_endo -71.41 155.64 59.68 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.034 2.489 . . . . 2.28 112.778 -179.491 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.562 HG23 ' H ' ' A' ' 90' ' ' GLY . 0.1 OUTLIER -141.25 -69.87 0.37 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.127 -0.488 . . . . 3.88 110.895 179.684 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.562 ' H ' HG23 ' A' ' 89' ' ' THR . . . -175.28 73.71 0.08 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 120.813 -0.708 . . . . 4.69 112.582 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -72.46 -35.84 68.36 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.499 0.185 . . . . 7.06 111.499 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 50.4 m170 . . . . . 0 N--CA 1.464 0.235 0 CA-C-O 120.816 0.341 . . . . 7.84 110.928 -179.872 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.781 0.324 . . . . 4.22 111.041 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.507 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 19.6 ttm-85 -126.79 128.9 47.32 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.228 -0.442 . . . . 3.57 110.916 -179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.787 ' HB3' HG21 ' A' ' 34' ' ' THR . 25.3 mt-10 -128.23 114.09 16.51 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.949 -0.568 . . . . 2.08 110.524 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.445 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -117.41 146.39 43.47 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.296 -0.411 . . . . 0.65 111.189 -179.633 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 13.5 mt-30 -79.22 150.86 31.5 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.025 -0.534 . . . . 1.67 110.819 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.735 HG12 HG13 ' A' ' 71' ' ' VAL . 15.5 m . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.556 -0.735 . . . . 1.47 111.839 -179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 120.504 0.192 . . . . 3.17 111.362 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.08 157.13 35.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.391 -0.368 . . . . 1.97 111.081 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.3 mp -147.11 125.84 4.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 109.654 -0.499 . . . . 1.34 109.654 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 91.68 8.61 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.101 0.477 . . . . 2.93 111.236 -179.432 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tp -88.46 134.15 33.93 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.432 -0.804 . . . . 2.09 111.589 -178.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.524 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 1.8 mt -89.05 116.12 30.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.67 -0.696 . . . . 1.94 110.185 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.509 ' HD3' ' HA ' ' A' ' 77' ' ' THR . 0.9 OUTLIER -68.09 118.64 11.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.443 -0.344 . . . . 3.1 111.167 -179.504 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.97 -173.63 40.84 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 121.078 -0.582 . . . . 1.78 112.623 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.5 -57.8 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.906 2.404 . . . . 2.77 112.481 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.46 -96.11 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.338 -0.392 . . . . 4.92 111.109 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.52 -140.5 3.08 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 120.232 -0.985 . . . . 2.3 113.686 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.616 ' HB3' ' CE2' ' A' ' 14' ' ' PHE . 4.1 mm? -83.99 -44.83 13.76 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.783 -0.208 . . . . 5.7 111.181 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.33 40.15 34.26 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.984 -0.627 . . . . 1.13 113.704 179.444 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.616 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 12.4 p90 -160.56 -174.29 4.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.92 0.36 . . . . 1.46 110.235 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.632 ' HB3' ' HG3' ' B' ' 305' ' ' GLN . 1.5 p -131.16 168.95 16.6 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.083 -0.34 . . . . 0.57 110.083 179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.426 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.28 170.73 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.917 0.389 . . . . 0.67 111.251 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.097 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -134.91 165.61 24.91 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.269 -1.382 . . . . 1.19 107.269 177.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.63 0.98 Allowed Glycine 0 C--O 1.228 -0.279 0 C-N-CA 118.247 -1.93 . . . . 1.29 115.386 179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 109.3 154.74 15.91 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.439 -0.886 . . . . 1.61 112.957 178.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.5 143.68 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 110.218 -0.29 . . . . 2.72 110.218 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.61 -16.98 22.58 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.887 -0.673 . . . . 1.56 112.875 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -142.08 26.39 1.85 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.301 0.641 . . . . 1.63 109.922 179.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 18.6 mt-30 -64.27 150.38 46.13 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.756 0.65 . . . . 2.34 112.756 -178.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.097 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 66.3 t60 -89.51 -26.89 20.65 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.181 -0.918 . . . . 0.92 111.203 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.509 HD12 ' CE2' ' A' ' 32' ' ' TYR . 7.7 mt -147.41 128.73 7.22 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.445 . . . . 1.51 110.563 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.47 127.64 26.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.671 2.247 . . . . 0.98 112.253 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.1 -55.01 0.54 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.046 -0.597 . . . . 1.06 112.691 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.93 113.78 26.1 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.873 0.368 . . . . 1.68 111.345 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.62 16.9 2.95 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.85 -0.614 . . . . 2.11 112.001 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.708 ' HB3' ' HG2' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -80.32 153.48 28.38 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.966 -0.383 . . . . 1.39 109.966 179.021 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.733 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.6 mp -74.42 129.31 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 112.251 0.463 . . . . 0.8 112.251 -178.141 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 15.7 m-85 -121.63 149.84 42.6 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.223 -0.444 . . . . 1.38 110.593 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.819 HG21 HD21 ' A' ' 48' ' ' LEU . 47.1 t -83.32 125.49 40.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.407 -0.36 . . . . 0.65 110.039 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.868 HG21 ' HB3' ' B' ' 303' ' ' GLU . 10.3 t -98.67 -23.99 15.24 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.356 0.872 . . . . 1.39 113.356 -178.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -164.88 123.94 1.79 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.177 0.436 . . . . 2.54 112.177 -179.356 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.486 ' CG2' ' HB2' ' A' ' 43' ' ' HIS . 17.2 mt -101.29 124.57 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.443 -0.344 . . . . 1.4 110.891 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mp -80.62 152.49 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.282 -0.417 . . . . 1.68 110.803 179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.45 144.6 54.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.825 0.345 . . . . 3.11 111.143 179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.1 14.68 66.4 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.985 -0.552 . . . . 3.15 113.615 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.14 164.92 28.78 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.943 -0.646 . . . . 2.8 112.945 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -44.81 -61.09 1.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.077 0.399 . . . . 3.0 112.077 -179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -62.41 -47.6 83.39 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.598 -0.274 . . . . 1.82 111.339 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 58.8 t-80 -53.22 -52.32 59.3 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.551 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -63.9 -40.78 97.3 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.192 -0.458 . . . . 2.66 111.46 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -51.51 66.59 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.526 -0.306 . . . . 3.24 110.944 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.62 -27.29 12.65 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.09 -0.576 . . . . 2.49 113.155 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -59.44 -49.36 78.08 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.77 0.285 . . . . 5.67 111.132 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 33' ' ' VAL . 2.7 tt -79.95 125.83 30.25 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.013 0.435 . . . . 1.68 111.226 -179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -133.22 145.62 50.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.655 -0.702 . . . . 1.54 110.192 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 50' ' ' ILE . 1.8 pp -47.14 126.79 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.764 0.316 . . . . 2.56 111.363 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.25 -25.24 7.48 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.088 -0.577 . . . . 1.1 113.367 -179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -69.61 152.97 44.11 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 117.462 0.631 . . . . 1.56 110.887 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.44 148.33 32.26 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.348 0.594 . . . . 3.23 111.157 179.646 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.724 HD13 HD21 ' A' ' 74' ' ' LEU . 1.8 mt -97.73 103.25 15.17 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.416 -0.811 . . . . 1.72 111.688 -179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 55' ' ' LEU . 1.2 tm? -69.29 -50.13 49.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.464 -0.789 . . . . 1.87 109.652 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -149.53 154.84 39.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.843 0.354 . . . . 0.67 111.851 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 60' ' ' VAL . 99.3 t -132.84 108.13 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.297 -0.41 . . . . 1.47 111.043 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 4.2 m120 61.01 44.52 10.27 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.309 -0.405 . . . . 1.49 111.489 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.424 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 7.8 t30 85.78 -16.86 0.43 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.612 0.597 . . . . 1.74 112.612 179.678 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.4 m -89.82 146.25 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 117.777 0.262 . . . . 0.54 110.378 179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -85.93 130.74 34.46 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.578 -0.449 . . . . 0.72 110.123 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 31' ' ' ILE . 5.1 tp -102.21 29.1 5.33 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.229 -0.441 . . . . 1.71 111.789 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.708 ' HG2' ' HB3' ' A' ' 30' ' ' SER . 0.6 OUTLIER -112.8 -18.97 12.17 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.328 0.492 . . . . 1.96 112.328 -179.336 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.64 49.89 1.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.82 0.343 . . . . 2.93 111.366 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 13.8 m -146.33 149.69 15.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.007 0.432 . . . . 0.8 112.131 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.1 p -64.41 168.44 5.75 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.572 -0.74 . . . . 1.53 110.074 178.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 21.0 t60 -55.5 -38.56 69.34 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 120.5 -0.48 . . . . 0.54 111.009 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -48.35 -53.5 17.27 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.555 0.217 . . . . 2.9 110.454 179.368 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -61.58 -32.99 73.12 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.304 -0.407 . . . . 1.84 111.082 179.228 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -60.1 -43.12 95.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.181 0.515 . . . . 0.44 110.455 178.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.855 HG13 HG12 ' B' ' 306' ' ' VAL . 37.2 t -80.4 -37.18 16.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.57 -0.741 . . . . 0.52 111.232 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.507 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 99.2 m -62.83 -32.01 73.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.719 -0.219 . . . . 0.61 111.537 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.92 -34.56 24.46 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.767 -0.197 . . . . 0.41 111.286 -179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.2 mm? -78.76 -37.33 41.37 Favored 'General case' 0 CA--C 1.523 -0.089 0 CA-C-O 120.854 0.359 . . . . 1.73 110.485 179.038 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' THR . 5.2 ptpt -75.16 -26.59 59.22 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.683 -0.689 . . . . 1.44 112.357 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -54.63 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.361 0.504 . . . . 1.55 112.361 -178.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 75' ' ' LYS . 56.8 p -81.75 125.2 30.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.858 -0.61 . . . . 2.6 111.469 -179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 t -135.71 -136.4 0.15 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.671 -0.695 . . . . 3.36 109.865 179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -87.77 -56.37 3.37 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.909 -0.775 . . . . 2.23 108.909 178.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -122.92 168.01 12.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.469 -0.787 . . . . 1.77 110.072 178.678 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -141.29 119.68 9.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.735 -0.469 . . . . 1.58 109.735 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -99.14 98.59 9.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.289 0.566 . . . . 1.72 110.622 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.523 ' CD1' HD21 ' A' ' 54' ' ' LEU . 4.2 tp -85.33 124.33 31.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.132 -0.94 . . . . 1.38 111.78 -178.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -111.0 105.88 14.78 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.955 -0.566 . . . . 1.56 109.955 178.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 53' ' ' LYS . 88.6 t -111.43 127.65 68.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.4 -0.364 . . . . 1.92 110.917 -179.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -89.7 153.06 21.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.173 -0.467 . . . . 1.46 111.368 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.4 117.59 68.92 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.067 -0.515 . . . . 4.2 110.655 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 57.6 Cg_endo -71.27 117.47 5.17 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.605 2.203 . . . . 2.28 112.45 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 t -158.03 132.83 8.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.781 0.324 . . . . 3.88 110.832 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.47 152.9 18.4 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.025 -0.607 . . . . 4.69 112.696 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 p -100.14 -50.81 3.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.635 0.255 . . . . 7.06 110.775 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 . . . . . 0 C--O 1.233 0.21 0 CA-C-N 116.234 -0.439 . . . . 7.84 111.106 179.892 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.695 0.283 . . . . 4.22 111.235 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.9 ttp180 -150.17 128.49 12.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.274 -0.421 . . . . 3.57 111.018 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.868 ' HB3' HG21 ' A' ' 34' ' ' THR . 6.5 mp0 -121.89 121.81 37.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.947 -0.57 . . . . 2.08 110.712 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.459 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -126.76 148.76 49.88 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.94 -179.686 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.632 ' HG3' ' HB3' ' A' ' 15' ' ' SER . 0.0 OUTLIER -77.93 158.83 29.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.306 -0.406 . . . . 1.67 111.087 179.678 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.855 HG12 HG13 ' A' ' 71' ' ' VAL . 14.6 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.118 -0.944 . . . . 1.47 111.647 -179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.697 0.284 . . . . 3.17 111.068 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.592 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.5 pm0 -122.71 159.09 28.69 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.113 -0.494 . . . . 1.97 111.376 -179.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 mp -144.0 137.98 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.374 -0.602 . . . . 1.34 109.374 179.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.7 91.95 5.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.314 0.578 . . . . 2.93 111.189 -179.851 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.503 HD13 ' HB1' ' A' ' 41' ' ' ALA . 3.8 mt -88.69 126.53 35.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.268 -0.878 . . . . 2.09 111.157 -178.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 tt -91.33 129.72 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.699 -0.682 . . . . 1.94 111.187 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -47.73 117.79 2.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.371 -0.377 . . . . 3.1 111.362 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.08 -161.9 37.86 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.113 -0.565 . . . . 1.78 113.162 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -82.64 34.31 0.55 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.688 2.925 . . . . 2.77 113.025 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.2 pttt -176.3 -70.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.611 -0.268 . . . . 4.92 110.65 179.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.02 -162.82 36.61 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.014 -0.612 . . . . 2.3 112.582 179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD22 ' CZ ' ' A' ' 14' ' ' PHE . 16.2 mt -48.77 -43.42 37.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.583 0.23 . . . . 5.7 111.512 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.65 50.92 33.43 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.995 -0.621 . . . . 1.13 113.509 179.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.784 ' CZ ' HD22 ' A' ' 12' ' ' LEU . 2.9 p90 -165.55 -172.91 2.58 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 110.064 -0.347 . . . . 1.46 110.064 179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -128.51 173.41 10.26 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.837 -0.431 . . . . 0.57 109.837 178.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.26 172.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.129 0.49 . . . . 0.67 111.039 179.625 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.124 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.22 165.89 25.06 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.082 -1.451 . . . . 1.19 107.082 177.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.065 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.37 131.74 1.28 Allowed Glycine 0 C--O 1.225 -0.468 0 C-N-CA 117.872 -2.109 . . . . 1.29 115.71 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 103.92 160.82 24.67 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.462 -0.875 . . . . 1.61 113.631 177.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG22 ' ND2' ' A' ' 29' ' ' ASN . 59.0 t -64.62 140.61 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 110.47 -0.196 . . . . 2.72 110.47 179.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.03 -20.79 9.01 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.918 -0.658 . . . . 1.56 113.035 -179.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.17 21.36 3.75 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.883 0.473 . . . . 1.63 110.526 179.208 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -59.15 146.93 37.06 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.525 0.565 . . . . 2.34 112.525 -178.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.124 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 68.1 t60 -88.82 -21.55 23.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.34 -0.845 . . . . 0.92 111.454 179.639 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.47 HD12 ' CE2' ' A' ' 32' ' ' TYR . 10.2 mt -149.92 129.34 6.4 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.604 -0.271 . . . . 1.51 110.851 -179.784 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.67 124.76 12.81 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.852 2.368 . . . . 0.98 112.564 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.34 -56.2 1.06 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.936 -0.649 . . . . 1.06 112.785 -179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.23 109.72 19.68 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.67 0.271 . . . . 1.68 110.783 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' ND2' HG22 ' A' ' 20' ' ' VAL . 5.9 m120 -88.43 15.71 7.48 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.325 -0.398 . . . . 2.11 111.749 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.616 ' C ' HD13 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -68.29 -179.62 1.35 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.681 0.277 . . . . 1.39 110.841 179.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.065 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.1 mm -99.06 111.07 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.8 111.308 179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' HB2' ' CG ' ' A' ' 24' ' ' HIS . 25.5 m-85 -110.81 144.12 40.31 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.085 -0.507 . . . . 1.38 111.825 -179.366 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.933 HG21 HD21 ' A' ' 48' ' ' LEU . 45.3 t -76.66 134.42 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.218 -0.446 . . . . 0.65 110.223 178.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.716 HG22 ' CE1' ' A' ' 24' ' ' HIS . 3.1 p -104.88 -31.61 9.19 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.248 0.833 . . . . 1.39 113.248 -178.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 13.7 mttm -158.51 120.47 3.57 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 111.724 0.268 . . . . 2.54 111.724 -179.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 14' ' ' PHE . 69.9 mt -94.83 118.79 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.645 0.26 . . . . 1.4 110.584 178.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.02 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 116.299 -0.409 . . . . 1.68 111.082 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -58.42 142.02 49.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.213 -0.449 . . . . 3.11 111.331 -179.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.27 23.66 64.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.926 -0.579 . . . . 3.15 113.414 179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.17 170.15 28.56 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.955 -0.64 . . . . 2.8 112.721 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.503 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -45.29 -56.64 4.68 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.053 0.39 . . . . 3.0 112.053 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.783 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -67.21 -49.88 62.9 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.682 -0.236 . . . . 1.82 111.284 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -48.93 -51.05 32.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.282 -0.417 . . . . 1.39 111.323 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -68.26 -36.61 79.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.219 -0.446 . . . . 2.66 111.421 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.24 -51.96 66.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.495 -0.321 . . . . 3.24 111.027 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.19 -19.06 48.99 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.002 -0.618 . . . . 2.49 113.313 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -79.3 -30.72 43.03 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.996 0.398 . . . . 5.67 111.383 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.933 HD21 HG21 ' A' ' 33' ' ' VAL . 1.4 tt -89.85 120.45 31.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.896 0.379 . . . . 1.68 111.189 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -128.51 142.52 51.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.812 -0.631 . . . . 1.54 110.403 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.2 mm -45.36 121.61 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.641 0.258 . . . . 2.56 111.198 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.99 -19.95 8.69 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.082 -0.58 . . . . 1.1 113.302 -179.473 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -65.97 156.23 34.24 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 117.675 0.737 . . . . 1.56 110.603 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.865 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.7 149.12 32.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.553 0.692 . . . . 3.23 111.591 -179.499 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.845 HD21 HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -102.4 104.77 15.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.072 -0.967 . . . . 1.72 111.763 -178.909 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 86' ' ' ALA . 22.7 tp -74.04 -51.25 16.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.279 -0.873 . . . . 1.87 109.6 178.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -157.85 155.03 28.96 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 111.982 0.364 . . . . 0.67 111.982 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.845 HG13 HD21 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -146.76 120.69 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.479 -0.328 . . . . 1.47 111.209 179.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 66.72 39.0 3.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.367 -0.379 . . . . 1.49 111.358 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.5 t30 82.66 -15.29 0.69 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.861 0.689 . . . . 1.74 112.861 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 57' ' ' VAL . 35.2 m -94.84 146.93 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 117.951 0.341 . . . . 0.54 110.672 179.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.6 p -86.2 131.51 34.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.911 0.386 . . . . 0.72 110.689 179.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.785 HD22 HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -103.0 30.59 4.71 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.887 -0.597 . . . . 1.71 111.661 179.327 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 0.4 OUTLIER -115.57 -20.15 10.3 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.4 0.518 . . . . 1.96 112.4 -178.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.58 38.78 4.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.841 0.311 . . . . 2.93 111.841 -179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 16.6 m -135.25 158.3 40.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 112.405 0.52 . . . . 0.8 112.405 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.493 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -69.2 -170.67 0.27 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.583 -0.735 . . . . 1.53 110.077 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.521 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 17.4 t60 -72.79 -40.27 66.04 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 120.402 -0.519 . . . . 0.54 111.073 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.25 -44.9 61.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.541 0.21 . . . . 2.9 110.614 179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.658 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 1.9 mp0 -66.89 -36.89 83.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.172 -0.467 . . . . 1.84 110.873 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.83 -42.94 94.67 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.142 0.496 . . . . 0.44 110.716 178.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.766 HG13 HG12 ' B' ' 306' ' ' VAL . 39.4 t -79.93 -37.15 17.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.748 -0.66 . . . . 0.52 111.57 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -64.65 -39.9 94.51 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.042 0.214 . . . . 0.61 111.184 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -70.48 -39.09 74.42 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.55 -0.295 . . . . 0.41 110.771 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.746 HD12 HD13 ' A' ' 12' ' ' LEU . 2.2 mm? -71.63 -33.56 69.04 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 109.545 -0.539 . . . . 1.73 109.545 178.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -74.91 -26.07 59.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.365 -0.834 . . . . 1.44 111.886 -179.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -77.17 64.34 2.58 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.118 0.485 . . . . 1.55 111.928 -179.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.0 p -123.06 132.72 54.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.017 -0.538 . . . . 2.6 110.689 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.2 m -117.27 -79.56 0.59 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.278 -0.419 . . . . 3.36 111.05 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -96.92 -50.55 4.6 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.761 0.315 . . . . 2.23 110.694 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.45 171.54 12.87 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.127 -0.488 . . . . 1.77 111.065 179.586 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.85 132.95 26.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 109.902 -0.407 . . . . 1.58 109.902 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -112.12 99.15 7.83 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.238 0.542 . . . . 1.72 110.651 179.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 tt -90.39 132.62 35.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.353 -0.839 . . . . 1.38 112.113 -178.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.592 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -118.27 142.64 47.27 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.493 -0.776 . . . . 1.56 109.73 178.859 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 53' ' ' LYS . 62.0 t -127.61 138.93 53.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.778 0.323 . . . . 1.92 111.468 -179.094 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.798 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -97.01 153.09 18.12 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.079 -0.51 . . . . 1.46 111.353 -179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.22 89.83 18.5 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.181 -0.463 . . . . 4.2 110.785 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 53' ' ' LYS . 59.2 Cg_endo -71.2 160.07 50.1 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.829 2.353 . . . . 2.28 112.537 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 p -97.63 -50.5 4.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.173 -0.467 . . . . 3.88 111.108 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.3 -143.72 25.18 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.062 -0.59 . . . . 4.69 112.632 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.7 m -99.9 -53.57 3.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.606 0.241 . . . . 7.06 110.864 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-N 116.313 -0.403 . . . . 7.84 110.824 179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.871 0.367 . . . . 4.22 111.551 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -66.91 132.44 47.98 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.185 -0.461 . . . . 3.57 111.062 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.639 ' HG2' ' HB2' ' A' ' 17' ' ' ALA . 5.3 mt-10 -122.71 130.39 52.89 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.955 -0.566 . . . . 2.08 110.468 179.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.479 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -124.8 153.01 43.16 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.897 0.38 . . . . 0.65 111.706 -179.156 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 27.1 mt-30 -83.31 151.57 25.52 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.906 -0.588 . . . . 1.67 110.889 179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.766 HG12 HG13 ' A' ' 71' ' ' VAL . 19.6 m . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.064 -0.969 . . . . 1.47 111.676 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.908 0.385 . . . . 3.17 111.098 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -130.62 159.17 37.98 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.919 -0.582 . . . . 1.97 111.091 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 mp -141.84 139.98 30.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 109.355 -0.609 . . . . 1.34 109.355 179.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 90.97 3.67 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.255 0.55 . . . . 2.93 111.37 -179.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.48 129.09 36.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.333 -0.849 . . . . 2.09 111.217 -179.31 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.77 127.52 44.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 115.918 -0.583 . . . . 1.94 111.071 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.81 107.72 5.38 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.196 -0.456 . . . . 3.1 110.762 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.66 -165.68 29.44 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.939 -0.648 . . . . 1.78 112.723 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.48 31.86 0.52 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.523 2.815 . . . . 2.77 113.205 -179.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -132.72 -72.78 0.51 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.538 0.209 . . . . 4.92 110.797 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.47 171.74 13.18 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.071 -0.585 . . . . 2.3 112.673 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 3.2 mp -34.5 -62.08 0.36 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.836 0.454 . . . . 5.7 111.838 -179.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 72.93 44.87 35.37 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.97 -0.633 . . . . 1.13 113.56 179.519 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.647 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 31.2 p90 -161.35 -174.09 4.13 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.069 -0.345 . . . . 1.46 110.069 179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.7 OUTLIER -129.57 169.68 14.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.58 0.229 . . . . 0.57 110.481 179.899 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.576 HG21 ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -156.06 170.52 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.954 0.407 . . . . 0.67 111.252 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.04 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.79 165.23 26.09 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.777 -1.564 . . . . 1.19 106.777 177.291 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.023 ' HA3' HD12 ' A' ' 31' ' ' ILE . . . 165.49 132.04 1.32 Allowed Glycine 0 C--O 1.223 -0.539 0 C-N-CA 117.296 -2.383 . . . . 1.29 116.352 179.02 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG3' ' A' ' 23' ' ' GLN . . . 105.67 157.11 22.36 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.533 -0.841 . . . . 1.61 113.285 177.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p -65.72 143.25 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 110.398 -0.223 . . . . 2.72 110.398 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.64 -18.39 15.45 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.784 -0.722 . . . . 1.56 112.476 -178.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -138.96 24.37 2.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.535 0.734 . . . . 1.63 110.016 179.062 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 19' ' ' GLY . 4.1 mt-30 -58.87 148.37 30.37 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.763 0.653 . . . . 2.34 112.763 -178.445 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.04 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 80.4 t60 -88.75 -23.25 22.96 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.283 -0.871 . . . . 0.92 111.963 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.751 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -159.63 130.37 3.69 Favored Pre-proline 0 CA--C 1.532 0.268 0 O-C-N 122.927 0.142 . . . . 1.51 111.381 -179.304 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.52 123.77 14.46 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.708 2.272 . . . . 0.98 112.585 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.17 -52.2 0.68 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.937 -0.649 . . . . 1.06 112.77 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.03 114.39 27.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.852 0.358 . . . . 1.68 111.245 -179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -86.72 17.27 4.07 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.991 -0.55 . . . . 2.11 112.022 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -83.34 161.74 21.31 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 110.363 -0.236 . . . . 1.39 110.363 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.023 HD12 ' HA3' ' A' ' 18' ' ' GLY . 1.6 mm -74.71 122.84 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 113.109 0.781 . . . . 0.8 113.109 -177.242 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.751 ' CZ ' HD11 ' A' ' 25' ' ' ILE . 26.2 m-85 -117.72 146.69 43.58 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.495 -0.775 . . . . 1.38 110.642 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.016 HG21 HD21 ' A' ' 48' ' ' LEU . 54.1 t -79.22 126.4 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 110.04 -0.355 . . . . 0.65 110.04 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.663 HG21 ' HB3' ' B' ' 303' ' ' GLU . 5.7 p -95.06 -24.99 16.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.043 0.757 . . . . 1.39 113.043 -178.203 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HB3' ' OG ' ' A' ' 15' ' ' SER . 11.9 tttt -169.46 129.11 1.02 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.774 0.286 . . . . 2.54 111.774 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 mt -102.27 125.62 56.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.666 0.27 . . . . 1.4 111.216 179.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD12 ' HA ' ' A' ' 14' ' ' PHE . 2.3 mp -81.16 150.64 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.285 -0.416 . . . . 1.68 110.455 179.394 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -65.95 147.25 53.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.883 0.373 . . . . 3.11 111.156 179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.97 15.53 56.08 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.951 -0.568 . . . . 3.15 113.817 179.865 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 167.07 32.56 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 120.916 -0.659 . . . . 2.8 112.885 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . . . -46.79 -56.87 5.52 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 111.949 0.351 . . . . 3.0 111.949 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.28 -50.08 69.3 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.6 -0.273 . . . . 1.82 111.085 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -51.77 -47.32 64.2 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.193 -0.458 . . . . 1.39 111.407 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mttm -66.89 -39.84 87.58 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.267 -0.424 . . . . 2.66 111.19 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.63 -52.01 65.02 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.45 -0.341 . . . . 3.24 111.028 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.3 -24.09 24.15 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.104 -0.57 . . . . 2.49 113.266 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -40.09 86.28 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.81 0.305 . . . . 5.67 111.272 -179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.016 HD21 HG21 ' A' ' 33' ' ' VAL . 3.0 tt -87.1 126.51 34.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.939 0.4 . . . . 1.68 111.4 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -132.48 144.41 50.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.703 -0.68 . . . . 1.54 110.27 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.8 mt -48.08 122.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.6 -0.273 . . . . 2.56 111.085 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.73 -21.94 8.32 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.242 -0.504 . . . . 1.1 113.457 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 p30 -68.66 158.77 33.42 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 117.578 0.689 . . . . 1.56 110.83 179.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.944 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.12 149.58 29.84 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.469 0.652 . . . . 3.23 111.532 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -101.93 113.22 26.24 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.19 -0.914 . . . . 1.72 111.778 -178.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 86' ' ' ALA . 27.1 tp -80.21 -56.54 4.15 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.413 -0.812 . . . . 1.87 110.184 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.27 151.91 32.49 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 121.128 -0.229 . . . . 0.67 111.289 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.84 ' O ' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -141.22 119.94 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.676 0.274 . . . . 1.47 111.249 179.55 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 21.8 m120 66.27 35.42 5.95 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.311 -0.404 . . . . 1.49 111.266 -179.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 5.1 t30 86.77 -18.26 0.32 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.648 0.61 . . . . 1.74 112.648 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 57' ' ' VAL . 30.0 m -90.33 148.26 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 117.823 0.283 . . . . 0.54 110.722 179.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.9 p -85.26 130.64 34.56 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.894 0.378 . . . . 0.72 110.35 179.229 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.824 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.0 tp -102.77 23.38 12.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.934 -0.575 . . . . 1.71 111.745 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -105.37 -19.79 13.69 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.48 0.548 . . . . 1.96 112.48 -179.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.51 51.54 1.81 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.951 0.405 . . . . 2.93 111.282 -179.749 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 12.0 m -141.34 155.37 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.163 0.506 . . . . 0.8 112.222 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.1 p -67.54 169.33 9.41 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.545 -0.752 . . . . 1.53 109.963 178.796 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.567 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 13.9 t60 -56.97 -39.92 75.53 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.423 -0.511 . . . . 0.54 110.747 -179.46 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -50.74 -48.34 59.11 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.559 0.219 . . . . 2.9 110.741 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.604 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 7.8 mm-40 -60.59 -35.82 77.05 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.178 -0.465 . . . . 1.84 111.369 179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 31' ' ' ILE . . . -59.77 -41.41 91.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.05 0.452 . . . . 0.44 110.628 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.749 HG13 HG12 ' B' ' 306' ' ' VAL . 54.9 t -80.46 -38.8 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.498 -0.774 . . . . 0.52 111.228 179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 95.2 m -64.93 -38.17 90.09 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.314 -0.403 . . . . 0.61 111.692 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.74 -39.64 56.86 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.791 -0.186 . . . . 0.41 111.177 -179.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 16' ' ' ILE . 7.9 mp -71.42 -29.61 65.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.917 0.389 . . . . 1.73 110.869 179.041 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -87.01 -22.61 25.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.725 -0.67 . . . . 1.44 112.024 -179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 72' ' ' THR . 26.9 t30 -78.4 69.49 4.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.952 0.406 . . . . 1.55 111.334 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HB ' ' A' ' 81' ' ' VAL . 0.1 OUTLIER -128.0 144.63 51.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.024 -0.535 . . . . 2.6 111.228 -179.781 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 p -115.84 -78.68 0.58 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.968 -0.56 . . . . 3.36 110.699 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -102.52 -46.99 4.59 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.654 -0.248 . . . . 2.23 111.227 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.34 168.69 16.52 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.665 0.269 . . . . 1.77 111.323 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.552 ' HB ' HG21 ' A' ' 77' ' ' THR . 8.5 p -141.89 128.45 19.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.899 -0.408 . . . . 1.58 109.899 178.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -103.96 98.96 8.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.72 110.949 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.465 ' HG ' HD21 ' A' ' 54' ' ' LEU . 2.6 tt -86.74 126.59 34.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.335 -0.848 . . . . 1.38 111.941 -178.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.1 129.02 55.3 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 115.675 -0.693 . . . . 1.56 110.215 179.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 53' ' ' LYS . 96.0 t -122.12 134.69 64.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.899 0.38 . . . . 1.92 111.525 -179.418 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -105.76 155.54 19.18 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.777 -0.647 . . . . 1.46 110.491 179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 19.9 tttm -113.54 104.91 55.35 Favored Pre-proline 0 C--O 1.234 0.244 0 CA-C-O 120.589 0.233 . . . . 4.2 110.566 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HD2' ' HA ' ' A' ' 87' ' ' LYS . 18.7 Cg_endo -59.32 142.43 99.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.793 2.329 . . . . 2.28 112.537 -179.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.0 t -162.69 140.63 8.33 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.247 -0.433 . . . . 3.88 111.048 -179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.24 71.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.069 -0.586 . . . . 4.69 113.326 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.7 m -76.45 -42.26 44.47 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 117.105 0.452 . . . . 7.06 111.158 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.4 m170 . . . . . 0 N--CA 1.462 0.157 0 CA-C-N 116.391 -0.368 . . . . 7.84 110.919 179.909 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.815 0.34 . . . . 4.22 111.156 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 3.3 tpm_? -87.22 121.86 30.23 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.144 -0.48 . . . . 3.57 110.959 -179.878 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.663 ' HB3' HG21 ' A' ' 34' ' ' THR . 19.0 mt-10 -129.85 93.91 3.61 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.96 -0.564 . . . . 2.08 110.106 179.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.474 HG21 HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -101.5 148.71 24.88 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.768 -0.651 . . . . 0.65 111.191 -179.303 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 10.3 mt-30 -85.1 148.87 25.92 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.127 -0.488 . . . . 1.67 110.512 179.166 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.749 HG12 HG13 ' A' ' 71' ' ' VAL . 19.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.059 -0.972 . . . . 1.47 111.697 -179.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.799 0.333 . . . . 3.17 111.441 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -113.18 159.12 19.6 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.19 -0.459 . . . . 1.97 111.257 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 mp -141.5 141.23 30.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.246 -0.65 . . . . 1.34 109.246 179.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.41 90.9 3.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.201 0.524 . . . . 2.93 111.064 179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.929 HD21 ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.63 126.15 35.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.428 -0.805 . . . . 2.09 111.567 -178.702 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.4 tt -93.51 128.81 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.646 -0.706 . . . . 1.94 110.831 179.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 tptt -54.74 116.19 2.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.863 0.363 . . . . 3.1 111.44 -179.527 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.21 -170.52 45.04 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 115.866 -0.606 . . . . 1.78 112.811 -179.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.36 42.09 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.528 2.819 . . . . 2.77 113.41 -179.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -171.38 -89.41 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.762 -0.199 . . . . 4.92 110.586 179.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.66 -129.59 1.09 Allowed Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.867 -0.683 . . . . 2.3 112.719 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 14' ' ' PHE . 7.0 mp -87.66 -49.37 7.2 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.511 0.196 . . . . 5.7 111.195 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 80.56 37.2 21.05 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 1.13 112.848 -179.74 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.526 ' CZ ' HD23 ' A' ' 12' ' ' LEU . 22.5 p90 -163.71 -173.77 3.4 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.251 0.22 . . . . 1.46 110.536 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 3.5 p -131.18 174.72 9.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.851 -0.425 . . . . 0.57 109.851 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -157.79 172.81 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.104 0.478 . . . . 0.67 111.252 179.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.998 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.5 165.99 24.23 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.21 -1.404 . . . . 1.19 107.21 177.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.52 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 165.96 128.17 0.95 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 118.141 -1.981 . . . . 1.29 115.523 179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.64 156.33 18.04 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.339 -0.934 . . . . 1.61 113.269 178.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.11 143.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.212 -0.292 . . . . 2.72 110.212 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.31 -19.4 10.69 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.865 -0.683 . . . . 1.56 112.844 -179.211 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' CB ' ' HB3' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -137.51 23.56 2.93 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.22 0.608 . . . . 1.63 109.905 178.996 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -61.88 148.35 43.7 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.083 0.771 . . . . 2.34 113.083 -178.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.998 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 66.5 t60 -89.33 -25.22 21.74 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.086 -0.961 . . . . 0.92 111.43 179.554 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -150.64 127.39 5.32 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.762 -179.592 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.81 128.44 30.33 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.617 2.211 . . . . 0.98 112.165 -179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.93 -57.96 0.43 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.097 -0.573 . . . . 1.06 112.432 -179.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -95.08 112.5 24.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.795 0.331 . . . . 1.68 111.041 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 15.96 4.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.131 -0.486 . . . . 2.11 111.791 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.6 155.41 25.67 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 110.053 -0.351 . . . . 1.39 110.053 179.235 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.68 ' HB ' HD23 ' A' ' 62' ' ' LEU . 1.5 mp -73.87 126.34 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 112.859 0.688 . . . . 0.8 112.859 -177.437 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 44.5 m-85 -119.17 147.39 44.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.892 -0.595 . . . . 1.38 110.699 178.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD21 ' A' ' 48' ' ' LEU . 38.0 t -75.96 130.94 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.825 -0.435 . . . . 0.65 109.825 178.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.844 HG22 ' CE1' ' A' ' 24' ' ' HIS . 13.8 p -101.57 -31.2 10.97 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.295 0.85 . . . . 1.39 113.295 -177.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 30.0 mmtm -159.14 121.77 3.58 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.667 0.247 . . . . 2.54 111.667 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 43' ' ' HIS . 9.4 mt -99.2 120.77 49.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 120.602 0.239 . . . . 1.4 110.811 179.092 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.37 145.18 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.355 -0.384 . . . . 1.68 110.755 179.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -61.18 148.26 41.4 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.851 0.358 . . . . 3.11 110.949 179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.46 18.26 36.13 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 115.972 -0.558 . . . . 3.15 113.594 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.4 170.73 37.49 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 121.009 -0.615 . . . . 2.8 112.882 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.929 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -48.29 -54.97 11.84 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.975 0.361 . . . . 3.0 111.975 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -68.23 -50.62 52.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.015 179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.9 t-80 -50.14 -46.8 54.21 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.119 -0.491 . . . . 1.39 111.67 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.2 mttt -73.18 -37.1 66.63 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.352 -0.386 . . . . 2.66 111.41 -179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -62.57 -55.51 26.58 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.585 -0.279 . . . . 3.24 110.844 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.94 10.0 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.067 -0.587 . . . . 2.49 113.188 179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.55 -39.85 94.94 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.917 0.359 . . . . 5.67 110.83 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.003 HD21 HG21 ' A' ' 33' ' ' VAL . 3.3 tt -89.63 122.04 32.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.963 0.411 . . . . 1.68 111.006 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -130.17 143.52 50.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.757 -0.656 . . . . 1.54 110.281 179.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.4 pt -46.98 122.69 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.612 0.244 . . . . 2.56 111.327 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.91 -21.25 8.41 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.123 -0.56 . . . . 1.1 113.212 -179.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.98 153.99 42.25 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.572 0.686 . . . . 1.56 110.768 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.869 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.36 149.52 27.76 Favored 'General case' 0 C--O 1.228 -0.076 0 CA-C-O 121.371 0.605 . . . . 3.23 111.266 -179.918 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -104.31 103.01 12.68 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.435 -0.802 . . . . 1.72 111.873 -178.688 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 86' ' ' ALA . 28.3 tp -73.99 -52.84 11.52 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.543 -0.753 . . . . 1.87 109.701 178.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 84' ' ' LYS . . . -152.62 150.04 29.09 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.382 -0.372 . . . . 0.67 110.98 179.306 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.833 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.8 p -141.46 123.1 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.717 0.294 . . . . 1.47 111.219 179.754 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 0.7 OUTLIER 66.21 32.96 7.61 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.459 -0.337 . . . . 1.49 111.163 -179.658 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 2.2 t-20 87.83 -19.52 0.23 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.937 -0.574 . . . . 1.74 112.468 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 57' ' ' VAL . 32.9 m -89.23 150.22 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 117.627 0.194 . . . . 0.54 110.837 179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.4 p -86.84 129.64 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.812 0.339 . . . . 0.72 110.407 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.68 HD23 ' HB ' ' A' ' 31' ' ' ILE . 2.1 tp -102.15 28.44 5.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.995 -0.548 . . . . 1.71 111.657 179.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.19 -20.06 12.03 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.34 0.496 . . . . 1.96 112.34 -179.038 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.24 51.65 1.44 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.822 0.344 . . . . 2.93 111.598 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.3 m -148.2 152.54 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.593 0.59 . . . . 0.8 112.593 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HB ' ' HG2' ' A' ' 68' ' ' GLU . 0.6 OUTLIER -66.55 168.09 9.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.467 -0.788 . . . . 1.53 109.868 178.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.0 t60 -55.56 -39.1 70.2 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.628 -0.429 . . . . 0.54 111.088 -179.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 66' ' ' THR . 3.7 pt-20 -49.75 -49.51 47.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.585 0.231 . . . . 2.9 110.53 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.641 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 8.6 mp0 -64.26 -34.46 78.16 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.135 -0.484 . . . . 1.84 110.82 179.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.65 -42.54 88.57 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.938 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.873 HG13 HG12 ' B' ' 306' ' ' VAL . 37.6 t -80.52 -35.07 14.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.609 -0.723 . . . . 0.52 111.257 179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.625 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 93.3 m -64.14 -35.91 82.32 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.467 -0.333 . . . . 0.61 111.508 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 57' ' ' VAL . . . -80.82 -34.76 33.72 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.784 -0.189 . . . . 0.41 111.311 -179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -70.24 -32.57 70.48 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.027 0.441 . . . . 1.73 110.134 178.678 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 72' ' ' THR . 3.0 pttt -90.53 -14.69 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.588 -0.733 . . . . 1.44 112.258 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 72' ' ' THR . 42.4 t30 -79.36 65.31 4.49 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.969 0.414 . . . . 1.55 111.031 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.0 p -124.18 132.08 53.59 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.048 -0.524 . . . . 2.6 111.093 -179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.5 m -109.81 -81.44 0.58 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.051 -0.522 . . . . 3.36 110.53 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -97.93 -52.51 3.69 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.619 0.247 . . . . 2.23 110.425 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.38 168.09 17.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 1.77 110.836 179.411 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 5' ' ' LEU . 12.7 p -142.23 122.02 10.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.599 -0.273 . . . . 1.58 110.317 178.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -95.91 98.62 10.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.219 0.533 . . . . 1.72 110.588 -179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 tt -89.09 132.27 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.362 -0.836 . . . . 1.38 112.067 -178.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -118.2 139.56 51.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 115.379 -0.828 . . . . 1.56 109.734 178.935 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 53' ' ' LYS . 83.8 t -127.93 141.0 47.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.002 0.43 . . . . 1.92 111.402 -179.029 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -84.3 139.69 32.14 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.765 -0.652 . . . . 1.46 110.85 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.0 107.83 25.74 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.367 -0.379 . . . . 4.2 111.054 -179.633 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.48 117.42 5.14 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.607 2.204 . . . . 2.28 112.396 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -138.01 -67.47 0.48 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.759 -0.2 . . . . 3.88 110.643 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.95 150.78 3.13 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.125 -0.56 . . . . 4.69 113.009 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 p -67.2 -39.04 86.29 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.58 0.229 . . . . 7.06 111.038 179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.969 0.414 . . . . 7.84 110.907 179.806 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.769 0.319 . . . . 4.22 111.067 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.483 ' HB3' ' CB ' ' A' ' 22' ' ' ASN . 38.6 ttp180 -106.02 129.3 54.16 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.121 -0.49 . . . . 3.57 110.953 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' THR . 21.1 mt-10 -126.97 117.43 22.5 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.91 -0.586 . . . . 2.08 110.48 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.553 ' CG2' HG21 ' A' ' 71' ' ' VAL . 0.8 OUTLIER -120.95 149.45 42.63 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.345 -0.389 . . . . 0.65 111.164 -179.535 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 16.3 mt-30 -79.55 152.74 29.96 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.079 -0.51 . . . . 1.67 111.052 179.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 71' ' ' VAL . 11.0 m . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.653 -0.689 . . . . 1.47 111.794 -179.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.86 0.362 . . . . 3.17 111.271 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.591 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 1.3 pm0 -131.05 159.42 37.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.026 -0.534 . . . . 1.97 110.863 -179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.55 136.53 35.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.43 -0.581 . . . . 1.34 109.43 179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER -99.98 91.22 4.7 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.351 0.596 . . . . 2.93 111.094 -179.833 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' HB2' HG13 ' A' ' 81' ' ' VAL . 8.2 mt -90.03 125.36 35.37 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.24 -0.891 . . . . 2.09 111.429 -179.186 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 tt -89.96 128.04 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.927 -0.579 . . . . 1.94 110.599 179.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.78 113.21 1.94 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.345 -0.389 . . . . 3.1 111.194 -179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 -178.98 35.12 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 121.054 -0.593 . . . . 1.78 112.714 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.09 48.63 2.93 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.424 2.749 . . . . 2.77 112.828 -179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -159.17 -61.23 0.07 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.661 0.267 . . . . 4.92 110.922 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 146.14 -140.43 8.84 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.201 -0.523 . . . . 2.3 112.1 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 74' ' ' LEU . 17.5 mt -87.48 -49.6 7.09 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.778 0.323 . . . . 5.7 110.444 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 40.83 24.06 Favored Glycine 0 C--N 1.335 0.475 0 CA-C-N 116.042 -0.526 . . . . 1.13 113.533 179.669 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.644 ' HA ' HD12 ' A' ' 37' ' ' ILE . 14.9 p90 -161.07 -174.33 4.32 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.246 -0.279 . . . . 1.46 110.246 179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -129.66 170.37 13.88 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 110.058 -0.349 . . . . 0.57 110.058 179.758 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' O ' ' HE1' ' A' ' 67' ' ' HIS . 0.2 OUTLIER -156.71 171.01 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.231 0.539 . . . . 0.67 111.599 179.935 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.929 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -135.76 167.79 20.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.186 -1.412 . . . . 1.19 107.186 177.194 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' A' ' 31' ' ' ILE . . . 166.27 122.82 0.62 Allowed Glycine 0 C--O 1.226 -0.385 0 C-N-CA 118.495 -1.812 . . . . 1.29 115.304 178.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.72 158.4 17.52 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.107 -1.044 . . . . 1.61 113.484 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 m -64.74 147.09 12.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 120.555 0.217 . . . . 2.72 110.424 179.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -19.61 18.23 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.76 -0.733 . . . . 1.56 112.504 -178.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.653 ' HB2' ' HB3' ' B' ' 302' ' ' ARG . 8.0 p30 -134.85 15.72 3.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.853 0.461 . . . . 1.63 110.27 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -45.08 136.42 4.89 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 113.122 0.786 . . . . 2.34 113.122 -178.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.929 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 57.1 t60 -89.84 -25.41 21.05 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.567 -0.742 . . . . 0.92 111.329 179.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -149.98 133.27 8.54 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.405 -0.361 . . . . 1.51 110.803 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.79 124.05 12.19 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.691 2.261 . . . . 0.98 112.486 -179.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 116.14 -37.35 3.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.026 -0.607 . . . . 1.06 112.94 -179.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.2 118.3 24.02 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.908 0.385 . . . . 1.68 111.825 -179.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -82.13 20.08 1.08 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.776 -0.647 . . . . 2.11 111.648 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 63' ' ' GLU . 0.1 OUTLIER -69.53 -179.44 1.71 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.815 0.341 . . . . 1.39 111.094 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.752 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -100.3 118.2 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.181 -0.463 . . . . 0.8 110.324 178.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 20.8 m-85 -113.96 143.65 44.38 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 1.38 112.03 -179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.88 HG21 HD21 ' A' ' 48' ' ' LEU . 56.1 t -80.48 126.21 39.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.071 -0.513 . . . . 0.65 109.733 178.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.723 HG21 ' HB3' ' B' ' 303' ' ' GLU . 9.3 t -100.24 -26.76 13.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.763 1.023 . . . . 1.39 113.763 -177.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER -158.59 121.12 3.67 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.24 0.473 . . . . 2.54 112.152 -179.436 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 HG22 ' HB2' ' A' ' 43' ' ' HIS . 5.5 mt -96.05 118.63 42.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.445 -0.343 . . . . 1.4 110.708 178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.644 HD12 ' HA ' ' A' ' 14' ' ' PHE . 3.1 mp -79.64 113.07 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.329 -0.396 . . . . 1.68 111.439 -179.729 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -34.76 145.85 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.628 0.371 . . . . 3.11 111.56 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.94 11.34 66.4 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.183 -0.532 . . . . 3.15 113.497 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.49 169.51 30.31 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 121.016 -0.611 . . . . 2.8 113.214 -179.664 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 5' ' ' LEU . . . -47.99 -53.92 14.57 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.144 0.424 . . . . 3.0 112.144 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -64.99 -50.7 65.29 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.525 0.202 . . . . 1.82 111.079 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.406 ' HB2' HG22 ' A' ' 36' ' ' ILE . 57.1 t-80 -52.05 -48.59 64.53 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 1.39 111.201 179.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -64.56 -40.01 94.8 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 2.66 111.047 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -61.39 -51.42 68.83 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.319 -0.401 . . . . 3.24 110.788 179.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.23 -18.71 50.63 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.967 -0.635 . . . . 2.49 113.437 179.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.1 -34.36 56.83 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.064 0.432 . . . . 5.67 111.487 -179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.88 HD21 HG21 ' A' ' 33' ' ' VAL . 2.1 tt -88.68 125.45 34.85 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.944 0.402 . . . . 1.68 111.106 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -133.59 144.39 49.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.734 -0.666 . . . . 1.54 110.206 179.637 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 pp -46.86 122.76 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.695 0.283 . . . . 2.56 111.307 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.68 -22.48 8.19 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.146 -0.55 . . . . 1.1 113.367 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -66.36 157.04 32.83 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 117.72 0.76 . . . . 1.56 110.752 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.922 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.5 149.21 31.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.511 0.672 . . . . 3.23 111.638 -179.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.758 HD21 ' HG ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -102.83 104.23 14.48 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.071 -0.968 . . . . 1.72 111.654 -178.978 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' HB2' ' N ' ' A' ' 86' ' ' ALA . 1.7 tt -73.56 -49.36 26.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.13 -0.941 . . . . 1.87 110.122 179.392 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.29 32.32 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.409 0.522 . . . . 0.67 112.409 -179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.885 ' O ' HG22 ' A' ' 60' ' ' VAL . 95.8 t -133.67 108.72 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.061 -0.518 . . . . 1.47 110.866 179.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 62.1 47.9 5.39 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.355 -0.384 . . . . 1.49 111.579 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 82.31 -15.39 0.69 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.001 0.741 . . . . 1.74 113.001 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.885 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.5 m -93.62 148.34 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 117.912 0.324 . . . . 0.54 110.393 179.453 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p -85.78 130.04 34.67 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.785 -0.366 . . . . 0.72 110.635 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.752 ' O ' HD13 ' A' ' 31' ' ' ILE . 3.4 tp -102.03 33.85 2.91 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.177 -0.465 . . . . 1.71 111.722 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.699 ' HA ' ' HA ' ' A' ' 30' ' ' SER . 4.2 tt0 -123.96 -16.99 6.41 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.582 0.586 . . . . 1.96 112.582 -179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.12 38.64 3.77 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.761 0.315 . . . . 2.93 111.665 -179.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 15.6 m -138.49 158.32 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.058 0.456 . . . . 0.8 112.132 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -173.93 0.57 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.483 -0.781 . . . . 1.53 110.182 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB2' ' CG ' ' A' ' 22' ' ' ASN . 21.6 t60 -70.06 -39.72 75.5 Favored 'General case' 0 C--N 1.334 -0.094 0 C-N-CA 120.249 -0.58 . . . . 0.54 110.898 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -49.17 -47.94 45.45 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.748 0.309 . . . . 2.9 110.405 179.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 2.0 mp0 -65.36 -35.04 79.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.852 -0.613 . . . . 1.84 110.947 179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -59.09 -43.11 91.81 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.418 . . . . 0.44 110.852 178.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.68 HG13 HG12 ' B' ' 306' ' ' VAL . 43.0 t -80.16 -35.14 15.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.704 -0.68 . . . . 0.52 110.94 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 44.7 m -63.38 -39.99 96.01 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.61 111.218 179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 62' ' ' LEU . . . -74.67 -37.41 62.69 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.647 -0.251 . . . . 0.41 111.148 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.729 HD23 ' O ' ' A' ' 70' ' ' ALA . 4.0 mm? -69.05 -34.58 75.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.202 0.525 . . . . 1.73 109.635 178.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -83.77 -15.99 46.41 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.159 -0.928 . . . . 1.44 112.026 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -80.9 60.71 4.23 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.023 0.44 . . . . 1.55 111.141 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 81' ' ' VAL . 41.3 p -120.74 117.15 26.72 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.078 -0.51 . . . . 2.6 111.074 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.8 m -91.2 -85.56 0.23 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.107 -0.497 . . . . 3.36 110.389 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.26 -42.91 6.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.671 0.272 . . . . 2.23 110.405 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.427 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -130.49 169.53 15.42 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.735 179.566 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.549 HG13 ' HB2' ' A' ' 5' ' ' LEU . 5.5 p -142.14 120.68 8.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 109.98 -0.378 . . . . 1.58 109.98 178.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -97.22 99.19 10.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.239 0.542 . . . . 1.72 110.787 -179.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.758 ' HG ' HD21 ' A' ' 54' ' ' LEU . 4.8 tt -88.15 129.4 35.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.214 -0.903 . . . . 1.38 112.204 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -117.43 136.65 53.04 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.646 -0.706 . . . . 1.56 109.778 178.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 53' ' ' LYS . 91.9 t -121.76 139.32 49.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.905 0.384 . . . . 1.92 111.568 -179.167 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.522 ' N ' ' HB2' ' A' ' 55' ' ' LEU . . . -89.69 146.33 24.6 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.921 -0.581 . . . . 1.46 111.221 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -92.22 118.41 68.12 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 116.326 -0.397 . . . . 4.2 110.89 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.54 156.81 62.9 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.576 2.184 . . . . 2.28 112.356 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.9 m -135.99 146.92 47.73 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.146 -0.479 . . . . 3.88 111.12 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.36 130.89 2.18 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.952 -0.642 . . . . 4.69 112.763 179.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p -79.14 -35.59 41.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.459 0.171 . . . . 7.06 111.235 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 120.848 0.356 . . . . 7.84 111.008 -179.948 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 120.8 0.334 . . . . 4.22 111.198 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.653 ' HB3' ' HB2' ' A' ' 22' ' ' ASN . 9.1 ttm-85 -149.74 121.04 7.84 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.103 -0.498 . . . . 3.57 110.547 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.903 ' HG3' ' HB2' ' A' ' 17' ' ' ALA . 1.2 mp0 -114.53 148.39 38.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.97 -0.559 . . . . 2.08 111.044 -179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.49 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.8 OUTLIER -144.37 143.25 30.85 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.217 -0.447 . . . . 0.65 110.96 179.985 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 22.9 mt-30 -73.89 153.12 39.98 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.21 -0.45 . . . . 1.67 110.999 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.68 HG12 HG13 ' A' ' 71' ' ' VAL . 11.2 m . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.123 -0.941 . . . . 1.47 111.386 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 120.859 0.361 . . . . 3.17 111.628 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.455 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -78.17 157.77 29.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.002 -0.544 . . . . 1.97 111.242 179.804 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG12 ' HD3' ' A' ' 47' ' ' LYS . 6.0 mt -139.6 139.91 37.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.552 -0.536 . . . . 1.34 109.552 179.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.605 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 4.4 tptt -103.89 90.69 3.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.226 0.536 . . . . 2.93 110.762 179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 81' ' ' VAL . 12.4 mt -100.04 131.02 46.25 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.197 -0.91 . . . . 2.09 112.13 -178.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.475 ' HB ' ' CZ ' ' A' ' 80' ' ' PHE . 17.2 tt -89.61 128.96 41.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.765 -0.652 . . . . 1.94 110.64 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -58.84 121.75 11.9 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.459 -0.337 . . . . 3.1 111.351 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.33 -149.88 17.46 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-N 115.842 -0.617 . . . . 1.78 112.212 179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.68 -77.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.591 2.194 . . . . 2.77 111.555 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -60.73 -65.83 0.63 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.525 0.202 . . . . 4.92 110.618 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.79 -103.92 0.24 Allowed Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.588 -0.815 . . . . 2.3 113.482 179.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.564 HD23 HD12 ' A' ' 74' ' ' LEU . 1.9 mp -87.35 -46.32 9.77 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.074 0.398 . . . . 5.7 112.074 -178.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' O ' ' HB ' ' A' ' 37' ' ' ILE . . . 78.4 40.36 19.54 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.787 -0.72 . . . . 1.13 113.012 -179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.544 ' CE2' ' HB3' ' A' ' 12' ' ' LEU . 9.9 p90 -163.81 -173.38 3.21 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 110.146 -0.316 . . . . 1.46 110.146 179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.597 ' HA ' ' HA ' ' B' ' 305' ' ' GLN . 0.6 OUTLIER -128.41 172.93 10.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.745 0.307 . . . . 0.57 110.304 179.573 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -156.84 171.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.67 110.802 179.676 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.057 ' HB3' ' HB2' ' A' ' 24' ' ' HIS . . . -137.87 166.81 23.1 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.073 -1.454 . . . . 1.19 107.073 177.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 31' ' ' ILE . . . 165.88 129.62 1.07 Allowed Glycine 0 C--O 1.227 -0.337 0 C-N-CA 118.138 -1.982 . . . . 1.29 115.459 179.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 66' ' ' THR . . . 105.56 160.31 23.05 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 120.433 -0.889 . . . . 1.61 113.816 177.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.48 141.5 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 120.543 0.211 . . . . 2.72 110.529 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.8 -21.59 7.55 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.843 -0.694 . . . . 1.56 112.76 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' B' ' 302' ' ' ARG . 0.2 OUTLIER -134.3 20.58 3.69 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.743 0.417 . . . . 1.63 110.636 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.38 149.4 38.42 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.683 0.623 . . . . 2.34 112.683 -178.745 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 1.057 ' HB2' ' HB3' ' A' ' 17' ' ' ALA . 62.0 t60 -89.58 -22.01 22.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.132 -0.94 . . . . 0.92 112.832 -178.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 32' ' ' TYR . 14.0 mt -149.13 130.17 7.1 Favored Pre-proline 0 CA--C 1.53 0.189 0 C-N-CA 121.163 -0.215 . . . . 1.51 111.362 -179.027 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.57 124.75 15.93 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.775 2.317 . . . . 0.98 112.265 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.93 -53.1 0.82 Allowed Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.961 -0.637 . . . . 1.06 112.515 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.57 111.73 23.59 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.659 0.266 . . . . 1.68 110.832 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -90.17 16.94 7.63 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.392 -0.367 . . . . 2.11 111.689 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -69.91 -179.06 1.73 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.617 0.246 . . . . 1.39 110.451 179.049 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.65 HD13 ' O ' ' A' ' 62' ' ' LEU . 1.7 mp -96.89 117.09 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.481 -0.488 . . . . 0.8 110.709 178.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 53' ' ' LYS . 24.5 m-85 -117.59 145.96 43.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.471 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD21 ' A' ' 48' ' ' LEU . 49.9 t -71.24 140.86 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.196 -0.456 . . . . 0.65 110.129 178.465 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.598 HG21 ' HB3' ' B' ' 303' ' ' GLU . 0.4 OUTLIER -112.33 -34.34 5.92 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.005 0.743 . . . . 1.39 113.005 -178.227 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG ' ' A' ' 15' ' ' SER . 58.4 mmtt -157.93 120.18 3.74 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.557 0.218 . . . . 2.54 111.397 -179.413 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.631 HG22 ' HB2' ' A' ' 43' ' ' HIS . 4.4 mt -95.16 118.04 40.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.665 0.269 . . . . 1.4 110.612 179.082 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.3 mp -74.9 144.61 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.361 -0.381 . . . . 1.68 111.046 -179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -58.32 144.5 41.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.3 -0.409 . . . . 3.11 110.956 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.74 22.17 56.56 Favored Glycine 0 CA--C 1.523 0.545 0 C-N-CA 121.227 -0.511 . . . . 3.15 113.465 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.63 168.17 32.94 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.033 -0.603 . . . . 2.8 112.727 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 5' ' ' LEU . . . -48.04 -53.29 16.83 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 111.751 0.278 . . . . 3.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 48' ' ' LEU . . . -69.85 -51.16 35.75 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.702 -0.226 . . . . 1.82 111.19 179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.631 ' HB2' HG22 ' A' ' 36' ' ' ILE . 59.2 t-80 -49.28 -46.53 46.51 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.314 -0.403 . . . . 1.39 111.383 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.34 -36.6 71.59 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.262 -0.426 . . . . 2.66 111.454 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -63.26 -53.41 53.42 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.609 -0.269 . . . . 3.24 111.129 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.77 -25.33 23.94 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.013 -0.613 . . . . 2.49 113.171 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' HG12 ' A' ' 3' ' ' ILE . 52.1 mttt -67.99 -38.37 82.59 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.949 0.374 . . . . 5.67 111.262 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.012 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 tt -89.45 124.49 34.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.875 0.369 . . . . 1.68 111.445 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -131.27 143.58 50.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.761 -0.654 . . . . 1.54 110.239 179.264 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 pp -47.15 124.37 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.619 0.247 . . . . 2.56 111.398 -179.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.9 -21.87 8.24 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.251 -0.499 . . . . 1.1 113.183 -179.353 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -70.43 158.64 35.65 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 117.592 0.696 . . . . 1.56 110.676 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.889 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -111.78 148.06 34.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.418 0.628 . . . . 3.23 111.372 179.588 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -94.41 102.52 14.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.122 -0.945 . . . . 1.72 111.451 -179.38 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 40.3 tp -68.73 -51.05 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.166 -0.924 . . . . 1.87 109.95 179.141 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 84' ' ' LYS . . . -151.6 153.07 33.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.034 0.445 . . . . 0.67 112.089 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.818 ' O ' HG22 ' A' ' 60' ' ' VAL . 66.6 t -129.23 105.84 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.098 -0.501 . . . . 1.47 110.971 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 12.2 m120 60.46 48.84 7.29 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.184 -0.462 . . . . 1.49 111.659 179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 58' ' ' ASN . 4.4 t30 84.94 -18.08 0.41 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 57' ' ' VAL . 2.8 m -91.39 150.51 3.75 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 CA-C-N 117.909 0.322 . . . . 0.54 110.262 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.8 p -88.3 128.29 35.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.84 0.352 . . . . 0.72 110.709 179.682 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.795 HD22 ' CG2' ' A' ' 57' ' ' VAL . 4.7 tp -102.55 31.52 4.04 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 116.07 -0.514 . . . . 1.71 111.442 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.33 -19.5 11.72 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.239 0.459 . . . . 1.96 112.239 -178.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.16 45.3 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.801 0.334 . . . . 2.93 111.563 -179.624 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 69' ' ' GLU . 17.2 m -138.63 157.69 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.29 0.478 . . . . 0.8 112.29 -179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -69.69 -169.72 0.26 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.428 -0.805 . . . . 1.53 109.745 178.724 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.533 ' CE1' ' HA ' ' A' ' 17' ' ' ALA . 15.1 t60 -75.84 -38.71 57.79 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.137 -0.625 . . . . 0.54 110.409 179.324 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.2 -44.59 61.62 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 110.333 -0.247 . . . . 2.9 110.333 179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' CB ' ' HB ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -69.1 -35.42 76.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.402 -0.363 . . . . 1.84 110.471 178.843 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.58 ' O ' HD23 ' A' ' 74' ' ' LEU . . . -58.06 -44.15 87.33 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.197 0.522 . . . . 0.44 110.703 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.678 HG13 HG12 ' B' ' 306' ' ' VAL . 46.6 t -80.79 -34.75 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.656 -0.702 . . . . 0.52 111.335 179.328 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.0 m -62.53 -38.33 89.58 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.555 -0.293 . . . . 0.61 110.987 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.54 52.91 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.609 -0.268 . . . . 0.41 111.026 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -72.56 -30.35 64.35 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.061 -0.348 . . . . 1.73 110.061 178.747 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.632 ' HD2' HG12 ' A' ' 71' ' ' VAL . 9.1 ptmt -90.11 -18.92 24.97 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.919 -0.582 . . . . 1.44 111.97 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -56.84 -27.18 59.79 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.85 0.315 . . . . 1.55 111.85 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.693 HG22 ' HB ' ' A' ' 81' ' ' VAL . 70.2 p -33.54 122.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.484 0.55 . . . . 2.6 112.484 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.0 m -105.9 -88.31 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.641 -0.709 . . . . 3.36 110.269 179.51 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -89.81 -48.81 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.591 -0.522 . . . . 2.23 109.591 178.716 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.605 ' CE2' ' HG3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -129.7 172.47 11.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.54 -0.754 . . . . 1.77 109.852 178.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.693 ' HB ' HG22 ' A' ' 77' ' ' THR . 3.6 p -141.76 119.64 8.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.931 0.396 . . . . 1.58 110.427 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -101.38 98.83 9.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.72 110.135 179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.445 ' CD1' HD21 ' A' ' 54' ' ' LEU . 3.8 tp -85.35 130.33 34.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.135 -0.938 . . . . 1.38 111.761 -178.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 3.0 mmpt? -113.22 110.62 20.7 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.692 -0.685 . . . . 1.56 109.338 178.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.889 HG13 ' O ' ' A' ' 53' ' ' LYS . 39.7 t -108.67 133.57 53.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.454 -0.339 . . . . 1.92 111.157 -178.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.666 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . . . -90.35 148.47 22.82 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.109 -0.496 . . . . 1.46 111.046 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.82 125.53 35.3 Favored Pre-proline 0 CA--C 1.53 0.207 0 CA-C-N 116.28 -0.418 . . . . 4.2 110.645 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.22 144.51 95.66 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.617 2.211 . . . . 2.28 112.236 -179.825 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.61 100.44 0.58 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.234 -0.439 . . . . 3.88 110.537 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -58.18 129.68 49.92 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.069 -0.586 . . . . 4.69 112.934 -179.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 m -90.74 -33.68 15.65 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.533 0.206 . . . . 7.06 111.021 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-N 116.378 -0.373 . . . . 7.84 111.186 179.979 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 301' ' ' ARG . . . . . . . . . . . . . 9.2 mtm-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 111.925 0.343 . . . . 4.22 111.925 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 302' ' ' ARG . . . . . 0.444 ' HD2' ' HB3' ' A' ' 22' ' ' ASN . 18.5 ttm180 59.57 86.79 0.09 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.999 0.428 . . . . 3.57 111.243 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 303' ' ' GLU . . . . . 0.598 ' HB3' HG21 ' A' ' 34' ' ' THR . 3.1 mt-10 -113.5 123.3 49.68 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.924 -0.58 . . . . 2.08 110.573 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 304' ' ' THR . . . . . 0.485 ' HB ' ' NE2' ' A' ' 67' ' ' HIS . 0.9 OUTLIER -116.92 151.03 37.5 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.349 -0.387 . . . . 0.65 111.635 -179.249 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 305' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 17.8 mt-30 -84.42 156.88 21.59 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.002 -0.545 . . . . 1.67 111.013 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.678 HG12 HG13 ' A' ' 71' ' ' VAL . 15.8 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.099 -0.953 . . . . 1.47 111.805 -179.559 . . . . . . . . 1 1 . 1 stop_ save_